Tun yaushe waɗannan alamun ke ci gaba?
kuma duk ciwon kirji ya kamata a bi da shi ta wannan hanyar musamman da shekarunka
kuma tare da zazzabi
kuma kuma yana bukatar a duba karfin jini na cholesterol
kuma kana da zazzabi yanzu?
Kuma kana da wannan ciwon kirji yanzu?
Kuma bã zã ku yi jinkirin numfashi ba?
kuma za ka iya gaya mini abin da sauran alamun kana da tare da wannan?
kuma yaya zafin jikinka ya kasance
kuma ina da tari ma
kuma ina da ɗan sanyi da tari
kuma ina da gaske ina da wani mummunan ciwo a kirji a yau
Kuma shin wannan lokaci ne da ya dace da zafin hay ɗinka?
kuma yana samun ciwon kirji
kuma ina ganin ina da ɗan zazzabi
kuma ina so ka bayyana inda ciwon kirji yake
kuma suna da zazzabi kuma
da kuma tarihin ciwon sukari
kuma ka san cewa ina jin kamar kirji na zai yi kama da
kuma ka san mutane suna tari a kaina a duk lokacin
kuma kuna da ciwon kirji
kuma ka ce wannan shi ne matsa lamba a kirjinku
kowa a cikin iyali yana da matsalar zuciya cututtukan zuciya ciwon zuciya ciwon zuciya high cholesterol high jini
wasu cututtuka ko matsalolin da kake lura da su a cikin jijiyoyin jijiyoyin?
Shin akwai wasu mutane marasa lafiya a gida da ke da cututtukan da kuke da su?
Shin kana da wasu alamun cututtuka?
Shin kana da wani rashin numfashi?
har yanzu kana da ciwon kirji
domin wannan lokacin zazzabin cizon sauro ne
amma kuma kada a bar mu a gefe don ciwon zuciya na zuciya
amma matsalar da ta fi muhimmanci yanzu ita ce wannan ciwon kirji
amma ina da wahalar numfashi
amma na san mutane da yawa suna tari a kaina
amma dole ne mu bi da kowane ciwon kirji da matuƙar tsanani
amma kuna numfashi daidai a yanzu, dama?
Saboda wannan ciwon kirji na manta da shi gaba daya
Shin kana jin kamar wani yana matsa maka kirji
har yanzu ina jin kamar rashin numfashi
suna gunaguni game da rashin lafiya da irin waɗannan cututtukan?
Shin kana da wani abu na kullum kamar hawan jini ko wani abu makamancin haka?
kana da wasu cututtuka masu tsanani kamar ciwon sukari?
Shin kana da wani rashin numfashi tare da wannan ciwon kirji?
kana da hawan jini?
Shin kana da rashin numfashi da ke tattare da hakan?
Ka san irin alamun da take da shi?
Ka ga hoton?
sha ruwa mai yawa a yau
Duk da haka ina yin gwaje-gwaje na ciwon sukari
Duk da haka tana da alamun da suka yi kama da na
Yaya zafin jikinka yake?
Yaya jini yake?
idan ka ci gaba da samun zazzabi mai yawa
idan kuna da zazzabi mai ɗari biyu ko fiye
idan ka yi tunanin cewa alamun ka ko kuma matsalolin ka na bukatar ka duba shi da kyau
Na yi zazzabi jiya
Ni ma ina da zazzabi mai tsanani
Na yi zazzabi jiya
Ina da ciwo mai zafi a cikin kirji
Ni ma ina da wahalar numfashi
Zan aiko maka da hoto
Ina da ciwon kirji a yau
Ina da ciwon kai da zazzabi a yau
a ganina, shi ne mura
A ganina wannan karamin mura ne
Shin kamar wani mutum ne mai nauyi da ke zaune a kirjinka?
Dukkanin ya fara ne da ciwon kai da kuma zazzabi a lokaci guda
Yana ciwo a tsakiyar kirji na
Yana da matsa lamba kamar ciwon kirji
Yana cikin kirji na
Yana tsakiyar kirji na
Yana tsakiyar kirji
Ina jin zafi a kirji
Na damu sosai game da wannan ciwon kirji
Ina so ka gaya mani a cikin bayanin wannan ciwon kirji
kamar hawan jini ko ciwon sukari
kamar a tsakiyar kirji
yanzu don zazzabi za ka iya shan tachipirina mai dadi
Mary, kwana nawa ka sha da cututtukan?
Yanzu ka ce kana da ciwon kirji
Wani lokaci ina jin zafi a kirji
ko kana da wasu alamun bayyanar cututtuka tare da wannan banda kawai ciwo
ko wani da yake zaune a kirjinka?
kusan iri ɗaya ne da zazzabi da ciwon kai da ciwon tsoka
a tsakiyar kirji na
nuna min a wannan hoton inda ka ji zafi
tun da kuna da zazzabi
Don haka kuna ganin cewa wasu daga cikin wadannan cututtuka na iya danganta da yin ciki?
Shin yaranku suna da irin wannan alamun?
Faɗa mini game da ciwon kirjinka
zazzabi ya ƙaru da dare
zazzabin da na sha a cikin kwanaki biyu da suka gabata
Jigogi ya fara ƙaruwa a daren jiya
Wannan shi ne Dr. Porter a cikin dakin gaggawa triage cibiyar
Za ka iya gaya mini kadan game da ciwon kirjinka?
Na ji zafi a gaban jikina a nan a kirji
Na ji zafi sosai a kirji
To, idan ina da wannan ciwo a kirji
wane irin ciwo kake da shi a kirjinka?
a lokacin da wannan ciwon kirji ya fara?
ina kake da ciwon kirji?
inda ka ji wannan ciwon kirji eel wannan kirji t
kana jin kamar ka matsa a kirjinka
Ka san ina da ciwon sukari da irin wannan abu
Ka ce kana da wannan ciwon kirji
Saurin karuwar cutar coronavirus (COVID-19) a cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai da Ingila, daga 1 ga Janairu zuwa 15 ga Maris, 2020
Kasuwancin cutar coronavirus (COVID-19) na nuna irin wannan yanayin a cikin ƙasashen Tarayyar Turai / Yankin Tattalin Arzikin Turai da Burtaniya wanda ke tabbatar da cewa, yayin da a wani mataki daban-daban dangane da ƙasa, cutar COVID-19 tana ci gaba da sauri a duk ƙasashe.
Dangane da gogewar Italiya, ƙasashe, asibitoci da raka'a masu kulawa mai tsanani ya kamata su kara shirye-shiryen su don karuwar marasa lafiya da ke fama da COVID-19 waɗanda za su buƙaci kula da lafiya, musamman ma kula da gaggawa.
A ranar 31 ga Disamba, 2019, an ruwaito wani rukuni na cututtukan huhu na rashin sani a Wuhan, lardin Hubei, China.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta kasar Sin ta ba da rahoton cewa mai haifar da cutar shine sabon coronavirus wanda yanzu ake kira mawuyacin cututtukan numfashi na coronavirus 2 (SARS-CoV-2).
Tun daga wannan lokacin, cutar da ta haifar da kamuwa da cutar SARS-CoV-2 an kira ta cutar coronavirus (COVID-19).
Shaidar zuwa yau ita ce kusan 80% na mutanen da ke da COVID-19 suna da wata cuta mai sauƙi, watau kamuwa da cutar tasowa tare da ko ba tare da cutar huhu ba, kuma yawancin waɗannan suna murmurewa.
A kusan kashi 14% na shari'o'in, COVID-19 ya zama mummunan cuta wanda ke buƙatar asibiti yayin da sauran 6% na shari'o'in ke fuskantar mummunan cuta da ke buƙatar kulawa mai tsanani.
Yawan marasa lafiya da aka kwantar a asibiti saboda COVID-19 kusan kashi 4 ne.
A cikin wannan binciken, mun kimanta yanayin yawan kamuwa da COVID-19 a kowace ƙasa ta Tarayyar Turai / Yankin Tattalin Arzikin Turai (EU / EEA) da Burtaniya (UK) kuma mun kwatanta su da na lardin Hubei, China.
Mun kuma kwatanta adadin shari'o'in COVID-19 na yanzu a cikin ƙasashen EU / EEA da Burtaniya da na Italiya a ranar 31 ga Janairu15 ga Maris 2020.
Maganganun COVID-19 a ƙasashen EU / EEA da Burtaniya
Bayan China, COVID-19 ta ci gaba da yaduwar ƙasa kuma motsin zuciyar cutar COVID-19 a sauran duniya a halin yanzu yana bin wannan ƙasar.
A ranar 11 ga Maris, 2020, Babban Daraktan Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin batun 5 ga Maris na Eurosurveillance 2020, Spiteri et al. sun ba da rahoton farkon mutanen Turai da aka tabbatar da cutar COVID-19 bisa ga ma'anar yanayin WHO.
A cikin EU/EEA, Faransa ta ba da rahoton farkon cututtuka uku na farko a ranar 24 ga Janairu 2020 a cikin mutanen da suka dawo daga Wuhan, lardin Hubei, China.
Ya zuwa 15 ga Maris, 2020, an gano shari'o'in COVID-19 a duk ƙasashen EU / EEA 30 da Burtaniya (UK), wanda tsakanin 31 ga Disamba, 2019 zuwa wannan ranar, an ba da rahoton shari'o'i 39,768 da mutuwar 1,727, tare da shari'o'i 17,750 da mutuwar 1,441 daga Italiya kawai.
Samun adadin da aka samu na kamuwa da cutar COVID-19
A Cibiyar Tarayya ta Turai don Rigakafin Cututtuka da Kulawa (ECDC), an sabunta adadin shari'o'in COVID-19 da aka sanar a kowace ƙasa a duniya, wanda aka samo daga tushe na hukuma kawai kamar su ƙasashe  Ma'aikatar Lafiya, hukumomin kiwon lafiya na ƙasa da na yanki da WHO, kowace rana a karfe 8:00 na safe.
An yi amfani da waɗannan bayanan don kimanta yanayin COVID-19 a cikin EU / EEA da Burtaniya, da kuma kwatanta su da na Italiya.
A matsayin wakilcin yaduwar shari'o'in COVID-19 masu aiki, mun lissafa raguwar kwanaki 14 na yawan cututtukan COVID-19, don haka muna la'akari da yanayin yanayin COVID-19, a kowace ƙasar EU / EEA da Burtaniya, a lokacin 1 ga Janairu zuwa 15 ga Maris 2020.
Mun kuma gabatar da jimlar adadin shari'o'in da aka sanar a kowace ƙasa a ranar 15 ga Maris, 2020 da karfe 8:00 na safe idan aka kwatanta da na Italiya don lokacin 31 ga Janairu15 ga Maris, 2020.
Hanyoyin COVID-19 a ƙasashen EU / EEA da Burtaniya
Hanyoyin da aka rage yawan cututtukan COVID-19 na kwanaki 14 a cikin ƙasashen EU / EEA da Burtaniya gabaɗaya sun bi na lardin Hubei (China) (Figure 1).
Ga EU/EEA da Burtaniya gabaɗaya, jimlar cutar COVID-19 ta fara ƙaruwa a kusa da ranar 21 ga Fabrairu sannan ta ƙaru sosai a kusa da ranar 28 ga Fabrairu 2020 (Kayan ƙarin).
Wannan yafi haifar da saurin karuwar adadin shari'o'in da aka ruwaito daga Italiya, amma duk sauran ƙasashen EU / EEA da Burtaniya sun nuna irin wannan haɓaka yanayin yawan cutar COVID-19 (Kayan kari).
Hoton 2 ya nuna jimlar adadin masu kamuwa da COVID-19, a cikin ƙasashen EU / EEA da Burtaniya idan aka kwatanta da na Italiya a cikin 31 Janairu15 Maris 2020.
Ya nuna cewa, a ranar 15 ga Maris da karfe 8:00 na safe, wasu ƙasashen EU/EEA 15 da Birtaniya sun riga sun ba da rahoton adadin adadin shari'o'i da aka kwatanta da na Italiya makonni 3 kawai da suka gabata ko kuma ƙasa da haka.
Sakamakonmu ya nuna cewa adadin mutanen da aka sanar da cutar COVID-19 suna ƙaruwa cikin sauri a cikin EU / EEA da Burtaniya.
Hanyoyin da aka lura a cikin yawan cutar COVID-19 sun nuna cewa annobar tana ci gaba da sauri a duk ƙasashe.
Wannan duk da cewa kasashe suna cikin matakai daban-daban, bambance-bambance a cikin martani na lafiyar jama'a na ƙasa, kuma wataƙila ma'anar shari'o'i daban-daban a cikin ƙasashe da ladabi daban-daban don zaɓar marasa lafiya waɗanda dole ne a gwada su don tabbatar da COVID-19, gami da gwajin kamawa.
A farkon Maris 2020, likitoci a yankunan da cutar ta shafa na Italiya sun bayyana halin da ake ciki inda kusan kashi 10% na marasa lafiya da ke fama da COVID-19 ke buƙatar kulawa mai tsanani kuma kafofin watsa labarai sun ba da rahoton cewa asibitoci da raka'a masu kulawa mai tsanani a waɗannan yankuna sun riga sun kai iyakar ƙarfin su.
Bayanai game da shigar da shari'o'in COVID-19 a asibiti da/ko na'urar kulawa mai tsanani a halin yanzu suna samuwa a matakin EU / EEA don kashi 6% da 1% na shari'o'in, bi da bi (ba a nuna bayanai ba).
Duk da haka, ya kamata a tattara su a cikin tsari don a cika bayanan sa ido na yanzu wanda ke mai da hankali kan yawan shari'o'in da aka ruwaito da kuma yawan mutuwar.
Wani binciken da aka gudanar a 201011 ya nuna bambancin da ke tsakanin wuraren da ake kula da marasa lafiya a Turai, daga 29.2 a Jamus zuwa 4.2 a kowace 100,000 a Portugal.
Wannan yana nufin cewa ƙasashe na iya samun albarkatu fiye da Italiya (12.5 wuraren kula da gaggawa da wuraren kula da matsakaici a kowace 100,000 mutane a 201011).
Ana ba da yanayin samfurin da ya shafi ƙoshin lafiyar lafiyar, tare da kimantawa ga kowace ƙasa ta EU / EEA da Burtaniya na yaduwar shari'o'in COVID-19 da aka kwantar a asibiti tare da haɗarin 90% na wucewa ƙarfin gado na kulawa mai tsanani, a cikin sabuntawa ta shida na ECDC mai saurin kimanta haɗari akan COVID-19.
Tun da har yanzu akwai wasu cututtuka a wasu yankuna a cikin kasashen EU/EEA da Birtaniya, kuma asibitoci da wuraren kula da gaggawa sukan yi wa wani yanki da aka ƙayyade yawan mutanen da ke cikin wuraren kula da gaggawa, ya kamata a ba da bayani game da cututtuka da wuraren kula da gaggawa a Nomenclature na yankunan yankuna don kididdiga 2 (NUTS-2).
Kwarewar Italiya da yanayin yanzu a wasu ƙasashe sun nuna cewa annobar COVID-19 tana ci gaba cikin sauri a cikin EU / EEA da Burtaniya.
Saboda haka, kasashe, asibitoci da raka'a masu kulawa da gaggawa ya kamata su shirya kansu don yanayin ci gaba da watsawar SARS-CoV-2 a cikin al'umma da kuma karuwar yawan marasa lafiya da ke fama da COVID-19 da ke buƙatar kula da lafiya, musamman ma kula da gaggawa, kamar wanda ke faruwa a yankunan da cutar ta shafa na Italiya.
Kamar yadda aka nuna a cikin binciken ECDC na kwanan nan, hanzari, mai aiki da kuma cikakkiyar hanya tana da mahimmanci don jinkirta yaduwar SARS-COV-2, tare da sauyawa daga hanyar hanawa zuwa hanyar ragewa, saboda tsammanin ƙaruwa mai sauri a cikin adadin shari'o'in na iya ba masu yanke shawara da asibitoci isasshen lokaci don fahimtar, karɓa da daidaita amsar su daidai idan ba a aiwatar da su ba a gaba.
A cikin saurin kimanta hadarin kuma an lissafa matakan kiwon lafiyar jama'a don rage tasirin cutar.
Akwai gajeren lokacin da ƙasashe za su iya ƙara haɓaka ƙoƙarin sarrafa su don rage yaduwar SARS-CoV-2 da rage matsin lamba akan kiwon lafiya.
Idan hakan bai faru ba, zai yiwu a samu karuwar marasa lafiya a cikin sauran kasashen EU/EEA da ke bukatar kulawa mai tsanani a cikin kwanaki ko makonni masu zuwa.
Cutar cutar Coronavirus 2019 (COVID-19), wanda cutar ta Coronavirus 2 (SARS-CoV-2), ta haifar da ta kashe mutane sama da 3,000 kuma ta kamu da fiye da 80,000 a China da sauran wurare a duniya, wanda ya haifar da bala'i ga mutane.
Kamar cutar ta homologous, SARS-CoV, wanda ya haifar da SARS a dubban mutane a 2003, SARS-CoV-2 na iya watsawa daga bats kuma yana haifar da irin waɗannan alamun ta hanyar irin wannan tsari.
Koyaya, COVID-19 yana da ƙarancin tsanani da mutuwa fiye da SARS amma yana da yawa fiye da watsawa kuma yana shafar tsofaffi fiye da matasa da maza fiye da mata.
Domin yawan littattafai da ake wallafawa game da wannan cuta da ke tasowa, wannan talifin yana ƙoƙarin ya ba da cikakken bayani game da batun bincike da ke ci gaba da sauri.
Za mu tattauna abubuwan da suka shafi cututtukan cututtuka, cututtuka, cututtuka, ganewar asali, magani, da kuma rigakafin cutar.
Ko da yake har yanzu ana bukatar amsoshin tambayoyi da yawa, muna fata wannan bita zai taimaka mana mu fahimci kuma mu kawar da wannan cuta mai barazana.
Bikin bazara a ranar 25 ga Janairu, 2020 ya zama abin tunawa da ba a taɓa gani ba ga duk Sinawa waɗanda aka bukaci su zauna a gida a duk lokacin hutu da makonni da yawa bayan haka saboda barkewar sabon cutar kwayar cuta.
Kwayar cutar tana da kamanceceniya da cutar coronavirus (CoV) wacce ta haifar da barkewar cutar ta hanyar numfashi mai tsanani (SARS) a cikin 2003; saboda haka, an sanya masa sunan SARS-CoV-2 ta Hukumar Lafiya ta Duniya (WHO) a ranar 11 ga Fabrairu, 2020, kuma cutar da ke tattare da ita an sanya masa sunan cutar COVID-19 (COVID-19).
Cutar ta fara ne a birnin Wuhan na kasar Sin, kuma da sauri ta bazu a duk kasar da kuma kusan mutane 50 a duniya.
Ya zuwa ranar 2 ga Maris, 2020, cutar ta haifar da fiye da mutane 80,000 da aka tabbatar da cutar COVID-19, tare da marasa lafiya sama da 40,000 da aka sallami da marasa lafiya sama da 3,000 da suka mutu.
WHO ta yi gargadin cewa COVID-19 ita ce maƙiyi na jama'a na 1 kuma yana da ƙarfi fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga takardu sama da 200 akan COVID-19 gami da ƙwayoyin cuta, cututtukan cututtuka, ilimin halayyar cututtuka, bincike, da magani tun daga rahoton farko a ranar 7 ga Janairu, 2020 wanda ya ƙayyade jerin ƙwayoyin cuta da aka keɓe daga marasa lafiya da yawa.
Wannan bita yana ƙoƙarin taƙaita ci gaban bincike a cikin sabon kuma da sauri ci gaban batun.
A duk lokacin da zai yiwu, za mu yi kokarin kwatanta COVID-19 da SARS da wani cuta da COVID ta haifar, ciwon huhu na Gabas ta Tsakiya (MERS, annobar a shekarar 2012).
Za mu kuma tattauna abin da muka koya game da hana cutar da kuma yadda za a yi ta a gaba, da kuma wasu tambayoyi da suka rage da suke da muhimmanci.
An yi la'akari da CoVs a matsayin masu cutar da ba su da cutar ga mutane, kuma sun fi haifar da kimanin kashi 15% na yawan sanyi 4.
Duk da haka, a wannan karni, mun haɗu da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Saboda haka, COVID-19 na yanzu shine barkewar COVID-19 ta uku a tarihin ɗan adam.
Kamar yadda aka nuna a Fig. Fig.1,1, an fara bayar da rahoton tarin cututtukan huhu da ba a san asalin su ba daga Wuhan a ranar 31 ga Disamba, 2019 ga Hukumar Lafiya ta Kasa ta China.
Bayan kwana bakwai aka saki jerin abubuwan da suka faru.
A ranar 15 ga Janairu, 2020, an bayar da rahoton mutuwar farko daga Wuhan.
A lokacin, annobar ta bazu cikin sauri zuwa biranen da ke kusa da birnin, larduna, da kuma ƙasashe.
A ranar 20 ga Janairu, an ruwaito cewa an kamu da cutar a wurin masu kula da lafiya, wanda ya nuna cewa ana iya kamuwa da cutar daga mutum zuwa mutum.
A ranar 23 ga watan Janairu, an kulle birnin Wuhan tare da dakatar da duk hanyoyin sufuri na jama'a.
A ranar 24 ga Janairu binciken asibiti na farko kan cutar ya ba da rahoton cewa, daga cikin marasa lafiya 41 da aka tabbatar da cutar, 21 ne kawai suka yi hulɗa kai tsaye da kasuwar abincin teku ta Wuhan wanda aka ɗauka wuri ne na fara kamuwa da cutar daga asalin dabba da ba a sani ba.
A ranar 30 ga Janairu, WHO ta bayyana barkewar cutar a matsayin gaggawa ga lafiyar duniya.
A lokacin da aka gabatar da wannan rahoton, cutar ta riga ta yada a duk ƙasar Sin da kuma kusan wasu ƙasashe 50 a duniya (Fig. (Fig.2).2).
Yayin da yanayin ke ci gaba da sauri, har yanzu ana bukatar a ƙayyade yadda cutar za ta iya faɗa da kuma yadda za ta yi tsanani.
A ranar 11 ga Fabrairu, 2020, wani binciken cibiyoyin da yawa akan marasa lafiya 8,866 ciki har da marasa lafiya 4,021 da aka tabbatar da COVID-19 sun gabatar da ƙarin sabuntaccen kwatancin annobar kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya kamu da mutane na kowane zamani, amma galibi a cikin shekaru 30-65.
Kusan rabin (47.7%) na mutanen da suka kamu da cutar sun fi shekaru 50, kaɗan ne kawai suka kai shekara 20, kuma mutane 14 ne kawai suka kamu da cutar suka kai shekaru 10.
SARS-CoV-2 ya kamu da maza da yawa (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ya faɗaɗa cikin rukuni galibi a cikin Hubei da kewaye da shi.
COVID-19 ya ɗauki matsakaici na kwanaki 5 (2-9) daga fara zuwa ganewar asali.
Matsakaicin lokacin incubacin ya kai kwanaki 4.8 (3.0-7.2).
Matsakaicin lokaci daga fara zuwa mutuwa ya kai kwanaki 9.5 (4.8-13).
Yawan haihuwa na asali (R0) ya kasance 3.77 (95% CI: 3.51- 4.05), kuma daidaitaccen R0 ya kasance 2.23-4.82.
Yawan mutanen da suka kamu da cutar ya karu sosai kafin 23 ga Janairu, 2020, daidai da lokacin jigilar kaya kafin bikin bazara a China.
Mutuwar marasa lafiya da aka tabbatar da cutar ta kasance 1.44% (95% CI: 1.10-1.86%), kuma daidaitaccen mutuwar dukkan marasa lafiya ya kasance 3.06% (95% CI: 2.02- 4. 59%).
Babban manyan abubuwan haɗari guda uku na COVID-19 sune jinsi (maza), shekaru (≥60) da kumburi mai tsanani.
CoVs wani rukuni ne na manyan kwayoyin cuta da ke dauke da nau'i guda na RNA na ji.
Ana iya raba su zuwa jinsuna huɗu, watau alpha, beta, gamma, da delta, daga cikinsu alpha- da beta-CoVs an san su suna kamuwa da mutane.
Glycoprotein na ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙu ƙuƙwalwar ƙuƙu ƙuƙwalwar ƙuƙu ƙuƙwalwar ƙuƙu ƙuƙwalwar ƙuƙu ƙuƙwalwar ƙuƙu ƙuƙwalwar ƙuƙu ƙuƙwalwar ƙuƙu ƙuƙwalwar ƙuƙu ƙuƙuƙu ƙuƙuƙu ƙuƙuƙu ƙuƙuƙu ƙuƙuƙu ƙuƙuƙu ƙuƙu ƙuƙuƙu ƙuƙu ƙuƙu ƙuƙu ƙuƙu ƙuƙu ƙuƙu ƙuƙu ƙu ƙuƙu ƙu ƙu ƙu ƙu ƙu ƙu ƙu ƙu ƙu ƙu ƙu ƙu ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ
An saki RNA na kwayar cutar zuwa cytoplasm; bayan kwayar kwayar cutar, RNA na genomic tare da glycoproteins da ƙwayoyin nucleocapsid sun kafa ƙwayoyin cuta masu dauke da virion, wanda daga baya ya haɗu da membrane na plasma don sakin cutar.
An ba da rahoton jerin kwayoyin halitta na farko na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano SARS-CoV-2 wani sabon nau'in beta-CoV ne tare da fiye da 99.98% na asalin kwayoyin halitta tsakanin samfuran 10 da aka tattara daga asalin wurin barkewar cutar, Kasuwar Kayayyakin Ruwa ta Huanan a Wuhan.
SARS-CoV-2 ta hanyar kwayoyin halitta ta fi kama da SARS-CoV fiye da MERS-CoV.
Ta hanyar daukar hoto na lantarki, an gano ƙwayoyin SARS-CoV-2 a cikin ƙananan sassan epithelium na hanyoyin numfashi na mutum.
An gano cewa ACE2 na mutum mai karɓar SARS-CoV-2 da SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 yana ɗaure da ACE2 na ɗan adam cikin rauni fiye da na SARS-CoV, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da kamuwa da cuta mai rauni a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 na iya kuma samar da sabon ɗan gajeren furotin da aka yi wa lambar ta orf3b da kuma furotin da aka ɓoye da aka yi wa lambar ta orf8.
Orf3b na SARS-CoV-2 na iya taka rawa a cikin cutar ta kwayar cuta kuma yana hana bayyana IFNβ; duk da haka, orf8 baya ƙunsar wani sanannen yanki ko dalili na aiki.
A ranar 18 ga Fabrairu, 2020, Zhou, da sauransu, sun ba da rahoton tsarin cryo-EM na cikakken tsawon ɗan adam ACE2 a ƙuduri 2.9 Å a cikin hadadden tare da mai jigilar amino acid B0AT1.
Sun gano cewa abin da ya faru, wanda ke da bayyanar bude da rufe, an haɗa shi a matsayin dimer kuma abin da ya faru na ACE2-B0AT1 zai iya ɗaure furotin S guda biyu, wanda ke ba da shaida ga ganewar CoV da kamuwa da cuta.
B0AT1 na iya zama manufa ta magani don binciken magunguna don hana kamuwa da cutar SARS-CoV-2.
Asalin da kuma mai masaukin baki
An san cewa SARS-CoV da MERS-CoV sun samo asali ne daga bats kuma an watsa su ga mutane ta hanyar cats da raƙuma, bi da bi.
Ta hanyar kwatancen phylogenetic na SARS-CoV-2 tare da sauran CoVs, an dauki bats a matsayin mai masaukin SARS-CoV-2 na asali saboda sabon kwayar cutar ta kasance 96% daidai da SARS-like CoVs biyu daga bats da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Duk da haka, ba a san ko wane matsakaici ne ya taimaka wa kwayar cutar ta ƙetare shinge na jinsin don ta kamu da mutane ba, kuma har yanzu ba a bayyana hanyar watsawa ba.
Ji, et al., sun ba da shawarar macizai a matsayin mai ɗaukar kwayar cutar daga bats zuwa mutane wanda ya ƙunshi haɗuwa da homologous a cikin furotin S.
A cewar wani bincike, masu bincike a Guangzhou, China, sun nuna cewa pangolins - dabbobi masu cin hanci da rashawa masu dogon hanci da ake amfani da su a cikin maganin gargajiya na kasar Sin - sune mai iya daukar nauyin SARS-CoV-2 bisa ga homology na kwayoyin halitta na 99% a cikin CoV da aka gano a cikin pangolins da SARS-CoV-2.
Duk da haka, bambanci na 1% da aka yada a cikin kwayoyin halitta guda biyu har yanzu babban bambanci ne; saboda haka, ana jiran sakamako mai mahimmanci don hujjoji na ainihi (Fig.
Abubuwan da ke tattare da sinadarai na SARS-CoV-2 ba a san su ba tukuna.
SARS-CoV da MERS-CoV na iya rayuwa a cikin in vitro na awanni 48 a cikin yanayin bushe kuma har zuwa kwanaki 5 a ƙarƙashin 20 °C da 40%-50% danshi.
SARS-CoV-2 na iya samun irin wannan kaddarorin.
An ruwaito cewa SARS-CoV-2 yana da ƙoshin lafiya ga hasken ultraviolet da zafi a 56 °C na minti 30; ether, 75% ethanol, maganin kashe cuta mai ƙunshe da chlorine, peracetic acid, chloroform, da sauran masu narkewa masu ƙanshi, amma ba chlorhexidine ba, na iya kashe kwayar cutar yadda ya kamata.
Dukan mutanen da ke duniya ba su da kariya ga SARS-CoV-2 kuma saboda haka suna iya kamuwa da sabon kwayar cutar.
A halin yanzu, babu cikakken binciken da aka ruwaito game da amsawar rigakafi ga SARS-CoV-2.
Saboda haka, zamu iya komawa ne kawai ga binciken da aka yi a baya akan sauran CoVs, musamman SARS-CoV da MERS-CoV (Fig. (Fig.4).4).
Gabaɗaya, bayan kwayar cuta ta mamaye mai masaukin, tsarin rigakafin da ya haifa na farko ne ke gane ta hanyar masu karɓar ganewar asali (PRRs) ciki har da masu karɓar lectin irin na nau'in C, mai karɓar Toll (TLR), mai karɓar NOD (NLR), da mai karɓar RIG-I (RLR).
Ta hanyar hanyoyi daban-daban, kwayar cutar tana haifar da bayyanar cututtukan kumburi, balaga na ƙwayoyin dendritic, da kuma haɗuwa da interferons na nau'in I (IFNs) waɗanda ke iyakance yaduwar kwayar cutar da hanzarta phagocytosis na macrophage na maganin rigakafin kwayar cuta.
Koyaya, furotin N na SARS-CoV na iya taimakawa kwayar cutar ta tsere daga amsawar rigakafi.
Ba da daɗewa ba, tsarin rigakafi na jiki zai shiga yaƙi da cutar.
T lymphocytes ciki har da CD4 + da CD8 + T cells suna taka muhimmiyar rawa a cikin tsaro.
Kwayoyin CD4+ T suna motsa ƙwayoyin B su samar da rigakafin ƙwayoyin cuta, kuma ƙwayoyin CD8+ T suna kashe ƙwayoyin da suka kamu da cutar kai tsaye.
Kwayoyin T masu taimakawa suna samar da cytokines masu hana kumburi don taimakawa kwayoyin da ke karewa.
Koyaya, CoV na iya hana ayyukan T cell ta hanyar haifar da apoptosis na T cells.
Hakanan rigakafin humoral ciki har da kari kamar C3a da C5a da antibodies yana da mahimmanci wajen yaki da kamuwa da kwayar cutar.
Misali, rigakafin da aka keɓe daga mai haƙuri da ya warke sun kawar da MERS-CoV.
A wani ɓangare kuma, yawan ƙwayar rigakafi na jiki yana haifar da ƙwayoyin cuta masu yawa a cikin gida wanda zai iya haifar da mummunan lalacewar huhu da sauran gabobin jiki, kuma, a mafi munin yanayin, rashin aiki da gabobin gabobin jiki da kuma mutuwa.
Cutar SARS-CoV-2, wanda aka nuna ta hanyar farawar rukuni, yana iya shafar tsofaffi masu fama da cututtukan cuta da mata masu juna biyu.
A yawancin mutane da ke da ƙwayoyin cuta da yawa ko kuma waɗanda ke da rashin ƙarfi, suna da mafi yawan haɗarin kamuwa da cutar fiye da wasu.
Matsakaicin lokacin incubacin SARS-CoV-2 shine kwanaki 1-14, galibi kwanaki 3-7 bisa ga binciken farkon shari'o'in 425 a Wuhan.
Duk da haka, wani bincike a kan mutane 1,099 ya nuna cewa lokacin shan magani ya kai kwanaki 3 a matsakaita kuma ya kasance daga kwana 0 zuwa 24.
Wani binciken da aka yi kwanan nan, kamar yadda aka bayyana a sama, ya nuna cewa lokacin ɓoyewa ya kai kwanaki 4.8 (3.0-7.2) bisa ga yawan alƙalai na mutane 8,866.
Yana da matukar muhimmanci ga hukumomin kiwon lafiya su daidaita lokacin killacewar da ya dace bisa ga lokacin da aka fi dacewa da shi, don haka hana mutane da suka kamu amma ba su da alamun cutar watsa cutar ga wasu.
A matsayin al'ada, ana buƙatar a killace mutane da suka kamu da cutar ko kuma suka kamu da ita har tsawon kwanaki 14.
Shin ya kamata a tsawaita lokacin killacewa zuwa kwanaki 24?
Sau da yawa zazzabi shine babban bayyanar farko na COVID-19, wanda ba zai iya kasancewa tare da wata alama ko wasu alamomi kamar tari mai bushewa, rashin numfashi, ciwon tsoka, warkewa, ciwon kai, ciwon wuya, rhinorrhea, ciwon kirji, diarrhea, ƙishirwa, da amai.
Wasu marasa lafiya sun sha wahala daga dyspnea da/ ko hypoxemia mako guda bayan fara cutar.
A cikin matsanancin hali, marasa lafiya sun ci gaba da ci gaba da ciwon hanzari na numfashi, da kuma shan wahala, da kuma cututtukan jini.
Dole ne a bincika marasa lafiya da zazzabi da/ko alamun numfashi da kuma zazzabi mai tsanani, har ma ba tare da cututtukan hotunan huhu ba, don gano cutar a farkon lokaci.
Wani binciken alƙaluma a ƙarshen Disamba na 2019 ya nuna cewa yawan alamun sun kasance 98% don zazzabi, 76% don tari mai bushe, 55% don dyspnea, da 3% don fitsari; 8% na marasa lafiya suna buƙatar taimakon iska.
An samu irin wannan binciken a cikin bincike guda biyu na baya-bayan nan na wani rukuni na iyali da rukuni da aka samu sakamakon kamuwa da cutar daga mutum marar alamun cutar.
Hakazalika, binciken alƙaluma a shekarar 2012 ya nuna cewa marasa lafiya na MERS-CoV suna da zazzabi (98%), tari mai bushe (47%), da rashin numfashi (55%) a matsayin manyan alamun su.
Koyaya, kashi 80% na su suna buƙatar tallafin iska, fiye da marasa lafiya na COVID-19 kuma daidai da mafi girman mutuwar MERS fiye da COVID-19.
An kuma lura da diarrhea (26%) da ciwon wuya (21%) a cikin marasa lafiya na MERS.
A cikin marasa lafiya na SARS, an nuna cewa zazzabi (99%-100%), tari mai bushe (29%-75%), dyspnea (40%-42%), diarrhea (20-25%), da ciwon wuya (13-25%) sune manyan alamun kuma ana buƙatar taimakon iska don kimanin 14%-20% na marasa lafiya.
A ranar 14 ga Fabrairu, mutuwar COVID-19 ta kai kashi 2% lokacin da aka tabbatar da shari'o'in sun kai 66,576 a duniya.
Hakazalika, mutuwar SARS a watan Nuwamba na 2002 ya kai 10% na 8,096 da aka tabbatar da cutar.
A cikin MERS, bisa ga binciken alƙaluma a watan Yuni na 2012, mutuwar ta kai kashi 37% na mutane 2,494 da aka tabbatar da cutar.
Wani binciken da aka yi a baya ya ruwaito cewa R0 na SARS-CoV-2 ya kai 6.47 tare da matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin
Ana kwatanta SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da alamun su, mutuwa, da R0 a cikin Tebur na Table1.1.
Lambobin da ke sama sun nuna cewa SARS-CoV-2 yana da damar yadawa fiye da MERS-CoV da SARS-CoV, amma ba shi da haɗari fiye da na biyun.
Saboda haka, yana da matukar kalubale don sarrafa annobar SARS-CoV-2 fiye da na MERS-CoV da SARS-CoV.
Ƙungiyoyin farawa sau da yawa suna faruwa a cikin iyali ɗaya ko daga taro ɗaya ko mota kamar jirgin ruwa.
Sau da yawa marasa lafiya suna da tarihin tafiya ko zama a Wuhan ko wasu yankunan da aka shafa ko kuma sun yi hulɗa da mutane ko marasa lafiya da suka kamu da cutar a cikin makonni biyu da suka gabata kafin farawar.
Koyaya, an ruwaito cewa mutane na iya ɗaukar cutar ba tare da alamun ba fiye da makonni biyu kuma marasa lafiya da aka warkar da su daga asibitoci na iya ɗaukar cutar sake, wanda ke aika da ƙararrawa don ƙara lokacin keɓewa.
Marasa lafiya suna da yawan fararen fararen jini (musamman lymphocytes) a farkon matakin.
Misali, an gano lymphopenia tare da yawan ƙwayoyin jini masu fari &lt; 4 × 109/L gami da yawan lymphocyte &lt; 1 × 109/L, da kuma matakan aminotransferase na aspartate da cutar viremia a cikin marasa lafiya 1,099 na COVID-19.
An kara yawan ƙwayar ƙwayar cuta da ƙwayar ƙwayar cuta da kuma myoglobin a cikin jinin wasu marasa lafiya, kuma an kara yawan furotin mai C-reactive da kuma kwararar erythrocyte a cikin jinin yawancin marasa lafiya.
A cikin marasa lafiya masu tsanani, an ƙara yawan D- dimer, wanda yake rage fasalin fibrin a cikin jini, kuma an rage yawan lymphocytes a hankali.
Ana samun rashin daidaito a cikin radiography na kirji a yawancin marasa lafiya na COVID-19 kuma ana nuna su ta wurin inuwa mai lalacewa ta biyu ko kuma rashin haske na gilashin ƙasa a cikin huhu.
A yawancin lokaci, marasa lafiya suna fama da ciwon huhu da ba a saba gani ba, da kuma cutar huhu da ke damun numfashi.
Sa'ad da cutar ta ARDS ta faru, ƙonewa da ba a sarrafawa, tarin ruwa, da kuma ci gaba da ciwon ƙwayar cuta suna ɓata iskar gas sosai.
Rashin aiki na nau'in I da nau'in II na ƙwayoyin cuta yana rage matakin surfactant kuma yana ƙara ƙarfin farfajiyar farfajiyar, don haka rage ikon huhu don faɗaɗa da kuma ƙara haɗarin fashewar huhu.
Saboda haka, sakamakon radiography na kirji mafi muni sau da yawa yana daidai da yanayin rashin lafiyar.
A ranar 18 ga Fabrairu, 2020, bincike na farko na cutar COVID-19 ya nuna ƙarancin ƙwayoyin cuta, samar da membrane na hyaline, da shigar da lymphocyte na tsakanin, da ƙwayoyin syncytial masu yawa a cikin huhu na mai haƙuri wanda ya mutu daga cutar, daidai da yanayin kamuwa da cutar kwayar cuta da ARDS kuma yayi kama da na marasa lafiya na SARS da MERS.
An yi amfani da gano SARS-CoV-2 RNA ta hanyar juyawa-transcriptase polymerase sarkar amsa (RT-PCR) a matsayin manyan ka'idoji don gano COVID-19.
Koyaya, saboda yawan ƙimar ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙaran
Wani yanayi irin wannan ya faru da aka gano SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar cututtuka, gwaje-gwajen dakin gwaje-gwaje, da kuma binciken radiological yana da muhimmanci kuma yana da muhimmanci don yin ganewar asali mai kyau.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana yarjejeniya ta amfani da fasaha ta SHERLOCK mai tushen CRISPR don gano SARS-CoV-2, wanda ke gano ɓangarorin RNA na SARS-CoV-2 na roba a 20 × 10-18 mol / L zuwa 200 × 10-18 mol / L (10-100 kwafi a kowace microliter shigarwa) ta amfani da sandar ruwa a ƙasa da awa ɗaya ba tare da buƙatar kayan aiki mai zurfi ba.
Muna fatan, sabuwar fasaha za ta iya inganta ƙwarewar da kuma saukin idan aka tabbatar da shi a cikin samfurori na asibiti.
Saboda rashin gogewa game da sabon CoV, likitoci zasu iya ba da kulawa mai goyan baya ga marasa lafiya na COVID-19, yayin da suke ƙoƙarin yin amfani da nau'ikan magunguna daban-daban waɗanda aka yi amfani da su ko kuma aka ba da shawarar a baya don maganin sauran CoVs kamar SARS-CoV da MERS-CoV da sauran cututtukan kwayar cuta (Table (Table2).2).
Waɗannan hanyoyin sun haɗa da magani na yanzu da kuma na gaba da maganin rigakafi, magungunan hana rigakafi, steroids, jini daga marasa lafiya da suka warke, magani na kasar Sin, da kuma taimakon tunani.
An kuma yi shawarar yin amfani da jini daga marasa lafiya da suka warke don magani.
Kamfanonin magunguna suna gaggauta wajen samar da rigakafi da alluran rigakafi ga cutar.
SARS-CoV-2 galibi yana kai hari ga huhu a farkon kuma mai yiwuwa yana kai hari, a ƙarami, ga sauran gabobin da ke nuna ACE2, kamar tsarin gastrointestinal da koda.
Duk da haka, rashin aiki na numfashi da kuma rashin aiki ne babban abin da ke barazana ga marasa lafiya kuma shi ne babban dalilin mutuwa.
Saboda haka, taimakon numfashi yana da muhimmanci don kawar da cututtuka da kuma ceton rayuka kuma ya haɗa da maganin oxygen na gaba ɗaya, oxygen mai yawa, iska mai ba da iska, da kuma iska mai ba da iska ta inji dangane da tsanani na cutar.
Dole ne a tallafa wa marasa lafiya da ke fama da cututtukan numfashi mai tsanani ta hanyar oxygenation na membrane na waje (ECMO), wani fasaha mai gyara na karkata da huhu da ake amfani da shi wajen magance rashin lafiyar zuciya ko numfashi mai barazana ga rayuwa.
Bugu da kari, kula da daidaiton electrolyte, rigakafi da magani na kamuwa da cuta ta biyu da kuma bugun jini, da kuma kare ayyukan gabobin rayuwa suma suna da mahimmanci ga marasa lafiyar SARS-CoV-2.
An san cewa hadarin cytokine ya haifar da matsanancin amsawar tsarin rigakafi a cikin marasa lafiya na SARS da MERS.
Cytokine storm wani nau'i ne na tsarin farfadowa da ke nunawa ta hanyar sakin jerin cytokines ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Wadannan cytokines suna sa ƙwayoyin rigakafi su saki yawan radicals masu kyauta wanda shine babban dalilin ARDS da rashin aiki na gabobin gabobin.
Maganin rigakafi yana da muhimmanci wajen magance hadari na cytokine, musamman a cikin marasa lafiya masu tsanani.
An yi amfani da corticosteroids da tocilizumab, wani anti-IL6 monoclonal antibody, don magance hadarin cytokine.
Sauran hanyoyin hana rigakafi don hadarin cytokine sun hada da daidaitawar amsawar rigakafin da kwayoyin T ke jagoranta; toshe IFN-γ, IL-1, da TNF; hana JAK; blinatumomab; mai hana siginar cytokine 4; da masu hana HDAC.
Ana amfani da steroids, a matsayin masu hana rigakafi, a cikin maganin SARS don rage tsanani na lalacewar kumburi.
Koyaya, steroids a cikin manyan allurai ba su da fa'ida ga mummunan rauni a huhu a cikin marasa lafiya na SARS da COVID-19.
Maimakon haka, suna iya haifar da mummunan sakamako masu illa, musamman osteonecrosis na jijiyoyin jini, wanda ke shafar hangen nesa.
Duk da haka, an ba da shawarar yin amfani da gajeren lokaci na corticosteroids a ƙananan zuwa matsakaici don yin hankali ga marasa lafiya masu cutar COVID-19.
A lokacin da aka rubuta wannan labarin, ba a tabbatar da maganin rigakafi na cutar ba.
Koyaya, an gano cewa shan remdesivir a cikin jini, analog na nucleotide, yana da tasiri a cikin wani mara lafiyar Amurka da ke fama da COVID-19.
Remdesivir sabon magani ne na rigakafin cuta wanda Gilead ta ci gaba da shi don maganin cututtuka da ƙwayoyin cuta na Ebola da Marlburg suka jawo.
Daga baya, remdesivir ya kuma nuna yiwuwar hana wasu kwayoyin RNA guda ɗaya da suka haɗa da MERS da SARS.
Dangane da waɗannan, Gilead ta ba da mahadi ga China don gudanar da gwaji a kan mutane da ke da cutar SARS-CoV-2, kuma ana sa ran sakamakon sosai.
Bugu da kari, an ba da shawarar baricitinb, interferon-α, lopinavir/ ritonavir, da ribavirin a matsayin magani mai yiwuwa ga marasa lafiya da ke fama da cututtukan numfashi na gaggawa.
Ana iya samun diarrhea, kumburi, kumburi, lalacewar hanta, da sauran sakamako masu illa bayan an yi maganin hade da lopinavir/ ritonavir.
Ya kamata a lura da yadda wadannan magunguna suke shafar wasu magunguna da ake amfani da su a cikin marasa lafiya.
Plasma daga marasa lafiya da suka warke da kuma samar da rigakafi
Ana yin amfani da jini daga marasa lafiya da suka warke daga wata cuta mai yaduwa don kula da wasu marasa lafiya da ke fama da wannan cuta ko kuma don kare mutane masu lafiya daga kamuwa da cutar.
Hakika, a yawancin lokaci, marasa lafiya da suka warke suna da ƙwayoyin rigakafi da yawa a cikin jininsu.
Kwayoyin rigakafi sune immunoglobulin (Ig) wanda kwayoyin B suka samar don yaƙar cututtuka da sauran abubuwa na waje kuma suna gane kwayoyin musamman a cikin cututtuka kuma su kawar da su kai tsaye.
Bisa ga wannan, an tattara jini daga jinin wasu marasa lafiya da suka warke daga COVID-19 kuma an yi musu allura a cikin marasa lafiya 10 da ke fama da ciwo mai tsanani.
A cikin sa'o'i 24, bayyanar cututtukan sun inganta, kuma sun rage ciwon kumburi da kuma ƙwayar cuta da kuma ingantaccen iskar oxygen a cikin jini.
Duk da haka, ana bukatar tabbatarwa da kuma bayyanawa domin a gabatar da hanyar da za a yi amfani da ita a manyan sikelin kafin a ci gaba da yin maganin musamman.
Bugu da ƙari, saboda tasirin magani, ya kamata a yi la'akari da wasu rashin amfani da ke tattare da jini.
Alal misali, rigakafi na iya yin tsananin motsa jiki kuma ya haifar da cututtukan cytokine, wanda zai iya zama haɗari ga rayuwa.
Yawan kwayoyin rigakafi a cikin jini yawanci ba su da yawa, kuma ana bukatar jini sosai don a yi maganin marasa lafiya masu tsanani.
Yana da wuya a samar da ƙwayoyin rigakafi na musamman da sauri don yaƙi da annoba ta duniya.
Saboda haka, yana da mahimmanci kuma mai amfani don ware ƙwayoyin B daga marasa lafiya da suka warke da kuma gano lambobin kwayoyin halitta da ke ba da lambar rigakafi masu tasiri ko kuma gano rigakafin rigakafi masu tasiri akan furotin na cutar.
Ta wannan hanyar, za mu iya ƙara yawan samar da rigakafi.
An yi amfani da TCM wajen magance cututtuka dabam dabam a ƙasar Sin tun shekaru dubbai da suka shige.
Duk da haka, tasirinsa ya dogara ne da haɗuwa da abubuwa da yawa a cikin tsari wanda ya bambanta dangane da ganewar asali na cutar bisa ga ka'idodin TCM.
Yawancin abubuwan da ke cikin kayan aiki ba a sani ba ko kuma ba su da tabbas saboda yana da wuya a cire da kuma tabbatar da irin waɗannan abubuwan ko kuma haɗuwa da su.
A halin yanzu, saboda rashin ingantaccen magani na musamman don COVID-19, TCM ya zama ɗayan manyan hanyoyin maye gurbin magani ga marasa lafiya masu sauƙi zuwa matsakaici ko waɗanda suka warke daga mawuyacin matakai.
Misali, Shu Feng Jie Du capsules da Lian Hua Qing Wen capsules an gano su na da tasiri wajen maganin COVID-19.
An lura da mafi girman yawan warkarwa a cikin kula da marasa lafiya na COVID-19 a larduna da yawa a China waɗanda suka yi amfani da TCM a cikin kashi 87% na marasa lafiyar su, gami da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da lardin Hubei, wanda ya yi amfani da TCM a cikin kusan 30% na marasa lafiyar COVID-19 kawai, ya kasance mafi ƙarancin ƙimar warkarwa (13%).
Duk da haka, wannan kwatancen ya yi daidai da yadda ake kwatanta wasu dalilai masu tasiri kamar yawan marasa lafiya da kuma tsanani da za a haɗa a cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aiki sun buga wani bincike don kwatanta maganin maganin yammacin duniya (WM) da maganin WM da TCM.
Sun gano cewa lokacin da ake bukata don dawo da zafin jiki, ɓacewar bayyanar cututtuka, da kuma asibiti ya fi guntu a cikin rukunin WM+TCM fiye da a cikin rukunin WM kawai.
Mafi ban sha'awa, yawan rashin lafiyar da ke tattare da bayyanar cututtuka (daga mai sauƙi zuwa mai tsanani) ya kasance mai ƙarancin gaske ga ƙungiyar WM+TCM fiye da ƙungiyar WM kawai (7.4% da 46.2%) da kuma mutuwar ta kasance ƙasa a cikin ƙungiyar WM+TCM fiye da ƙungiyar WM kawai (8.8% da 39%).
Duk da haka, inganci da aminci na TCM har yanzu suna jiran ƙarin gwaje-gwaje masu kyau a kan manyan sikelin da kuma a cibiyoyi da yawa.
Zai kuma zama mai ban sha'awa don bayyana tsarin ayyuka da kuma bayyana abubuwan da ke cikin maganin TCM ko kuma haɗuwa da su idan zai yiwu.
Marasa lafiya da ake zargin ko kuma an tabbatar da COVID-19 galibi suna fuskantar babban tsoro game da cutar mai yaduwa da mutuwa, kuma mutanen da ke keɓewa suna fuskantar gundura, kadaici, da fushi.
Bugu da ƙari, alamun kamuwa da cuta kamar zazzabi, hypoxia, da tari da kuma sakamako masu illa na magani kamar rashin barci da corticosteroids ke jawowa na iya jawo ƙarin damuwa da kuma baƙin ciki na tunani.
A farkon fasalin barkewar cutar SARS, an ruwaito wasu cututtukan cututtukan hankali da suka hada da ciwon ciki, damuwa, tashin hankali, tashin hankali na motsi, alamun rashin hankali, haushi, har ma da son kashe kansa.
Dole ne a bi hanyar tuntuɓar da ke cikin killacewa, a matsayin ɓangare na amsoshin lafiyar jama'a ga barkewar COVID-19, na iya sa mutane su kasance da damuwa da laifi game da tasirin kamuwa da cuta, killacewa, da lalata a kan iyalansu da abokansu.
Saboda haka, ya kamata a ba da kulawar lafiyar hankali ga marasa lafiya na COVID-19, mutane da ake zargi, da mutanen da ke hulɗa da su da kuma jama'a da ke cikin bukata.
Taimakon ilimin halayyar dan adam ya kamata ya hada da kafa kungiyoyin kiwon lafiyar hankali na fannoni da yawa, sadarwa mai kyau tare da sabuntawa na yau da kullun da daidai game da barkewar cutar SARS-CoV-2 da tsare-tsaren magani da kuma amfani da na'urori da aikace-aikacen lantarki na ƙwararru don kauce wa kusanci da juna.
Ana bukatar allurar rigakafi mai inganci don katse sarkar watsawa daga wuraren ajiye dabbobi da mutane masu kamuwa da cutar zuwa ga masu karɓa kuma sau da yawa suna ba da ƙarin magani na riga-kafi a cikin maganin cututtukan da ke faruwa da ƙwayoyin cuta masu tasowa.
An yi ƙoƙari don haɓaka alluran rigakafin S-protein don samar da antibodies masu tsayayya da tsayayya da tsayayya da SARS-CoV na dogon lokaci da ƙarfi.
An kimanta alluran rigakafin da aka rage a rayuwa a cikin samfurin dabba don SARS.
Duk da haka, ba a riga an ƙayyade ingancin wadannan alluran rigakafi a cikin tsofaffi da kuma samfurin ƙalubalen kisa da kariya daga kamuwa da cutar zoonotic ba kafin a fara binciken asibiti.
Wannan na iya faruwa ne saboda SARS ta mutu shekaru 17 da suka gabata kuma ba a samu wani sabon kamuwa da cutar ba tun daga lokacin.
Akasin haka, ana ci gaba da samun wasu lokuta da kuma tarin cutar MERS a Gabas ta Tsakiya kuma suna yadawa zuwa wasu yankuna saboda ci gaba da samun tushen zoonotic a yankunan da ke da iyaka.
An kirkiro dabarun allurar rigakafi don MERS ta amfani da kwayar cutar da ba ta aiki ba, plasmids na DNA, masu ɗaukar kwayar cutar, nanoparticles, ƙwayoyin ƙwayoyin cuta kamar ƙwayar cuta da kuma ƙananan sinadarai masu haɗuwa da wasu kuma an kimanta su a cikin samfurin dabba.
Ci gaban allurar rigakafi mai aminci da inganci akan SARS-CoV-2 ga mutanen da ba su da rigakafi aiki ne na gaggawa da mahimmanci don sarrafa annobar da ke gudana.
Duk da haka, yana da wuya a shawo kan wannan matsala saboda tsawon lokaci (ma'aunin watanni 18) da ake bukata don samar da allurar rigakafi da kuma canje-canje masu saurin gaske na CoVs.
A matsayin sabon cuta, COVID-19 ya fara bayyana cikakken yanayin asibitin sa a cikin dubban marasa lafiya.
A yawancin lokuta, marasa lafiya za su iya warkewa a hankali ba tare da a samu wani sakamako ba.
Koyaya, kamar SARS da MERS, COVID-19 yana da alaƙa da babban kamuwa da cuta da mutuwa a cikin marasa lafiya masu fama da mummunan yanayi.
Saboda haka, gina samfurin tsinkaya don cutar yana da mahimmanci ga hukumomin kiwon lafiya su ba da fifiko ga ayyukansu, musamman a yankunan da aka iyakance albarkatun.
Dangane da binciken asibiti da aka ruwaito har zuwa yanzu, dalilai masu zuwa na iya shafar ko kuma su kasance masu alaƙa da tsinkayen marasa lafiya na COVID-19 (Table (Table33):
Shekaru: Shekara ita ce mafi mahimmancin abin da ya sa aka gano cutar SARS, wanda kuma ya shafi COVID-19.
COVID-19 ya faru ne a cikin shekaru 30-65 tare da 47.7% na waɗanda marasa lafiya sun wuce 50 a cikin binciken da aka yi na shari'o'i 8,866 kamar yadda aka bayyana a sama.
Marasa lafiya da ke buƙatar kulawa mai tsanani sun fi haɗari da rashin lafiya da rikitarwa na asali kuma sun fi waɗanda ba su da (a matsakaicin shekaru 66 da 51), wanda ke ba da shawarar shekaru a matsayin mai nunawa ga sakamakon marasa lafiya na COVID-19.
Jima'i: SARS-CoV-2 ya kamu da maza fiye da mata (0.31/100,000 da 0.27/100,000), kamar yadda aka bayyana a sama.
Cutar zuciya da rikitarwa: Marasa lafiya da ke fama da COVID-19 da ke buƙatar kulawa mai tsanani suna da mafi yawan haɗarin shan wahala daga rauni mai tsanani na zuciya da kuma rashin saurin jini.
Abubuwan zuciya kuma sune babban dalilin mutuwar marasa lafiya na SARS.
An ruwaito cewa SARS-CoV-2 na iya ɗaurewa da cholangiocytes masu kyau na ACE2, wanda zai iya haifar da rashin aikin hanta a cikin marasa lafiya na COVID-19.
Ya kamata a lura cewa shekaru da kuma cututtuka suna da nasaba sosai kuma suna iya sa juna su yi rashin lafiya.
Abubuwan da aka gano a dakin gwaje-gwaje: Matsayin furotin mai aiki da C (CRP) a cikin jini yana nuna tsanani na kumburi ko raunin da aka samu a cikin ƙwayoyin halitta kuma an ce yana iya zama sanadin cutar, amsa ga magani, da kuma farfadowa.
An kuma gabatar da batun daidaita matakin CRP da tsanani da kuma hangen nesa na COVID-19.
Bugu da ƙari, haɓakar lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Wadannan enzymes suna bayyana sosai a cikin gabobin da yawa, musamman a zuciya da hanta, kuma suna saki a lokacin lalacewar nama.
Saboda haka, suna nuna rashin aikin zuciya ko na hanta.
Babban alamun asibiti: Za a yi la'akari da radiography na kirji da ci gaban lokaci na alamun asibiti tare da sauran batutuwan don hango sakamakon da rikitarwa na COVID-19.
Yin amfani da kwayoyin cuta: Kamar yadda aka bayyana a sama, steroids suna da rigakafi da ake amfani da su a matsayin magani na maganin cututtuka don rage yawan cutar kumburi.
Tun da aka yi amfani da babban adadin corticosteroids a cikin marasa lafiya masu fama da SARS, mutane da yawa da suka tsira sun sha wahala daga osteonecrosis na jijiyoyin jini tare da nakasa na tsawon rai da rashin ingancin rayuwa.
Saboda haka, idan ya cancanta, ya kamata a yi amfani da steroids a ƙananan sashi kuma na ɗan gajeren lokaci a cikin marasa lafiya na COVID-19.
Matsalar hankali: Kamar yadda aka bayyana a sama, a lokacin barkewar COVID-19 marasa lafiya da yawa sun sha wahala daga damuwa mai yawa kamar yadda galibi suka jimre da tsawan lokacin killacewa da rashin tabbas mai tsanani kuma suka ga mutuwar dangi da abokan marasa lafiya.
Yana da muhimmanci a ba da shawara ta tunani da kuma goyon baya na dogon lokaci don a taimaka wa waɗannan marasa lafiya su warke daga damuwa kuma su koma rayuwa ta al'ada.
Bisa ga nazarin alƙaluma har zuwa yanzu, COVID-19 yana da alamun cututtukan cututtuka daban-daban daga SARS.
Baya ga sake fasalinsa a ƙananan hanyoyin numfashi, SARS-CoV-2 na iya sake fasalinsa cikin inganci a cikin hanyoyin numfashi na sama kuma yana haifar da sauƙi ko babu alamun a farkon farkon kamuwa da cuta, kamar sauran CoVs waɗanda ke haifar da sanyi na yau da kullun.
Saboda haka, marasa lafiya da suka kamu da cutar a farkon lokacin ko lokacin ɓoyewa na iya samar da ƙwayoyin cuta da yawa a lokacin ayyukan yau da kullum, wanda ke haifar da ƙalubale mai yawa ga sarrafa cutar.
Koyaya, an yi la'akari da watsa SARS-CoV lokacin da marasa lafiya ke da mummunan rashin lafiya, yayin da yawancin watsawar ba ta faru a farkon matakin ba.
Saboda haka, barkewar cutar COVID-19 ta yanzu ta fi muni da wahala a sarrafa ta fiye da barkewar cutar SARS.
A halin yanzu ana yin manyan ƙoƙari a China ciki har da kulle Wuhan da biranen da ke kewaye da shi da kuma ci gaba da killace kusan dukkanin jama'a da fatan katse watsa SARS-CoV-2.
Duk da cewa wadannan ayyukan sun yi mummunan lahani ga tattalin arziki da sauran bangarorin kasar, yawan sabbin marasa lafiya yana raguwa, yana nuna jinkirin annobar.
Mafi kyawun kimantawa shine cewa annobar za ta ƙare a watan Maris kuma matakin raguwa zai ɗauki watanni 3-4.
Amma, wasu masana ba su da irin wannan ra'ayin.
Paul Hunter, da sauransu, sun kiyasta cewa COVID-19, wanda ya zama kamar ya fi SARS kamuwa da cuta, ba zai ƙare a cikin 2020.
Ira Longini, da sauransu, sun kafa samfurin don hango ko hasashen sakamakon annobar kuma sun ba da shawarar cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan duniya.
Wata kungiya ta Kanada ta ruwaito cewa an gano SARS-CoV-2 a cikin duka tsakanin turbinate da kuma gashin ƙuƙwalwar marasa lafiya waɗanda suka warke kuma suka bar asibiti makonni 2 da suka gabata, wanda ke nuna cewa sabon kwayar cutar da aka gano na iya zama wani yanayi mai kama da cutar mura.
Duk da haka, a kasar Sin an samu alamun da ke nuna cewa akwai alkawura masu kyau dangane da raguwar yawan sababbin cututtuka, wanda ke nuna cewa dabarun da ake amfani da su a yanzu sun yi aiki.
An yi hasashen cewa cutar Ebola za ta iya haddasa mutum miliyan ɗaya da kuma mutuwar mutane miliyan rabin.
Amma, ta hanyar killacewa da kuma warewa, an kawar da cutar.
Yana yiwuwa, kamar SARS-CoV, SARS-CoV-2 na iya zama mai rauni a kamuwa da cuta kuma daga ƙarshe ya mutu ko ya zama ƙarancin cutar mai cutar da ke rayuwa tare da mutane.
Ana ba da kwatancen annobar COVID-19 da ta SARS da MERS a ƙasa (Fig. (Fig.55).
SARS-CoV-2 yana iya watsawa ta hanyar tari ko cizon yatsa, kuma wataƙila ta hanyar tuntuɓar kai tsaye da kayan da cutar ta gurbata.
An kuma gano cutar a cikin kwayoyin halitta, wanda ya haifar da sabon yiwuwar watsa kwayoyin halitta daga kwayoyin halitta zuwa bakin.
Wani binciken da aka yi kwanan nan a kan shari'o'i 138 ya nuna cewa 41% na shari'o'in sun yiwu ne sakamakon kamuwa da cuta ta hanyar asibiti, ciki har da marasa lafiya 17 da ke fama da wasu cututtuka na baya da kuma masu kula da kiwon lafiya 40.
Saboda haka, ya kamata a yi amfani da hankali sosai don a kāre mutane, musamman ma masu kula da lafiya, masu kula da zamantakewar jama'a, 'yan'uwa na iyali, abokan aiki, har ma da waɗanda suke tare da marasa lafiya ko kuma waɗanda suke da cutar.
Hanyar farko ta karewa da za a iya amfani da ita don rage haɗarin kamuwa da cuta ita ce ta hanyar sanya abin rufe fuska; duka amfani da abin rufe fuska na tiyata da abin rufe fuska na numfashi na N95 (series # 1860s) yana taimakawa wajen sarrafa yaduwar ƙwayoyin cuta.
Masks na fuska na tiyata suna hana saɓo daga ruwa daga mutumin da ke da cutar ta tashi a cikin iska ko kuma su manne a kan farfajiyar kayan, inda za su iya wucewa ga wasu.
Duk da haka, kawai N95 (series # 1860s) masks na iya karewa daga shan virions kamar ƙananan 10 zuwa 80 nm, tare da kashi 5% na virions kawai na iya shiga gaba ɗaya; SARS-CoV-2 yayi kama da SARS-CoV a girman kuma duka suna da kimanin 85 nm.
Tunda ƙwayoyin cuta na iya shiga ko da masks na tiyata biyar da aka tara tare, masu ba da kiwon lafiya da ke hulɗa kai tsaye da marasa lafiya dole ne su sa masks na N95 (series # 1860s) amma ba masks na tiyata ba.
Baya ga abin rufe fuska, masu ba da sabis na kiwon lafiya ya kamata su sa rigunan keɓewa don rage haɗuwa da ƙwayoyin cuta.
Hakanan ƙwayoyin cuta na iya kamuwa da mutum ta idanunsu.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da SARS-CoV-2 duk da cewa ya sa abin rufe fuska na N95; ƙila cutar ta shiga jikinsa ta idanunsa masu kumburi.
Saboda haka, masu kula da lafiya ya kamata su saka riguna masu tsabta ko tabarau yayin da suke aiki da marasa lafiya.
Ga jama'a a yankunan da cutar ta shafa ko kuma waɗanda za a iya shafawa, ana ba da shawarar sosai cewa kowa ya wanke hannayensu da sabulu mai kashe kashe cuta sau da yawa fiye da yadda aka saba, ya yi ƙoƙarin kasancewa a gida don keɓe kansa kuma ya rage hulɗa da mutanen da ke da cutar.
An yi la'akari da cewa kafa uku ne nesa da ya dace da mutane su guje wa wani mai haƙuri.
Wadannan ayyuka hanyoyi ne masu inganci don rage hadarin kamuwa da cuta da kuma hana yaduwar cutar.
Kodayake SARS-CoV-2 ya zo a matsayin sabon kwayar cutar ga duniyar ɗan adam, babban homologin sa ga SARS-CoV kamar yadda aka ruwaito a ranar 7 ga Janairu 2020 ya kamata ya haifar da babban faɗakarwa ga China bisa tushen ƙwaƙwalwar ta game da barkewar cutar SARS a 2003.
Duk da haka, ba har zuwa 19 ga Janairu 2020 ba ne darektan Cibiyar Kula da Cututtuka ta Wuhan ya ƙarfafa 'yan ƙasa ta hanyar cewa sabon kwayar cutar tana da ƙarancin kamuwa da cuta da iyakanceccen haifuwa daga mutum zuwa mutum kuma ba matsala ce don hana da kuma hana cutar.
Wannan sakon ya rage tsananin fargaba ga jama'a, musamman lokacin da duk kasar ke shirin bikin bazara, kuma an rasa lokacin da ya dace don hana cutar a ƙaramar sikelin da ta samu a Wuhan.
Hukumomin da ke kula da cututtuka a kasar Sin za su iya koyon darasi mai wuya kuma su yi gyara a nan gaba.
Alal misali, waɗannan hukumomi ya kamata su kasance (1) masu hankali yayin yin sanarwa a fili kamar yadda kowane kalma ke da mahimmanci ga 'yan ƙasa kuma zai iya canza halin su da yanke shawara; (2) mafi m da kuma amsawa ga bayanai na yau da kullun daga asibitoci maimakon jiran rahotanni na yau da kullun daga likitoci ko jami'ai; (3) mafi ƙuntatawa don hana yiwuwar annobar a farkon matakinta maimakon ƙoƙarin ta'azantar da jama'a; da kuma (4) mafi sau da yawa don ba da umarni na musamman da tasiri don ƙara wayar da kan jama'a game da cututtukan annobar da kuma gwadawa da inganta tsarin amsawar al'umma a lokaci-lokaci.
Fashewar COVID-19 da sabon kwayar cutar SARS-CoV-2 ta haifar ya fara ne a ƙarshen Disamba 2019.
A cikin kasa da watanni biyu, ya bazu ko'ina cikin China da kuma kusan wasu ƙasashe 50 a duniya a lokacin wannan rubuce-rubuce.
Tunda cutar ta yi kama da SARS-CoV kuma alamun sun yi kama da tsakanin COVID-19 da SARS, barkewar COVID-19 ta haifar da jin cewa SARS tana maimaitawa.
Duk da haka, akwai wasu bambance-bambance masu ban mamaki tsakanin COVID-19 da SARS, waɗanda ke da mahimmanci don hana annobar da kula da marasa lafiya.
COVID-19 yana shafar tsofaffi fiye da matasa da maza fiye da mata, kuma tsanani da yawan mutuwa suna da girma a cikin tsofaffi fiye da matasa.
SARS tana da mafi girma mutuwar fiye da COVID-19 (10.91% vs. 1.44%).
Marasa lafiya na COVID-19 suna watsa kwayar koda kuwa basu da alamun cutar yayin da marasa lafiya na SARS yawanci suke yin hakan lokacin da suke da mummunan rashin lafiya, wanda ke haifar da wahala sosai wajen hana yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana a wani ɓangare dalilin da ya sa SARS-CoV-2 ya yadu da sauri kuma ya fi SARS-CoV yawa.
Gwajin RNA na yau da kullun don SARS-CoV-2 na iya zama mara kyau a cikin wasu marasa lafiya na COVID-19.
A wani bangare kuma, marasa lafiya da suka warke za su iya sake samun cutar.
Wadannan binciken sun kara hadarin yaduwar cutar sosai.
Ganin irin wannan ci gaban da ake samu cikin bincike kan COVID-19, har yanzu akwai wasu mahimman batutuwa da za a warware, kamar haka:
Daga ina SARS-CoV-2 ya fito?
Kodayake an gano homolog na kwayoyin halitta 96% tsakanin SARS-CoV-2 da CoVs biyu na SARS-kamar bats, har yanzu ba za mu iya kammala cewa SARS-CoV-2 daga bats ne ba.
Wane dabba ne ya ba da cutar daga wanda ya haife ta, wato, bats zuwa mutane?
Idan ba mu san amsoshin tambayoyi na 1 da 2 ba, ba za mu iya hana watsawa ba, kuma annobar za ta iya sake faruwa a kowane lokaci.
Kodayake samfurin kwayoyin halitta da nazarin halittu sun nuna cewa SARS-CoV-2 yana ɗaure da ACE2, ta yaya ainihin cutar ta shiga cikin ƙwayoyin hanyoyin numfashi kuma ta haifar da canje-canje na cutar?
Shin kwayar cutar tana ɗaure ƙwayoyin da ke nuna ACE2 a wasu gabobin jiki?
Idan ba mu sami amsoshi masu kyau ga waɗannan tambayoyin ba, ba za mu iya samun ganewar asali da kuma magani mai kyau ba.
Har yaushe cutar za ta ci gaba?
Ta yaya kwayar ta samo asali a lokacin da ake watsa ta tsakanin mutane?
Shin zai zama annoba a duniya, ya mutu kamar SARS ko kuma ya sake komawa a kai a kai kamar mura?
Yana da muhimmanci amma yana iya ɗaukar lokaci kafin a sami amsoshin waɗannan tambayoyin da kuma wasu tambayoyi da yawa.
Duk da haka, ko da yaya kudin da za mu kashe, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri kuma mu dawo da rayuwarmu zuwa al'ada.
Asalin zoonotic na kwayar cutar corona a cikin mutane
Cutar da kuma daidaitawa sun haifar da juyin halitta na kwayar cutar corona (CoVs) da masu karɓar bakinsu, gami da mutane, tsawon dubban shekaru.
Kafin 2003, an san cewa CoVs na mutum (HCoVs) biyu suna haifar da rashin lafiya mai sauƙi, kamar sanyi.
Fashewar cutar ta hanyar numfashi mai tsanani (SARS) da cutar ta hanyar numfashi ta Gabas ta Tsakiya (MERS) sun juya tsabar kudi don bayyana yadda cutar HCoV zata iya zama mai lalata da barazana ga rayuwa.
Fitowar SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ta sake tura CoVs cikin hasken ido kuma ta ba mu mamaki da babban yaduwar sa amma rage cututtukan cututtuka idan aka kwatanta da 'yar'uwarta SARS-CoV.
kamuwa da cutar HCoV cutar dabba ce kuma fahimtar asalin HCoVs na dabba zai taimaka mana sosai.
Yawancin HCoVs sun samo asali ne daga bats inda ba su da cutar.
Hakanan an san masu karɓar ruwa na tsakiya na wasu HCoVs.
Gano dabbobi masu gida yana da tasiri kai tsaye a rigakafin cututtukan mutane.
Binciken hulɗar da CoV- mai masaukin baki a cikin dabbobi na iya samun muhimmiyar fahimta game da cutar CoV a cikin mutane.
A cikin wannan bita, muna gabatar da bayyani game da ilimin da ke akwai game da HCoVs bakwai, tare da mai da hankali kan tarihin gano su da kuma asalin su na zoonotic da watsa tsakanin jinsuna.
Yana da mahimmanci, muna kwatanta da bambanta HCoVs daga hangen nesa na juyin halitta na kwayar cutar da kuma sake haɗuwa da kwayoyin halitta.
Ana tattauna cutar COVID-19 ta yanzu a wannan mahallin.
Bugu da kari, an kuma nuna bukatun don sauyawar mai masaukin baki da kuma tasirin juyin halittar kwayar cutar akan cutar.
Coronaviruses (CoVs) suna cikin dangin Coronaviridae, wanda ya ƙunshi rukuni na ɓoye, mai kyau-ji, guda-tsiri RNA ƙwayoyin cuta.
Wadannan ƙwayoyin cuta waɗanda ke da babbar ƙwayoyin cuta na 26 zuwa 32 kilobases tsakanin ƙwayoyin cuta na RNA an kira su CoVs saboda yanayin su na kama da kambi a ƙarƙashin microscope na lantarki.
A tsarin, CoVs suna da kwayoyin halitta marasa rarrabuwa waɗanda ke da ƙungiya iri ɗaya.
Kimanin kashi biyu bisa uku na genom din sun ƙunshi manyan manyan manyan tsarin karatu (ORF1a da ORF1b), waɗanda aka fassara zuwa pp1a da pp1ab replicase polyproteins.
Ana sake sarrafa polyproteins don samar da sunadarai 16 wadanda ba na tsarin ba, wanda aka sanya nsp1 ~ 16.
Rashin ɓangaren kwayoyin halitta ya ƙunshi ORFs don furotin na tsarin, ciki har da spike (S), envelope (E), membrane (M) da nucleoprotein (N).
An kuma sanya wasu furotin na kayan aiki na musamman ta hanyar tsarin CoV daban-daban.
Dangane da bambancin jerin sunadarai, ana rarraba CoVs zuwa jinsuna huɗu (alpha-CoV, beta-CoV, gamma-CoV da delta-CoV), daga cikinsu jinsunan beta-CoV suna ƙunshe da yawancin HCoVs kuma an raba su zuwa zuriya huɗu (A, B, C da D).
Shaidar ilimin lissafi ta nuna cewa bats da rodents suna aiki a matsayin tushen gene na yawancin alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune babban tanadin gamma-CoVs da delta-CoVs.
Shekaru dubbai, CoVs sun ci gaba da ƙetare shinge na jinsuna kuma wasu sun fito a matsayin manyan cututtukan mutum.
Ya zuwa yanzu, an san nau'ikan CoV bakwai na mutum (HCoVs).
Daga cikinsu HCoV-229E da HCoV-NL63 sune alpha-CoVs.
Sauran beta-CoVs guda biyar sun haɗa da HCoV-OC43, HCoV-HKU1, mawuyacin cututtukan numfashi na cutar coronavirus (SARS-CoV), cutar coronavirus ta ciwon huhu ta Gabas ta Tsakiya (MERS-CoV) da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 yawanci suna haifar da alamun bayyanar cututtuka, kamar sanyi na yau da kullun da / ko fitsari.
Sabanin haka, SARS-CoV, MERS-CoV da sabon gano SARS-CoV-2 suna da cutar cututtuka sosai, suna haifar da kamuwa da cututtukan ƙananan hanyoyin numfashi a cikin marasa lafiya da yawa tare da mafi girman damar haɓaka cututtukan cututtukan numfashi mai tsanani (ARDS) da bayyanar cututtukan huhu.
An ware nau'in HCoV-229E na farko, B814, daga zubar da hanci na marasa lafiya da mura a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an tara ƙarin ilimi ta hanyar nazarin zurfi akan HCoV-229E da HCoV-OC43, duka biyun suna haifar da alamun da ke iyakance kansu.
A zahiri, an yarda da ra'ayin cewa kamuwa da cutar HCoVs gabaɗaya ba ta da lahani har sai barkewar SARS.
Cutar SARS da ta faru a shekara ta 2003 ita ce mafi muni a tarihin zamani, ta kamu da mutane sama da 8,000 tare da mutuwar kashi 10% na cutar.
Shekaru goma bayan haka, annobar cutar ta hanyar numfashi ta Gabas ta Tsakiya (MERS) ta jawo ci gaba da yaduwar cutar a yankin Larabawa kuma ta bazu zuwa sauran duniya.
Sabuwar cutar HCoV ta 2019 (2019-nCoV), wanda daga baya aka sake masa suna SARS-CoV-2, ita ce mai haifar da annobar cutar coronavirus ta 2019 (COVID-19), wanda ya kashe fiye da 3,120 kuma ya kamu da mutane sama da 91,000 a ranar 3 ga Maris, 2020.
An yi ta yin gargadi kuma dole ne duniya ta shirya don annobar SARS-CoV-2 mai zuwa.
Dukkanin HCoVs bakwai suna da asalin zoonotic daga bats, beraye ko dabbobi na gida.
Lines da yawa na shaida suna tallafawa asalin juyin halitta na duk HCoVs daga bats, inda ƙwayoyin cuta suka dace da kyau kuma ba su da cutar amma suna nuna bambancin kwayoyin halitta mai yawa.
Cutar COVID-19 ta kawo gagarumin kalubale na kiwon lafiya, kimiyya, zamantakewa da kuma halin kirki ga Sin da duniya.
Bin diddigin asalin HCoVs na zoonotic yana ba da tsarin fahimtar tarihin halitta, ƙarfin motsawa da abubuwan ƙuntatawa na tsalle-tsalle na jinsuna.
Wannan kuma na iya jagorantar ko sauƙaƙe binciken tanadi, matsakaici da haɓaka dabbobi masu karɓar bakuncin SARS-CoV-2, tare da mahimman tasirin rigakafin ɓarkewar gaba.
A cikin wannan bita mun gabatar da bayyani game da asalin zoonotic, watsa tsakanin jinsuna da kuma kamuwa da cutar HCoVs.
Musamman, muna nunawa da tattauna batun gama gari cewa ƙwayoyin cuta na HCoVs na iyaye galibi ba su da cutar a cikin masu karɓar bakuncin su na halitta amma sun zama masu cutar bayan watsa tsakanin nau'ikan zuwa sabon mai karɓar.
Mun kuma sake nazarin yanayin juyin halittar HCoV inda karuwar kamuwa da cutar sau da yawa yakan zo tare da raguwar cutar.
An kuma tattauna sakamakon barkewar cutar SARS-CoV-2 a wannan mahallin.
An san dabbobi tun daga ƙarshen shekarun 1930.
Kafin warewar farko ta HCoV-229E strain B814 daga fitowar hanci na marasa lafiya waɗanda suka kamu da sanyi na yau da kullun, an ware nau'ikan CoVs daban-daban a cikin dabbobi daban-daban da suka kamu da cutar, gami da turkey, linzamin kwamfuta, saniya, alade, cat da kare.
A cikin shekarun da suka gabata, an gano HCoVs bakwai.
Takaitaccen taƙaitaccen tarihin gano HCoV a cikin tsari na lokaci (Table 1) zai zama mai ba da bayani da kuma koyawa.
An ware nau'in HCoV-229E na farko daga hanyoyin numfashi na marasa lafiya da ke da kamuwa da cutar ta hanyar numfashi a shekara ta 1966, kuma daga baya an daidaita shi don girma a cikin layukan ƙwayoyin huhu na WI-38.
Marasa lafiya da ke kamuwa da cutar HCoV-229E sun nuna alamun sanyi na yau da kullun, gami da ciwon kai, cizon yatsa, rashin lafiya da ciwon wuya, tare da zazzabi da tari da aka gani a cikin 10 ~ 20% na lokuta.
Daga baya a 1967, an ware HCoV-OC43 daga al'adun kwayoyin halitta da kuma wucewa ta hanyar layi a cikin kwakwalwar beraye masu shayarwa.
Abubuwan asibiti na kamuwa da cutar HCoV-OC43 suna kama da waɗanda HCoV-229E ya haifar, wanda ba a iya bambanta su da bayyanar cututtuka tare da sauran cututtukan hanyoyin numfashi kamar ƙwayoyin cuta na A da rhinoviruses.
Dukansu HCoV-229E da HCoV-OC43 suna rarraba a duniya, kuma suna da saurin watsawa a lokacin hunturu a cikin yanayin zafi.
Yawanci, lokacin shan waɗannan ƙwayoyin cuta guda biyu bai kai mako ɗaya ba, kuma a bi shi da kusan mako biyu na rashin lafiya.
A cewar wani binciken da aka yi na masu sa kai a kan mutane, mutane masu lafiya da suka kamu da cutar HCoV-229E sun kamu da sanyi mai sauƙi.
Wasu marasa lafiya da ke fama da rashin lafiyan jiki ne kawai suka kamu da cututtukan ƙananan hanyoyin numfashi.
SARS, wanda aka fi sani da atypical pneumonia, shine cutar ta farko da aka rubuta da kyau ta hanyar HCoV a tarihin ɗan adam kuma wakili na etiological shine SARS-CoV, HCoV na uku da aka gano.
Ana iya gano farkon cutar SARS a ƙarshen 2002 a lardin Guangdong na kasar Sin.
Cutar SARS ta haifar da shari'o'i 8,096 da aka ruwaito tare da mutuwar 774, wanda ya bazu a cikin ƙasashe da nahiyoyi da yawa.
Baya ga masu yadawa, an kiyasta cewa kowane hali zai iya haifar da kimanin shari'o'i biyu na biyu, tare da lokacin incuba na kwanaki 4 zuwa 7 kuma ƙwanƙolin ƙwayar cuta yana bayyana a ranar 10 ta rashin lafiya.
Marasa lafiya da suka kamu da SARS-CoV da farko suna da myalgia, ciwon kai, zazzabi, rashin lafiya da sanyi, sannan dyspnea, tari da wahalar numfashi a matsayin alamun bayyanar cututtuka.
Lymphopenia, gwajin aikin hanta da kuma karuwar creatine kinase sune cututtukan dakin gwaje-gwaje na SARS.
An kuma lura da lalacewar alveolar da ta bazu, yaduwar kwayoyin epithelial da karuwar macrophages a cikin marasa lafiya na SARS.
Kimanin kashi 20-30 na marasa lafiya suna bukatar kulawa mai tsanani da kuma iska mai iska.
Baya ga ƙananan hanyoyin numfashi, gabobin jiki da yawa ciki har da na gastrointestinal tract, hanta da koda na iya kamuwa da cutar a cikin waɗannan mawuyacin hali, yawanci tare da hadari na cytokine, wanda zai iya zama mai kisa musamman a cikin marasa lafiya da ke da rashin lafiya.
An fara ware cutar ne daga binciken da aka yi a huhu na wani dangi na mai cutar da ya zo Hong Kong daga Guangzhou.
Tun daga lokacin, an yi ƙoƙari sosai wajen gudanar da bincike kan cutar HCoV.
An ware HCoV-NL63 daga wani yaro mai watanni 7 daga Netherlands a ƙarshen 2004.
Da farko an gano cewa yana da yawa a cikin yara ƙanana, tsofaffi da marasa lafiya da ke fama da cututtukan numfashi.
Bayyana coryza, conjunctivitis, zazzabi, da bronchiolitis na kowa ne a cikin cutar da HCoV-NL63 ta haifar.
Wani bincike mai zaman kansa ya bayyana warewar wannan kwayar daga samfurin hanci daga wani yaro mai watanni 8 da ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi a Netherlands, a zahiri an rarraba shi a duniya.
An kiyasta cewa HCoV-NL63 yana da kusan kashi 4.7% na cututtukan numfashi na yau da kullun, kuma mafi yawan cututtukan yana faruwa a farkon bazara, bazara da hunturu.
HCoV-NL63 yana da alaƙa da cututtukan laryngitis na hanawa, wanda aka fi sani da croup.
A wannan shekarar, an ware HCoV-HKU1 daga wani mutum mai shekaru 71 wanda aka kwantar da shi asibiti tare da ciwon huhu da bronchiolitis a Hong Kong.
Baya ga cutar huhu da bronchiolitis da aka samu a cikin al'umma, an ruwaito HCoV-HKU1 yana da alaƙa da matsanancin ɓacin asma.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, an gano HCoV-HKU1 a duk duniya, yana haifar da cututtukan numfashi masu sauƙi.
Dukkanin wadannan HCoVs huɗu da aka samu a cikin al'umma sun dace da mutane sosai kuma gabaɗaya ba sa da yiwuwar canzawa don haifar da cututtukan cututtuka masu cutar, kodayake haɗari sun faru saboda dalilai da ba a sani ba kamar a cikin wani hali mai wuya na nau'in HCoV-NL63, wanda kwanan nan aka ruwaito yana haifar da kamuwa da cutar ta hanyar numfashi a cikin China.
Gabaɗaya, lokacin da waɗannan HCoVs suka sami ikon watsawa yadda ya kamata kuma su ci gaba da kasancewa cikin mutane, suna zama marasa ƙarfi ko masu cutar.
An fara ware MERS-CoV a shekarar 2012 daga huhu na wani mai shekaru 60 da haihuwa wanda ya kamu da cutar huhu mai tsanani da kuma rashin aikin koda a Saudiyya.
Yayin da yawancin lokuta da aka tabbatar da su a dakin gwaje-gwaje suka fito ne daga Gabas ta Tsakiya, an ruwaito wasu lokuta da aka shigo da su daga ƙasashen Turai da Tunisia da kuma wasu ƙasashen da aka yi amfani da su wajen yin hulɗa da su.
Wani annobar na biyu ya faru a Koriya ta Kudu a shekarar 2015 tare da kamuwa da cutar 186 da aka tabbatar.
Halin da ake nunawa a asibiti na MERS ya yi kama da na SARS, wanda ake nuna shi ta hanyar ci gaba da kamuwa da cutar huhu.
Ba kamar SARS ba, yawancin marasa lafiya da ke da MERS sun sami rashin aikin koda mai tsanani, wanda har yanzu ya zama na musamman ga MERS tsakanin cututtukan da HCoV ke haifarwa.
Fiye da kashi 30% na marasa lafiya suna da alamun cututtukan gastrointestinal, kamar fitsari da amai.
Ya zuwa 14 ga Fabrairu, 2020, an ba da rahoton fiye da shari'o'in da aka tabbatar da su a cikin dakin gwaje-gwaje sama da 2500 tare da yawan mutuwar mutane da suka kai kashi 34.4%, wanda ya sa MERS-CoV ya zama ɗayan ƙwayoyin cuta mafi lalacewa da aka sani ga mutane.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano tarin marasa lafiya na cutar huhu da aka sani a baya cewa suna da alaƙa da kamuwa da cutar SARS-CoV-2 a Wuhan, lardin Hubei, China.
Hukumar Lafiya ta Duniya ta ayyana barkewar kamuwa da cutar ta hanyar numfashi ta kasa da ta haifar da SARS-CoV-2 a matsayin gaggawa na Lafiya ta Jama'a na Kula da Lafiya ta Duniya kuma ta sanya sunan cutar COVID-19.
Ya zuwa 3 ga Maris, 2020, an tabbatar da shari'o'i 90,053 a duk duniya, tare da mutuwar kashi 3.4%.
A cikin wannan yanayin, yawan mutuwar mutane a Hubei, China, ya kai 4.2%, yayin da a waje da shi ya kai 1.2%.
SARS-CoV-2 yana haifar da kamuwa da cutar numfashi mai tsanani kamar SARS-CoV da MERS-CoV, wanda aka gabatar a matsayin zazzabi, tari da rashin numfashi.
Ana kuma ganin ciwon ciki a wasu marasa lafiya.
Ciwon huhu yana ɗaya daga cikin alamun da suka fi tsanani kuma yana iya saurin zama ciwon huhu mai tsanani.
Kodayake SARS-CoV da SARS-CoV-2 suna da kamanceceniya sosai saboda homology na jerin nucleotide mai girma na 82%, suna haɗuwa cikin rassa daban-daban a cikin itacen phylogenetic.
SARS-CoV-2 a bayyane yake ba shi da ƙwayoyin cuta amma yana da sauƙin watsawa idan aka kwatanta da SARS-CoV da MERS-CoV.
An bayar da rahoton mutane marasa alamun cutar da suka kamu da cutar SARS-CoV-2 kuma suna iya taimakawa wajen saurin yaduwar ta a duniya.
Kwatanta da bambanta SARS-CoV-2 da sauran HCoVs shida ya nuna kamanceceniya da bambance-bambance masu ban sha'awa.
Na farko, lokacin incuba da tsawon lokacin cutar HCoV suna kama da juna.
A wannan batun, SARS-CoV-2 yana bin yanayin gaba ɗaya na sauran HCoVs shida.
Na biyu, tsanani na bayyanar cututtukan COVID-19 yana tsakanin SARS-CoV da HCoVs huɗu da aka samu a cikin al'umma (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da cutar SARS-CoV-2 tana nuna halaye waɗanda aka fi gani yayin kamuwa da cutar HCoVs da aka samu a cikin al'umma, gami da gabatar da marasa takamaiman, masu sauƙi ko ma babu alamun cutar.
A gefe guda kuma, ana iya ganin karamin karamin adadin masu fama da COVID-19 kamar yadda ake gani a cikin cutar SARS-CoV, kodayake rabo ya ɗan ƙasa.
Na uku, watsa SARS-CoV-2 kuma yana nuna wasu halaye masu ban sha'awa na HCoVs da aka samo daga al'umma da SARS-CoV.
A gefe guda, watsawar SARS-CoV-2 tana da girma kamar HCoVs da aka samu a cikin al'umma.
A gefe guda kuma, har yanzu ana buƙatar tabbatar da ko watsawar SARS-CoV-2 ta ragu bayan wucewa a cikin mutane kamar yadda yake a cikin lokuta na SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin samfurori na ƙura.
Ko watsawar SARS-CoV-2 ta hanyar bakin tayi tana taka muhimmiyar rawa kamar yadda take a cikin SARS-CoV aƙalla a ƙarƙashin wasu yanayi har yanzu ana buƙatar bayyana ta hanyar nazarin gaba.
Hakanan yana da matukar sha'awa don ganin ko SARS-CoV-2 na iya nuna yanayi kamar yadda yake a cikin yanayin HCoVs da aka samo daga al'umma.
Duk da haka, siffofin SARS-CoV-2 ciki har da watsawa, kamuwa da cuta da kuma yaduwar ci gaba bayan wucewa a cikin mutane zai yi tasiri a kan makomar ƙarshe na barkewar cutar COVID-19.
Dukkanin HCoVs huɗu da aka samo daga al'umma waɗanda ke haifar da bayyanar cututtuka masu sauƙi an daidaita su da kyau ga mutane.
Daga wani hangen nesa, yana iya zama gaskiya cewa mutane sun dace da waɗannan HCoVs huɗu.
A wasu kalmomin, duka biyu na iya zama masu tsira daga annobar HCoV ta dā.
An kawar da HCoVs da ke haifar da cututtuka masu tsanani a cikin mutane da kuma mutane da suka sami cututtukan HCoV masu tsanani.
Don wannan ya faru, HCoVs dole ne su sake yin yawa a cikin mutane zuwa isa don ba da damar tarin canje-canje masu dacewa waɗanda ke magance abubuwan ƙuntatawa na mai masaukin baki.
A wannan ma'anar, yayin da cutar SARS-CoV-2 ta daɗe kuma ta sami mutane da yawa, hakan zai iya sa ta dace da mutane sosai.
Idan ya daidaita da kyau, zai yi wuya a dakatar da yaduwarsa ga mutane ta hanyar killacewa ko kuma wasu matakan hana kamuwa da cuta.
Shekaru da yawa, CoVs huɗu da aka samu a cikin al'umma suna yawo a cikin mutane, suna jawo sanyi a cikin mutane masu rashin ƙarfi.
Waɗannan ƙwayoyin ba sa bukatar wani tanadi na dabbobi.
Akasin haka, SARS-CoV da MERS-CoV masu cutar cututtuka ba su dace da mutane ba kuma ba za a iya ci gaba da watsa su a cikin mutane ba.
Suna bukatar su ci gaba da kuma yada su a cikin wuraren da suke ajiye su kuma su nemi damar da za su iya kai wa mutane da za su iya kai wa gabbobin, wataƙila ta hanyar ɗaya ko fiye da masu karɓar baƙi da kuma masu karfafawa.
SARS-CoV-2 yana da halaye waɗanda suke kama da SARS-CoV/MERS-CoV da HCoVs huɗu da al'umma ta samo.
Yana da matukar yaduwa kamar HCoVs da aka samu a cikin al'umma, aƙalla a yanzu.
Koyaya, yana da ƙwayoyin cuta fiye da HCoVs da aka samo daga al'umma kuma ba shi da ƙwayoyin cuta fiye da SARS-CoV ko MERS-CoV.
Ya rage a ga ko zai dace da mutane kuma ya yi yawo a cikin mutane ba tare da wani tanadi ko kuma wani dabba mai gida ba.
Kafin tattauna asalin dabbobi na HCoVs, zai taimaka mana sosai don tattauna ma'anoni da halaye na juyin halitta, na halitta, tanadi, matsakaici da haɓaka masu karɓar bakuncin HCoVs.
Dabba tana aiki a matsayin mai ɗaukar hoto na HCoV idan tana da kakan da ke da alaƙa da juna wanda ke da babban homology a matakin jerin nucleotide.
Kwayar cutar ta asali yawanci tana da kyau kuma ba ta da cutar a cikin wannan mai masaukin.
Hakazalika, wani gidan ajiya mai masaukin baki yana riƙe da HCoV a kai a kai kuma na dogon lokaci.
A lokuta biyu, masu karɓar baƙi suna kamuwa da cutar ta halitta kuma su ne masu karɓar HCoV ko kwayar iyayenta.
Akasin haka, idan HCoV an gabatar da shi zuwa ga wani mai masaukin baki kafin ko kusa da gabatarwarsa ga mutane, ba a daidaita shi da kyau ga sabon mai masaukin ba kuma galibi yana da cututtuka.
Wannan mai watsa shiri na tsakiya na iya zama tushen zoonotic na kamuwa da cutar ɗan adam kuma yana taka rawar mai karfafawa ta hanyar ba da damar kwayar cutar ta sake karuwa sannan kuma ya watsa ta ga mutane don ƙara girman kamuwa da cutar ɗan adam.
HCoV na iya kamuwa da kamuwa da cutar ta mutuwa idan ba zai iya ci gaba da watsawa a cikin mai masaukin baki ba.
Akasin haka, HCoVs na iya daidaitawa da mai masaukin baki har ma da kafa cutar ta dindindin.
A wannan yanayin, mai karɓar bakuncin na tsakiya ya zama mai karɓar bakuncin ajiyar ruwa na halitta.
Bayanai na cututtuka sun nuna a baya cewa cutar ta SARS ta kasance tana da alaƙa da dabbobi masu farauta.
Binciken da aka yi game da cutar ta seroprevalence ya nuna cewa masu sayar da dabbobi suna da yawan cutar IgG da ke hana cutar ta SARS-CoV idan aka kwatanta da na yawan jama'a.
An fara gano masks na dabbobi masu cin nama (Paguma larvata) da kuma kare racoon a kasuwannin dabbobi masu rai don ɗaukar kwayar cutar SARS-CoV-kamar wacce kusan ta dace da SARS-CoV.
Wannan an tallafawa ta hanyar kai tsaye ta hanyar gaskiyar cewa ba a sake ba da rahoton SARS ba bayan an kashe dukkan 'yan tsirarun a kasuwannin.
Koyaya, an ruwaito cewa masks na dabbar dabba daga daji ko gonaki ba tare da haɗuwa da kasuwannin dabbobi masu rai ba sun kasance masu ƙyama ga SARS-CoV, yana ba da shawarar cewa masks na dabba na dabba na iya zama matsakaiciyar mai karfafawa kawai amma ba ajiyar halitta na SARS-CoV ba.
Abin lura, tun da kashi 80% na dabbobi daban-daban a kasuwannin Guangzhou suna da rigakafin cutar SARS-CoV, ba za a iya cire yiwuwar cewa nau'ikan ƙananan dabbobi masu shayarwa na iya zama masu karfafawa na SARS-CoV ba.
Dukkanin wadannan sun bayyana a matsayin masu daukar nauyin SARS-CoV.
Binciken da aka yi na gano dabba mai gida na SARS-CoV ya bayyana wani nau'in bat CoV, wanda ake kira SARS-related Rhinolophus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), wanda ke wanzu a cikin bat na doki na kasar Sin.
Wadannan bats suna da kyau ga anti-SARS-CoV antibodies da kuma tsarin kwayoyin halitta na SARSr-Rh-BatCoV HKU3.
Wannan da sauran CoVs na bats suna da daidaituwa na kashi 88-92% na jerin nucleotide tare da SARS-CoV.
Wadannan binciken sun kafa tushe ga sabon ra'ayi cewa bats dauki bakuncin fitowar cututtukan mutum.
An gano wasu CoVs masu kama da SARS (SL-CoVs) daga bats, amma babu wanda sai ɗaya da aka sanya WIV1 za a iya ware shi a matsayin kwayar rai.
An san enzyme 2 mai canza angiotensin na mutum (ACE2) shine mai karɓar SARS-CoV.
WIV1 wanda aka samo daga samfurin ƙwayoyin halittar bats ya nuna cewa yana amfani da bat, civet da ACE2 na mutum a matsayin mai karɓar shiga cikin sel.
Abin mamaki, kwayoyin cutar SARS na marasa lafiya sun iya hana WIV1.
Ya zuwa yanzu, WIV1 yana wakiltar magajin SARS-CoV mafi kusanci a cikin bats, yana raba homology na kashi 95% na jerin nucleotide.
Kodayake babban homology tsakanin waɗannan ƙwayoyin cuta biyu, ana ganin cewa WIV1 ba shine ainihin mahaifa na SARS-CoV ba kuma bats ba su da gidan ajiyar SARS-CoV.
Nazarin Phylogenetic ya tattara MERS-CoV zuwa rukuni ɗaya da bats CoV-HKU4 da bats CoV-HKU5.
Bat CoV-HKU4 da MERS-CoV suna amfani da mai karɓar mai karɓar guda ɗaya, dipeptidyl peptidase 4 (DPP4), don shigar da kwayar cutar.
RNA-daidaitaccen RNA polymerase jerin MERS-CoV suna da kusa da juna a cikin bat beta-CoVs da aka gano daga Turai da Afirka.
Har zuwa yanzu, ba a samu wani MERS-CoV mai rai a cikin bats na daji ba.
MERS-CoV da kuma dan uwansa mafi kusa CoV-HKU25 suna da homology na kashi 87% na jerin nucleotide.
Saboda haka, bats bazai iya zama mai karɓar bakuncin MERS-CoV ba.
A gefe guda kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa rakuman dromedary suna da cutar seropositive ga kwayoyin rigakafin da ke hana cutar ta MERS-CoV, kamar yadda rakuman da ke Gabas ta Tsakiya suka samo asali a ƙasashen Afirka da yawa.
An ware MERS-CoV mai rai wanda ya yi daidai da kwayar cutar da aka samu a cikin mutane daga swabs na hanci na raƙuma dromedary, wanda ya ƙara nuna cewa raƙuma suna aiki a matsayin mai masaukin ajiyar MERS-CoV mai aminci.
Hakanan yana da mahimmanci a lura cewa a gaba ɗaya ana ganin bayyanar cututtuka masu sauƙi amma an lura da yaduwar cutar a cikin raƙuma waɗanda aka kamu da su ta hanyar gwaji da MERS-CoV.
Abin lura, raƙuma da suka kamu da cutar suna zubar da ƙwayoyin cuta ba kawai ta hanyar numfashi ba amma ta hanyar ƙwayoyin ƙwayoyin cuta da kuma bakin ciki, wanda kuma shine babban hanyar zubar da ƙwayoyin cuta daga bats.
Duk da haka, har yanzu akwai tambayoyi tun da yawancin mutane da aka tabbatar da cutar MERS ba su da tarihin tuntuɓar raƙuma kafin bayyanar cututtuka, wanda ya dace da hanyar watsawa daga mutum zuwa mutum ko hanyoyin watsawa da ba a sani ba da suka shafi jinsunan dabbobi da ba a san su ba waɗanda ke da MERS-CoV.
SARS-CoV-2 yana da homology na nucleotide na 96.2% tare da bat CoV RaTG13 wanda aka keɓe daga Rhinolophus affinis bats.
Kamar yadda yake a cikin shari'o'in SARS-CoV da MERS-CoV, bambancin tsari tsakanin SARS-CoV-2 da RaTG13 ya yi yawa don sanya alaƙar iyaye.
Wato, bats bazai iya zama mai karɓar bakuncin SARS-CoV-2 ba sai dai idan an gano kusan CoVs iri ɗaya na bats a nan gaba.
Ana iya ɗauka cewa, masu karɓar bakuncin dabbobi na SARS-CoV-2 ya kamata su kasance cikin jinsunan dabbobin daji da aka sayar da su kuma aka kashe su a Kasuwar Kasuwancin Kayayyakin Ruwa ta Huanan, wanda yawancin farkon shari'o'in COVID-19 suka danganta da su, wanda ke nuna yiwuwar watsa dabba zuwa mutum.
Yawancin binciken da aka yi kwanan nan dangane da tsarin metagenomic sun nuna cewa ƙungiyar ƙananan dabbobi masu shayarwa da ke cikin haɗari da ake kira pangolins (Manis javanica) na iya ɗaukar tsoffin beta-CoVs da suka shafi SARS-CoV-2.
Waɗannan sabbin kwayoyin halitta na pangolin CoV suna da daidaituwa na 85-92% na jerin nucleotide tare da SARS-CoV-2.
Duk da haka, suna da alaka da RaTG13 tare da kusan 90% na ainihi a matakin jerin nucleotide.
Sun haɗu cikin ƙananan layin biyu na ƙwayoyin cuta masu kama da SARS-CoV-2 a cikin itacen phylogenetic, ɗayan wanda ke da yankin haɗin mai karɓa (RBD) mai kama da SARS-CoV-2, tare da 97.4% amino acid jerin sunayen.
A akasin haka, RBDs na SARS-CoV-2 da RaTG13 sun fi bambanta, kodayake suna da digiri mafi girma na homology na jerin a cikin dukkanin kwayoyin halitta.
Wani binciken da aka yi a baya kan pangolins masu rashin lafiya ya kuma ba da rahoton gano ƙwayoyin cuta na kwayar cuta daga samfurori na huhu, wanda ya bayyana cewa yana da alaƙa da SARS-CoV-2.
Wannan binciken ya ɗauki hanyoyin haɗuwa daban-daban da kuma sarrafawa ta hannu don samar da jerin kwayoyin halitta na ɓangare wanda ya ƙunshi kusan 86.3% na cikakken ƙwayar cuta.
Ba za mu iya hana yiwuwar cewa pangolin yana ɗaya daga cikin dabbobi masu karɓar bakuncin SARS-CoV-2.
Koyaya, a halin yanzu babu wata hujja da ke tallafawa asalin pangolin kai tsaye na SARS-CoV-2 saboda bambancin tsari tsakanin SARS-CoV-2 da beta-CoVs masu alaƙa da pangolin SARS-CoV-2.
Bugu da kari, nisan da ke tsakanin SARS-CoV-2 da RaTG13 ya fi na tsakanin SARS-CoV-2 da pangolin SARS-CoV-2 da ke da alaƙa da beta-CoVs.
Hanyar juyin halitta na SARS-CoV-2 a cikin bats, pangolins da sauran dabbobi masu shayarwa har yanzu ba a kafa su ba.
Yayin da aka sami homology mafi girma a cikin RBDs tsakanin SARS-CoV-2 da pangolin, SARS-CoV-2 da ke da alaƙa da beta-CoVs, SARS-CoV-2 da RaTG13 suna da homology mafi girma a cikin tsarin kwayoyin halitta.
Yana da matukar zato cewa babban matakin kamanceceniya tsakanin RBDs na pangolin SARS-CoV-2 da ke da alaƙa da beta-CoVs da SARS-CoV-2 yana motsawa ta hanyar juyin halitta mai juyawa wanda ke daidaitawa da zaɓaɓɓu.
Wani takaddama na adawa da shi na goyon bayan sake haɗuwa tsakanin beta-CoV mai alaƙa da SARS-CoV-2 da RaTG13 a cikin nau'in dabbobi na daji na uku.
A matsayin mai motsawa a juyin halitta, sake haɗuwa yana da yawa a tsakanin beta-CoVs.
Har yanzu alƙali ba su san ainihin asalin SARS-CoV-2 ba.
Baya ga HCoVs masu cutar cututtuka, an kuma yi nazarin asalin HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar ilimin lissafi ta nuna cewa duka HCoV-NL63 da HCoV-229E na iya fitowa daga CoVs na bats, yayin da aka sami ƙwayoyin cuta na HCoV-OC43 da HCoV-HKU1 a cikin rodents.
An ruwaito cewa wani cutar ta bat da ake kira ARCoV.2 (Appalachian Ridge CoV) da aka gano a cikin fararen bat na Arewacin Amurka ya nuna dangantaka mai kyau da HCoV-NL63.
A gefe guda, HCoV-229E yana da alaƙa ta hanyar kwayoyin halitta da wani CoV bat, mai suna Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, yayin da aka yi zargin camelids ne kuma a matsayin mai masaukin sa na tsakiya.
Don bayyanawa, an taƙaita ilimin yanzu game da asalin dabbobi na sanannun HCoVs a Hoto 1 da Table 2.
Nazarin Phylogenetic ya ba da hujja game da abubuwan da suka faru na watsa HCoVs tsakanin jinsuna a tarihi.
Lokacin da HCoV-OC43 ya tsallaka nau'in don kamuwa da mutane daga dabbobin gida a kusa da 1890, an rubuta annobar kamuwa da cutar numfashi.
Tarihin watsa HCoV-229E tsakanin jinsuna bai bayyana ba.
An gano alpha-CoVs na bat da ke da alaƙa da HCoV-229E.
Tsakanin su akwai alpaca alpha-CoV.
Akwai shaidu da dama da suka nuna cewa cutar tana yaduwa daga bats zuwa mutane kai tsaye.
Na farko, mutane amma ba alpacas ba za su iya yin hulɗa da bats a cikin wani yanki na muhalli.
Maimakon haka, mutane suna da dangantaka ta kud da kud da alpacas.
Na biyu, alpha-CoVs na bats da ke da alaƙa da HCoV-229E sun bambanta kuma ba su da cutar a cikin bats, yayin da alpaca alpha-CoV ya haifar da barkewar cutar numfashi a cikin dabbobi da aka kamu da cutar.
A ƙarshe, ba a gano alpaca alpha-CoV a cikin dabbobi na daji ba.
Saboda haka, ba za a iya ware yiwuwar cewa alpacas za su sami alpha-CoV mai alaƙa da HCoV-229E daga mutane ba.
A gaskiya, bats sune tushen kai tsaye na cututtukan cututtukan mutum ciki har da kwayar cutar rabies, kwayar cutar Ebola, kwayar Nipah da kwayar Hendra.
Saboda haka ba abin mamaki bane cewa bats na iya watsa HCoV-229E kai tsaye ga mutane.
A madadin haka, yayin da alpha-CoVs na bats ke aiki a matsayin tarin kwayoyin HCoV-229E, alpacas da raƙuma dromedary na iya aiki a matsayin masu watsa shirye-shiryen watsa shirye-shiryen watsa kwayar cutar ga mutane, daidai kamar yadda yake a cikin yanayin MERS-CoV.
MERS-CoV misali ne mai kyau na watsa tsakanin jinsuna daga bats zuwa dromedary raƙuma da kuma daga dromedary raƙuma zuwa mutane.
An san asalin juyin halitta na MERS-CoV daga bats a farkon ganowa kuma an kuma karfafa shi ta hanyar binciken da aka samu.
A bayyane yake cewa bats suna samar da tarin kwayoyin cutar don musayar kwayoyin halitta tsakanin jinsuna da kuma watsa tsakanin jinsuna.
Rayuwa mai tsawo, yankunan da ke cike da mutane, da kuma dangantaka da mutane da kuma iyawar tashi suna da kyau sosai don yatsa su zama 'yan ta'adda masu yada kwayar cutar.
A gefe guda, an gabatar da MERS-CoV ga raƙuman dromedary na shekaru da yawa.
Yana da kyau don waɗannan raƙuman da suka juya daga wani matsakaici zuwa wani barga da kuma na halitta reservoir host.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana riƙe da ƙarancin canjin canji a cikin waɗannan dabbobi.
Yaduwar ta zuwa ga mutane shine hatsari kuma mutane sun kasance mai ɗaukar hoto na MERS-CoV saboda ba za a iya ci gaba da watsa ta ba.
Sabanin rawar raƙuma a watsa cutar MERS-CoV, rawar pangolin, idan akwai, a watsa SARS-CoV-2 ta bambanta.
Musamman, pangolin beta-CoVs suna da cutar cututtuka sosai a cikin pangolins.
Suna iya zama masu karɓar bakuncin beta-CoVs masu alaƙa da SARS-CoV-2, kamar yadda suke da civets a cikin yanayin SARS-CoV.
Dole ne a ware ko kuma a ware wasu yiwuwar watsa SARS-CoV-2 tsakanin jinsuna daga dabbobi zuwa mutane a cikin nazarin gaba.
Da farko, bats na iya zama mai karɓar bakuncin wani kwayar cutar SARS-CoV-2 da ke da alaƙa da kusan iri ɗaya da SARS-CoV-2.
Mutane za su iya raba yanayin halittu da bats ta hanyar yanka nama ko hakar kwal.
Na biyu, pangolins na iya kasancewa ɗaya daga cikin masu karfafawa na matsakaici wanda aka gabatar da sabon kwayar cutar SARS-CoV-2.
Mutane suna kamuwa da cutar ta hanyar cin nama da kuma cin nama.
Yana yiwuwa cewa dabbobi masu shayarwa da yawa ciki har da dabbobin gida suna da saukin kamuwa da SARS-CoV-2.
Ana buƙatar binciken dabbobi na gida da na daji don gano kwayoyin cutar.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da daidaitawar SARS-CoV-2 na iya faruwa a cikin nau'in na uku wanda ke da hulɗa da bats da pangolins.
Ana ci gaba da bincike kan asalin dabbobi na SARS-CoV-2.
Baya ga nau'ikan dabbobi masu gida, manyan dalilai guda uku na ɓangaren kwayar cutar suna da mahimmanci wajen sauƙaƙa CoVs don ƙetare shingen nau'in.
Da farko, yawan mutations da suke samu a RNA replication.
Idan aka kwatanta da sauran kwayoyin RNA guda ɗaya, ana iya ɗaukar ƙididdigar ƙididdigar ƙididdigar ƙwayoyin cuta na CoVs a matsayin moderate zuwa high tare da matsakaicin adadin maye gurbin da ke ~10-4 maye gurbin a kowace shekara a kowane wuri 2, dangane da matakin daidaitawar CoV zuwa sabbin masu masaukin baki.
CoVs suna da exoribonuclease mai gyarawa, wanda sharewa yana haifar da canzawa mai yawa da raguwa ko ma rashin rayuwa.
Abin sha'awa, an san analog na nucleotide Remdesivir don hana kwayar CoV ta hanyar hana wannan exoribonuclease da RNA-daidaitaccen RNA polymerase.
Remdesivir yana ɗaya daga cikin magungunan anti-SARS-CoV-2 mafi alƙawarin da za a gwada a cikin gwaji na asibiti.
Duk da haka, yawan mutations na CoVs sun fi na masu karɓar su sau miliyan.
Bugu da ƙari, yawanci yawan canjin ya yi yawa idan CoVs ba su dace da mai masaukin ba.
Idan aka kwatanta da SARS-CoV tare da yawan canjin canji, yawan canjin SARS-CoV-2 a bayyane yake ƙasa, yana nuna cewa an daidaita shi da mutane sosai.
Wataƙila an riga an daidaita shi zuwa wani mai kula da gidan da ke kusa da mutane.
Baya ga SARS-CoV-2, wannan kuma ya shafi MERS-CoV, wanda ya dace da raƙuman dromedary.
A ka'idar, ba shi yiwuwa cewa jujjuyawar kwayoyin halitta zai sa alluran rigakafi da magungunan rigakafin cutar SARS-CoV-2 ba su da tasiri cikin sauri.
Na biyu, babban RNA genome a cikin CoVs yana nuna ƙarin filastik a cikin gyare-gyare na genome don mutations da sake haɗuwa, don haka ƙara yiwuwar co-juyin halitta tsakanin jinsuna, wanda ke da amfani ga fitowar sabon CoVs lokacin da yanayin ya zama dacewa.
Wannan yana goyan bayan manyan ɗakunan karatu na musamman da aka buɗe da kuma ayyukan furotin da aka yi wa lambar zuwa ƙarshen 3′ na kwayoyin halitta.
Na uku, CoVs suna canza samfuran bazuwar da sau da yawa yayin kwafin RNA ta hanyar tsarin copy-choice na musamman.
A cikin mai masaukin da ke aiki a matsayin jirgin ruwa mai haɗuwa, sauyawar zaren yana faruwa sau da yawa yayin rubutun RNA na CoV.
Babban homologous full-length da subgenomic RNAs iya sake haɗuwa don samar da sabon CoVs.
An sami shaidar phylogenetic na sake haɗuwa ta halitta a cikin duka HCoV-HKU1 da HCoV-OC43, da kuma CoVs na dabba kamar bats SL-CoV da batCoV-HKU9.
Hadin gwiwar kwayar cuta da mai watsawa dangane da watsawa
Baya ga abubuwa uku na kwayar cuta da aka ambata a sama, hulɗar kwayar cuta da mai karɓar mai karɓar wani muhimmin abu ne mai tasiri a watsa tsakanin jinsuna.
A nan, ana ɗaukar sake haɗuwa da SARS-CoV a matsayin misali na yau da kullun, wanda kuma ya nuna hujjojin zaɓi mai kyau yayin abubuwan watsa tsakanin nau'ikan.
Dangane da kwatancen bincike tsakanin ɓangarorin SARS-CoVs na ɗan adam da na ɗan adam, ana tsammanin SARS-CoV ya sami saurin daidaitawa a cikin masu masaukin baki daban-daban, musamman tare da canji a RBD na furotin S.
Gabaɗaya, RBD a cikin furotin S na CoV yana hulɗa da mai karɓar sel kuma ana zaɓar shi sosai ta hanyar amsawar rigakafin mai masaukin baki.
A cikin SARS-CoV, RBD yana cikin amino acid na 318 zuwa 510 akan ɓangaren S1, wanda ke ɗaure da ACE2 na ɗan adam da kuma coreceptors don shigar da kwayar cutar.
RBD na SARS-CoV yana iya gane masu karɓar ACE2 na dabbobi daban-daban, gami da bats, civet, linzamin kwamfuta da kare raccoon, yana ba da damar watsa kwayar cutar tsakanin jinsuna.
A gaskiya ma, an lura da amino acid 6 kawai da suka bambanta da kwayoyin cuta na mutum da na civet a cikin RBD kuma 4 daga cikinsu suna cikin ƙwayar mai ɗaurewa don hulɗa da mai karɓar ACE2.
Civet SARS-CoV yana da K479N da S487T mutations a cikin RBD, wanda zai iya haɓaka haɗuwa da hulɗar furotin mai ƙwanƙwasa tare da mai karɓar ACE2 na ɗan adam.
A wasu kalmomi, waɗannan maye gurbin amino acid biyu na iya zama masu muhimmanci ga daidaitawar kwayar cutar ga mutane.
Yana da mahimmanci cewa SARS-CoV-2 yana da karɓar sel iri ɗaya tare da SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin sashin S1 na furotin S yana nuna cewa alaƙar haɗin furotin S da ACE2 na ɗan adam na iya canzawa.
A zahiri, binciken cryo-EM ya nuna cewa wannan haɗin yana da alaƙa sau 10 zuwa 20 fiye da na tsakanin ƙwayoyin ACE2 na mutum da SARS-CoV S.
Hakanan zai zama da ban sha'awa don tantance ko ana buƙatar wani coreceptor don watsa SARS-CoV-2.
Abin sha'awa, HCoV-NL63 kuma yana ɗaure da ACE2 amma tare da wani ɓangare na S.
Akwai sauran masu karɓar HCoV da yawa, kamar aminopeptidase N don HCoV-229E, da 9-O-acetylated sialic acid don HCoV-OC43.
Hakanan zasu iya ba da lissafin nasarar daidaita waɗannan CoVs a cikin mutane bayan watsa tsakanin jinsuna daga dabbobi masu masaukin su.
Baya ga masu karɓar sel, sakamakon watsa HCoVs tsakanin nau'ikan kuma yana ƙarƙashin sauran abubuwan dogaro da ƙuntatawa na mai masaukin baki.
Bambanci na waɗannan furotin masu karɓar baƙi tsakanin mutane da masu karɓar HCoVs na halitta kamar bats, rakumi dromedary da rodents na iya zama shinge ga watsa tsakanin jinsuna.
HCoVs dole ne su karɓi abubuwan dogaro da mai masaukin baki da kuma lalata abubuwan hana masaukin baki don nasarar watsa tsakanin jinsuna.
A wannan yanayin, ana iya ganowa da kuma nuna halaye masu ƙayyadewa na kwayoyin a wannan muhimmin yanki na hulɗa da kwayar cuta.
Yin bincike ba tare da nuna bambanci ba a cikin dukkanin kwayoyin halittar mutum game da masu karɓar baƙi da abubuwan hanawa SARS-CoV-2 ta amfani da fasahar zamani ta CRISPR na iya zama mai amfani.
Fitowar sabbin HCoVs: koma zuwa ƙasa sifili
Bambancin CoVs na bats yana ba da dama mai yawa don fitowar sabbin HCoVs.
A wannan ma'anar, CoVs na bats suna aiki ne a matsayin tarin kwayoyin HCoVs.
Bugu da kari, saurin maye gurbin da kuma sake haɗuwa da kwayoyin halittar halittar halittar HCoV kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan tsari.
Alal misali, saye ko asarar sababbin kwayoyin gina jiki masu ƙididdigar sunadaran suna da damar canza tsarin ƙwayar cuta.
Daga cikin furotin na SARS-CoV, an yi tunanin ORF8 yana da mahimmanci wajen daidaitawa ga mutane, kamar yadda aka ware kwayar cutar bat da ke da alaƙa da SARS-CoV amma an gano cewa tana ba da furotin ORF8 daban-daban.
An gano fasalin kawar da nucleotide 29 na SARS-CoVs a cikin nau'ikan da aka keɓe a farkon annobar ɗan adam.
Wannan sharewa ya raba ORF8 zuwa ORF8a da ORF8b kuma ana tsammanin shi ne maye gurbin da ke inganta sauyawar masu masauki.
Bugu da ƙari, SARS-CoV yana da tarihin sake haɗuwa da zuriyar alpha- da gamma-CoVs, inda aka gano ƙananan ƙananan yankuna masu haɗuwa a cikin RNA-daidaitaccen RNA polymerase.
An kuma gano wuraren sake haɗuwa a cikin nsp9, mafi yawan nsp10, da kuma sassa na nsp14.
Hakazalika, an nuna cewa annobar MERS-CoV ta sami abubuwan sake haɗuwa tsakanin zuriyoyi daban-daban, wanda ya faru a cikin raƙuman dromedary a Saudi Arabia.
Baya ga SARS-CoV da MERS-CoV, an lura da abubuwan sake haɗuwa a cikin sauran HCoVs, inda HCoVs suka sake haɗuwa da sauran CoVs na dabba a cikin kwayoyin su na ba-tsara.
Ya kamata kuma a yi gargadi cewa zabin mutum na iya taimakawa wajen sauye-sauye da ba a so a cikin kwayoyin halitta na kwayar cuta, wanda ya fi dacewa ya haifar da kawar da ƙwayoyin cuta daga matsin zabin da aka yi, kamar na tsarin rigakafi na mai masaukin baki.
Misali na waɗannan tasirin shine asarar cikakken tsawon ORF4 a cikin nau'in samfurin HCoV-229E, saboda kawar da nucleotide biyu.
Duk da yake ana iya lura da ORF4 mai kyau a cikin kwayar cutar bats da raƙuma da ke da alaƙa da HCoV-229E, alpaca alpha-CoV yana nuna shigar nucleotide guda ɗaya, wanda ya haifar da canjin tsarin.
A ƙarshe amma ba mafi ƙarancin ba, juyin halittar sabon HCoVs kuma yana motsawa ne ta hanyar matsin zaɓa a cikin masu karɓar bakuncin su.
An gano alamun bayyanar cututtuka marasa alama ko kuma masu sauƙi ne kawai lokacin da bats suka kamu da CoVs, wanda ke nuna daidaitawar juna tsakanin CoVs da bats.
An bayyana cewa bats suna da kyau da aka daidaita zuwa CoVs anatomically da physiologically.
Alal misali, lahani a cikin kunna amsa mai ƙonewa a cikin bats yana rage cututtukan da CoVs ke jawowa.
Bugu da ƙari, aikin ƙwayoyin halitta masu kisa a cikin bats an danne shi saboda haɓakar ƙwayar ƙwayar halitta mai kisa mai hanawa NKG2/CD94 da ƙananan matakin bayyanawa na manyan kwayoyin haɗin haɗin gwiwa na aji na I.
Bugu da ƙari, babban matakin nau'ikan oxygen mai aiki (ROS) da aka samar daga babban aikin maye gurbin bats zai iya hana kwafin CoV kuma ya shafi gyarawa ta exoribonuclease, don haka samar da matsin lamba don samar da nau'ikan kwayar cutar da ke da cutar sosai lokacin da aka gabatar da su a cikin sabon mai masaukin baki.
Ƙarin kwayoyin CoV na iya samo asali ta hanyar sake haɗuwa, wanda ke haifar da samun sababbin furotin ko siffofin furotin don daidaitawar mai masaukin baki.
Saboda haka, ba zato ba tsammani bane cewa sabbin HCoVs guda uku sun bayyana a cikin shekaru ashirin da suka gabata.
CoVs ba su da cututtuka ko kuma suna haifar da alamun bayyanar cututtuka a cikin masu karɓar bakinsu kamar bats da raƙuma.
Suna yin kwayar halitta sosai ba tare da su jawo rigakafin jiki ba.
A nan ne asirin dalilin da ya sa ake ganin masu dauke da cututtuka marasa alamar cututtuka da kuma abin da ke haddasa cututtuka masu tsanani a cikin mutum.
Alamun cututtuka sun fi yawa saboda yawan aikin rigakafi da kuma hadarin cytokine inda idan amsawar rigakafi ta kasance mai karfi, cutar huhu za ta fi tsanani.
Akasin haka, a cikin masu dauke da cututtuka marasa alamar cututtuka, an cire maganin rigakafi daga kwayar cutar CoV.
Hanyar da ta dace ta kawar da maganin rigakafi na iya samun sakamako mai kyau a maganin cutar SARS-CoV-2.
Amsar interferon tana da ƙarfi sosai a cikin bats.
Saboda haka, gudanar da interferon nau'in I aƙalla a farkon matakin kamuwa da cutar SARS-CoV-2 a cikin mutane ya kamata ya kasance mai amfani.
Bugu da ƙari, NLRP3 yana da lahani a cikin bats.
Ta wannan hanyar, hana NLRP3 kumburi tare da MCC950 na iya zama da amfani a cikin maganin COVID-19.
Fitowar SARS-CoV-2 ya biyo bayan jigon da SARS-CoV da MERS-CoV suka samo asali.
Yayin da aka gano wani bat beta-CoV wanda ke da kashi 95% na homology na nucleotide tare da SARS-CoV, akwai kuma wani bat-CoV wanda ke da kashi 96% na homology na nucleotide tare da SARS-CoV-2.
Yayin da aka gano cewa civets da sauran dabbobi a kasuwannin suna da ƙwayoyin cuta iri ɗaya da SARS-CoV, ba a gano masu karɓar bakuncin SARS-CoV-2 ba.
An gano pangolin beta-CoVs masu kama da SARS-CoV-2, wanda ke nuna cewa pangolin na iya zama ɗayan masu karɓar bakuncin matsakaici ko pangolin beta-CoVs na iya ba da gudummawar ɓangarorin gene ga sigar ƙarshe ta SARS-CoV-2.
Ko da yake tambayoyi sun kasance, babu wata hujja cewa SARS-CoV-2 an yi ta ne da gangan ko kuma ba zato ba tsammani.
CoVs sun koma cikin hasken rana saboda barkewar cutar SARS-CoV-2.
Nazarin CoVs a cikin bats da sauran dabbobi ya canza tunaninmu sosai game da mahimmancin asalin zoonotic da wuraren adana dabbobi na HCoVs a cikin watsawar ɗan adam.
Shaidu masu yawa sun nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 suna da asalin yatsa kuma ana watsa su ga mutane ta hanyar masu karɓar bakuncin matsakaici.
Ganin cewa kamuwa da cutar SARS-CoV ta samo asali ne daga hulɗa tsakanin mutane da fararen fata a kasuwanni, rufe kasuwanni masu ruwa da kashe fararen fata a ciki na iya kawo ƙarshen annobar SARS.
Ta wannan dalili, ya kamata a cire pangolin daga kasuwannin rigar don hana yaduwar zoonotic, saboda gano zuriya da yawa na pangolin beta-CoVs da ke da alaƙa da SARS-CoV-2.
Koyaya, ko kuma yadda SARS-CoV-2 ke watsawa ga mutane ta hanyar pangolins da sauran dabbobi masu shayarwa har yanzu ana bayyana su a cikin binciken da za a yi a nan gaba.
A gefe guda, MERS-CoV ya kasance a cikin raƙuman dromedary na dogon lokaci.
Waɗannan raƙuman suna da muhimmanci wajen sufuri da kuma tushen nama, madara, fata da kayayyakin ulu ga mutanen yankin.
An rarraba su sosai a Gabas ta Tsakiya da Afirka.
Saboda haka ba zai yiwu a sadaukar da dukkan raƙuma don sarrafa MERS ba, kamar yadda aka yi a kasuwannin dabbobin daji a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da sake barkewar cutar MERS, ya kamata a dauki cikakken tsari don samar da ingantattun alluran rigakafi na MERS-CoV ga raƙuma, a hade da sauran matakan hana kamuwa da cuta.
Tun da ba za mu iya kawar da waɗannan ƙwayoyin ba, za a iya samun sababbin nau'o'in kwayoyin halitta da za su iya haifar da barkewar cutar.
Akwai nau'i-nau'i na CoVs da ke yawo a cikin daji.
Musamman, CoVs na bats da ke da damar zoonotic suna da bambanci sosai.
Akwai dama mai yawa da wadannan CoVs na zoonotic za su samu ci gaba da kuma sake haɗuwa, wanda zai haifar da fitowar sababbin CoVs da za su iya kamuwa da su kuma/ko su zama masu kisa ga mutane a nan gaba.
Ya kamata a daina cin dabbobi a wasu wurare a kasar Sin don rage hulɗa da dabbobi da mutane.
Tare da wahalar SARS, MERS da COVID-19, ya kamata a kafa shiri da shirin amsawa mafi kyau.
A gaskiya, ƙwayoyin cuta da yawa sun daɗe suna wanzuwa a duniya.
Suna zama a cikin wuraren da suke ajiye ruwa har sai an samu damar yin hakan.
Ko da yake bats suna da halaye da yawa da ke taimaka wa mutane su yi yaduwar ƙwayoyin cuta, za a iya rage haɗarin da mutane suke da shi da bats da sauran jinsunan dabbobin daji idan aka koya wa mutane su guji su.
Ana bukatar ci gaba da lura da dabbobi masu shayarwa domin a fahimci yanayin halittu na CoVs da kuma wadanda suke da su a yanayi, wanda zai zama da amfani wajen hana yaduwar dabba zuwa mutum da kuma barkewar cutar a nan gaba.
A ƙarshe, hanya mafi inganci don hana cutar zoonosis ita ce mutane su nisanta kansu daga yanayin halittu na wuraren ajiyar kwayoyin halitta na ƙwayoyin cuta.
Har yanzu akwai wasu abubuwa da suka ɓace a cikin jigon asalin SARS-CoV-2.
Da farko, idan bats suka watsa kwayar cutar SARS-CoV-2 ga pangolins, zai zama da ban sha'awa a ga a wace yanayi bats da pangolins zasu iya raba yanayin muhalli iri ɗaya.
Na biyu, idan bats suna da matsayi na musamman wajen watsawa, ya kamata a san yadda mutane suke tuntuɓar bats.
Na uku, idan dabba mai shayarwa ta uku ta zama mai masaukin baki na gaskiya, dole ne a bayyana yadda take hulɗa da jinsuna daban-daban ciki har da mutane, bats da pangolins.
A ƙarshe, tun da dabbobi masu shayarwa da yawa ciki har da dabbobin gida na iya zama masu saurin kamuwa da SARS-CoV-2, ya kamata a gudanar da saka idanu da kuma kamuwa da cutar gwaji.
Idan ya kasance yatsa, pangolin ko wani dabba mai shayarwa, ana sa ran cewa za a gano SARS-CoV-2 ko kwayoyin iyayensa waɗanda kusan iri ɗaya ne a cikin mahaifarsa na halitta a nan gaba.
Ci gaba da bincike a wannan fannin zai bayyana hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, tare da mahimman tasirin rigakafi da sarrafa COVID-19 a cikin mutane.
Ana bukatar sabunta ka'idodin ganewar asali na COVID-19 mutumin da ake zargi  da kuma mutumin da aka tabbatar 
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagorar shawara mai sauri don ganewa da magani na cutar coronavirus (2019-nCoV) ta shekara ta 2019, kuma wannan jagorar ta ba da kwarewarmu kuma tana da kyakkyawar ma'ana don yaƙar wannan annobar a duk duniya.
Koyaya, cutar coronavirus 2019 (COVID-19) sabuwar cuta ce, hankali da iliminmu suna ƙaruwa a hankali bisa ga binciken bincike da ƙwarewar aikin asibiti; saboda haka, ana sabunta dabarun bincike da magani koyaushe.
A cikin wannan wasikar, mun amsa wani bayani game da jagorarmu kuma mun samar da sabbin ka'idodin ganewar asali na masu zargin hali da masu tabbatar da hali bisa ga sabuwar Jagorar Ganowa da Kulawa don COVID-19 (sarrafa ta bakwai) da Kwamitin Lafiya na Jamhuriyar Jama'ar Sin ya fitar.
A watan Disamba na 2019, sabon coronavirus na 2019 (2019-nCoV) ya haifar da barkewar cutar, wanda yanzu ana kiran shi da sunan cutar coronavirus 2019 (COVID-19) kuma an sanya sunan cutar ta coronavirus 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta bayyana COVID-19 a matsayin annoba.
Don yaƙi da kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta haɓaka jagorar shawara mai sauri kuma an buga ta ta kan layi a cikin Nazarin Likitan Soja a ranar 06 ga Fabrairu 2020.
Tun lokacin da aka buga shi, mutane sun mai da hankali sosai.
Ka lura duk da haka cewa COVID-19 sabon cuta ne, hankali da iliminmu suna ƙaruwa a hankali bisa ga binciken bincike da kuma kwarewar aikin asibiti; saboda haka, ana sabunta dabarun bincike da magani koyaushe.
Misali, Jagorar Bincike da Kula da COVID-19 da Kwamitin Lafiya na Kasa na Jamhuriyar Jama'ar Sin (http://www.nhc.gov.cn/) ya fitar, tsakanin 16 ga Janairu 2020 zuwa 3 ga Maris 2020, ya fitar da bugu bakwai tare da wasu mahallin da aka canza sosai.
Yanzu jagorarmu ta karbi tsokaci daga Zhou da sauransu, sun gabatar da wata shawara mai sauki dangane da kwarewarsu ta asibiti.
Aikin su ya kara da cewa akwai sabbin hujjoji ga jagorarmu kuma yana da mahimmanci ga wannan annobar a duniya.
Muna goyon bayan aikin da suke yi kuma muna gode musu.
Duk da haka, aikin su kuma yana buƙatar sabuntawa bisa ga sabon Maganar Gano da Kulawa don COVID-19 (Fita na bakwai) da kuma binciken kwanan nan.
A cewar bugu na bakwai (3 ga Maris 2020), don tabbatar da zargin cutar ya kamata a haɗa kowane abu na tarihin cututtukan cututtuka tare da abubuwa biyu na bayyanar cututtuka don yin cikakken bincike, ko kuma ya kamata a sadu da abubuwa uku na bayyanar cututtuka idan ba tare da bayyanar cututtuka ba:
Tarihin cututtukan cututtuka: (1) tarihin tafiya ko zama a birnin Wuhan da yankunan da ke kewaye da shi, ko wasu al'ummomin da aka ruwaito shari'o'in COVID-19 a cikin kwanaki 14 na ƙarshe kafin farawar bayyanar cututtuka; (2) tarihin tuntuɓar cututtuka masu kamuwa da cutar SARS-CoV-2 (tare da gwajin nucleic acid mai kyau); (3) tarihin tuntuɓar marasa lafiya da ke da zazzabi ko alamun numfashi daga birnin Wuhan da yankunan da kewaye da shi, ko wasu al'ummomin da aka ruwaito COVID-19 a cikin kwanaki 14 na ƙarshe kafin farawar bayyanar cututtuka; (4) tarihin tuntuɓar rukuni na tabbataccen shari'o'in (≥ 2 lokuta da ke da zazzabi da / ko alamun numfashi sun faru a cikin makonni 2 a cikin ƙananan yankuna, kamar gida, ofis, aji na makaranta, da sauransu).
Bayyanar asibiti: (1) zazzabi da / ko alamun numfashi; (2) tare da siffofin daukar hoto na kamuwa da COVID-19; (3) jimlar ƙididdigar ƙwayoyin fari na jini da ke nuna al'ada, raguwa, ko raguwar ƙididdigar lymphocyte a farkon matakin farawa.
Ana buƙatar tantance tabbataccen yanayin bisa ga wata sanannen sanannen sanarwa da wata alama ta cutar ko kuma na binciken kwayoyin halitta kamar haka: (1) gwajin PCR na ainihi mai kyau ga SARS-CoV-2; (2) jerin kwayoyin cuta na ƙwayar cuta mai ƙwayar cuta wanda ke nuna babban daidaituwa da sanannun ƙwayoyin cuta na coronavirus; (3) tabbatacce ga takamaiman IgM antibody da IgG antibody zuwa SARS-CoV-2 a gwajin magani; ko canjin IgG antibody na SARS-CoV-2 daga mai kyau zuwa mai kyau, ko kuma titer ya karu ≥4 sau a cikin farfadowa fiye da a cikin farfadowa.
Muna iya ganin cewa an ƙara gwajin PCR na ainihin lokacin don nucleic acid a cikin hanyoyin numfashi ko samfurin jini zuwa bugu na biyu (18 Janairu 2020) da na uku (22 Janairu 2020).
An kara gano cututtukan jini a bugu na huɗu (27 Janairu 2020) da na biyar (8 Fabrairu 2020); sannan kuma an kara shaidar serological a bugu na bakwai.
Wadannan gyare-gyare bisa ga masu bincike sun ci gaba da aiki don neman mafi kyawun kayan gano nucleic acid don ganewar asali mai sauri, da kuma samfurori daga hanyoyin numfashi ciki har da samfurin jini, wanda ya kara samun samfurori daban-daban, kuma ya goyi bayan kawo sakamakon ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar
Bugu da ƙari, akwai ƙarin shaidu da ke tuna mana mu yi hankali da marasa lafiya marasa alamun bayyanar cututtuka da marasa alamun cututtuka.
Saboda haka, ya kamata a sabunta jadawalin kwararar Zhou da abokan aiki, saboda sun rarraba mutumin da ba shi da alamun asibiti a matsayin low risk.
Dole ne a tabbatar da tsarin ƙididdigar a cikin ƙarin aikin asibiti da kuma nazarin.
A ƙarshe, muna fatan ƙarin hujjoji na kai tsaye za su zo kuma mu kira masu karatu su ba da ra'ayinsu.
Don ganewar asali na maki mai zargi da maki mai tabbatarwa, muna ba da shawarar bin sabbin jagororin ƙasashensu da kuma bi su.
Ƙungiyarmu za ta sabunta jagorarmu a kan lokaci don ba da taimako.
Bangladesh ta ba da rahoton sabbin mutuwar biyar sakamakon COVID-19, mafi girma a kowace rana
A jiya, Bangladesh ta tabbatar da wasu mutane biyar da suka mutu sakamakon COVID-19 a ranar.
Wannan shi ne adadin mutuwar da aka samu a rana daya saboda cutar.
A jiya, Cibiyar Kula da Cututtuka, Kula da Cututtuka da Bincike ta Bangladesh (IEDCR) ta ba da rahoton cewa adadin mutanen da aka rubuta da cutar sun haɗa da mutane 114 da ke aiki da kuma mutane 33 da suka warke waɗanda ke zaune a gida.
An samu mutuwar mutane 17 a duniya.
A wani taron labarai na kan layi, darektan IEDCR, Dokta Meerjady Sabrina Flora, ta ce wadanda suka mutu sun hada da maza hudu da mace daya.
A cewar Dr. Meerjady, mutane biyu sun wuce shekaru 60, biyu sun kasance tsakanin shekaru 51 zuwa 60, ɗayan kuma yana da shekaru 41 zuwa 50.
Ta kuma ce biyu daga cikin wadanda aka kashe sun fito ne daga Dhaka.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba a ranar 11 ga Maris.
Wani jami'in asibiti ya shaida wa Anadolu Agency, wata jaridar labarai ta gida, cewa daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, darektan Hukumar yaki da cin hanci da rashawa ta Bengal, wanda aka kula da shi a asibitin Kuwait Maitree.
A ranar Asabar, a cikin wani bidiyo na kan layi, Ministan Sufuri da Bridges na Bangladesh Obaidul Quader ya ce za a rufe sufurin jama'a na tsawon lokaci fiye da yadda aka shirya, har zuwa wannan Asabar mai zuwa.
Wannan rufewar jigilar jama'a ta fara ne a ranar 26 ga Maris kuma an shirya ta ƙare a ranar Asabar, 4 ga Afrilu.
Har ila yau, ana ba da izinin jigilar kayayyakin da ake bukata, wato, magani, mai da abinci.
Labaran farko na kamuwa da cutar COVID-19 a Bangladesh sun kasance a ranar 8 ga Maris, a cikin mutane biyu da suka dawo daga Italiya da kuma matar ɗaya daga cikinsu.
A ranar 19 ga Maris, waɗannan ukun sun riga sun warke.
SARS-CoV-2 ya wuce kamuwa da cuta miliyan ɗaya a duniya
A ranar Alhamis, jimlar adadin masu kamuwa da cutar SARS-CoV-2 ta wuce miliyan ɗaya a duk duniya, bayanan Jami'ar Johns Hopkins sun nuna.
Akalla mutuwar dubu 52 an danganta su da COVID-19, cutar da coronavirus ta haifar.
Wannan muhimmin abu ya faru a ranar da Malawi ta tabbatar da kamuwa da cutar coronavirus ta farko kuma Zambia ta sami mutuwar farko da ta shafi coronavirus.
Koriya ta Arewa ta ce, a ranar Alhamis, ita ce ɗaya daga cikin ƙasashe kalilan da suka rage ba tare da kamuwa da cutar coronavirus ba.
A jiya, Hukumar Lafiya ta Duniya ta ba da rahoton mutane 1,051,635 da aka tabbatar da cutar, ciki har da mutane 79,332 a cikin sa'o'i ashirin da huɗu kafin karfe 10 na safe na ranar 4 ga Afrilu, a lokacin Turai ta Tsakiya (0800 UTC).
A Amurka, an yi rikodin sama da mutane dubu 244 da suka kamu da cutar coronavirus, wanda ya danganta da mutuwar akalla 5,900.
Labarin CBS News, yana ambaton bayanan Jami'ar Johns Hopkins, akwai mutuwar Amurka sama da 1,000 a ranar Laraba sakamakon kamuwa da cutar coronavirus.
A faɗin duniya, ƙasashe sun sanar da tsauraran matakai don hana cutar yaduwa.
A ranar Alhamis, magajin garin Moscow Sergei Sobyanin ya tsawaita dokar kulle a birnin har zuwa 1 ga watan Mayu.
A kasa, Shugaba Vladimir Putin ya bayyana cewa za a ci gaba da biyan 'yan Rasha ba tare da su je aiki ba har zuwa 30 ga Afrilu.
Majalisar dokokin Portugal ta kada kuri'ar tsawaita dokar ta baci ta kasa da kwanaki 15; an amince da kuri'un 215 a baya, goma sun ki amincewa, kuma daya ya ki amincewa.
Saudiyya ta tsawaita dokar hana fita a cikin biranen Makka da Madina don tsawon yini; a baya, dokar ta fita tana aiki ne kawai tsakanin 3 na yamma da 6 na safe.
Thailand ta shirya aiwatar da dokar hana fita tsakanin 10 na yamma da 4 na safe.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jihar ta tsawaita dokar zama a gida har zuwa 1 ga Mayu.
Shaguna a Ostiraliya sun rage iyakar takardar wanka ta kowace ma'amala
A ranar Lahadi da Asabar da yamma, shagunan sayar da kayayyaki na Australiya Woolworths da Coles sun rage ƙuntatawa kan sayen takardar wanka zuwa biyu da ɗaya kunshin a kowace ma'amala a duk shagunan a matakin ƙasa, bi da bi.
ALDI ta kuma gabatar da iyaka na kunshin guda, a ranar Litinin.
An sanya waɗannan iyakokin a matsayin saƙonni a kan cajin kuɗi, da kuma shafukan Facebook na sarkar.
An ruwaito masu siye suna tarawa saboda tsoron COVID-19 idan mutane suna buƙatar keɓe kansu.
A ranar Laraba, kamfanin Woolworths ya kuma iyakance sayen takardar bayan gida zuwa fakitin daya a kowane tsari.
Wadannan canje-canjen sun biyo bayan ƙuntatawa na farko na hudu-pack a kowace ma'amala da Woolworths da Coles suka gabatar a ranar 4 da 5 ga Maris bi da bi.
" Coles, a cikin sanarwar ta ta 8 ga Maris, ta ruwaito cewa tare da takunkumin kunshin hudu a wuri, ""manyan shaguna har yanzu suna siyarwa a cikin sa'a daya na isarwa"", kuma ya kira buƙatar ""marasa misaltuwa"", yayin da ALDI, a cikin wani sakon Facebook a ranar Talata, ya kira shi ""maras tsammani"". "
" Tallace-tallace sun tashi a cikin "karawa mai ƙarfi "a makon da ya gabata, a cewar mai magana da yawun Woolworths. "
Duka na Costco a Canberra kuma ya iyakance adadin da aka yarda da shi zuwa fakiti biyu a makon da ya gabata.
Don kara rage karancin, Coles ya ba da umarni daga manyan fakitoci daga masu samarwa da kuma kara yawan isar da sako, Woolworths ya ba da umarni na karin kaya, yayin da ALDI ta ba da kayayyaki don shirin ranar Laraba na musamman da wuri.
Russell Zimmerman, darektan ƙungiyar masu sayar da kayayyaki na Australiya, ya ce 'yan kasuwa suna ƙoƙarin ƙara yawan kayayyaki, amma ƙuntatawa na majalisar gari a kan lokacin kawo kaya ta manyan motoci suna sa ya yi wuya.
Yana tsammanin farashin samarwa zai karu, yayin da masu samarwa ke kokarin biyan bukatar, kuma ƙananan kayayyaki.
A ranar Talata, ALDI ta sanar da cewa bayan an saki hannun jari da wuri, wasu shaguna ba za su iya gudanar da bikin ranar Laraba ba.
A wani rahoto na News.com.au, Dr. Gary Mortimer, masanin sayar da kayayyaki daga Jami'ar Fasaha ta Queensland, ya ce shagunan suna cika kaya a kowace dare.
Ya lura cewa takardar bayan gida abu ne mai yawa, wanda ke haifar da karancin adadin kayayyaki, kuma, lokacin da aka sayar, ya bar manyan wuraren da ke cikin shelf a banza, yana ƙarfafa jin ƙarancin.
"Coles da Woolworths suna da ra'ayi [da] idan akwai yalwa da abubuwa a kan shiryayye, idan samfurin kamar toilet rolls da sanitizer za a iya [saya] kuma suna nan a cikin yawa, za ka yiwuwa rage tsoro"," ya ce Russell Zimmerman a ABC News. "
Mai samar da takardar bayan gida da aka sake amfani da ita wanda ke ba da shara ya ce a ranar Laraba ta gabata za su ƙare da kayayyaki.
Kimberly-Clark, wanda ke yin Kleenex Toilet Tissue, da Solaris Paper wanda ke yin Sorbent, sun jaddada cewa suna aiki 24/7 don kula da wadata, a cewar rahoton News.com.au.
Domain.com, wani shafin yanar gizon ƙasa, ya ruwaito wasu masu sayar da ƙasa suna ba da takardar wanka kyauta ga mai ba da kyauta na farko a cikin gwanjo a Melbourne, lokacin da aka gudanar da ƙananan gwanjo saboda masu siye suna da hutu a ƙarshen mako mai tsawo na Ranar Ma'aikata.
A ranar Alhamis, jaridar NT News, wata jarida ce da ake buga a birnin Darwin, an saka wani shafi na takwas da aka saka a ciki don a yanke shi kuma a yi amfani da shi a matsayin takardar bayan gida.
A farkon shagunan sun ƙi yin takunkumi, a cewar wani rahoto daga ABC Australia a ranar 3 ga Maris inda suka ce ba su da shirin yin takunkumi kan sayayya.
Russell Zimmerman ya kara da cewa wasu kayayyaki ma suna da matukar bukatarsu, ciki har da masks, sanitizer, kayan bushewa, wanke hannu da gari.
Hakazalika, a waje da Ostiraliya, a ranar Lahadi da yamma an lura da wani babban kanti na Birtaniya mai suna Ocado da ke sayar da takardar bayan gida ta Andres zuwa cikin kwantena biyu.
Hukumar Lafiya ta Duniya ta ayyana cutar COVID-19 a matsayin annobar
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana barkewar cutar COVID-19  cutar da coronavirus SARS-CoV-2  ta haifar da ita a matsayin annoba.
" Ko da yake kalmar "zazzabin cizon sauro" tana nufin yadda cutar ta yadu, ba yadda hatsari ke da gaske ba, WHO ta lura da bukatar tura gwamnatoci zuwa aiki: "
"Dukkanin kasashe na iya canza yanayin annobar".
"Idan kasashe suka gano, su gwada, su bi da su, su ware su, su bi da su kuma su karfafa mutanensu a cikin amsa", in ji Tedros Adhanom Ghebreyesus, Darakta Janar na WHO. "
"Muna matukar damuwa da matakan da ke damun yaduwar da kuma tsanani da kuma matakan da ke damun rashin aiki.
"Dangane da Dr. Tom Frieden, tsohon darektan Cibiyoyin Kula da Cututtuka da Rigakafin Amurka, annobar ta kasance "maras kyau. "
" Ya ce, a cikin wani jawabi da CNN ta wallafa a watan Fabrairu, ""sai da mura, ba a gano wani kwayar cutar numfashi ba daga fitowar zuwa ci gaba da yaduwar duniya. "" "
" Ghebreyesus ya bayyana irin wannan ra'ayi, yana cewa ""ba mu taɓa ganin annobar da coronavirus ya haifar ba. "" "
Ya ci gaba da cewa, "kuma ba mu taba ganin annobar da za a iya sarrafawa a lokaci guda ba.
Sabon matsayi a matsayin annoba ya biyo bayan shawarar WHO a watan Janairu don ayyana barkewar cutar a matsayin gaggawa na lafiyar jama'a na damuwa ta duniya.
"Darakta na Cibiyar Allergy da Cututtuka na Ƙasar Amirka, Dokta Anthony Fauci, ya ce game da annobar, ""ƙarshe, zai yi muni. ""
A ranar Alhamis, Associated Press ta ruwaito akwai akalla mutane 126,000 da suka kamu da COVID-19 a duniya, wanda ya haifar da mutuwar sama da 4,600.
Cutar coronavirus ta 201920 annobar cutar coronavirus ce mai gudana ta cutar coronavirus ta 2019 (COVID-19), wanda cutar ta coronavirus ta 2 (SARS-CoV-2) ta haifar.
An gano barkewar cutar a Wuhan, China, a watan Disamba na 2019, an ayyana ta a matsayin gaggawa na lafiyar jama'a na damuwa ta duniya a ranar 30 ga Janairu, 2020, kuma an amince da ita a matsayin annoba a ranar 11 ga Maris, 2020.
Ya zuwa ranar 10 ga Afrilu, 2020, an samu kimanin mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe da yankuna 210 da suka haifar da mutuwar kusan 97,000.
Mutane 364,000 ne suka warke.
An kiyasta yawan mutuwar mutane da suka kamu da cutar a kasar Sin ya kai kashi 4 cikin dari, yayin da a duniya ya kasance daga kashi 13.04 cikin dari a Algeria zuwa kashi 0.08 cikin dari a New Zealand.
Alamomin da aka fi gani sun haɗa da zazzabi, tari da kuma rashin numfashi.
Abubuwan da za su iya jawo wa mutum ciwon huhu da kuma ciwon hanci na numfashi.
Lokaci daga fallasawa zuwa bayyanar cututtuka yawanci yana kusa da kwanaki biyar, amma zai iya kasancewa daga kwana biyu zuwa goma sha huɗu.
Babu wani magani na musamman na riga-kafi ko maganin rigakafi da aka sani.
Maganin farko shine magani mai nuna alamomi da tallafi.Hakan matakan rigakafin da aka bada shawarar sun hada da wanke hannu, rufe bakinka lokacin tari, kiyaye nesa da sauran mutane, da kuma saka idanu da keɓe kai ga mutanen da suke zargin suna da kamuwa da cutar.
Hukumomi a dukan duniya sun amsa ta wajen yin amfani da takunkumin tafiye-tafiye, killace mutane, dokar hana fita, da kuma rufe wuraren aiki.
Cutar ta haifar da mummunan rikice-rikice na zamantakewar tattalin arziki na duniya, jinkirta ko soke abubuwan wasanni, addini, siyasa da al'adu, da yaduwar karancin kayayyaki wanda ya karu da cinikin firgita.
Makarantu da jami'o'i sun rufe a ƙasashe 193 ko kuma a yankuna dabam-dabam, kuma hakan ya shafi kusan kashi 99.4 cikin ɗari na ɗaliban duniya.
Bayanai marasa kyau game da cutar sun bazu a kan layi, kuma an sami abubuwan da suka faru na ƙiyayya da nuna bambanci ga Sinawa, wasu mutane na asalin Asiya ta Gabas da Kudu maso Gabas da kuma wasu daga yankunan da ke da manyan cututtukan cutar.
Saboda rage yawan tafiye-tafiye da rufe masana'antun nauyi, an rage gurɓataccen iska da kuma fitar da carbon.
Hukumomin lafiya a Wuhan, China (babban birnin lardin Hubei) sun ba da rahoton tarin cututtukan huhu na sanannen dalili a ranar 31 ga Disamba, 2019, kuma an fara bincike a farkon Janairu, 2020.
Yawancin lokuta suna da alaƙa da kasuwar sayar da kayan teku ta Huanan kuma saboda haka ana tsammanin cutar ta fito ne daga dabbobi.
An san kwayar cutar da ta haifar da barkewar cutar da SARS-CoV-2, sabon kwayar cutar da aka gano da ke da alaƙa da kwayar cutar corona na bats, kwayar cutar corona ta pangolin, da SARS-CoV. An gano cewa mutumin da aka fara sani da alamun cutar ya kamu da rashin lafiya a ranar 1 ga Disamba, 2019, kuma wannan mutumin bai da alaƙa da alamar kasuwa mai zafi a baya ba.
Daga cikin farkon tarin cututtukan da aka ruwaito a watan Disamba na 2019, kashi biyu bisa uku sun kasance suna da alaƙa da kasuwa.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tabbatar ba daga South China Morning Post ya nuna cewa wani lamari da aka gano tun daga ranar 17 ga Nuwamba, 2019, a cikin wani mutum mai shekaru 55 daga lardin Hubei, na iya zama na farko.A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa, yayin da aka ruwaito cewa sabbin shari'o'in sun ragu a China amma ba zato ba tsammani suka karu a Italiya, Iran, da Koriya ta Kudu, yawan sabbin shari'o'in da ke waje da China sun zarce adadin sabbin shari'o'in a cikin China a karon farko.
Akwai yiwuwar rashin bayar da rahoto sosai game da cututtuka, musamman a tsakanin waɗanda suke da alamun da suka fi sauƙi.
A ranar 26 ga Fabrairu, an samu rahotanni kadan a tsakanin matasa, inda matasa 19 da ke ƙasa da kashi 2.4% na masu cutar a duniya. Babban mai ba da shawara kan kimiyya na Burtaniya, Patrick Vallance, ya kiyasta cewa kashi 60% na yawan mutanen Birtaniya za su bukaci kamuwa da cutar kafin a samu rigakafin garken da ke da tasiri.
Maganganu suna nufin yawan mutanen da aka gwada su don COVID-19, kuma an tabbatar da gwajin su tabbatacce bisa ga ƙa'idodin hukuma.
A ranar 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3% na yawanta, kuma ƙasashe da yawa sun yi manufofin hukuma don kada su gwada waɗanda ke da alamun bayyanar cututtuka kawai, kamar Italiya, Netherlands, Spain, da Switzerland.
Wani binciken da aka buga a ranar 16 ga Maris ya gano cewa a China, har zuwa 23 ga Janairu, an kiyasta kashi 86% na kamuwa da COVID-19 ba a gano su ba, kuma waɗannan kamuwa da marasa takaddun sun kasance tushen kamuwa da cutar ga kashi 79% na shari'o'in da aka rubuta.
Wani bincike na kididdiga da aka wallafa a ranar 30 ga Maris ya kiyasta cewa yawan kamuwa da cuta a Italiya ya fi yawan wadanda aka ruwaito.
Bayani na farko na yawan haihuwa na asali (R0) don COVID-19 ya kasance 1.4 zuwa 2.4.
Wani bincike da Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta Amirka ta wallafa ya nuna cewa zai iya zama 5.7.
Yawancin mutanen da ke da COVID-19 suna warkewa.
Ga waɗanda ba su da cutar, lokaci daga bayyanar cututtuka zuwa mutuwa ya kasance tsakanin kwanaki 6 zuwa 41, kuma mafi yawan kwanaki 14 ne.
Ya zuwa ranar 10 ga Afrilu, 2020, kimanin mutuwar 97,000 an danganta su da COVID-19.
A kasar Sin, a ranar 5 ga Fabrairu, kusan kashi 80% na mutuwar sun kasance a cikin waɗanda suka wuce shekaru 60, kuma kashi 75% suna da yanayin kiwon lafiya na baya ciki har da cututtukan zuciya da ciwon sukari. Lambobin hukuma na mutuwar daga cutar COVID-19 galibi suna nufin mutanen da suka mutu waɗanda suka tabbatar da COVID daidai da ƙa'idodin hukuma.
Yawan mutanen da suka mutu na gaske daga COVID-19 na iya zama mafi girma, saboda ba zai haɗa da mutanen da suka mutu ba tare da yin gwaji ba - misali a gida, a gidajen tsofaffi, da sauransu.
Bayanai na ɓangare daga Italiya sun gano cewa yawan mutuwar da aka yi a lokacin annobar ya wuce adadin mutuwar COVID ta hukuma da kashi 4-5x.
" Wata kakakin cibiyar kula da cututtuka da rigakafin cututtuka ta Amurka (CDC) ta yarda da cewa "Mun san cewa [adadin mutuwar da aka bayyana] ƙididdigar ƙididdiga ce", sanarwa da rahotanni na ƙididdigar ƙididdiga a Amurka ke tabbatar da irin wannan ƙididdigar sau da yawa tana faruwa a cikin annoba, kamar annobar mura ta 2009 H1N1. Mutuwar farko da aka tabbatar a Wuhan a ranar 9 ga Janairu 2020. "
Mutuwar farko a wajen kasar Sin ta faru ne a ranar 1 ga Fabrairu a Philippines, kuma mutuwar farko a wajen Asiya ta faru ne a Faransa a ranar 14 ga Fabrairu.
A ranar 28 ga Fabrairu, a wajen ƙasar Sin, an yi rajistar mutuwar mutane fiye da goma sha biyu a ƙasar Iran da Koriya ta Kudu da kuma Italiya.
A ranar 13 ga Maris, fiye da kasashe da yankuna arba'in sun ba da rahoton mutuwar, a kowace nahiya sai Antarctica. Ana amfani da matakan da dama don ƙididdige mutuwar.
Wadannan lambobi sun bambanta bisa ga yanki da lokaci, kuma suna rinjayar yawan gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokaci tun farkon barkewar cutar, da kuma halaye na yawan jama'a kamar shekaru, jinsi, da lafiyar gaba ɗaya.
Dangane da kididdigar Jami'ar Johns Hopkins, yawan mutuwar duniya zuwa kashi 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu 2020.
Yawan ya bambanta bisa ga yankuna.
A China, kimantawa game da mutuwar zuwa yanayin ya ragu daga 17.3% (ga waɗanda suka fara bayyanar cututtuka 110 Janairu 2020) zuwa 0.7% (ga waɗanda suka fara bayyanar cututtuka bayan 1 Fabrairu 2020).Sauran matakan sun haɗa da yawan mutuwar shari'a (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu daga cutar, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan waɗanda suka kamu (suna kamuwa da cutar da ba a gano su ba) waɗanda suka mutu daga cutar.
Wadannan kididdiga ba su da iyaka ga lokaci kuma suna bin wani yanki na al'umma daga kamuwa da cuta zuwa warwarewa.
Yawancin masana kimiyya sun yi ƙoƙarin lissafa waɗannan lambobin don yawan jama'a.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta kimanta cewa yawan mutuwar kamuwa da cuta a cikin annobar a matsayin cikakke ya kasance tsakanin 0.1% zuwa 0.39%.
Babban kimantawar wannan zangon ya dace da sakamakon gwajin bazuwar farko na COVID-19 a Jamus, da kuma nazarin kididdiga wanda ke nazarin tasirin gwajin akan kimantawar CFR.
Hukumar WHO ta ce za a iya sarrafa annobar.
Ba a san lokacin da cutar za ta fara ba kuma za ta iya bambanta bisa ga wurin da ta auku.
" Maciej Boni na Jami'ar Jihar Penn ya bayyana, ""An bar cutar ba tare da an sarrafa ta ba, yawanci cututtukan cututtuka suna daidaitawa sannan kuma suna fara raguwa lokacin da cutar ta ƙare daga masu karɓar baƙi. "
"Amma kusan ba zai yiwu a yi wani tunani mai kyau a yanzu game da lokacin da wannan zai kasance".
" Babban mai ba da shawara kan harkokin likitancin gwamnatin kasar Sin Zhong Nanshan ya yi jayayya cewa ""za a iya kawo karshen wannan a watan Yuni"" idan za a iya karfafa dukkan kasashe su bi shawarar WHO kan matakan da za a dauka don dakatar da yaduwar cutar. "
"A ranar 17 ga Maris, Adam Kucharski na Makarantar Lafiya ta London &amp; Tropical Medicine ya bayyana cewa SARS-CoV-2 ""zai yi yawo, mai yiwuwa na shekara ɗaya ko biyu"". "
"Dangane da binciken da kwalejin Imperial ta gudanar wanda Neil Ferguson ya jagoranci, za a buƙaci nisan jiki da sauran matakan ""har sai an sami allurar rigakafi (mai yiwuwa watanni 18 ko fiye) ". "
" William Schaffner na Jami'ar Vanderbilt ya bayyana, ""Ina tsammanin ba zai yiwu wannan coronavirus ba saboda yana da sauƙin watsawa zai ɓace gaba ɗaya"" kuma zai iya zama cuta ta yanayi, yana dawowa kowace shekara"". "
Rashin ƙarfi na dawowar zai dogara ne akan rigakafin garken da kuma girman juyin halitta.
Alamun COVID-19 na iya zama marasa ƙayyadaddun kuma mutanen da ke kamuwa da cutar na iya zama marasa bayyanar cututtuka.
Alamomin biyu da suka fi kowa a duniya sune zazzabi (88%) da tari mai bushe (68%).
Alamomin da ba a yawan gani ba sun hada da gajiya, samar da ƙura a cikin numfashi (phlegm), rashin jin ƙanshin, rashin numfashi, ciwon tsoka da na haɗin gwiwa, ciwon wuya, ciwon kai, sanyi, kumburi, haemoptysis, diarrhea, ko cyanosis. WHO ta ce kusan mutum ɗaya cikin shida ya kamu da rashin lafiya mai tsanani kuma yana da wahalar numfashi.
Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka na Amurka (CDC) sun lissafa alamun gaggawa kamar wahalar numfashi, ciwon kirji ko matsa lamba, rikicewa kwatsam, wahalar farkawa, da fuska ko lebe mai shuɗi; ana ba da shawarar kula da likitanci nan da nan idan waɗannan alamun sun kasance. Ƙarin ci gaban cutar na iya haifar da mummunan ciwon huhu, cututtukan shan numfashi mai tsanani, sepsis, raunin septic da mutuwa.
Wasu daga cikin waɗanda suka kamu da cutar na iya zama marasa alamun cututtuka, ba su da alamun asibiti amma suna da sakamakon gwajin da ya tabbatar da kamuwa da cutar, don haka masu bincike sun ba da shawara cewa waɗanda suka yi kusa da waɗanda suka kamu da cutar su kamata a saka idanu sosai kuma a bincika su don a kawar da kamuwa da cutar.
Kimanin China na rashin alamar cututtuka sun kasance daga kaɗan zuwa 44%.
Lokacin incubacin da aka saba yi (lokacin da ke tsakanin kamuwa da cuta da farawar bayyanar cututtuka) ya kasance daga kwana ɗaya zuwa 14; yawanci kwanaki biyar ne.A matsayin misali na rashin tabbas, kimantawar kashi na mutanen da ke fama da COVID-19 waɗanda suka rasa ƙanshin su da farko ya kasance 30% kuma daga baya ya faɗi zuwa 15%.
Har yanzu ana gano wasu bayanai game da yadda cutar take yaduwa.
Ana ganin cewa cutar tana yaduwa ne a lokacin da mutum ya yi kusa da shi kuma ta hanyar ƙananan saukad da ke fitowa yayin tariwa, cizon yatsa, ko magana; tare da kusanci a cikin mita 1 zuwa 2 (3 zuwa 6 feet).
Bincike ya nuna cewa tari da ba a rufe shi ba zai iya sa sa sa saukowar saukowar saukowa daga mita 4.5 zuwa mita 8.2.
Wasu sun ba da shawarar cewa ƙwayoyin cuta na iya watsawa ta hanyar ƙananan saukad da waɗanda ke kasancewa na tsawon lokaci a cikin iska, wanda za a iya samarwa yayin magana. Hakanan ana iya samar da saukad da numfashi yayin numfashi, gami da lokacin magana, kodayake ƙwayoyin cuta ba a yawanci kewayawa ta iska.
Waɗannan saukad da za su iya shiga cikin bakinsu ko hancin mutanen da ke kusa da su ko kuma su shiga cikin huhu.
Wasu hanyoyin likita kamar su intubation da kuma karyar zuciya da huhu (CPR) na iya sa a yi numfashi a cikin iska kuma hakan ya haifar da yaduwar iska.
Zai iya yaduwa idan mutum ya taɓa wani abu da ya gurɓata, har da fata, sa'an nan kuma ya taɓa idanunsa da hanci ko bakinsu.
Ko da yake akwai damuwa cewa zai iya yada ta wurin ƙura, an yi imanin cewa wannan haɗarin ba shi da yawa.
Gwamnatin China ta musanta yiwuwar watsa SARS-CoV-2 ta hanyar magungunan jiki. Kwayar cutar tana da yawa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yaduwar na iya yiwuwa kafin bayyanar cututtuka da kuma a cikin matakan cutar.
Mutane sun gwada cutar ta tabbatacce har zuwa kwanaki uku kafin bayyanar cututtuka wanda ke nuna cewa ana iya watsawa kafin bayyanar cututtuka masu mahimmanci.
Rahotanni kaɗan ne kawai na asymptomatic lokuta da aka tabbatar da su a cikin dakin gwaje-gwaje, amma an gano watsawar asymptomatic ta wasu ƙasashe a lokacin binciken ganowa.
Cibiyar Tsaro da Sarrafa Cututtuka ta Turai (ECDC) ta bayyana cewa ko da yake ba a san yadda cutar take yaduwa ba, mutum ɗaya yakan kamu da wasu biyu zuwa uku. Kwayar tana rayuwa na awanni zuwa kwanaki a farfajiya.
Musamman, an gano cewa za a iya gano cutar har zuwa kwanaki uku a kan filastik (polypropylene) da karfe mai bakin karfe 304, kwana ɗaya a kan kwali, da har zuwa sa'o'i huɗu a kan tagulla.
Duk da haka, wannan ya bambanta dangane da danshi da zafin jiki.Babbobin gida da sauran dabbobi sun gwada tabbatacce ga COVID-19.
Babu wata hujja da ta nuna cewa dabbobi za su iya watsa kwayar cutar ga mutane, ko da yake hukumomin Birtaniya sun ba da shawarar wanke hannuwan mutum bayan ya yi hulɗa da dabbobi, kamar bayan ya yi hulɗa da wasu wurare da mutane da suka kamu da cutar suka taɓa.
Cutar coronavirus ta 2 (SARS-CoV-2) cuta ce ta musamman, wadda aka fara ware daga mutane uku da ke fama da cutar huhu da ke da alaƙa da tarin cututtukan cututtukan numfashi a Wuhan.
Dukkanin fasalulluka na sabon kwayar cutar SARS-CoV-2 suna faruwa ne a cikin ƙwayoyin cuta na coronavirus masu alaƙa a cikin yanayi.Bayan jikin mutum, sabulu na gida yana kashe kwayar, wanda ke warware murfin kariya.SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
An yi zaton cewa yana da asalin zoonotic.
Nazarin kwayoyin halitta ya nuna cewa coronavirus ta hanyar kwayoyin halitta ta haɗu da jinsin Betacoronavirus, a cikin subgenus Sarbecovirus (lineage B) tare da nau'ikan bat biyu.
Ya kasance daidai da kashi 96% a matakin kwayoyin halitta na sauran samfurori na cutar coronavirus (BatCov RaTG13).
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa akwai bambanci guda daya na amino acid a wasu sassan jerin kwayoyin halitta tsakanin kwayoyin cutar daga pangolins da wadanda daga mutane.
Kwatantawar dukkanin kwayoyin halitta zuwa yau ya gano aƙalla 92% na kayan kwayoyin halitta da aka raba tsakanin cutar ta pangolin coronavirus da SARS-CoV-2, wanda bai isa ya tabbatar da cewa pangolin shine mai masaukin baki ba.
Ana iya gano kamuwa da cutar ta wucin gadi bisa ga bayyanar cututtuka, ko da yake tabbatarwa shine a ƙarshe ta hanyar jujjuyawar rikodin polymerase chain reaction (rRT-PCR) na ɓoyewar da aka kamu da shi ko CT imaging.
Wani binciken da ya kwatanta PCR da CT a Wuhan ya nuna cewa CT ya fi PCR da muhimmanci, ko da yake ba shi da ƙayyadaddun bayanai, tare da yawancin siffofin hotunansa da ke haɗuwa da sauran cututtukan huhu da cututtukan cututtuka.
" Tun daga watan Maris na shekarar 2020, Kwalejin Radiology ta Amirka ta ba da shawarar cewa "" kada a yi amfani da CT don yin bincike ko a matsayin gwajin layi na farko don gano COVID-19"".
WHO ta wallafa wasu hanyoyin gwajin RNA na SARS-CoV-2, tare da na farko da aka fitar a ranar 17 ga Janairu.
Gwajin yana amfani da rikitarwa na rikitarwa na polymerase na real-time (rRT-PCR).
Ana iya yin gwajin a kan samfurori na numfashi ko jini.
A yawancin lokaci, ana samun sakamako a cikin 'yan sa'o'i ko kwanaki.
A kullum ana yin wannan gwajin ne a kan wani gashin hanci na nasopharyngeal, ko da yake ana iya amfani da gashin wuya. Yawancin dakunan gwaje-gwaje da kamfanoni suna ci gaba da gwajin kwayoyin cuta, wanda ke gano rigakafi.
A ranar 6 ga Afrilu, 2020, babu wani daga cikin wadannan da aka tabbatar da cewa ya isa ya zama daidai don a amince da shi don amfani da shi a ko'ina.
A Amurka an amince da gwajin serological da Cellex ta samar don amfani da gaggawa ta hanyar dakunan gwaje-gwaje masu takaddun shaida kawai.
Abubuwan da ke nuna hoton hoto a kan radiographs da computed tomography (CT) na mutanen da ke da alamun cututtuka sun haɗa da rashin haske na gilashin gilashin gilashi na waje da kuma rashin zubar da jini.
Kungiyar Radiological ta Italiya tana tattara wani bayanan yanar gizo na duniya na binciken hotunan ga wadanda aka tabbatar da cutar.
Saboda haɗuwa da sauran cututtukan kamar adenovirus, yin hotunan ba tare da tabbacin PCR ba yana da iyakantaccen ƙayyadaddun bayanai wajen gano COVID-19.
Wani babban bincike a kasar Sin ya kwatanta sakamakon CT na kirji da PCR kuma ya nuna cewa ko da yake daukar hoto ba shi da ƙayyadaddun bayani game da kamuwa da cuta, amma ya fi sauri kuma ya fi saurin fahimta, wanda ya nuna cewa ana iya yin la'akari da shi a matsayin kayan aikin bincike a yankunan da ake fama da cutar.
An kirkiro cibiyoyin sadarwa na kwakwalwa na kwakwalwa da ke dogara ne akan ilimin kere kere don gano siffofin daukar hoto na cutar ta hanyar daukar hoto da CT.
Hanyoyi na hana kamuwa da cutar sun haɗa da kiyaye tsabta ta mutum, wanke hannu, guje wa taɓa idanu, hanci, ko baki da hannayensu da ba a wanke ba, da kuma tari ko cizon cizon sauro a cikin wani kayan da aka saka a cikin kwandon shara.
An shawarci waɗanda suka riga sun kamu da cutar su saka abin rufe fuska a wurin jama'a.
Ana kuma ba da shawarar yin nesa da jiki don hana yaduwar. Gwamnatoci da yawa sun ƙuntata ko kuma sun ba da shawara game da duk baƙon tafiya zuwa da daga ƙasashe da yankunan da cutar ta shafa.
Amma, cutar ta kai matakin da ta yadu a wurare da yawa a duniya.
Wannan yana nufin cewa cutar tana yaduwa a cikin al'ummomi, kuma wasu membobin al'umma ba su san inda ko yadda aka kamu da su ba. Ana ba da shawarar masu ba da sabis na kiwon lafiya da ke kula da wanda zai iya kamuwa da cutar su yi amfani da ƙa'idodin tsaro, matakan tsaro na tuntuɓar, da kuma kariya ga idanu.Sanya ido na tuntuɓar wata hanya ce mai mahimmanci ga hukumomin kiwon lafiya don ƙayyade tushen kamuwa da cuta da hana ci gaba da watsawa.
Amfani da bayanan wuri daga wayoyin hannu ta gwamnatoci don wannan dalili ya haifar da damuwa game da sirrin sirri, tare da Amnesty International da fiye da kungiyoyi 100 da suka fitar da sanarwa suna kiran iyakance irin wannan sa ido.
An aiwatar da aikace-aikacen hannu daban-daban ko kuma an gabatar da su don amfani da son rai, kuma tun daga ranar 7 ga Afrilu, 2020, ƙungiyoyin masana sama da goma suna aiki akan hanyoyin da ke da alaƙa da sirrin sirri, kamar amfani da Bluetooth don yin rikodin kusanci na mai amfani da wasu wayoyin hannu.
Masu amfani za su karɓi saƙo idan sun kasance a kusa da wani wanda ya gwada tabbatacce ga COVID-19. Ra'ayoyi marasa kyau suna yawo game da yadda za a hana kamuwa da cuta; misali, wanke hanci da kuma yin gargling da ruwan sha ba su da tasiri.
Babu allurar rigakafin COVID-19, kodayake ƙungiyoyi da yawa suna aiki don haɓaka ɗaya.
Ana bada shawara a wanke hannu don hana yaduwar cutar.
Hukumar Kula da Cututtuka ta ce mutane su wanke hannuwansu da sabulu da ruwa aƙalla na dakika ashirin, musamman bayan sun je gidan wanka ko kuma idan hannuwansu sun ƙazantu sosai; kafin su ci abinci; da kuma bayan sun busa hanci, sun yi tari ko sun yi ta hakowa.
Wannan ya faru ne domin a waje da jikin mutum, sabulu na gida ne yake kashe kwayar, kuma sabulu mai kariya yana busawa.
CDC ta kuma bada shawarar yin amfani da maganin hana shan giya na hannu tare da akalla kashi 60% na giya a cikin girma idan sabulu da ruwa ba su da sauƙi.
Hukumar WHO ta shawarci mutane su guji taɓa idanu, hanci, ko baki da hannayensu da ba a wanke ba.
Ana iya kwantar da farfajiya da wasu magunguna (a cikin minti daya na bayyanar da maganin kashe cuta don farfajiyar karfe mara kyau), ciki har da 6271% ethanol, 50100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.27.5% povidone-iodine.
Sauran maganin, kamar benzalkonium chloride da chrohexidine gluconate, ba su da tasiri sosai.
Hukumar ta CDC ta ba da shawarar cewa idan ana zargin ko kuma an tabbatar da wani mutum da cutar COVID a wani wuri kamar ofishi ko makarantar kula da yara, ya kamata a kashe dukkan wuraren kamar ofisoshin, dakunan wanka, wuraren da ake amfani da su, da kayan lantarki kamar kwamfutar hannu, allon tabawa, keyboard, na'urorin sarrafawa ta nesa, da na'urorin ATM da marasa lafiya ke amfani da su.
Ƙungiyoyin kiwon lafiya sun ba da shawarar cewa mutane su rufe bakinsu da hancinsu da ƙuƙwalwar ƙuƙwalwa ko kuma wani abu idan suna tari ko suna yin sneezing, kuma su kawar da duk wani abu nan da nan.
Ana ba da shawarar yin amfani da abin rufe fuska don waɗanda suke da cutar, domin saka abin rufe fuska zai iya rage yawan jini da kuma nesa da za a yi da saɓo na numfashi da aka warwatsa sa'ad da suke magana da kuma yin sneezing da kuma tari.
Hukumar WHO ta ba da umarni kan lokacin da kuma yadda za a yi amfani da abin rufe fuska.
"A cewar Stephen Griffin, masanin ilimin cututtuka a Jami'ar Leeds, ""Sanya abin rufe fuska na iya rage yawan mutane su taɓa fuskokinsu, wanda shine babban tushen kamuwa da cuta ba tare da tsabtace hannu ba. ""An kuma ba da shawarar yin amfani da abin rufe fuska ga waɗanda ke kula da wani wanda zai iya samun cutar. "
Hukumar WHO ta ba da shawarar cewa masu lafiya su sa abin rufe fuska ne kawai idan suna cikin haɗari, kamar waɗanda ke kula da mutumin da ke da COVID-19, kodayake sun kuma yarda cewa sanya abin rufe fuska na iya taimaka wa mutane su guji taɓa fuskarsu.
Kasashe da dama sun fara karfafa amfani da abin rufe fuska ga jama'a.
A Amurka, CDC ta ba da shawarar yin amfani da abin rufe fuska na likita wanda ba na likita ba wanda aka yi da masana'anta. China ta ba da shawarar musamman amfani da abin rufe fuska na likita na waje da aka yi amfani da shi ta hanyar masu lafiya na jama'a, musamman idan sun zo kusa (1 mita (3 ft ko ƙasa da haka) tare da wasu mutane.
Hong Kong ta ba da shawarar yin amfani da abin rufe fuska na tiyata lokacin da kake amfani da sufuri na jama'a ko kuma lokacin da kake zama a wurare masu yawan jama'a.
Jami'an kiwon lafiya na Thailand suna karfafa mutane su yi masks na fuska a gida kuma su wanke su kowace rana.
Jamhuriyar Czech da Slovakia sun haramta fita a fili ba tare da saka abin rufe fuska ko rufe hanci da bakinka ba.
A ranar 16 ga Maris, Vietnam ta bukaci kowa ya sa abin rufe fuska lokacin da ya je wuraren jama'a don kare kansa da wasu.
Gwamnatin Austria ta ba da umarni cewa duk wanda ya shiga kantin sayar da kayayyaki dole ne ya sa abin rufe fuska.
Isra'ila ta bukaci dukkan mazauna su sa abin rufe fuska a lokacin da suke jama'a.
Taiwan, wadda ta samar da masks miliyan 10 a rana tun tsakiyar watan Maris, ta bukaci fasinjojin jiragen kasa da bas din da ke tsakanin birane su sa masks a ranar 1 ga Afrilu.
Panama ta sanya yin amfani da abin rufe fuska a duk lokacin da suka fita waje, yayin da kuma bayar da shawarar yin wani gida-gida fuska mask ga wadanda ba za su iya saya fuska mask.
An kuma yi amfani da abin rufe fuska a Japan, Koriya ta Kudu, Malaysia, da kuma Singapore.
Nisawar zamantakewa (wanda aka fi sani da nesa ta jiki) ya haɗa da ayyukan sarrafa kamuwa da cuta da aka yi niyya don rage yaduwar cutar ta hanyar rage kusanci tsakanin mutane.
Hanyoyin sun haɗa da killacewa; ƙuntatawa a tafiye-tafiye; da kuma rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo, ko kuma cibiyoyin kasuwanci.
Mutane na iya amfani da hanyoyin nisantar zamantakewa ta hanyar kasancewa a gida, iyakance tafiya, guje wa wuraren da mutane suke ɗungum, yin amfani da gaisuwa ba tare da tuntuɓar ba, da nisantar da kansu daga wasu.
Yawancin gwamnatoci yanzu suna ba da umarni ko kuma bayar da shawarar nisantar zamantakewa a yankunan da cutar ta shafa.
Matsakaicin girman tattara da hukumomin gwamnati da kungiyoyin kiwon lafiya na Amurka suka ba da shawarar an rage shi da sauri daga mutane 250 (idan babu sanannen yaduwar COVID-19 a wani yanki) zuwa mutane 50, daga baya zuwa mutane 10.
"A ranar 22 ga Maris, 2020, Jamus ta haramta taron jama'a na mutane fiye da biyu.Masu tsufa da waɗanda ke da yanayin kiwon lafiya kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini, da tsarin rigakafi da aka lalata suna fuskantar haɗarin kamuwa da cuta mai tsanani da rikitarwa kuma CDC ta ba da shawarar su zauna a gida gwargwadon iko a yankunan barkewar cutar.A ƙarshen Maris, 2020, WHO da sauran hukumomin kiwon lafiya sun fara maye gurbin amfani da kalmar ""nesa ta zamantakewa"" da ""nesa ta jiki"", don bayyana cewa makasudin shine rage hulɗa ta jiki yayin kiyaye alaƙar zamantakewa, ko dai a zahiri ko a nesa. "
"Amfani da kalmar ""tsayawa ta zamantakewa"" ya haifar da tasirin cewa mutane suyi aiki a cikin cikakken keɓewar zamantakewa, maimakon ƙarfafa su su ci gaba da tuntuɓar wasu ta hanyar madadin. Wasu hukumomi sun ba da umarnin lafiyar jima'i don amfani yayin annobar. "
Waɗannan sun haɗa da shawarwari na yin jima'i da mutumin da kake zama da shi kawai, wanda ba shi da cutar ko alamun cutar.
An ba da shawarar keɓe kai a gida ga waɗanda aka gano cewa suna da COVID-19 da waɗanda suka yi zargin sun kamu da cutar.
Hukumomin kiwon lafiya sun ba da cikakkun umarni don keɓancewar kai. Gwamnatoci da yawa sun ba da umarni ko kuma sun ba da shawarar keɓancewa ga dukan mutanen da ke zaune a wuraren da cutar ta shafa.
An bayar da umarnin da suka fi karfi game da keɓe kai ga waɗanda ke cikin rukunin haɗari mai girma.
Wadanda suka kasance a cikin haɗari da wani wanda ke da COVID-19 da kuma waɗanda suka yi tafiya kwanan nan zuwa wata ƙasa ko yanki tare da yaduwar yaduwar yaduwar cutar an shawarce su da su keɓe kansu na kwanaki 14 daga lokacin da aka fara nuna su.
Hanyoyi na sarrafa barkewar cutar su ne hana ko kuma kawar da cutar, da kuma rage ta.
Ana gudanar da hana cutar a farkon fasalin barkewar cutar kuma ana nufin ganowa da ware masu kamuwa da cutar da kuma gabatar da wasu matakan hana kamuwa da cutar da yin allurar rigakafi don hana cutar yadawa ga sauran al'umma.
Lokacin da ba zai yiwu a hana yaduwar cutar ba, sai a ci gaba da yin ƙoƙari don rage yaduwar: ana ɗaukar matakan da za su rage yaduwar da kuma rage tasirinsa a kan tsarin kiwon lafiya da kuma al'umma.
Ana iya yin haɗuwa da matakan hanawa da kuma ragewa a lokaci guda.
Dakatar da cutar na bukatar karin matakan da za su iya kawar da cutar ta hanyar rage yawan haihuwa zuwa kasa da 1.Sashe na gudanar da barkewar cutar kamuwa da cuta na kokarin rage cutar, wanda ake kira rage cutar ta cutar.
Wannan yana rage hadarin cewa ana cika ayyukan kiwon lafiya kuma yana ba da karin lokaci don a samar da alluran rigakafi da kuma hanyoyin magani.
Hanyoyin da ba na magunguna ba waɗanda zasu iya magance barkewar cutar sun haɗa da matakan rigakafin mutum, kamar tsabtace hannu, saka abin rufe fuska, da keɓe kai; matakan al'umma da ke nufin nesa da jiki kamar rufe makarantu da soke taron taro; haɗin gwiwar al'umma don ƙarfafa karɓa da shiga cikin irin waɗannan ayyukan; da kuma matakan muhalli kamar tsabtace farfajiyar. An ɗauki ƙarin matakan muhalli da nufin hana barkewar cutar a China da zarar an bayyana tsananin barkewar cutar, kamar killace dukan birane da kuma sanya takunkumin hana tafiye-tafiye.
Sauran ƙasashe kuma sun ɗauki matakai daban-daban da ke nufin rage yaduwar cutar.
Koriya ta Kudu ta gabatar da bincike mai yawa da kuma killacewa, kuma ta ba da gargadi game da motsi na mutane da suka kamu da cutar.
Singapore ta ba da tallafi na kuɗi ga waɗanda suka kamu da cutar da suka keɓe kansu kuma ta ɗora wa waɗanda suka kasa yin hakan manyan tarar.
Taiwan ta kara yawan samar da abin rufe fuska kuma ta yi wa tarin kayan kiwon lafiya hukunci.Samuwa don Burtaniya da Amurka sun nuna cewa ragewa (sannuwa amma ba a dakatar da yaduwar annobar ba) da kuma hanawa (dakatar da ci gaban annobar) suna da manyan ƙalubale.
Manufofin ragewa na iya rage yawan bukatar kiwon lafiya da kashi biyu bisa uku da kuma mutuwar da rabi, amma har yanzu suna haifar da mutuwar dubbai da kuma tsarin kiwon lafiya da ke cike da wahala.
Ana iya ficewa don hanawa amma dole ne a ci gaba har sai cutar ta yi yawo a cikin yawan mutane (ko har sai an sami allurar rigakafi, idan hakan ya fara), saboda watsawa in ba haka ba da sauri ya dawo lokacin da aka sassauta matakan.
Tsayar da dogon lokaci don kawar da annobar yana haifar da farashi na zamantakewa da tattalin arziki.
Babu takamaiman magungunan rigakafin cutar da aka amince da su don COVID-19, amma ana ci gaba da ci gaba da ci gaba, gami da gwada magungunan da ke akwai.
Shan magani don sanyi, shan ruwa, da kuma hutawa zai iya taimaka wa mutum ya rage alamun.
Dangane da tsanani, ana iya bukatar maganin oxygen, ruwa a cikin jini, da kuma taimakon numfashi.
Yin amfani da kwayoyin steroids zai iya sa sakamakon ya yi muni.
Ana binciken wasu sinadarai da aka amince da su a baya don maganin wasu cututtukan kwayar cutar don amfani dasu wajen magance COVID-19.
WHO ta kuma bayyana cewa wasu "tubace-tubace na gargajiya da na gida" na iya samar da taimako ga alamun da SARS-CoV-19 ya haifar. "
WHO ta bayyana karuwar iyawa da daidaita kula da lafiya ga bukatun marasa lafiyar COVID-19 a matsayin matakin mayar da martani na asali ga barkewar cutar.
ECDC da ofishin yanki na Turai na WHO sun ba da jagororin ga asibitoci da sabis na kiwon lafiya na farko don sauya albarkatu a matakai da yawa, gami da mai da hankali kan ayyukan dakin gwaje-gwaje zuwa gwajin COVID-19, soke hanyoyin zaɓin lokacin da zai yiwu, warewa da keɓe marasa lafiya masu cutar COVID-19, da haɓaka ƙarfin kulawa mai tsanani ta hanyar horar da ma'aikata da haɓaka yawan masu iska da gado masu samuwa.
Akwai ka'idoji daban-daban game da inda yanayin farko (wanda ake kira zero mai haƙuri) zai iya fitowa.
An fara gano mutum na farko da aka kamu da cutar coronavirus a ranar 1 ga Disamba, 2019 a Wuhan, Hubei, China.
A cikin wata daya, yawan mutanen da suka kamu da cutar coronavirus a Hubei ya karu a hankali.
Wadannan sun fi dacewa da kasuwar sayar da kayan teku ta Huanan, wanda kuma ke sayar da dabbobi masu rai, kuma wata ka'ida ita ce cewa kwayar ta fito ne daga ɗayan waɗannan nau'ikan dabbobi; ko kuma, a wasu kalmomin, tana da asalin zoonotic. An lura da tarin cutar huhu da ba a san dalilinsa ba a ranar 26 ga Disamba kuma likitan Zhang Jixian ya kula da shi a Asibitin lardin Hubei, wanda ya sanar da Wuhan Jianghan CDC a ranar 27 ga Disamba.
"A ranar 30 ga watan Disamba, wani rukuni na likitoci a asibitin Wuhan sun gargadi abokan aikin su game da "Coronavirus na SARS". "
'Yan sanda sun tsauta wa takwas daga cikin waɗannan likitoci, ciki har da Li Wenliang, domin sun yada jita-jita, kuma wasu, Ai Fen, sun tsauta mata da shugabanninta domin sun yi ta yin gargadi.
Daga bisani Hukumar Lafiya ta Wuhan ta fitar da sanarwar jama'a a ranar 31 ga Disamba kuma ta sanar da WHO.
An bayar da rahoton isasshen shari'o'in cutar huhu da ba a sani ba ga hukumomin kiwon lafiya a Wuhan don fara bincike a farkon watan Janairu.A farkon farkon barkewar cutar, adadin shari'o'in ya ninka kusan sau bakwai da rabi.
A farkon da tsakiyar watan Janairu na 2020, cutar ta bazu zuwa wasu lardunan China, wanda ƙaurawar Sabuwar Shekarar Sin ta taimaka kuma Wuhan ta zama cibiyar sufuri da babban musayar jirgin ƙasa.
A ranar 20 ga watan Janairu, kasar Sin ta ba da rahoton kusan sabbin mutane 140 a rana guda, ciki har da mutane biyu a Beijing da kuma daya a Shenzhen.
Bayanai na hukuma na baya sun nuna cewa mutane 6,174 sun riga sun sami alamun cutar a ranar 20 ga Janairu 2020.Ya zuwa 26 ga Maris, Amurka ta riga ta wuce China da Italiya tare da mafi yawan adadin masu kamuwa da cutar a duniya.Ya zuwa ranar 9 ga Afrilu, 2020, an ba da rahoton fiye da miliyan 1.61 a duk duniya; sama da mutane 97,000 sun mutu kuma sama da 364,000 sun warke.
Kasashe da yankuna kusan 200 sun sami akalla mutum ɗaya.
Saboda annobar a Turai, ƙasashe da yawa a yankin Schengen sun takaita motsi kyauta kuma sun kafa kulawar kan iyakoki.
Sakamakon haka ya shafi matakan hanawa kamar killace mutane (wanda ake kira umarnin zama a gida, umarnin zama a gida, ko kulle-kulle) da kuma dokar hana fita.A ranar 2 ga Afrilu, kusan mutane miliyan 300, ko kusan kashi 90% na yawan jama'a, suna ƙarƙashin wani nau'in kulle-kulle a Amurka, fiye da mutane miliyan 50 suna cikin kulle-kulle a Philippines, kimanin mutane miliyan 59 suna cikin kulle-kulle a Afirka ta Kudu, kuma mutane biliyan 1.3 suna cikin kulle-kulle a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya suna karkashin wani nau'i na kulle-kulle, wanda ya karu zuwa mutane biliyan 2.6 kwanaki biyu bayan hakakusa da kashi ɗaya bisa uku na yawan duniya.
An gano farkon wanda aka tabbatar da cutar COVID-19 a ranar 1 ga Disamba, 2019 a Wuhan; wani rahoto da ba a tabbatar da shi ba ya nuna cewa farkon wanda aka fara kamuwa da ita a ranar 17 ga Nuwamba.
Dakta Zhang Jixian ta lura da tarin cututtukan huhu na sananne a ranar 26 ga Disamba, wanda asibitinta ya sanar da Wuhan Jianghan CDC a ranar 27 ga Disamba.
Gwajin kwayoyin halitta na farko na samfurin marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna kasancewar cutar coronavirus kamar SARS.
Hukumar Lafiya ta Wuhan ta ba da sanarwar jama'a a ranar 31 ga Disamba.
An sanar da Hukumar WHO a wannan rana.
" Yayin da aka samu wadannan sanarwar, 'yan sanda sun gargadi likitoci a Wuhan da " yada jita-jita" game da annobar. "
" Hukumar kiwon lafiya ta kasar Sin ta fara da'awar cewa babu "bayyanewar shaida" na yaduwar mutum zuwa mutum. "
"A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani babban yunkuri wanda daga baya babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping ya bayyana shi a matsayin "yaƙin jama'a" don dakile yaduwar cutar. "
"A cikin abin da aka bayyana a matsayin ""babban killace a tarihin ɗan adam"", an sanar da kwandon kiwon lafiya a ranar 23 ga Janairu don dakatar da tafiya zuwa da fita daga Wuhan, wanda aka faɗaɗa zuwa jimlar birane 15 a Hubei, yana shafar jimlar mutane miliyan 57. "
An haramta amfani da motoci masu zaman kansu a birnin.
An soke bikin Sabuwar Shekara ta kasar Sin (25 ga Janairu) a wurare da yawa.
Hukumomi sun kuma sanar da gina asibitin wucin gadi, asibitin Huoshenshan, wanda aka kammala a cikin kwanaki 10.
An gina wani asibiti bayan haka, asibitin Leishenshan, don kula da ƙarin marasa lafiya.
Baya ga sabbin asibitocin da aka gina, kasar Sin ta kuma mayar da wasu wurare 14 a Wuhan, kamar cibiyoyin taro da filayen wasa, zuwa asibitocin wucin gadi.A ranar 26 ga Janairu, gwamnati ta kafa wasu matakan dakile barkewar COVID-19, gami da bayar da sanarwar lafiya ga matafiya da tsawaita hutun bikin bazara.
Jami'o'i da makarantu a fadin kasar sun rufe.
Yankunan Hong Kong da Macau sun kafa wasu matakai, musamman ma game da makarantu da jami'o'i.
An kafa matakan aiki na nesa a yankuna da dama na kasar Sin.
An kafa takunkumin tafiye-tafiye a cikin Hubei da wajenta.
An canja hanyoyin sufuri na jama'a, kuma an rufe gidajen tarihi a dukan ƙasar Sin.
" An yi amfani da sarrafa motsi na jama'a a birane da yawa, kuma an kiyasta cewa kimanin mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci wasu nau'ikan ƙuntatawa a waje. Bayan barkewar cutar ta shiga matakin ta duniya a watan Maris, hukumomin China sun ɗauki tsauraran matakai don hana kwayar cutar " shigowa " daga wasu ƙasashe. "
Misali, Beijing ta sanya dokar killacewa ta kwanaki 14 ga duk matafiya na duniya da suka shiga birnin.A ranar 23 ga Maris, kasar Sin ta tsakiya ta samu kamuwa da cutar guda daya a cikin kwanaki biyar da suka gabata, a wannan yanayin ta hanyar matafiyi da ke komawa Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya ba da rahoton cewa an dakatar da yaduwar cututtukan da aka watsa a cikin gida kuma an sarrafa barkewar cutar a China.
A wannan ranar an sassauta takunkumin tafiye-tafiye a Hubei, ban da Wuhan, watanni biyu bayan an sanya dokar kulle. Ma'aikatar Harkokin Wajen China ta sanar a ranar 26 ga Maris 2020 cewa za a dakatar da shiga masu riƙe da biza ko izinin zama daga ranar 28 ga Maris, ba tare da cikakken bayani game da lokacin da wannan manufar za ta ƙare ba.
Wadanda suke son shiga kasar Sin za su nemi biza a ofisoshin jakadancin kasar Sin ko kuma ofisoshin jakadancin kasar.
Gwamnatin kasar Sin ta karfafa harkokin kasuwanci da masana'antu su sake budewa a ranar 30 ga Maris, kuma ta samar da kunshin karfafa kudi ga kamfanoni. Majalisar Jiha ta ayyana ranar makoki da za ta fara da minti uku na shiru a ranar 10 ga Afrilu, 4 ga Afrilu, daidai da bikin Qingming, kodayake gwamnatin tsakiya ta nemi iyalai su yi biyayya ta yanar gizo a cikin kiyaye nesa ta jiki don kauce wa sake barkewar COVID-19.
An tabbatar da cewa COVID-19 ta bazu zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020 daga China.
Hukumar kula da lafiya ta kasar ta ruwaito karuwar adadin wadanda suka kamu da cutar a ranar 20 ga watan Fabrairu, wanda ya fi yawa ne saboda taron da aka yi a Daegu na wani sabon motsi na addini da aka sani da Shincheonji Church of Jesus.
An yi zargin cewa masu bin Shincheonji da ke ziyartar Daegu daga Wuhan ne suka haifar da cutar.
Ya zuwa ranar 22 ga Fabrairu, daga cikin mabiya 9,336 na cocin, 1,261 ko kusan 13% sun ba da rahoton alamun. Koriya ta Kudu ta ba da sanarwar matakin tsaro mafi girma a ranar 23 ga Fabrairu 2020.
A ranar 28 ga Fabrairu, an ba da rahoton fiye da 2,000 da aka tabbatar da cutar a Koriya, wanda ya karu zuwa 3,150 a ranar 29 ga Fabrairu.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan an tabbatar da gwajin da ya tabbatar da cewa sojoji uku sun kamu da cutar.
An kuma shafi jadawalin jiragen sama kuma saboda haka an canza su. Koriya ta Kudu ta gabatar da abin da aka yi la'akari da shi mafi girma da kuma mafi kyawun shirin a duniya don bincika yawan jama'a don cutar, da ware duk wani mai kamuwa da cutar da kuma ganowa da killace waɗanda suka tuntube su.
Hanyoyin binciken sun haɗa da tilasta kai tsaye ga bayyanar cututtuka ta sababbin masu shigowa na duniya ta hanyar aikace-aikacen hannu, gwajin gwaji na drive-thru don cutar tare da sakamakon da ke samuwa a rana mai zuwa, da haɓaka ƙarfin gwajin don ba da damar gwada mutane har zuwa 20,000 kowace rana.
An dauki shirin Koriya ta Kudu a matsayin nasara wajen sarrafa barkewar cutar duk da cewa ba a killace dukkan biranen ba. An fara rarrabuwa al'ummar Koriya ta Kudu a kan yadda Shugaba Moon Jae-in ya amsa matsalar.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman tsige Moon saboda abin da suka ce gwamnati ta yi wa annobar cutar, ko kuma suna yaba wa martani.
A ranar 23 ga watan Maris, an ruwaito cewa Koriya ta Kudu ta sami mafi ƙarancin adadin masu kamuwa da cutar a rana ɗaya a cikin makonni huɗu.
A ranar 29 ga Maris an ruwaito cewa daga 1 ga Afrilu za a sanya duk sababbin masu zuwa kasashen waje a cikin killace na makonni biyu.
A cewar rahotanni na kafofin watsa labarai a ranar 1 ga Afrilu, Koriya ta Kudu ta karbi buƙatun taimako don gwajin cutar daga ƙasashe 121 daban-daban.
Iran ta ba da rahoton farkon tabbatar da kamuwa da cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Qom, inda, a cewar Ma'aikatar Lafiya da Ilimin Likita, mutane biyu suka mutu a ƙarshen wannan rana.
Matakan da gwamnati ta sanar da su na farko sun haɗa da soke kide-kide da sauran abubuwan al'adu, wasanni, da addu'o'in Juma'a, da rufe jami'o'i, cibiyoyin ilimi na sama, da makarantu.
Iran ta ba da riyal tiriliyan biyar don yaki da cutar.
Shugaban kasar Hassan Rouhani ya ce a ranar 26 ga Fabrairu 2020 cewa babu wani shiri na killace yankunan da cutar ta shafa, kuma mutane ne kawai za a killace su.
An sanar da tsare-tsaren rage zirga-zirgar tsakanin birane a watan Maris, ko da yake zirga-zirga mai yawa tsakanin birane kafin Sabuwar Shekarar Farisa ta Nowruz ta ci gaba.
Masallatai na Shi'a a Qom sun kasance a bude ga mahajjata har zuwa 16 ga Maris 2020. Iran ta zama cibiyar yaduwar cutar bayan China a watan Fabrairu.
A cikin ikirarin rufe girman cutar a Iran, fiye da kasashe goma sun gano shari'o'insu zuwa Iran a ranar 28 ga Fabrairu, wanda ke nuna cewa girman cutar na iya zama mafi tsanani fiye da shari'o'in 388 da gwamnatin Iran ta ruwaito a wannan ranar.
An rufe majalisar dokokin Iran, inda aka ruwaito cewa 23 daga cikin 'yan majalisarta 290 sun tabbatar da cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta bukaci hukumomin kurkuku na Iran da su saki masu kare hakkin dan Adam da aka tsare saboda rashin amincewarsu da zaman lafiya, kuma su sake dukkan fursunonin da suka cancanta.
Ya bayyana cewa akwai babban haɗarin yaduwar cutar a cibiyoyin da aka rufe kamar cibiyoyin tsare, waɗanda kuma ba su da isasshen kulawar likita.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana guda, wanda shine mafi yawan mutane da aka rubuta a kasar tun lokacin da cutar ta fara.
Akalla 'yan siyasa 12 da kuma tsoffin jami'an gwamnati na Iran sun mutu daga cutar a ranar 17 ga Maris.
A ranar 23 ga watan Maris, Iran tana fuskantar sabbin mutane 50 a kowace awa da kuma sabon mutuwar mutum daya a kowane minti 10 saboda cutar coronavirus.
Wani jami'in WHO ya ce, akwai yiwuwar samun adadin mutane biyar da suka kamu da cutar a Iran fiye da yadda ake bayar da rahoto.
An kuma nuna cewa takunkumin Amurka kan Iran na iya shafar karfin kudi na kasar wajen amsa cutar.
Babban Kwamishinan Majalisar Dinkin Duniya na 'Yancin Dan Adam ya bukaci a sassauta takunkumin tattalin arziki ga kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da barkewar cutar ta bazu zuwa Italiya a ranar 31 ga Janairu, lokacin da 'yan yawon bude ido biyu na kasar Sin suka tabbatar da cutar SARS-CoV-2 a Roma.
Al'amuran sun fara ƙaruwa sosai, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen zuwa da daga China kuma ta ayyana dokar ta baci.
Daga bisani an gano wani rukuni na marasa alaƙa na shari'o'in COVID-19, farawa da mutane 16 da aka tabbatar da cutar a Lombardy a ranar 21 ga Fabrairu.A ranar 22 ga Fabrairu, Majalisar Ministoci ta ba da sanarwar sabon doka don hana barkewar cutar, gami da killace mutane sama da 50,000 daga garuruwa daban-daban 11 a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce, "A yankunan da cutar ta bulla, ba za a ba da izinin shiga da fita ba. "
"An riga an ba da umarnin dakatar da ayyukan aiki da wasanni a waɗannan yankuna. "A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar yayin da Italiya ta kai mutuwar 100. "
Duk manyan wasanni, ciki har da wasannin ƙwallon ƙafa na Serie A, za a gudanar da su a rufe har zuwa Afrilu, amma a ranar 9 ga Maris, an dakatar da duk wasanni gaba ɗaya na akalla wata ɗaya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan dukkanin ayyukan kasuwanci sai dai manyan kantuna da kantunan magani. A ranar 6 ga Maris, Kwalejin Italiyanci na Anaesthesia, Analgesia, Resuscitation da Kulawa mai tsanani (SIAARTI) ta wallafa shawarwari game da halayyar likita game da yarjejeniyar rarrabuwa da za a iya amfani da su.
A ranar 19 ga watan Maris, Italiya ta zarce China a matsayin ƙasa da ta fi yawan mutuwar da ke tattare da cutar coronavirus a duniya bayan ta ba da rahoton mutuwar 3,405 daga annobar.
A ranar 22 ga Maris, an ruwaito cewa Rasha ta aika da jiragen soja tara da kayan aikin likita zuwa Italiya.
Ya zuwa ranar 5 ga Afrilu, an sami kamuwa da cutar 128,948 da aka tabbatar, mutuwar 15,887, da kuma warkewar 21,815 a Italiya, tare da yawancin waɗannan shari'o'in da suka faru a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa haɗuwa da yawan tsofaffin mutanen Italiya da rashin iyawar gwada duk waɗanda suka kamu da cutar har zuwa yau na iya taimakawa wajen yawan mutuwar.
Amsar Burtaniya ga cutar ta fara fitowa a matsayin ɗayan ƙasashe masu nutsuwa, kuma har zuwa 18 ga Maris 2020, gwamnatin Burtaniya ba ta sanya kowane nau'in nisan zamantakewa ko matakan killace jama'a ga 'yan ƙasa ba.
A sakamakon haka, gwamnati ta sami zargi saboda rashin saurin da ake ɗauka da kuma ƙarfinsa a cikin amsawa ga damuwar da jama'a ke fuskanta.A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar da ke ba da shawara game da duk balaguro da alaƙar zamantakewa ba, yana ba da shawarar mutane su yi aiki daga gida idan ya yiwu kuma su guji wuraren da suka dace kamar mashaya, gidajen abinci, da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnatin ta sanar da cewa duk wuraren shakatawa kamar mashaya da wuraren motsa jiki za su rufe da wuri-wuri, kuma ta yi alkawarin biyan har zuwa 80% na albashi na ma'aikata zuwa iyakar £ 2,500 a kowane wata don hana rashin aikin yi a cikin rikicin. A ranar 23 ga Maris, Firayim Minista ya sanar da tsauraran matakan nisan zamantakewa, ya hana tarurruka na mutane fiye da biyu da kuma iyakance tafiya da ayyukan waje zuwa abin da aka ɗauka da gaske ya zama dole.
Ba kamar matakan da suka gabata ba, 'yan sanda sun aiwatar da waɗannan ƙuntatawa ta hanyar ba da tarar kuɗi da kuma tarwatsa taron.
" An umarci mafi yawan kasuwancin su rufe, tare da musayar kasuwancin da aka ɗauka ""mafi mahimmanci"", ciki har da manyan kasuwanni, kantuna, bankuna, shagunan kayan aiki, tashoshin mai, da garages. "
A ranar 20 ga Janairu, an tabbatar da sanannen mutum na farko na COVID-19 a jihar Washington ta Pacific Northwest a cikin wani mutum wanda ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rundunar aikin Coronavirus ta Fadar White House a ranar 29 ga Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya ta jama'a, kuma ta sanya takunkumi kan shiga ga matafiya daga China.
Ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka, babban cibiyar kiwon lafiyar jama'a ta gwamnatin Amurka, ta sanar da cewa sun haɓaka kayan gwajin kansu.
Duk da haka, Amirka ta soma gwajin da jinkiri, kuma hakan ya rufe ainihin yadda annobar ta bulla a lokacin.
Gwaje-gwajen sun lalace ta hanyar kuskuren kayan gwajin da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar gwamnatin tarayya ga kayan gwajin da ba na gwamnati ba (ta hanyar jami'o'i, kamfanoni da asibitoci) har zuwa ƙarshen Fabrairu, da kuma takamaiman ka'idoji don mutane su cancanta don gwajin har zuwa farkon Maris (an buƙaci umarnin likita daga baya).
A ranar 27 ga Fabrairu, jaridar The Washington Post ta ruwaito cewa an yi gwaje-gwaje kasa da 4,000 a Amirka.
A ranar 13 ga Maris, jaridar The Atlantic ta ba da rahoton cewa an yi gwaje-gwaje kasa da 14,000.
"A ranar 22 ga watan Maris, Associated Press ta ruwaito: ""Mutane da yawa da ke da alamun cututtuka da umarnin likita sun jira awanni ko kwanaki don gwaji. ""Bayan an ba da rahoton mutuwar farko a Amurka a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ayyana dokar ta baci, wani mataki da sauran jihohi suka bi nan da nan. "
Makarantu a yankin Seattle sun soke darussan a ranar 3 ga Maris, kuma a tsakiyar watan Maris, makarantu a duk faɗin ƙasar sun rufe.A ranar 6 ga Maris, 2020, an sanar da Amurka game da tsinkayen tasirin sabon coronavirus a ƙasar ta hanyar rukuni na masu ilimin cututtuka a Kwalejin Imperial ta London.
A wannan ranar ne Shugaba Trump ya rattaba hannu kan Dokar Bayar da Ƙarin Bayar da Kayan Aikin Shirye-shiryen Coronavirus da Amsa, wanda ya ba da dala biliyan 8.3 a cikin kudaden gaggawa ga hukumomin tarayya don amsa cutar.
Ƙungiyoyi sun sa ma'aikata su yi tafiya ba tare da yin taro ba, kuma sun ƙarfafa ma'aikata su yi aiki daga gida.
An soke taron wasanni da yanayi.A ranar 11 ga Maris, Trump ya sanar da takunkumin tafiye-tafiye ga yawancin Turai, ban da Burtaniya, na kwanaki 30, daga 13 ga Maris.
Kashegari, ya faɗaɗa ƙuntatawa don ya haɗa da Burtaniya da Ireland.
A ranar 13 ga Maris, ya ayyana dokar ta baci ta kasa, wanda ya ba da kudaden tarayya don amsawa ga rikicin.
Tun daga ranar 15 ga Maris, kamfanoni da yawa sun rufe ko rage lokutan aiki a duk faɗin Amurka don ƙoƙarin rage yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da annobar a duk jihohi 50 da kuma gundumar Columbia. A ranar 23 ga Maris, an ruwaito cewa New York City tana da shari'o'in cutar coronavirus 10,700, wanda ya fi yawan adadin masu cutar a Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan ya ce ana ganin an yi amfani da nesa ta zamantakewa, yayin da kimar ninka yawan masu kamuwa da cutar ta ragu daga kwanaki 2.0 zuwa kwanaki 4.7.
Ya zuwa 28 ga Maris, akwai mutane 32,308 da aka tabbatar da cutar a Birnin New York, kuma mutane 672 sun mutu daga cutar.A ranar 26 ga Maris, an ruwaito cewa Amurka ta sami ƙarin adadin masu kamuwa da cutar coronavirus fiye da kowace ƙasa a duniya, gami da China da Italiya.Ya zuwa 8 ga Afrilu, an tabbatar da mutane 400,335 a Amurka, kuma mutane 12,841 sun mutu.
A cewar rahotanni na kafofin watsa labarai a ranar 30 ga watan Maris, Shugaban Amurka Trump ya yanke shawarar tsawaita ka'idodin nisan zamantakewa har zuwa 30 ga Afrilu.
A wannan ranar, jirgin Amurka mai suna USNS Comfort, wato, wani asibiti mai ɗauke da gado dubu, ya sauka a birnin New York.
A ranar 3 ga Afrilu, Amurka ta yi rikodin mutuwar mutane 884 sakamakon cutar coronavirus a cikin awanni 24.
A jihar New York, mutane 100,000 ne suka kamu da cutar a ranar 3 ga Afrilu. An soki Fadar White House saboda ta rage girman barazanar da kuma sarrafa saƙonnin ta hanyar umarci jami'an lafiya da masana kimiyya su daidaita sanarwa da wallafe-wallafen da suka shafi cutar tare da ofishin mataimakin shugaban kasa Mike Pence.
An samu karbuwa a kan yadda Trump ke kula da rikicin.
Wasu jami'an Amurka da masu sharhi sun soki Amurka dangane da shigo da kayan aiki masu mahimmanci, gami da kayayyakin kiwon lafiya na asali, daga China.
An yi amfani da nazarin tsarin tafiye-tafiyen jirgin sama don taswirar da hango ko hasashen yanayin yaduwar kuma an buga shi a cikin Jaridar Travel Medicine a tsakiyar Janairu 2020.
Dangane da bayanan 2018 daga International Air Transport Association, Bangkok, Hong Kong, Tokyo, da Taipei sun sami mafi yawan matafiya daga Wuhan.
An kuma ruwaito Dubai, Sydney, da Melbourne a matsayin wuraren da mutane ke tafiya daga Wuhan.
An ruwaito cewa Bali ta fi kasa a cikin biranen da suka fi shahara 20 a cikin shirye-shirye, yayin da aka dauki biranen Ostiraliya a matsayin mafi iyawa. Ostiraliya ta fitar da shirin gaggawa na gaggawa don sabon Coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ya bayyana cewa har yanzu akwai abubuwa da yawa da za a gano game da COVID-19, kuma cewa Ostiraliya za ta jaddada kula da iyakoki da sadarwa a cikin martani ga annobar.
A ranar 21 ga Maris, an bayyana gaggawa na lafiyar mutum a Ostiraliya.
Saboda ingantaccen killace jigilar jama'a a Wuhan da Hubei, kasashe da dama sun shirya kwashe 'yan ƙasarsu da ma'aikatan diflomasiyya daga yankin, musamman ta hanyar jiragen haya na ƙasar gida, tare da hukumomin China da ke ba da izini.
Kanada, Amirka, Japan, Indiya, Sri Lanka, Ostiraliya, Faransa, Argentina, Jamus, da kuma Thailand sun kasance cikin na farko da suka shirya ƙaura da 'yan ƙasarsu.
Pakistan ta ce ba za ta kwashe wani dan kasar Sin ba.
A ranar 7 ga Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko kuma danginsu ban da' yan Poland hudu, da wani dan kasar Sin, da kuma dan kasar Indiya.
'Yan ƙasar Poland da China da kuma Indiya sun tashi daga jirgin zuwa ƙasar Poland, inda jirgin ya tsaya kafin ya bi hanyarsa zuwa ƙasar Brazil.
An killace 'yan kasar Brazil da suka je Wuhan a wani sansanin soji kusa da Brasília.
A wannan ranar, an kwashe 'yan Kanada 215 (176 daga jirgin sama na farko, da 39 daga jirgin sama na biyu da gwamnatin Amurka ta haya) daga Wuhan zuwa CFB Trenton don a killace su na makonni biyu.
A ranar 11 ga Fabrairu, wani jirgin sama na Kanada 185 daga Wuhan ya sauka a CFB Trenton.
Hukumomin Ostiraliya sun kwashe 'yan ƙasa 277 a ranar 3 da 4 ga Fabrairu zuwa Cibiyar Kula da Tsibirin Kirsimeti, wanda aka sake amfani da shi a matsayin cibiyar killacewa, inda suka zauna har tsawon kwanaki 14.
Jirgin motsa jiki na New Zealand ya isa Auckland a ranar 5 ga Fabrairu; fasinjojinsa (ciki har da wasu daga Ostiraliya da Pacific) an killace su a sansanin sojan ruwa a Whangaparoa, arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa a kan jirgin ruwa mai suna Diamond Princess.
A ranar 21 ga Fabrairu, jirgin sama da ke dauke da fasinjoji 129 na Kanada da aka kwashe daga Diamond Princess ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasar daga Iran. A ranar 14 ga Maris, jirgin saman South African Airways da gwamnatin Afirka ta Kudu ta haya ya koma ƙasar 'yan Afirka ta Kudu 112.
An gudanar da binciken likita kafin tashi, kuma an bar 'yan Afirka ta Kudu huɗu da ke nuna alamun cutar coronavirus don rage haɗarin.
Sai dai 'yan Afirka ta Kudu da suka samu gwajin rashin lafiya ne aka mayar da su.
Sakamakon gwajin ya tsarkake dukkan 'yan Afirka ta Kudu, gami da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal, 'yan sanda da sojoji da ke cikin aikin agaji wanda, a matsayin matakin tsaro, dukansu suka kasance a karkashin sa ido da ke cikin killacewa na tsawon kwanaki 14 a The Ranch Resort.
A ranar 20 ga Maris, Amurka ta fara janye dakarunta daga Iraki saboda annobar.
A ranar 5 ga Fabrairu, ma'aikatar harkokin wajen kasar Sin ta bayyana cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar, da Iran) sun aika da taimako ga kasar Sin.
Wasu daliban kasar Sin a jami'o'in Amurka sun hada kai don taimakawa wajen aika taimako zuwa sassan da cutar ta shafa a kasar Sin, tare da wata kungiya a yankin Chicago da aka ruwaito sun gudanar da aikawa da masks N95 50,000 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu. Kungiyar taimakon agaji ta Direct Relief, a cikin haɗin kai da FedEx, ta aika da masks na fuska 200,000 tare da sauran kayan kariya na mutum, gami da safofin hannu da riguna, ta hanyar jigilar iska ta gaggawa zuwa asibitin Wuhan Union zuwa 30 ga Janairu.
"A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da kyautar dala miliyan 100 ga WHO don tallafawa bincike da aikin maganin rigakafi tare da kare "ƙungiyoyin da ke cikin haɗari a Afirka da Kudancin Asiya". "
Interaksyon ta ruwaito cewa gwamnatin kasar Sin ta ba da masks 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan Sanata Richard Gordon ya tura masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, Red Cross ta Singapore ta sanar da cewa za ta aika da tallafin dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da masks miliyan daya ga Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da kayayyakin kiwon lafiya sama da tan 13 zuwa Wuhan, Malaysia ta sanar da bayar da safofin hannu na kiwon lafiya miliyan 18 ga China, Jamus ta ba da kayayyakin kiwon lafiya daban-daban ciki har da riguna na Hazmat 10,000, kuma Amurka ta ba da kayayyakin kiwon lafiya tan 17.8 ga China kuma ta yi alkawarin ƙarin dala miliyan 100 a cikin tallafin kuɗi ga ƙasashe da cutar ta shafa. Bayan da ya bayyana cewa cututtuka a China sun daidaita, ƙasar ta aika da taimako ga ƙasashe daban-daban da cutar ta shafa.
A watan Maris, kasar Sin da Cuba da Rasha sun aika da kayayyakin kiwon lafiya da masana don taimakawa Italiya wajen magance barkewar cutar coronavirus.
Dan kasuwa Jack Ma ya aika da kayan gwaji miliyan 1.1 da abin rufe fuska miliyan 6, da kuma riguna masu kariya 60,000 zuwa Addis Ababa, Habasha don rarrabawa ta Tarayyar Afirka.
Daga baya ya aika da kayan gwaji 5,000, masks 100,000 da kuma na'urori na iska 5 zuwa Panama.
Ma ta kuma ba da kayayyakin kiwon lafiya ga Kanada. Netherlands, Spain, Turkiyya, Georgia, da Jamhuriyar Czech sun nuna damuwarsu game da masks da kayan gwajin da aka yi a kasar Sin.
Misali, Spain ta janye kayan gwajin coronavirus na kasar Sin 58,000 tare da daidaito na kashi 30% kawai, yayin da Netherlands ta janye masks na fuska na kasar Sin 600,000 wadanda suka lalace.
Belgium ta dawo da masks 100,000 da ba za a iya amfani da su ba, wanda ake zaton daga China ne, amma a gaskiya sun fito ne daga Colombia.
A wani bangare kuma, an samu tallafin da kasar Sin ke bayarwa a wasu sassan Latin Amurka da Afirka. A ranar 2 ga Afrilu, Bankin Duniya ya kaddamar da ayyukan gaggawa na tallafawa kasashe masu tasowa.
Hukumar WHO ta yaba wa kokarin da hukumomin kasar Sin ke yi wajen sarrafa cutar da kuma hana ta.
" WHO ta lura da bambanci tsakanin barkewar cutar SARS ta 2002 zuwa 2004, inda aka zargi hukumomin kasar Sin da ɓoyewa wanda ya hana rigakafin da ƙoƙarin dakile ta, da kuma rikicin da ke faruwa a yanzu inda gwamnatin tsakiya ta "bayar da sabuntawa na yau da kullun don kauce wa firgita kafin hutun Sabuwar Shekara ta Lunar". "
"A ranar 23 ga Janairu, a mayar da martani ga shawarar da hukumomin tsakiya suka yanke na aiwatar da haramcin sufuri a Wuhan, wakilin WHO Gauden Galea ya lura cewa yayin da yake "ba shakka ba shawarar da WHO ta bayar ba", shi ma "yana da matukar mahimmanci alama ce ta sadaukar da kai don hana cutar a wurin da ta fi yawaitawa" kuma ya kira ta "marasa misaltuwa a tarihin lafiyar jama'a".A ranar 30 ga Janairu, bayan tabbatar da yaduwar mutum zuwa mutum a wajen China da kuma karuwar adadin shari'o'in a wasu ƙasashe, WHO ta ayyana barkewar cutar a matsayin Balaguro na Lafiya ta Jama'a na Duniya (PHEIC), PHEIC na shida tun lokacin da aka fara kiran matakin a lokacin annobar cutar mura ta 2009".
" Babban Daraktan WHO Tedros Adhanom ya ce PHEIC ya faru ne saboda "hadarin yaduwar duniya, musamman ga ƙasashen da ke da ƙananan da matsakaitan kudade ba tare da ingantaccen tsarin kiwon lafiya ba. "
"A martani ga aiwatar da takunkumin tafiye-tafiye, Tedros ya bayyana cewa ""babu dalilin da zai sa a dauki matakan da ba su da muhimmanci ga tafiye-tafiye da cinikayya ta duniya"" kuma cewa ""WHO ba ta bada shawarar rage cinikayya da motsi ba. ""
"A ranar 5 ga watan Fabrairu, WHO ta yi kira ga al'ummar duniya don ba da gudummawar dala miliyan 675 don tallafawa shirye-shiryen dabarun a ƙasashen da ke da ƙananan kudade, ta ba da bayanin gaggawa don tallafawa waɗancan ƙasashen da "ba su da tsarin gano mutanen da suka kamu da cutar, koda kuwa ta fito". "
" Tedros ya kara da cewa "mu ne kawai masu karfi kamar yadda mu rauni link"" kuma ya bukaci kasa da kasa da al'umma su "" zuba jari a yau ko biya more daga baya".A ranar 11 ga Fabrairu, WHO a wani taron manema labarai kafa COVID-19 a matsayin sunan cutar. "
A wannan rana, Tedros ya bayyana cewa Sakataren Janar na Majalisar Dinkin Duniya António Guterres ya amince ya samar da "ikon dukan tsarin Majalisar Dinkin Duniya a cikin amsa".
" An kunna tawagar kula da rikicin Majalisar Dinkin Duniya a sakamakon haka, yana ba da damar daidaita dukkanin ayyukan Majalisar Dinkin Duniya, wanda WHO ta ce zai ba su damar "daidaitawa kan maganin kiwon lafiya yayin da sauran hukumomi zasu iya kawo kwarewarsu don ɗaukar tasirin zamantakewa, tattalin arziki da ci gaban ci gaban annobar". "
" A ranar 14 ga watan Fabrairu, an kunna tawagar hadin gwiwar WHO da kasar Sin don samar da masana na duniya da na WHO a kasar Sin don taimakawa wajen gudanar da aikin gida da kimanta "zafin hali da kuma yaduwar cutar" ta hanyar gudanar da bita da tarurruka tare da manyan cibiyoyin kasa da kuma gudanar da ziyara ta filin don kimanta "sakamakon ayyukan amsawa a larduna da jihohi, gami da birane da karkara". A ranar 25 ga Fabrairu, WHO ta bayyana cewa "Duniya ya kamata ta yi karin shirye-shirye don yiwuwar annobar coronavirus, "da ke cewa yayin da har yanzu ya yi wuri sosai don kiran ta annoba, ƙasashe ya kamata duk da haka su kasance "a cikin wani mataki na shiri".
"Domin amsawa ga barkewar cutar a Iran, WHO ta aika da ƙungiyar hadin gwiwa a can don kimanta halin da ake ciki.A ranar 28 ga Fabrairu, jami'an WHO sun ce za a ɗaga kimantawar barazanar coronavirus a matakin duniya daga "babba" zuwa "mai girma sosai", matakin mafi girma na faɗakarwa da kimanta haɗari. "
" Mike Ryan, darektan zartarwa na shirin gaggawa na kiwon lafiya na WHO, ya yi gargadin a cikin wata sanarwa cewa ""Wannan gwaji ne na gaskiya ga kowace gwamnati a duniya: farka. "
"Wannan kwayar cutar na iya zuwa kuma kana bukatar ka kasance a shirye, " yana mai da hankali cewa matakan da suka dace na amsawa na iya taimakawa duniya ta kauce wa" mafi munin sa ".
" Ryan ya kara da cewa bayanan da ake samu a yanzu ba su ba da izinin jami'an kiwon lafiya na jama'a su bayyana annobar duniya ba, yana mai cewa irin wannan sanarwar za ta nufin ""mu a zahiri muna karbar cewa kowane mutum a duniya zai kasance a cikin wannan cutar. ""
A ranar 11 ga Maris, WHO ta ayyana barkewar cutar coronavirus a matsayin annoba.
"Darakta Janar ya ce WHO ta "ji damuwar ta sosai game da matakan da ke damun yaduwar da kuma tsanani, da kuma matakan da ke damun rashin aiki". WHO ta fuskanci manyan zargi saboda abin da ake gani a matsayin rashin isasshen kula da cutar, gami da sanarwar gaggawa ta kiwon lafiyar jama'a da kuma rarraba cutar a matsayin annobar. "
Sakamakon ya hada da wata takarda ga Daraktan Darakta na WHO Tedros Adhanom don ya mika mukaminsa, wanda mutane 733,000 suka sanya hannu a ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, masana dubban kare hakkin bil adama na Majalisar Dinkin Duniya sun jaddada girmama hakkin kowane mutum yayin annobar COVID-19.
Kungiyar masana ta bayyana cewa kowa yana da hakkin yin ayyukan ceto rai kuma gwamnati tana da wannan alhakin.
Ƙungiyar ta jaddada cewa rashin albarkatu ko inshorar lafiya bai kamata ya zama hujja ga nuna bambanci ga wani rukuni ba.
Masana sun jaddada cewa kowa yana da hakkin samun lafiya, ciki har da nakasassu, na ƙarancin al'umma, tsofaffi, waɗanda suka yi gudun hijira, marasa gida, waɗanda ke rayuwa a cikin yanayi mai wuya, waɗanda ke tsare, da kuma 'yan gudun hijira da sauran kungiyoyin da ba a bayyana su ba da suke bukatar tallafin gwamnati.
Kungiyoyin gwamnati na duniya suna magance tasirin tattalin arziki da zamantakewar al'umma na rikicin COVID-19.
Kungiyar hadin kan tattalin arziki da ci gaba ta kaddamar da dandamali don samar da bayanai a kan hanyoyin da ake bi a ƙasashe a duniya, da kuma ra'ayoyi da shawarwari.
Daga manufofi don ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya zuwa magance tasirin kulle-kulle da ƙuntatawa kan tafiya, cibiyar dijital ta ƙunshi mai bin diddigin Manufofin Kasashe, kuma tana nufin taimaka wa ƙasashe su koya daga juna da kuma sauƙaƙe daidaitaccen amsa duniya ga ƙalubalen coronavirus.
Gwamnatin kasar Sin ta yi ta sukar Amurka, Ministan Birtaniya na ofishin majalisar ministocin kasar Michael Gove, da kuma dan shugaban kasar Brazil Jair Bolsonaro Eduardo Bolsonaro saboda yadda ta magance annobar, wadda ta fara a lardin Hubei na kasar Sin.
An kori wasu masu gudanarwa a matakin larduna na Jam'iyyar Kwaminisancin China (CPC) saboda yadda suka gudanar da ayyukan killacewa a tsakiyar China, a matsayin alamar rashin jin daɗin yadda tsarin siyasa ya amsa barkewar cutar a waɗancan yankuna.
Wasu masu sharhi sun yi imanin cewa wannan matakin na nufin kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin jama'a kan barkewar cutar coronavirus.
Wasu jami'an kasar Sin, misali Zhao Lijian sun ƙi amincewa da barkewar cutar coronavirus da ta fara a Wuhan, a madadin ka'idodin makirci game da COVID-19 da ke fitowa daga Amurka ko Italiya.
" Gwamnatin Amurka ta Donald Trump ta ambaci coronavirus a matsayin "kwararriyar cutar Sin" ko "kwararriyar Wuhan" yana cewa "tsabtace-tsabtace na kasar Sin ya sanya kwayar cutar da ta zama annobar duniya", wanda wasu masu sukar suka soki a matsayin wariyar launin fata da kuma "ruɓewa daga gazawar gwamnatinsa na hana cutar". "
" Daily Beast ta samu sakon gwamnatin Amurka wanda ya bayyana dabarun sadarwa da ke da asali a Majalisar Tsaro ta Kasa, tare da an ambaci dabarar a matsayin ""Dukkanin game da China ne. "
"An gaya mana mu yi kokarin fitar da wannan sakon ta kowace hanya, ciki har da taron manema labarai da kuma fitowar talabijin. " "Taro kamar Politico, Foreign Policy, da Bloomberg sun yi ikirarin cewa kokarin da kasar Sin ke yi na aikawa da taimako zuwa kasashen da cutar ta shafa na daga cikin wani bangare ne na yunkurin yada labarai na neman tasiri a duniya. "
"Shugaban siyasar kasashen waje na EU Josep Borrell ya yi gargadin cewa akwai "wani bangare na siyasa ta ƙasa wanda ya haɗa da gwagwarmayar tasiri ta hanyar juyawa da kuma 'yancin karimci.'"
"Borrell ya kuma ce ""China tana tura sakon da karfi cewa, sabanin Amurka, ita ce mai daukar nauyin da kuma amintaccen abokin tarayya. """
Kasar Sin ta kuma bukaci Amurka ta soke takunkumin da ta dauka kan Syria, Venezuela da Iran, yayin da ake zargin ta tura taimakon kasashen biyu na baya.
Jack Ma ya ba da masks 100,000 ga Cuba an hana shi ta hanyar takunkumin Amurka a ranar 3 ga Afrilu.
An kuma zargi hukumomin Amurka da karkatar da tallafin da aka ba wasu kasashe zuwa kasarsu.
Kuma an ruwaito rikice-rikice game da abin rufe fuska tsakanin wasu ƙasashe, kamar Jamus, Austria da Switzerland; da Jamhuriyar Czech da Italiya.
Bugu da ƙari, Turkiyya ta kama ɗaruruwan na'urorin numfashi da aka yi amfani da su a ƙasar Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin hadin kai da Tarayyar Turai ke yi da Italiya da cutar coronavirus ta shafa.
" Maurizio Massari, jakadan Italiya a EU, ya ce ""Kamar dai kasar Sin ta amsa a bangare biyu. "
"Lalle ne, wannan ba alama ce mai kyau na hadin kai na Turai ba".
A ranar 22 ga Maris, bayan ya yi wa Firayim Ministan Italiya Giuseppe Conte magana ta waya, shugaban Rasha Vladimir Putin ya shirya sojojin Rasha su aika da likitocin soja, motocin kashe kwayoyin cuta na musamman, da kuma wasu kayan aikin likita zuwa Italiya.
" Jaridar La Stampa ta Italiya ta ambaci wani sanannen "tushen siyasa mai girma" cewa kashi 80 cikin dari na taimakon Rasha ba su da amfani ko kuma ba su da amfani ga Italiya".
"Wannan majiyar ta zargi Rasha da fara wani "matsayi da diplomasiyya" yaudarar. "
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya Luigi Di Maio sun ƙi amincewa da rahotannin kafofin watsa labarai kuma sun nuna godiyarsu.
Rasha ta kuma tura jirgin saman sufuri da taimakon likita zuwa Amurka.
"Mai magana da yawun Kremlin Dmitry Peskov ya ce ""lokacin da yake ba da taimako ga abokan aikinsa na Amurka, [Putin] ya ɗauka cewa lokacin da masana'antun Amurka na kayan aikin likita da kayan aiki suka sami ƙarfi, za su iya mayar da martani idan ya cancanta. "" "
" An shirya shirin NATO na "Defender 2020" a Jamus, Poland, da kuma kasashen Baltic, wanda shine mafi girma daga cikin atisayen NATO tun bayan karshen yakin sanyi, za a gudanar a cikin raguwa. "
"Sakataren Janar na Kamfen don Kashe Makamai na Nukiliya Kate Hudson ta soki aikin Defender 2020: ""A cikin rikicin lafiyar jama'a na yanzu, yana barazanar rayukan ba kawai sojojin Amurka da ƙasashen Turai da yawa da ke shiga ba amma mazaunan ƙasashen da suke aiki. "" Gwamnatin Iran ta sami mummunan tasiri daga kwayar cutar, tare da kusan 'yan majalisa goma sha biyu da aka kamu da cutar da kuma wasu manyan siyasa goma sha biyar na yanzu ko na baya. "
Shugaban Iran Hassan Rouhani ya rubuta wasika ga shugabannin duniya yana neman taimako a ranar 14 ga Maris, 2020, yana cewa kasarsa tana gwagwarmaya don yaƙar cutar saboda rashin samun damar zuwa kasuwannin duniya sakamakon takunkumin Amurka akan Iran. Cutar ta haifar da kira ga Amurka ta ɗauki manufofin zamantakewar da aka saba da su a wasu ƙasashe masu arziki, gami da kula da lafiya ta duniya, kula da yara ta duniya, izinin iyali da aka biya, da kuma ƙarin kuɗin da ake bayarwa ga lafiyar jama'a.
Masu nazarin siyasa sun yi hasashen cewa zai iya shafar damar da Donald Trump zai sake zabar a zaben shugaban kasa na 2020. Dangantakar diflomasiyya tsakanin Japan da Koriya ta Kudu ta tabarbare saboda annobar.
" Koriya ta Kudu ta soki Japan da "ƙoƙarin killace-killace da rashin fahimta da kuma aiki" bayan da Japan ta sanar da cewa duk wanda ya zo daga Koriya ta Kudu za a sanya shi cikin killace-kwana biyu a wuraren da gwamnati ta nada. "
A farkon Koriya ta Kudu an yi ta nuna bambanci game da yadda Shugaba Moon Jae-in ya amsa wa rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman tsige Moon saboda abin da suka ce gwamnati ta yi wa annobar, ko kuma suna yaba da martani.Cutar ta ba wa ƙasashe damar wuce dokar ta baci a matsayin martani.
Wasu masu sharhi sun nuna damuwa cewa zai iya ba gwamnatoci damar ƙarfafa ikonsu.
A Hungary, majalisa ta amince da izinin firaministan kasar, Viktor Orbán, ya yi mulki ta hanyar doka har abada, ya dakatar da majalisa da kuma zaben kuma ya hukunta wadanda ake ganin sun yada bayanan karya game da cutar da kuma yadda gwamnati ke magance rikicin.
An zargi barkewar cutar coronavirus da karancin wadata a lokuta da dama, sakamakon karuwar amfani da kayan aiki a duniya don yaƙar barkewar cutar, sayen firgita, da katsewar masana'antu da ayyukan kayan aiki.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargadi game da karancin magunguna da kayan aikin likita saboda karuwar bukatar mabukaci da katsewar masu samarwa.
Ƙari ga haka, a wasu yankuna, mutane sun soma yin tawaye don su sayi kayayyaki da suka sa a cire kayayyakin da suke da muhimmanci kamar abinci da takardar bayan gida da kuma ruwan kwalba, kuma hakan ya sa aka yi rashin abinci.
Musamman masana'antun fasaha sun yi gargadi game da jinkirin jigilar kayayyakin lantarki.
A cewar babban darektan WHO Tedros Adhanom, bukatar kayan kariya ta mutum ta ƙaru sau 100.
Wannan bukatar ta kai ga karuwar farashin har zuwa sau ashirin na farashin al'ada kuma ta haifar da jinkiri a kan samar da kayayyakin kiwon lafiya na watanni hudu zuwa shida.
Hakan ya kuma sa a duniya babu kayan kariya na mutum, kuma Hukumar WHO ta yi gargadin cewa hakan zai sa ma'aikatan kiwon lafiya cikin haɗari.
A Ostiraliya, annobar ta ba da sabuwar dama ga masu sayen daigou don sayar da kayayyakin Ostiraliya zuwa China.
Wannan aikin ya haifar da karancin kayan abinci ga jarirai a wasu manyan kasuwanni kuma daga baya gwamnatin Ostiraliya ta hana shi. Duk da yawan cututtukan COVID-19 a Arewacin Italiya da yankin Wuhan, da kuma babban buƙatar samfuran abinci, an ceci yankuna biyu daga karancin abinci.
Matakan da kasar Sin da Italiya suka dauka na hana tarawa da kuma cinikin kayayyakin da suka fi muhimmanci sun yi nasara, kuma sun kauce wa gagarumin karancin abinci da aka yi tsammani a Turai da kuma Arewacin Amirka.
Arewacin Italiya tare da yawan aikin gona ba ta da raguwa mai yawa, amma farashin na iya tashi bisa ga wakilan masana'antu.
An samu abinci a kan shelves na ɗan lokaci, har ma a birnin Wuhan, yayin da jami'an gwamnatin kasar Sin suka saki naman alade don tabbatar da isasshen abinci ga al'umma.
Akwai irin wannan dokar a Italiya da ta bukaci masu samar da abinci su ajiye kayayyaki don irin wannan gaggawa.
An ji lalacewar tattalin arzikin duniya a China: a cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin China ya sha wahala sosai a farkon watanni biyu na 2020 saboda matakan da gwamnati ta ɗauka don rage yaduwar cutar, kuma tallace-tallace na kiri sun faɗi da kashi 20.5%.
Tunda babban yankin kasar Sin babban cibiyar tattalin arziki ne da masana'antu, an ga barkewar cutar ta haifar da babbar barazana ga tattalin arzikin duniya.
Agathe Demarais na Economist Intelligence Unit ya yi hasashen cewa kasuwanni za su ci gaba da kasancewa masu saurin canzawa har sai an bayyana wani hoto mai kyau game da sakamakon da zai iya faruwa.
A watan Janairun 2020, wasu masu sharhi sun kiyasta cewa tasirin tattalin arzikin annobar a kan ci gaban duniya zai iya wuce na barkewar cutar SARS ta 2002-2004.
Wani ƙididdiga daga wani masanin Jami'ar Washington a St. Louis ya ba da tasiri na dala biliyan 300 a kan sarkar samar da kayayyaki a duniya wanda zai iya wuce shekaru biyu.
" An ruwaito cewa kungiyar kasashen da ke fitar da man fetur (OPEC) ta "rubuce" bayan da farashin mai ya ragu sosai saboda karancin bukatar kasar Sin. "
Kasuwancin jari na duniya sun faɗi a ranar 24 ga Fabrairu saboda ƙaruwar yawan masu kamuwa da COVID-19 a wajen babban yankin China.
A ranar 27 ga Fabrairu, saboda damuwa game da barkewar cutar coronavirus, alamun jari daban-daban na Amurka ciki har da NASDAQ-100, S&amp;P 500 Index, da Dow Jones Industrial Average sun nuna raguwar su mafi girma tun daga 2008, tare da Dow ya faɗi maki 1,191, mafi girma a cikin rana ɗaya tun lokacin rikicin kuɗi na 2007-08.
Dukkanin alamun sun ƙare makon da ya ragu fiye da 10%.
A ranar 28 ga Fabrairu, Scope Ratings GmbH ta tabbatar da darajar cinikin mallakar kasar Sin, amma ta ci gaba da samun sakamako mara kyau.
Hannun jari ya sake faɗuwa bisa tsoron coronavirus, mafi girma ya faɗi a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai soma raguwa.
Masanin tattalin arziki Mohamed El-Erian ya yaba da matakan gaggawa na bankunan tsakiya da na jihohi.
Bankunan tsakiya suna yin aiki da sauri fiye da yadda suka yi a lokacin rikicin kudi na 2008.
Yawon shakatawa na ɗaya daga cikin ɓangarorin da aka fi shafa saboda haramcin tafiya, rufe wuraren jama'a gami da wuraren jan hankali, da kuma shawarwarin gwamnatoci game da kowane tafiya a duk faɗin duniya.
A sakamakon haka, kamfanonin jiragen sama da yawa sun soke jiragen saboda raguwar buƙata, gami da British Airways, China Eastern Airlines, da Qantas, yayin da kamfanin jirgin saman yankin na Burtaniya Flybe ya rushe.
Tasirin da ya shafi masana'antar jirgin ruwa ya kasance a matakin da ba a taɓa gani ba.
An kuma rufe tashoshin jirgin kasa da tashoshin jiragen ruwa da dama.
Wannan annoba ta yi daidai da Chunyun, wata babbar lokacin tafiya da ke hade da bikin Sabuwar Shekara ta kasar Sin.
Gwamnatocin ƙasa da na yanki sun soke wasu abubuwan da suka shafi taron jama'a da yawa, gami da bukukuwa na Sabuwar Shekara na shekara-shekara, tare da kamfanoni masu zaman kansu da kansu suna rufe shagunan su da wuraren yawon buɗe ido kamar Hong Kong Disneyland da Shanghai Disneyland.
An rufe abubuwan da ake yi na Sabuwar Shekara ta Wata da wuraren yawon bude ido da yawa don hana taro, ciki har da Ƙarshen Birni a Beijing da kuma bikin haikalin gargajiya.
A cikin larduna 24 na kasar Sin, gundumomi da yankuna 31, hukumomi sun tsawaita hutun Sabuwar Shekara zuwa 10 ga Fabrairu, suna ba da umarnin yawancin wuraren aiki kada su sake buɗewa har zuwa wannan ranar.
Wadannan yankuna sun wakilci 80% na GDP na kasar da 90% na fitarwa.
Hong Kong ta ɗaga matakin amsa cutar ta kamuwa da cuta zuwa mafi girma kuma ta ayyana dokar ta baci, ta rufe makarantu har zuwa Maris kuma ta soke bikin Sabuwar Shekara. An shafi ɓangaren sayar da kayayyaki a duniya, tare da rage lokutan kantin sayar da kaya ko rufewar wucin gadi.
Ziyarar da ake yi wa 'yan kasuwa a Turai da Latin Amirka ta ragu da kashi 40%.
Kasashen Arewacin Amirka da Gabas ta Tsakiya sun ga raguwar 50  60%.
Wannan kuma ya haifar da raguwar 3343% a cikin zirga-zirgar ƙafa zuwa cibiyoyin cin kasuwa a watan Maris idan aka kwatanta da Fabrairu.
Masu gudanar da cibiyoyin cinikayya a duk faɗin duniya sun ɗora ƙarin matakai, kamar ƙara tsabtace jiki, shigar da na'urorin bincike na zafi don bincika zafin jiki na masu siye, da soke abubuwan da suka faru.A cewar kimar Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka, koma bayan tattalin arziki da annobar ta haifar na iya barin mutane miliyan 14 zuwa 22 a cikin matsanancin talauci a Latin Amurka fiye da yadda za a kasance a wannan yanayin ba tare da annobar ba.
A watan Janairu da Fabrairu na shekarar 2020, a lokacin da annobar ta kai sama a birnin Wuhan, kimanin mutane miliyan 5 a kasar Sin sun rasa ayyukansu.
Yawancin ma'aikatan da ke aiki a yankunan karkara kusan miliyan 300 na kasar Sin sun makale a gidajensu a lardunan cikin gida ko kuma a lardin Hubei. A watan Maris na 2020, fiye da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Cutar cutar coronavirus na iya kashe ayyuka miliyan 47 a Amurka kuma yawan rashin aikin yi na iya kaiwa kashi 32%, a cewar kimantawar bankin Federal Reserve Bank na St. Louis.Lakin kulle-kullen Indiya ya bar dubban miliyoyin ma'aikatan Indiya (wanda ake biya ta hanyar albashin yau da kullun) marasa aiki.Binciken daga Cibiyar Angus Reid ya gano cewa kashi 44% na iyalai na Kanada sun sami wasu nau'ikan rashin aikin yi.Kusan ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da aka shiga kulle-kullen a tsakiyar Maris 2020.
A rabin rabin watan Maris, ma'aikata 4 na Faransa sun nemi albashi na rashin aikin yi na wucin gadi kuma ma'aikata 1 na Birtaniya sun nemi tsarin bashi na duniya. Kusan kamfanoni miliyan biyar a Jamus sun tura ma'aikatansu zuwa tsarin aikin gajeren lokaci da gwamnati ke tallafawa da ake kira Kurzarbeit.
Faransa da Birtaniya sun amince da tsarin biyan kuɗin gajeren lokaci na Jamus.
Ayyukan wasan kwaikwayo da bangarorin al'adun gargajiya sun yi matukar tasiri ta hanyar annobar, yana shafar ayyukan kungiyoyi da kuma mutaneda ke aiki da kuma masu zaman kansua duniya.
Kungiyoyin fasaha da al'adu sun yi ƙoƙari su ci gaba da aikinsu (sau da yawa ana tallafawa ta hanyar gwamnati) don samar da damar samun al'adun al'adu ga al'umma, kula da lafiyar ma'aikatansu da jama'a, da tallafawa masu fasaha idan ya yiwu.
A watan Maris na 2020, a duk faɗin duniya kuma a digiri daban-daban, an rufe gidajen tarihi, dakunan karatu, wuraren wasan kwaikwayo, da sauran cibiyoyin al'adu har abada tare da soke ko jinkirta nunin su, abubuwan da suka faru da wasan kwaikwayon su.
A sakamakon haka an yi ƙoƙari sosai don samar da sabis na madadin ta hanyar dandamali na dijital. Wani sabon abu kuma da ke saurin saurin saurin cutar shine soke ayyukan addini, manyan abubuwan da suka faru a wasanni, da sauran abubuwan zamantakewa, kamar bukukuwa da kide kide, tarurrukan fasaha, da nunin kayan ado.
Har ila yau, masana'antar fim sun sami matsala. Vatican ta sanar da cewa an soke bikin mako mai tsarki a Roma, wanda ya faru a makon ƙarshe na lokacin fansar Kirista na Lent.
Yawancin majami'u sun ba da shawarar Kiristoci tsofaffi su zauna a gida maimakon halartar Mass a ranar Lahadi; wasu majami'u sun ba da sabis na coci ta hanyar rediyo, watsa shirye-shiryen kai tsaye ta yanar gizo ko talabijin yayin da wasu ke ba da sabis na bautar mota.
Da yake Roman Catholic Diocese na Roma ta rufe majami'un da ɗakin sujada da kuma St. Peter's Square da aka yi wa baƙi Kiristoci, wasu kungiyoyin addini sun soke ayyukan da kuma iyakance taron jama'a a majami'u, masallatai, majami'u, haikalin da gurdwaras.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa kuma daga bisani an rufe wuraren ibada, yayin da Saudiyya ta haramta shigar da baƙi da mazaunanta zuwa wuraren tsarki a Makka da Madina.
Cutar ta haifar da babbar matsala ga kalandar wasanni a duniya tun lokacin yakin duniya na biyu.
Yawancin manyan abubuwan wasanni an soke ko kuma an dage su, gami da gasar zakarun Turai ta 2019  20, gasar Premier ta 2019  20, gasar zakarun Turai ta 2020, gasar zakarun Turai ta 2019  20, da gasar NHL ta 2019  20.
" Cutar ta rushe tsare-tsaren wasannin Olympics na bazara na 2020, wanda a asali an tsara don farawa a ƙarshen Yuli; Kwamitin Olympic na Duniya ya sanar a ranar 24 ga Maris cewa za a sake shirya taron zuwa kwanan wata bayan 2020 amma ba a baya ba kafin lokacin bazara na 2021".
Wannan ya sa yawancin masu caca suka koma kan layi, tare da shafukan caca na kan layi da yawa suna ba da rahoton ƙaruwar ƙimar sabon rajista. Masana'antar nishaɗi ma an shafa, tare da ƙungiyoyin kiɗa daban-daban suna dakatar da ko soke waƙoƙin kiɗa.
Yawancin manyan gidajen wasan kwaikwayo kamar waɗanda ke Broadway sun dakatar da duk wasan kwaikwayon.
" Wasu masu fasaha sun gano hanyoyin da za su ci gaba da samarwa da raba aiki ta hanyar intanet a matsayin madadin aikin kai tsaye na gargajiya, kamar raye-raye na raye-raye ko ƙirƙirar "ƙungiyoyi" na yanar gizo don masu fasaha su yi aiki, rarraba, da kuma tallata ayyukansu. "
A kan layi, yawancin abubuwan da ke faruwa a Intanet game da cutar coronavirus sun bazu kamar yadda mutane da yawa suka juya zuwa ban dariya da kuma jan hankali a cikin rashin tabbas.
Tun bayan barkewar COVID-19, an lura da ƙiyayya, ƙiyayya da wariyar launin fata a kan mutanen da ke fitowa daga kasar Sin da Asiya ta Gabas, da kuma a kan mutanen da ke fitowa daga wurare masu zafi a Turai, Amurka da sauran ƙasashe.
An lura da tsoro, shakka, da kuma ƙiyayya a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amirka, da kuma yankin Asiya da Fasifik.
Rahotanni daga watan Fabrairu (lokacin da yawancin shari'o'in har yanzu suka kasance a cikin China) sun rubuta ra'ayoyin wariyar launin fata da aka bayyana a cikin ƙungiyoyi daban-daban a duk duniya na Sinawa waɗanda suka cancanci cutar ko karɓar abin da aka ce ya cancanci fansa.
Wasu ƙasashen Afirka ma sun ga yadda halin da ake ciki game da kasar Sin ya ƙaru.
Mutane da yawa da ke zaune a Wuhan da Hubei sun ba da rahoton nuna bambanci bisa ga asalin yankin su.
An tallafawa 'yan kasar Sin, a kan layi da kuma wajen layi, da kuma wajen wadanda ke yankunan da cutar ta shafa.
Bayan barkewar cutar ta hau kan sabbin kasashe masu zafi, mutanen Italiya, ƙasa ta farko a Turai da ta sami mummunan barkewar COVID-19, za su iya fuskantar zargin da kuma nuna rashin jin daɗin al'umma. 'Yan ƙasa a ƙasashe da suka haɗa da Malaysia, New Zealand, Singapore, da Koriya ta Kudu sun fara sanya hannu kan takardun neman tallafin da ke hana Sinawa shiga ƙasashensu don ƙoƙarin dakatar da cutar.
A Japan, hashtag #ChineseDontComeToJapan ya zama sananne a Twitter.
Mutanen kasar Sin da kuma sauran 'yan Asiya a Birtaniya da Amurka sun ruwaito karuwar cin zarafin wariyar launin fata, da kuma hare-hare.
" Shugaban Amurka Donald Trump ya fuskanci sukar da ake yi masa saboda ya kira cutar coronavirus da "Cinese Virus", kalmar da masu sukar ke la'akari da ita nuna wariyar launin fata da adawa da kasar Sin. "
Masu zanga-zangar a Ukraine sun kai hari kan motocin bas da ke dauke da 'yan Ukraine da kasashen waje da aka kwashe daga Wuhan zuwa Novi Sanzhary.
An ruwaito cewa daliban da suka zo daga arewa maso gabashin Indiya, wanda ke da iyaka da China, kuma suna karatu a manyan biranen Indiya sun sami zalunci dangane da barkewar cutar coronavirus.
" Shugaban jam'iyyar Bharatiya Janata Party a jihar West Bengal Dilip Ghosh ya bayyana cewa Sinawa sun lalata yanayi kuma "saboda haka Allah ya ɗauki fansa a kansu. "
" Daga bisani ofishin jakadancin kasar Sin a Kolkata ya yi Allah wadai da wannan furucin, yana cewa "ba daidai ba ne". A kasar Sin, cutar ta addabi baƙi da kuma nuna wariyar launin fata ga mazauna kasar Sin, inda aka kwatanta 'yan kasashen waje a matsayin "ƙazamar ƙasashen waje" da kuma "kashewa".
Jaridu da yawa da ke da bangon biyan kuɗi sun cire su saboda wasu ko duk labaran da suka yi game da cutar coronavirus.
Masu wallafa kimiyya da yawa sun wallafa takardun kimiyya da suka shafi annobar.
Wasu masana kimiyya sun zaɓi raba sakamakon su da sauri akan sabobin preprint kamar bioRxiv.
Cutar cututtuka mai tasowa  Cutar cututtuka na cutar mai tasowa, sau da yawa sabon abu a cikin fasalin barkewar cutar ko yanayin watsawa
Duniya da cututtuka  Bayani na duniya da kuma yaduwar cututtuka
Jerin annoba da annoba  Jerin adadin mutuwar da aka yi saboda cututtukan cuta
Tafiya ta dabbobi da kuma cutar dabbobi  Hadarin kiwon lafiya da ke tattare da cinikin dabbobi masu rarrafe
Gwajin dakin gwaje-gwaje don cutar coronavirus ta numfashi 2019 (COVID-19) da kuma cutar SARS-CoV-2 da ke da alaƙa ya haɗa da hanyoyin gano kasancewar kwayar cutar da waɗanda ke gano rigakafin da aka samar don amsa kamuwa da cuta.
Kasancewar ƙwayoyin cuta a cikin samfuran an tabbatar da su ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwajin na musamman ne kuma an tsara shi ne don gano RNA na cutar SARS-CoV-2 kawai.
Ana amfani da shi don tabbatar da cututtuka na kwanan nan ko kuma masu aiki.
Ana iya amfani da gano rigakafi (serology) don ganewar asali da kuma lura da yawan jama'a.
Gwaje-gwajen rigakafin jiki sun nuna yawan mutanen da suka kamu da cutar, ciki har da waɗanda alamunsu ba su da tsanani sosai don su ba da rahoto ko kuma waɗanda ba su da alamun cutar.
Ana iya sanin ainihin mutuwar cutar da kuma matakin rigakafin garken a cikin yawan jama'a daga sakamakon wannan gwajin.
Saboda iyakancewar gwajin, a watan Maris na 2020 babu ƙasashe da ke da tabbataccen bayanai game da yaduwar cutar a cikin yawan jama'arsu.
A ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da 3% na yawan jama'arta, kuma akwai bambance-bambance masu yawa a cikin yawan gwajin da aka yi a tsakanin ƙasashe.
Wannan bambancin zai iya shafar yawan mutuwar da aka ruwaito, wanda zai iya zama da yawa a wasu ƙasashe.
Yin amfani da rikitarwa na rikitarwa na polymerase chain reaction (rRT-PCR) na ainihi, ana iya yin gwajin a kan samfurori na numfashi da aka samu ta hanyoyi daban-daban, ciki har da nasopharyngeal swab ko samfurin sputum.
Sakamakon yana samuwa a cikin 'yan sa'o'i zuwa kwanaki 2.
Gwajin RT-PCR da aka yi da gashin wuya yana da tabbaci ne kawai a makon farko na cutar.
Daga baya, cutar za ta iya ɓacewa a cikin garkuwar yayin da take ci gaba da yawaita a cikin huhu.
Ga mutanen da suka kamu da cutar da aka gwada a mako na biyu, za a iya ɗaukar samfurin daga hanyoyin numfashi ta hanyar tsotsa ko kuma a yi amfani da kayan tari (sputum).
An haɓaka ɗayan gwajin PCR na farko a Charité a Berlin a watan Janairun 2020 ta amfani da ainihin lokacin jujjuyawar polymerase mai jujjuyawar jujjuyawar (rRT-PCR), kuma ya zama tushen kayan aikin 250,000 don rarraba ta Hukumar Lafiya ta Duniya (WHO).
Burtaniya ta kuma samar da gwajin a ranar 23 ga Janairu 2020.Kamfanin Kogenebiotech na Koriya ta Kudu ya samar da kayan aikin gano SARS-CoV-2 na asibiti, wanda ya dogara da PCR (PowerChek Coronavirus) a ranar 28 ga Janairu 2020.
" Yana neman gene na ""E"" wanda duk beta coronaviruses ke rabawa, da kuma gene na RdRp na musamman ga SARS-CoV-2.A China, BGI Group na ɗaya daga cikin kamfanoni na farko da suka sami izinin gaggawa daga Hukumar Kula da Kayan Likitancin Kasa ta China don kit ɗin gano SARS-CoV-2 na PCR.A Amurka, Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka (CDC) suna rarraba 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel zuwa dakunan gwaje-gwaje na lafiyar jama'a ta hanyar Resurse na Reagent na Duniya. "
Ɗaya daga cikin gwaje-gwaje uku na kwayoyin halitta a cikin tsofaffin juzu'in kayan gwajin sun haifar da sakamako mara kyau saboda abubuwan da ba su dace ba, da kuma ƙarancin gwaji a CDC a Atlanta; wannan ya haifar da matsakaicin samfurori ƙasa da 100 a rana da aka sarrafa cikin nasara a cikin Fabrairu 2020.
Gwaje-gwaje da ke amfani da abubuwa biyu ba a ƙaddara su zama abin dogaro ba har zuwa 28 ga Fabrairu 2020, kuma ba a ba da izinin fara gwaji ga dakunan gwaje-gwaje na jihohi da na gida ba har zuwa lokacin.
Hukumar Abinci da Magunguna ta amince da gwajin a ƙarƙashin Izinin Amfani da Gaggawa. Labs na kasuwanci na Amurka sun fara gwaji a farkon Maris 2020.
Daga 5 ga Maris 2020 LabCorp ta sanar da samun gwajin COVID-19 a duk ƙasar bisa RT-PCR.
Quest Diagnostics ta kuma samar da gwajin COVID-19 a duk fadin kasar daga ranar 9 ga Maris, 2020.
Babu iyakancewar adadi da aka sanar; dole ne a tattara samfurin kuma a sarrafa shi bisa ga bukatun CDC.
A Rasha, Cibiyar Nazarin Kwayar cuta da Fasaha ta VECTOR ce ta haɓaka da kuma samar da gwajin COVID-19.
A ranar 11 ga Fabrairu 2020 Hukumar Kula da Lafiya ta Tarayya ta yi rijistar gwajin.A ranar 12 ga Maris, 2020, an ruwaito cewa Cibiyar Asibitin Mayo ta haɓaka gwajin gano kamuwa da COVID-19.A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don gwajin da za a iya yi a cikin awanni 3.5 a cikin babban girma, don haka ba da damar inji ɗaya ya yi kimanin gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa (EUA) ga Laboratories na Abbott don gwaji akan tsarin m2000 na Abbott; FDA ta ba da izini iri ɗaya ga Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta karɓi EUA daga FDA don gwajin da ke ɗaukar kimanin minti 45.
Hukumar ta FDA ta amince da gwajin da ke amfani da fasahar isothermal nucleic acid amplification maimakon PCR.
Tun da wannan ba ya bukatar jerin juyawa na zafin jiki wannan hanya zai iya samar da sakamako mai kyau a cikin minti biyar da kuma sakamakon da ba shi da kyau a cikin minti 13.
A halin yanzu akwai kimanin 18,000 na waɗannan injunan a Amurka kuma Abbott na tsammanin haɓaka masana'antu don isar da gwaje-gwaje 50,000 a kowace rana. Ana haɓaka gwajin da ke amfani da kwayar cutar monoclonal wanda ke ɗaure musamman da furotin nucleocapsid (N furotin) na sabon coronavirus a Taiwan, tare da fatan cewa zai iya samar da sakamako a cikin mintuna 15 zuwa 20 kamar gwajin mura mai sauri.
" Wani bita na wallafe-wallafen Maris 2020 ya kammala cewa ""Radiographs na kirji ba su da ƙimar ganewar asali a farkon matakan, yayin da CT [tomography na kwamfuta] binciken na iya kasancewa har ma kafin bayyanar cututtuka. "" "
Abubuwan da ke cikin CT sun hada da nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ukan nau'ikan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan na nau'ukan na nau'ukan na nau'ukan na nau'ukan na nau'u.
Ƙarƙashin ƙwayar cuta, da kuma ci gaba da ci gaba da ciwon yayin da cutar ta ci gaba.
Wani binciken da ya kwatanta PCR da CT a Wuhan a wurin da cutar ta barke ya nuna cewa CT tana da matukar damuwa fiye da PCR, kodayake ba ta da ƙayyadaddun bayanai, tare da yawancin fasalulluka na daukar hoto da ke haɗuwa da sauran cututtukan huhu da cututtukan cututtuka.
" Tun daga Maris 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa ""Ba za a yi amfani da CT don yin bincike don ko a matsayin gwajin layi na farko don gano COVID-19 ba". "Tun daga Maris 2020, CDC ta ba da shawarar PCR don binciken farko. "
Wani ɓangare na amsawar rigakafi ga kamuwa da cuta shine samar da rigakafi ciki har da IgM da IgG.
Ana iya amfani da su wajen gano kamuwa da cuta a cikin mutane tun daga kwanaki 7 ko makamancin haka bayan bayyanar cututtuka, don ƙayyade rigakafi, da kuma a lura da yawan jama'a. Ana iya yin gwaje-gwaje a cikin dakunan gwaje-gwaje na tsakiya (CLT) ko kuma ta hanyar gwajin wurin kulawa (PoCT).
Tsarin sarrafa kansa mai girma a cikin dakunan gwaje-gwaje na asibiti da yawa za su iya yin waɗannan gwaje-gwajen amma kasancewa su zai dogara da yawan samarwa ga kowane tsarin.
A CLT ana amfani da jini guda daya na jini, ko da yake ana iya amfani da kwayoyin jini na dindindin don bin tsarin rigakafi.
A cikin PoCT ana samun jini guda ɗaya ta hanyar tsage fata.
Ba kamar hanyoyin PCR ba, ba a buƙatar matakin cirewa kafin gwaji.A ranar 26 ga Maris, 2020, FDA ta sanya sunayen hukumomi 29 waɗanda suka ba da sanarwar ga hukumar kamar yadda ake buƙata kuma yanzu suna iya rarraba gwajin rigakafin su.
Ya zuwa ranar 7 ga Afrilu, 2020, FDA ta amince da gwaji guda ɗaya kawai a ƙarƙashin izinin amfani da gaggawa.A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don kayan gwajin su, waɗanda zasu iya gano IgG da IgA antibodies da cutar a cikin samfurin jini.
Ilimin gwaji yana da samfurori ɗari da yawa a cikin awanni kuma saboda haka ya fi sauri fiye da gwajin PCR na yau da kullun na RNA na kwayar cuta.
Ana iya gano rigakafin kwanaki 14 bayan fara kamuwa da cuta. A farkon watan Afrilu, Birtaniya ta gano babu wani daga cikin kayan gwajin rigakafin da ta saya da ya isa a yi amfani da shi.
" Hong Kong ta kafa tsarin da ake zargin marasa lafiya za su iya zama a gida, "" sashen gaggawa zai ba da bututun samfurin ga mai haƙuri"", za su yi ta zubar da shi, su aika da shi kuma su sami sakamakon gwajin ɗan lokaci bayan haka. NHS ta Burtaniya ta sanar da cewa tana yin gwaji da tsarin da za a gwada masu zargin a gida, wanda ke kawar da haɗarin mai haƙuri ya kamu da wasu idan sun zo asibiti ko kuma dole ne su kashe motar asibiti idan an yi amfani da ita.A gwajin gwaji na COVID-19 don masu zargin, ƙwararren likita na kiwon lafiya yana ɗaukar samfurin ta amfani da matakan tsaro masu dacewa. "
Cibiyoyin motsa jiki sun taimaka wa Koriya ta Kudu ta yi wasu gwaje-gwaje mafi sauri, mafi girma a kowace ƙasa.A Jamus, Ƙungiyar Likitocin Kula da Lafiya ta Dokar ta ce a ranar 2 ga Maris, tana da damar yin gwajin kusan 12,000 a rana a cikin yanayin tafiya kuma an gwada 10,700 a makon da ya gabata.
Asusun inshorar lafiya ne ke biyan kuɗin idan likita ya umurci gwajin.
A cewar shugaban cibiyar Robert Koch, Jamus tana da iyawar yin gwaje-gwaje 160,000 a kowane mako.
Daga 19 Maris an ba da gwaji a cikin manyan birane da yawa.
A ranar 26 ga Maris, 2020 ba a san yawan gwaje-gwajen da aka yi a Jamus ba, saboda an ba da rahoton sakamako mai kyau kawai.
" Binciken dakin gwaje-gwaje na farko ya bayyana cewa daga makon kalanda 12/2020 an gwada samfurori akalla 483,295 har zuwa da ciki har da makon 12/2020 da samfurori 33,491 (6.9%) sun tabbatar da cutar SARS-CoV-2.A Isra'ila, masu bincike a Technion da Asibitin Rambam sun haɓaka kuma sun gwada wata hanya don gwada samfurori daga marasa lafiya 64 a lokaci guda, ta hanyar haɗa samfurori da ƙarin gwaji kawai idan an gano samfurin da aka haɗa da tabbatacce.A Wuhan an buɗe dakin gwaje-gwaje na gaggawa na mita 2000 mai suna ""Huo-Yan"" (Sin: 火眼, ko ""Fire Eye"" a Turanci) a ranar 5 ga Fabrairu 2020 ta BGI, wanda zai iya sarrafa samfurori sama da 10,000 a rana. "
Tare da aikin da Wanda ya kafa BGI, Wang Jian ya duba kuma ya dauki kwanaki 5, samfurin ya nuna cewa a Hubei za a sami kashi 47% mafi girma kuma farashin da ya dace na magance killacewa zai ninka idan wannan ƙarfin gwajin bai zo kan layi ba.
An bi dakin gwaje-gwaje na Wuhan nan da nan ta hanyar dakin gwaje-gwaje na Huo-Yan a Shenzhen, Tianjin, Beijing, da Shanghai, a jimlar birane 12 a fadin kasar Sin.
A ranar 4 ga Maris, 2020 jimlar yawan gwajin yau da kullun ya kai gwaje-gwaje 50,000 a rana. An saki tushen budewa, ƙirar da aka saki ta Origami Assays wanda zai iya gwada samfurori 1122 na marasa lafiya don COVID19 ta amfani da ƙirar 93 kawai. Ana iya gudanar da waɗannan ƙirar daidaitawa a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar sarrafa ruwan robotic ba.
A watan Maris, karancin da kuma rashin isasshen adadin reagent ya zama abin ƙyama ga gwajin taro a cikin EU da Birtaniya da Amurka.
Wannan ya sa wasu marubuta su binciki tsarin shirya samfurori wanda ya shafi dumama samfurori a 98 °C (208 °F) na minti 5 don sakin kwayoyin RNA don ƙarin gwaji.A ranar 31 ga Maris an sanar da cewa Hadaddiyar Daular Larabawa yanzu tana gwada yawan yawanta don Coronavirus a kowane mutum fiye da kowane ƙasa, kuma tana kan hanya don haɓaka matakin gwaji don isa ga yawan jama'a.
"Wannan ya faru ne ta hanyar haɗuwa da damar motsa jiki, da sayen dakin gwaje-gwaje na yawan jama'a daga Group 42 da BGI (bisa ga dakin gwaje-gwajen gano gaggawa na ""Huo-Yan"" a China). "
An gina shi a cikin kwanaki 14, dakin gwaje-gwaje na iya gudanar da dubban gwaje-gwajen RT-PCR a kowace rana kuma shi ne na farko a duniya a wannan sikelin da za a yi aiki a wajen China.
An kirkiro girke-girke daban-daban na gwaji da ke nufin sassa daban-daban na bayanan kwayoyin cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan, da Amurka.
Hukumar Lafiya ta Duniya ta amince da tsarin samar da kayayyaki na Jamus da aka aika zuwa ƙasashen da ba su da kuɗin da za su samu su yi amfani da su.
An buga girke-girke na Jamus a ranar 17 ga Janairu, 2020; yarjejeniyar da Cibiyoyin Kula da Cututtuka na Amurka suka haɓaka ba ta kasance har zuwa 28 ga Janairu, jinkirta gwaje-gwajen da ke akwai a Amurka. China da Amurka sun sami matsaloli tare da amincin kayan gwajin a farkon barkewar cutar, kuma waɗannan ƙasashe da Ostiraliya ba su iya samar da wadatattun kayan aiki don gamsar da buƙata da shawarwari don gwaji ta masana kiwon lafiya ba.
Akasin haka, masana sun ce wadatar gwajin Koriya ta Kudu ta taimaka wajen rage yaduwar sabon coronavirus.
Gwamnatin Koriya ta Kudu ta gina ƙarfin gwaji, galibi a cikin dakunan gwaje-gwaje na kamfanoni masu zaman kansu, a cikin shekaru da yawa.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira da a kara yawan shirye-shiryen gwaji a matsayin hanya mafi kyau don rage ci gaban annobar COVID-19. Babban buƙatar gwaji saboda yaduwar cutar ya haifar da raguwar ɗaruruwan dubban gwaje-gwaje a cikin dakunan gwaje-gwaje na Amurka masu zaman kansu, kuma wadatar swabs da magungunan sinadarai sun zama masu wahala.
A watan Maris na shekarar 2020 kasar Sin ta ba da rahoton matsaloli game da daidaito a cikin kayan gwajin ta.
" A Amurka, kayan gwajin da CDC ta haɓaka suna da "kurakurai; " sannan gwamnati ta kawar da shingen da ya hana gwajin sirri. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Bioeasy Biotechnology Co Ltd na kasar Sin, amma ta gano cewa sakamakon bai dace ba. "
Kamfanin ya bayyana cewa sakamakon da bai dace ba na iya kasancewa sakamakon rashin karbar samfurori ko amfani da kayan aikin daidai.
Ma'aikatar Spain ta ce za ta janye kayan aikin da suka dawo da sakamakon da bai dace ba, kuma za ta maye gurbin su da wani kayan aikin gwaji daban-daban da Shenzhen Bioeasy ta bayar. 80% na kayan aikin gwajin da Jamhuriyar Czech ta saya daga China sun ba da sakamakon da bai dace ba. Slovakia ta sayi kayan aikin gwaji miliyan 1.2 daga China wanda aka gano ba daidai ba.
" Firayim Minista Matovič ya ba da shawarar a jefa su cikin Danube. Ateş Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta saya daga China suna da "ƙimar kuskure mai yawa" kuma ba ta "sa su cikin amfani ba. "" Birtaniya ta sayi kayan gwajin miliyan 3.5 daga China amma a farkon Afrilu 2020 ta sanar da cewa ba za a iya amfani da su ba. "
Gwaje-gwaje, wanda aka bi da keɓewa na waɗanda suka tabbatar da cutar da cutar ta SARS-CoV-2 da kuma bin diddigin waɗanda mutanen da suka yi hulɗa da su suka yi da cutar, sun haifar da sakamako mai kyau.
Masu bincike da ke aiki a garin Vò na Italiya, wurin mutuwar COVID-19 na farko a Italiya, sun gudanar da gwaje-gwaje biyu a kan dukan mutanen kusan 3,400, da ke da wata rata ta kwanaki goma.
Kimanin rabin mutanen da suka samu sakamako mai kyau ba su da wata alama, kuma duk wadanda aka gano sun kasance a cikin killace.
Da yake an hana yin tafiya zuwa garin, hakan ya kawar da sababbin cututtuka gaba ɗaya.
Tare da bin diddigin hulɗa mai ƙarfi, ƙuntatawa kan tafiya mai shigowa, gwaji, da keɓewa, annobar cutar coronavirus ta 2020 a Singapore ta ci gaba da jinkiri fiye da sauran ƙasashe masu tasowa, amma ba tare da tsauraran ƙuntatawa ba kamar tilasta rufe gidajen abinci da wuraren sayar da kayayyaki.
An soke taron da yawa, kuma Singapore ta fara ba da shawara ga mazauna su zauna a gida a ranar 28 ga Maris, amma makarantu sun sake buɗewa a kan lokaci bayan hutun hutu a ranar 23 ga Maris.
Wasu ƙasashe da yawa sun kuma magance cutar ta hanyar bin diddigin hulɗa mai ƙarfi, ƙuntatawa kan tafiya zuwa, gwaji, da keɓewa, amma tare da kulle-kulle marasa ƙarfi, kamar Iceland da Koriya ta Kudu.
Wani bincike na kididdiga ya gano cewa ƙasashen da suka yi gwaji da yawa, dangane da yawan mutuwar, suna da ƙananan adadin mutuwar, wataƙila saboda waɗannan ƙasashen sun fi iya gano waɗanda ke da alamun rashin lafiya ko kuma babu alamun cutar.
WHO ta ba da shawarar cewa ƙasashe da ba su da ƙarfin gwaji da dakunan gwaje-gwaje na ƙasa tare da ƙarancin gogewa kan COVID-19 su aika da samfuransu biyar na farko masu kyau da na farko goma na COVID-19 zuwa ɗayan dakunan gwaje-gwaje na WHO 16 don tabbatarwa.
Daga cikin dakunan gwaje-gwaje 16 da aka yi amfani da su, 7 suna Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amirka da kuma 1 a Ostiraliya.
A cikin jadawalin da ke gaba, shafi Abin da ya dace a matsayin % na gwaje-gwaje yana rinjayar manufofin gwajin ƙasar.
Kasar da ke gwada mutanen da aka kwantar a asibiti ne kawai za ta sami sakamako mai kyau a cikin kashi na gwaje-gwaje fiye da ƙasar da ke gwada dukkan 'yan ƙasa, ko suna nuna alamun cutar ko a'a, sauran abubuwa suna daidai.
Wanke hannu (ko wanke hannu), wanda aka fi sani da tsabtace hannu, shi ne wanke hannuwan mutum don kawar da ƙasa, kitse, ƙwayoyin cuta, ko wasu abubuwa marasa kyau.
" Wanke hannu da sabulu a kai a kai a wasu "lokaci masu mahimmanci" a rana yana hana yaduwar cututtuka da yawa, misali, diarrhea da cholera, waɗanda ake watsawa ta hanyar ƙura. "
Mutane kuma za su iya kamuwa da cututtukan numfashi kamar mura ko sanyi, misali, idan ba su wanke hannayensu kafin su taɓa idanunsu, hanci, ko bakinsu (watau, mucous membranes).
Abubuwa biyar da suka fi muhimmanci a rana da ake bukatar a wanke hannu da sabulu su ne: kafin da bayan bayan bayan bayan bayan, bayan an wanke kafafun yaron ko kuma an canja suturarsa, kafin a ciyar da yaron, kafin a ci da kuma kafin da kuma bayan an shirya abinci ko kuma bayan an yi amfani da nama mai naman alade, kifi, ko naman kaji.
Idan babu ruwa da sabulu, za a iya wanke hannayensu da toka. Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannu:
Kafin, a lokacin, da kuma bayan da ake shirya abinci.
Kafin ka kula da wani mai ciwo da kuma bayan ka kula da shi.
Bayan an canja dinai ko kuma an tsabtace yaron da ya yi amfani da gidan wanka.
Bayan ka busa hanci, ka yi tari ko ka yi ta hurawa.
Bayan sun taɓa dabba, abincin dabba, ko kuma sharar dabba.
Tsarkake hannu na likita yana nufin ayyukan tsabtace jiki da suka shafi hanyoyin likita.
Yin wanke hannu kafin a ba da magani ko kuma magani zai iya hana ko kuma rage yaduwar cutar.
Babban manufar wanke hannu a likitanci shi ne tsabtace hannu daga kwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta da za su iya haifar da cuta) da kuma sinadarai da za su iya haifar da lahani ko cututtuka.
Wannan yana da mahimmanci ga mutanen da ke kula da abinci ko aiki a fannin likita, amma kuma aiki ne mai mahimmanci ga jama'a.
Wanke hannu yana da fa'idodi masu yawa ga lafiyar jiki, ciki har da rage yaduwar mura, coronavirus, da sauran cututtuka masu yaduwa; hana cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cutuka.
rage yawan mutuwar jarirai a gida.
Wani bincike da aka yi a shekara ta 2013 ya nuna cewa yin wanka da hannu da kyau zai iya sa yara da ba su kai shekara biyar ba su yi tsayi sosai.
A ƙasashe masu tasowa, ana iya rage yawan yaran da ke mutuwa saboda cututtukan numfashi da kuma fitsari ta wajen yin canje-canje a halayyarsu, kamar wanke hannu da sabulu.
Wannan aikin mai sauƙi zai iya rage yawan mutuwa daga waɗannan cututtuka da kusan kashi 50%.
Yin amfani da kayan wanke hannu zai iya rage yawan cututtukan da ke jawo ciwon ciki da kashi ɗaya bisa uku, kuma hakan zai iya kwatanta da samar da ruwa mai tsabta a yankunan da ba su da isashen kuɗi sosai.
48% na rage cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Ciwon huhu, babban ciwon ARI, shi ne sanadin mutuwa na farko a cikin yara da ba su kai shekara biyar ba, kuma an kiyasta cewa yara miliyan 1.8 ne suke mutuwa a kowace shekara.
A kowace shekara, kusan yara miliyan 3.5 ne suke mutuwa sakamakon ciwon ciki da kumburi.
A cewar UNICEF, wanke hannu da sabulu kafin cin abinci da kuma bayan yin amfani da gidan wanka ya zama halin da ya zama ruwan dare a gare mu.
Ana yin wanke hannu a cikin sauran ayyukan tsabtace jiki a matsayin wani ɓangare na shirye-shiryen ruwa, tsabtace jiki da tsabtace jiki (WASH).
Wanke hannu kuma yana karewa daga impetigo wanda ake watsawa ta hanyar kai tsaye ta jiki.
Wani sakamako mai illa na wanke hannu shi ne cewa wanke hannu sau da yawa zai iya haifar da lalacewar fata saboda bushewar fata.
Wani bincike da aka yi a shekara ta 2012 a ƙasar Denmark ya nuna cewa wanke hannu sosai zai iya sa mutum ya yi saurin yin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin
Ana kuma ganin wanke hannu sau da yawa a matsayin ɗaya daga cikin alamun rashin lafiyar da ake kira Obsessive-compulsive disorder (OCD).
Akwai lokatai biyar masu muhimmanci a rana inda wanke hannu da sabulu yake da muhimmanci don rage yaduwar cutar ta hanyar magunguna: bayan amfani da gidan wanka (jin ruwa, zubar da ciki), bayan wanke kasan yaro (canja takalma), kafin ciyar da yaro, kafin cin abinci da kuma kafin/bayan shirya abinci ko kuma sarrafa nama mai raw, kifi, ko kaji.
Sauran lokatai da ya kamata a yi amfani da hanyar wanke hannu don hana yaduwar cutar sun haɗa da kafin a yi maganin wani ciwo ko kuma bayan an yi maganin; bayan an yi maniyyi, an yi tari, ko kuma an busa hanci; bayan an taɓa takardar dabbobi ko kuma an yi amfani da dabbobi; da kuma bayan an taɓa shara.
A ƙasashe da yawa, mutane ba sa wanke hannu da sabulu.
Wani binciken da aka yi game da wanke hannu a kasashe 54 a shekarar 2015 ya gano cewa a matsakaita, kashi 38.7% na iyalai sun yi wanke hannu da sabulu.Binciken da aka yi a shekarar 2014 ya nuna cewa Saudiyya ce ta fi yawan wanke hannu da sabulu kashi 97 cikin ɗari; Amurka kusa da tsakiyar kashi 77 cikin ɗari; da kuma China da ta fi ƙarancin kashi 23 cikin ɗari.Yanzu akwai hanyoyin sauya halaye da yawa don ƙara karɓar halayyar wanke hannu da sabulu a lokuta masu mahimmanci.Watar hannu ta rukuni ga yaran makaranta a wasu lokutan rana wani zaɓi ne a cikin ƙasashe masu tasowa don haɓaka wanke hannu a cikin halayyar yara.
" Shirin Kula da Lafiya na Muhimmanci wanda Ma'aikatar Ilimi ta Philippines ta aiwatar misali ne na matakin da ake ɗauka don inganta lafiyar yara da ilimi. "
Yin wankewar dabbobi sau biyu a shekara, da kuma wanke hannu kullum da sabulu, da kuma wanke hakora kullum da fluoride, shi ne ainihin shirin wannan ƙasar.
An kuma yi amfani da shi sosai a Indonesia.
Ana cire kwayoyin daga fata ta hanyar ƙara sabulu ko kuma wanke-wanke zuwa ruwa.
Babban aikin sabulu da kayan wankewa shine rage shinge ga bayani, da kuma kara solubility.
Ruwa shi kaɗai ba shi da amfani wajen tsabtace fata domin kitse da furotin da ke cikin ƙasa ba sa narkewa cikin ruwa.
Amma, ana samun ruwa mai kyau don tsaftacewa.
Sabulu mai ƙarfi, saboda yadda ake sake amfani da shi, zai iya ɗauke da ƙwayoyin cuta da aka samu daga amfani da su a dā.
Ƙananan bincike da suka yi game da canja wurin kwayoyin daga sabulu mai tsabta da aka gurɓata sun kammala cewa ba zai yiwu ba a canja wurin kwayoyin ba saboda an wanke su da kumfa.
" CDC har yanzu ta ce ""sabo mai ruwa tare da sarrafawa kyauta don bayarwa ya fi dacewa"". "
An yi amfani da sabulu na rigakafi don ya sa mutane su san lafiyarsu.
Har zuwa yau, babu wata hujja cewa yin amfani da maganin kashe kwayoyin ko maganin kashe kwayoyin cuta da aka ba da shawarar ya zaɓi kwayoyin da ke da juriya ga kwayoyin cuta a cikin yanayi.
Duk da haka, sabulu na maganin rigakafi suna dauke da magungunan rigakafi na yau da kullum kamar triclosan, wanda ke da jerin sunayen kwayoyin da ke da ƙarfi.
Saboda haka, ko da ba a zaɓa nau'in maganin rigakafi na maganin rigakafi ba, ba za su iya zama masu tasiri kamar yadda ake tallata su ba.
Baya ga surfactant da kuma kare fata wakili, da sophisticated formulations iya dauke da acid (acetic acid, ascorbic acid, lactic acid) a matsayin pH mai kula, antimicrobially aiki benzoic acid da kuma ƙarin fata conditioners (aloe vera, bitamin, menthol, shuka tsantsa).A m bincike daga University of Oregon School of Public Health ya nuna cewa m sabulu ne kamar yadda mai amfani-grade antibacterial sabulu dauke da triclosan a hana cututtuka da kuma kawar da kwayoyin daga hannayen.
Ruwan da ke da zafi da zai iya wanke hannuwanmu ba shi da zafi sosai don ya kashe ƙwayoyin cuta.
Kwayoyin cuta suna girma da sauri a zafin jiki (37 °C).
Duk da haka, ruwa mai dumi da sabulu ya fi ruwan sanyi da sabulu tasiri wajen cire man fetur na halitta da ke riƙe da ƙasa da ƙwayoyin cuta.
Amma, bisa ga abin da mutane suke gaskatawa, bincike na kimiyya ya nuna cewa yin amfani da ruwa mai dumi ba ya rage yawan kwayoyin a hannayenmu.
Mai tsabtace hannu ko maganin hana hana shan magani na hannu wani magani ne na tsabtace hannu wanda ba ya tushen ruwa.
A ƙarshen shekarun 1990 da farkon karni na 21, giya rub ba-ruwa tushen kayan tsabtace hannu (wanda aka fi sani da giya tushen rub hannu, antiseptic hannu rub, ko hannu sanitizers) fara samun shahararsa.
Mafi yawansu suna dogara ne akan isopropyl barasa ko ethanol da aka tsara tare da wani abu mai narkewa kamar Carbomer (polymer na acrylic acid) a cikin gel, ko wani humictant kamar glycerin a cikin ruwa, ko kumfa don sauƙin amfani da rage tasirin bushewa na barasa.
Ƙara hydrogen-peroxide mai narkewa yana ƙara ƙaruwa ga aikin antimicrobial. Kayan tsabtace hannu da ke dauke da akalla 60 zuwa 95% barasa suna da inganci mai kashe kwayoyin.
Abin sha mai tsabtace jiki yana kashe kwayoyin cuta, kwayoyin da ke hana shan magani da yawa (MRSA da VRE), tarin fuka, da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, allurar rigakafi, mura, da kuma cutar hanta) da kuma naman gwari.
Maganin wankewa da giya mai dauke da giya mai kashi 70% ya kashe kashi 99.97% (3.5 log reduction, kwatankwacin ragewa da decibel 35) na kwayoyin a hannayen mutum a cikin dakika 30 bayan amfani da shi da kuma kashi 99.99% zuwa 99.999% (4 zuwa 5 log reduction) na kwayoyin a hannayen mutum minti 1 bayan amfani da su. Maganin wankewa da hannu sun fi tasiri a kan kwayoyin halitta kuma sun fi tasiri a kan wasu ƙwayoyin cuta.
Kayan tsabtace hannu da aka yi amfani da giya kusan ba su da tasiri sosai a kan ƙwayoyin cuta na nau'in norovirus (ko Norwalk), wanda shine mafi yawan sanadin cututtukan gastroenteritis. Dole ne a yi amfani da maganin hana kamuwa da cuta na hannu ko rub da giya don a yi wanka sosai ko kuma a rufe hannuwan biyu.
Ana shafa gaba da baya na hannayen biyu da tsakanin da kuma ƙarshen yatsunsu na kimanin dakika 30 har sai ruwa, kumfa ko gel ya bushe.
Dole ne a wanke yatsunsu sosai, kuma a shafa su a hannayen hannu biyu. Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta Amurka ta ba da shawarar wanke hannu a kan wanke hannu, musamman idan hannuwan suna da ƙazanta sosai.
Ana amfani da waɗannan magunguna sosai saboda sauƙin amfani da su da kuma saurin kashe kwayoyin cuta; duk da haka, ba za su maye gurbin wanke hannu ba sai dai idan sabulu da ruwa ba su da.
Yin amfani da kayan wanke hannu da aka yi amfani da su a kai a kai zai iya haifar da bushewar fata sai dai idan an kara da kayan wankewa da/ko kayan wanke fata ga kayan aikin.
Ana iya rage ko kawar da tasirin bushewa na barasa ta hanyar ƙara glycerin da/ko wasu masu sanyaya a cikin kayan aikin.
A cikin gwaji na asibiti, maganin hana shan giya da ke dauke da kayan wankewa ya haifar da rashin haushi da kuma bushewar fata fiye da sabulu ko kuma kayan wankewa na maganin rigakafi.
Allergic contact dermatitis, contact urticaria syndrome ko kuma rashin jin daɗi ga barasa ko kayan kara da ke cikin rubbing hannayen giya ba sa faruwa.
Ƙananan yanayin da zai iya haifar da cututtukan fata da ke sa mutum ya yi fushi ya zama abin sha'awa idan aka kwatanta da wanke hannu da sabulu da ruwa.
Duk da ingancin su, kayan da ba su da ruwa ba ba ba su wanke hannayensu da kayan halitta, amma kawai suna kashe su.
Saboda haka, maganin hana shan ruwa da kuma sabulu ba su da tasiri sosai wajen hana kamuwa da cututtuka da yawa, domin har ila suna da hannuwansu.
Ingancin maganin hana shan giya na hannu ya dogara sosai da sinadarai da kuma tsari, kuma a tarihi yana da giya da giya masu amfani da su da yawa.
A kwanan nan, an nuna cewa magungunan da ke amfani da benzalkonium chloride suna da ci gaba da aiki mai tsanani da kuma haɗuwa da kwayoyin bayan amfani, ba kamar barasa ba, wanda aka nuna ya rage ingancinsa bayan amfani da shi sau da yawa, wataƙila saboda ci gaba da sakamako masu illa na fata.
Mutane da yawa a yankunan da ba su da kuɗi sosai ba ba za su iya sayen sabulu kuma su yi amfani da toka ko ƙasa a maimakon haka.
Ƙura ko ƙasa za su iya yin aiki sosai fiye da ruwa, amma ba su da amfani sosai kamar sabulu.
Wani abin da ya sa mutane damuwa shi ne, idan ƙasa ko toka sun gurɓata da kwayoyin cuta, hakan zai iya sa a ƙara yaduwar cututtuka maimakon a rage su.
Kamar sabulu, toka kuma yana kashe ƙwayoyin cuta domin idan ya haɗu da ruwa, yana yin maganin alkaline.
WHO ta ba da shawarar toka ko yashi a matsayin madadin sabulu idan sabulu ba ya samuwa.
Hanyar wanke hannu da ta dace da cibiyoyin kula da cututtuka na Amirka suka ba da shawarar don hana yaduwar cutar ta ƙunshi matakai masu zuwa:
Hannunsu suna da ruwa mai dumi ko sanyi.
Ana ba da shawarar yin amfani da ruwa mai gudana domin za a iya gurɓata wuraren da ake yin ruwa a tsaye, amma yanayin zafin ruwan ba ya shafan yadda ake yin ruwa.
Ka shafa hannunka da sabulu mai yawa, ka shafa su a bayan hannu, tsakanin yatsunsu, da kuma ƙarƙashin kusoshi.
Sabulu yana kawar da kwayoyin cutar daga fata, kuma bincike ya nuna cewa mutane suna wanke hannuwansu sosai sa'ad da suke amfani da sabulu maimakon ruwa kawai.
Ka wanke shi na akalla sakan 20.
Yin wanke jiki yana haifar da taɓawa, wanda ke taimaka wa mutum ya kawar da kwayoyin daga fata, kuma yin wanke jiki na tsawon lokaci yana kawar da ƙarin kwayoyin.
Ka wanke shi a ƙarƙashin ruwa mai gudana.
Yin wanka a cikin wani tafki zai iya sake gurɓata hannuwan.
Ka bushe da tawul mai tsabta ko kuma ka bar iska ta bushe.
Hannun da ke da ruwa da kuma rigar suna da sauƙin sake kamuwa da cutar.Sashe da aka fi rasa su ne yatsan hannu, wuyan hannu, wuraren da ke tsakanin yatsunsu, da kuma ƙarƙashin kusoshi.
Ƙusa da kuma gashin ƙusa na iya ɗauke da ƙwayoyin cuta.
Ana yawan ba da shawarar yin amfani da maganin shafawa don hana hannayen su bushe; fata mai bushewa na iya haifar da lalacewar fata wanda zai iya ƙara haɗarin kamuwa da cuta.
" Za a iya yin zaɓuɓɓuka masu ƙarancin kuɗi don sauƙaƙe wanke hannu inda ruwa da / ko sabulu ba su da samuwa misali, zuba ruwa daga jerrycan mai rataye ko kabeji tare da ramuka masu dacewa da / ko amfani da toka idan ya cancanta a ƙasashe masu tasowa.A cikin yanayi tare da iyakancewar samar da ruwa (kamar makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai hanyoyin adana ruwa, kamar ""tippy-taps"" da sauran zaɓuɓɓukan ƙarancin kuɗi. "
Tipy-tap fasaha ce mai sauƙi ta yin amfani da tukunya da aka rataye ta igiya, da kuma hannun da aka yi amfani da ƙafa don zuba ruwa kadan a kan hannayen da kuma sabulu.
Yin bushewar hannu da kyau wani muhimmin ɓangare ne na tsarin tsabtace hannu, amma akwai wasu muhawara game da yadda za a bushe hannu a cikin wanke-wanke na jama'a.
Ƙari ga haka, bincike da ake yi a kan littattafan da ake amfani da su a gidajen wanka ya nuna cewa wanki na takarda ya fi tsabta fiye da na'urar busar hannu da ake amfani da ita a gidajen wanka.
A shekara ta 2008, Jami'ar Westminster, London, ta gudanar da bincike, kuma masana'antar takarda ta tallafa wa taron taro na Turai, don kwatanta matakan tsabta da takarda take bayarwa, masu bushewa hannu na iska mai dumi da kuma masu bushewa hannu na iska mai iska na zamani.
Bayan an wanke hannuwan da kuma bushe su da na'urar bushewa da iska mai dumi, an gano cewa adadin kwayoyin ya ƙaru da kashi 194% a kan yatsunsu da kuma kashi 254% a hannuwan hannu.
Drying tare da jet-air dryer ya haifar da karuwar yawan kwayoyin a kan yatsun yatsunsu da kashi 42% da kuma a kan hannayen hannu da kashi 15%.
Bayan wanke da kuma bushe hannu da tawul na takarda, an rage yawan kwayoyin a matsakaita har zuwa kashi 76% a kan yatsun yatsunsu da kuma har zuwa kashi 77%. Masana kimiyya sun kuma gudanar da gwaje-gwaje don tabbatar da ko akwai yiwuwar gurɓataccen gurɓataccen masu amfani da wanka da kuma yanayin wanka sakamakon kowane irin hanyar bushewa.
Jirgin-jirgin sama mai bushewa, wanda ke busa iska daga na'urar a saurin da aka ce ya kai 180 m/s (650 km/h; 400 mph), yana iya busa kwayoyin cuta daga hannayensu da na'urar kuma yana iya gurɓata sauran masu amfani da gidan wanka da kuma yanayin gidan wanka har zuwa mita 2 daga nesa.
Yin amfani da na'urar bushewa ta hannu mai iska mai dumi yana yada kwayoyin cuta har zuwa mita 0.25 daga na'urar bushewa.
Towels na takarda ba su nuna yaduwar ƙwayoyin cuta ba.A shekara ta 2005, a cikin wani bincike da TÜV Produkt und Umwelt ya gudanar, an kimanta hanyoyin bushewa na hannu daban-daban.
An lura da canje-canje masu zuwa a yawan kwayoyin bayan an bushe hannayen:
Akwai masana'antun bushewa na hannu da yawa, kuma an kwatanta bushewa na hannu da bushewa da tawul ɗin takarda.
Yin wanke hannu ta amfani da kayan wanke hannu na iya zama wani zaɓi yayin tafiya idan babu sabulu da ruwa.
Dole ne a ƙunsar da maganin hana shan giya a hannu aƙalla kashi 60 cikin ɗari na giya.
Da daɗewa bayan da likitan Hungary Ignaz Semmelweis ya gano cewa yana da amfani sosai wajen hana cututtuka a asibiti, sai aka soma yin wanke hannu.
Akwai na'urori na lantarki da ke ba da bayanai don su tuna wa ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani bincike ya nuna cewa yawan kamuwa da cutar ya ragu da shan su.
Ana yin wanke hannu a lokacin da ake yin magani na akalla sakan 15, ana amfani da sabulu da ruwa ko kuma gel don wanke hannu da kuma shafa kowane sashe na hannayensu.
Ya kamata a shafa hannayen hannu tare da adadi da suka haɗu.
Idan akwai wasu abubuwa a ƙarƙashin ƙusa, za a iya amfani da goga don cire shi.
Tun da yake ƙwayoyin cuta suna iya kasancewa a cikin ruwa a hannayenmu, yana da muhimmanci mu wanke su sosai kuma mu shafa su da tawul mai tsabta.
Bayan an bushe, ya kamata a yi amfani da tawul ɗin takarda don kashe ruwa (kuma a buɗe kofa ta fita idan ya cancanta).
Wannan zai hana a sake gurɓata hannayensu daga waɗannan farfajiyar.
" Manufar wanke hannu a cikin kiwon lafiya shine cire kwayoyin cuta (" " kwayoyin cuta ") da kuma kauce wa watsa su. "
Jaridar New England Journal of Medicine ta ruwaito cewa rashin wanke hannu a yawancin wuraren da ake yin magani ba shi da kyau, saboda haka, likitoci da ma'aikatan jinya da yawa suna manta su wanke hannuwansu kafin su taɓa marasa lafiya, kuma hakan yana sa su kamu da ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kuma wasu ayyuka masu sauƙi za su iya rage yawan kamuwa da cututtukan jini da suka shafi kateter da kashi 66 cikin ɗari. Hukumar Lafiya ta Duniya ta wallafa wani takarda da ta nuna yadda ake wanke hannu da kuma shafa hannu a fannonin kiwon lafiya.
Za a iya samun rubutun jagorar tsabtace hannayen hannu ta ƙungiyar a shafin yanar gizon ta don ra'ayin jama'a.
Whitby da sauransu sun gudanar da bincike mai dacewa.
Kayan aiki na kasuwanci na iya auna da kuma tabbatar da tsabtace hannu, idan ana buƙatar tabbatar da bin ka'idoji.
" Hukumar Lafiya ta Duniya tana da "Lokaci Biyar" don wanke hannu: "
bayan an fallasa shi ga jini/ruwayen jiki
kafin aikin aseptic, kuma
" bayan kula da marasa lafiya. Ƙara sinadarai masu maganin antiseptic zuwa sabulu ("" magani "ko " maganin rigakafi ") yana ba da aikin kashewa ga mai wanke hannu. "
Ana iya yin irin wannan aikin kashewa kafin a yi tiyata ko kuma a wuraren da kwayoyin da ke da tsayayyar maganin rigakafi suke da yawa. Don 'scrub' hannayen mutum don tiyata, ya zama dole a sami famfo wanda za a iya kunnawa da kashewa ba tare da taɓa shi da hannayensu ba, wasu chlorhexidine ko yodium wanka, tawul ɗin sterile don bushewa da hannu bayan wanka, da kuma goga mai sterile don wankewa da kuma wani kayan aiki mai sterile don tsaftacewa a ƙarƙashin kusoshi.
Ya kamata a cire dukan kayan ado.
Wannan aikin yana bukatar wanke hannuwan da hannayensu har zuwa ƙugu, yawanci na minti 26.
Ba a bukatar yin wanka na tsawon minti 10.
Idan kana wanke hannu, dole ne ka hana ruwa daga hannunka ya koma hannunka.
Bayan an gama wanke hannu, ana bushe hannuwan da wata masana'anta marar amfani kuma ana saka rigar tiyata.
Don a rage yaduwar ƙwayoyin cuta, zai fi kyau a wanke hannuwanku ko kuma a yi amfani da maganin kashe-kayan hannu kafin a kula da wani mai ciwo da kuma bayan an yi hakan.
Don hana kamuwa da cututtukan staphylococcal a asibitoci, an gano cewa mafi girma amfanin wanke hannu ya zo daga farkon 20% na wanke, kuma cewa kadan ƙarin amfanin da aka samu a lokacin da aka kara yawan wanke hannu fiye da 35%.
Wankewa da sabulu mai tsabta yana haifar da fiye da sau uku na yawan cututtukan cututtukan cuta na kwayar cuta da aka watsa zuwa abinci idan aka kwatanta da wankewa da sabulu mai ƙwayoyin cuta. Kwatanta wanke hannu da maganin shan giya tare da wanke hannu da sabulu mai ƙwayoyin cuta na tsawon lokaci na dakika 30 ya nuna cewa wanke hannu da giya ya rage gurɓatar kwayoyin cuta da kashi 26% fiye da sabulu mai ƙwayoyin cuta.
Amma sabulu da ruwa sun fi tasiri fiye da shafa hannu da aka yi amfani da giya don rage cutar mura ta H1N1 A da kuma ƙwayar Clostridium difficile daga hannayen.Hadakar da za a yi don inganta tsabtace hannu a cikin yanayin kiwon lafiya na iya haɗa da koyar da ma'aikata game da wanke hannu, ƙara yawan wanke hannu da aka yi amfani da giya, da kuma tunatarwa ta rubutu da ta baki ga ma'aikata.
Akwai bukatar ƙarin bincike a kan abin da wadannan tsoma baki ne mafi tasiri a daban-daban kiwon lafiya saituna.
A ƙasashe masu tasowa, ana ganin wanke hannu da sabulu a matsayin hanya mai kyau da ba ta da tsada kuma da ta fi muhimmanci wajen samun lafiya da kuma abinci mai gina jiki.
Amma rashin wadatar ruwa mai kyau, sabulu ko kuma kayan wanke hannu a gidajen mutane, a makarantu da kuma wuraren aiki ya sa ya zama ƙalubale a cimma halaye na wanke hannu a duniya.
Alal misali, a yawancin yankunan karkara na Afirka, ba a yawan wanke kayan wanki da hannu a kusa da kowane gidan wanka na jama'a ko kuma na masu zaman kansu, ko da yake akwai zaɓuɓɓuka masu rahusa don gina wuraren wanke hannu.
Amma, yawan wanke hannu da aka yi a ƙasa zai iya zama sakamakon halin da aka yi a dā maimakon rashin sabulu ko ruwa.
Tallafawa da kuma tallata wanke hannu da sabulu na iya shafar yanke shawara kan manufofi, ya kara wayar da kan jama'a game da amfanin wanke hannu kuma ya haifar da canjin halin mutane na dogon lokaci.
Don wannan ya yi aiki yadda ya kamata, ana bukatar saka idanu da kuma kimantawa.
" Binciken tsarin nazarin 70 ya gano cewa hanyoyin da aka yi amfani da su a cikin al'umma suna da tasiri wajen kara wanke hannu a cikin LMICs, yayin da kamfen ɗin tallan zamantakewa ba su da tasiri sosai. Misali ɗaya don inganta wanke hannu a makarantu shine "Taron Tauraruwa Uku" na UNICEF wanda ke ƙarfafa makarantu su ɗauki matakai masu sauƙi, masu arha don tabbatar da cewa ɗalibai suna wanke hannayensu da sabulu, a tsakanin sauran bukatun tsabta. "
Idan aka cimma matsakaicin ka'idoji, makarantu za su iya motsawa daga taurari daya zuwa uku.
Gina wuraren wanke hannu na iya zama wani ɓangare na kamfen na tallata wanke hannu da ake yi don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya misali ne na wani kamfen na wayar da kan jama'a wanda ke ƙoƙarin cimma canjin hali.A sakamakon annobar coronavirus ta 2019-20, UNICEF ta inganta karɓar emoji na wanke hannu.
Kadan ne kawai suka yi la'akari da yawan kudin da ake samu na wanke hannu a kasashe masu tasowa dangane da DALYs da aka kauce masa.
Amma, wani bincike ya nuna cewa yin amfani da sabulu wajen wanke hannu yana da amfani sosai fiye da yin amfani da ruwa da kuma tsabtace jiki.
" Muhimmancin wanke hannu ga lafiyar ɗan adam  musamman ga mutanen da ke cikin yanayi mai rauni kamar uwaye waɗanda suka haifi jarirai ko sojoji da suka ji rauni a asibitoci  an fara gane su a tsakiyar karni na 19 ta hanyar majagaba biyu na tsabtace hannu: likitan Hungary Ignaz Semmelweis wanda ya yi aiki a Vienna, Austria da Florence Nightingale, "mai kafa aikin jinya na zamani" na Ingilishi. "
A lokacin, yawancin mutane suna ganin cewa miyagun ƙwayoyi ne suke sa mutane su kamu da cutar.
A cikin shekarun 1980, barkewar cutar da ke tattare da abinci da cututtukan da ke tattare da kiwon lafiya sun sa Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka na Amurka su inganta tsabtace hannu a matsayin hanya mai mahimmanci don hana yaduwar kamuwa da cuta.
Futar da cutar mura ta alade a shekarar 2009 da annobar COVID-19 a shekarar 2020 sun haifar da karuwar wayar da kan jama'a a ƙasashe da yawa game da mahimmancin wanke hannu da sabulu don kare kanka daga irin waɗannan cututtukan cututtuka.
" Alal misali, an rataye wasu hotunan da ke dauke da "daidai hanyoyin wanke hannu" a kusa da wanke hannu a cikin gidajen wanka na jama'a da kuma a cikin gidajen wanka na gine-ginen ofis da filayen jirgin sama a Jamus. "
" Maganar ""wanke hannuwan mutum daga"" wani abu, yana nufin bayyana rashin son mutum ya dauki alhakin abu ko raba hadin kai a cikinsa. "
An samo asali ne daga nassi na Littafi Mai Tsarki a cikin Matta inda Pontius Pilate ya wanke hannunsa game da shawarar da aka yanke na giciye Yesu Kristi, amma ya zama magana da ke da amfani sosai a wasu al'ummomin Ingilishi.
A cikin Macbeth na Shakespeare, Lady Macbeth ta fara wanke hannayenta a cikin ƙoƙari don tsabtace wani tabo na tunanin, wakiltar lamirinta mai laifi game da laifukan da ta aikata kuma ta sa mijinta ya aikata.
An kuma gano cewa bayan mutane sun tuna ko kuma sun yi tunanin wasu ayyuka marasa kyau, suna wanke hannuwansu sau da yawa fiye da wasu, kuma suna daraja kayan wanke hannu sosai.
"Bugu da kari, wadanda aka ba da izinin wanke hannayensu bayan irin wannan tunani ba su da damar shiga wasu ayyukan "tsabtace" na biyan kuɗi, kamar aikin sa kai. "
Addinai suna ba da shawarar wanke hannu don dalilai na tsabta da na alama.Wasan hannu na alama, ta amfani da ruwa amma ba sabulu don wanke hannu, wani ɓangare ne na wanke hannu na al'ada wanda ke cikin addinai da yawa, gami da Bahá'í Faith, Hinduism, tevilah da netilat yadayim a Yahudanci, Lavabo a Kiristanci, da Wudhu a Islama. Addinai kuma suna ba da umarnin wanke hannu na tsabta, musamman bayan wasu ayyuka.
Addinin Hindu, Yahudanci da Musulunci sun umurci wanke hannuwan bayan amfani da gidan wanka.
Kuma addinin Hindu, Buddha, Sikh, Yahudanci da Musulunci sun umurci wanke hannu kafin da kuma bayan kowane abinci.
Kula da haɗarin COVID-19 a wuraren aiki
Gudanar da haɗarin aiki don COVID-19 shine amfani da hanyoyin aminci da kiwon lafiya na aiki don sarrafa haɗari don hana cutar coronavirus 2019 (COVID-19).
Gudanar da haɗari mai kyau a wurin aiki ya dogara da wurin aiki da aikin aiki, bisa ƙididdigar haɗarin tushen fallasawa, tsanani na cutar a cikin al'umma, da abubuwan haɗari na ma'aikata na mutum waɗanda zasu iya kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya a Aikin Amurka (OSHA), wuraren da ake samun haɗarin rashin aiki suna da ƙarancin hulɗa na aiki da jama'a da sauran abokan aiki, wanda ake ba da shawarar matakan hana kamuwa da cuta na asali, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, ɗabi'ar numfashi, da kuma kula da tsabtace yau da kullun da kuma kashe ƙwayoyin cuta na yanayin aiki.
Ayyukan haɗarin haɗari na matsakaici sun haɗa da waɗanda ke buƙatar sau da yawa ko kusanci da mutane waɗanda ba a san su ko kuma ake zargin suna da COVID-19, amma na iya kamuwa da cutar saboda watsawar al'umma ko tafiya ta duniya.
Wannan ya hada da ma'aikata da ke da hulɗa da jama'a kamar a makarantu, wuraren aiki da yawan jama'a, da kuma wasu wuraren sayar da kayayyaki masu yawa.
Gudanar da haɗari ga wannan rukunin, ban da matakan hana kamuwa da cuta na asali, sun haɗa da iska ta amfani da matattarar iska mai inganci, masu tsotsa, da kuma samun kayan kariya na mutum idan aka sami wani da ke da COVID-19.
OSHA ta yi la'akari da ma'aikatan kiwon lafiya da gawawwakin da aka fallasa ga wanda aka sani ko kuma ake zargin yana da COVID-19 a cikin haɗarin haɗarin haɗari mai girma, wanda ke ƙaruwa zuwa haɗarin haɗari mai girma idan ma'aikata suka yi hanyoyin samar da sinadarai a kan, ko tattara ko sarrafa samfurori daga, wanda aka sani ko ake zargin yana da COVID-19.
Ƙarin haɗari da ya dace da waɗannan ma'aikata sun haɗa da sarrafa injiniya kamar ɗakunan iska mai matsa lamba, da kuma kayan kariya na mutum da suka dace da aikin.
Cutar COVID-19 na iya haifar da sakamako da yawa a wurin aiki.
Ma'aikata suna iya kasancewa a waje domin suna rashin lafiya, suna bukatar su kula da wasu, ko kuma suna tsoron yin aiki.
Hanyoyin kasuwanci na iya canzawa, duka a cikin abin da ake buƙata, da kuma hanyoyin samun waɗannan kaya (kamar sayayya a lokacin da ba a cikin lokutan da suka fi girma ba ko ta hanyar isar da kaya ko sabis na motsawa).
A ƙarshe, za a iya katse jigilar kayayyaki daga yankunan yanki da COVID-19 ya shafa sosai. Ana iya amfani da shirin shirye-shiryen cututtuka da shirin amsawa don jagorantar matakan kariya.
Shirye-shiryen suna magance matakan haɗari da ke tattare da wuraren aiki da ayyuka daban-daban, gami da tushen fallasawa, abubuwan haɗari da ke fitowa daga gida da kuma al'ummomin al'umma, da abubuwan haɗari na ma'aikata na musamman kamar tsufa ko cututtukan kiwon lafiya na kullum.
Sun kuma bayyana matakan da ake bukata don magance wadannan hadarin, da kuma tsare-tsaren gaggawa na yanayi da za su iya tasowa sakamakon barkewar cutar.
Shirye-shiryen shirye-shiryen cututtuka masu yaduwa da kuma amsawa na iya kasancewa bisa ga shawarwari na kasa ko na kasa.
Manufofin da ake bi don magance barkewar cutar sun hada da rage watsawa tsakanin ma'aikata, kare mutanen da ke da haɗarin kamuwa da rikitarwa na kiwon lafiya, kula da ayyukan kasuwanci, da kuma rage tasirin da ke shafar sauran hukumomi a cikin sarkar wadatarsu.
Matsayin rashin lafiya a cikin al'umma inda kasuwancin yake yana shafar yadda ake amsawa.
Tsarin kula da haɗari shine tsarin da aka yi amfani dashi a cikin aminci da lafiya a aiki don rarraba matakan haɗari ta hanyar inganci.
Inda ba za a iya kawar da haɗarin COVID-19, ingantattun sarrafawa sune sarrafa injiniya, sannan na gudanarwa, da kuma kayan kariya na sirri.
Gudanar da aikin injiniya ya ƙunshi ware ma'aikata daga haɗarin da ke tattare da aiki ba tare da dogaro da halayen ma'aikata ba, kuma zai iya zama mafita mafi tsada don aiwatarwa.
Gudanar da gudanarwa shine canje-canje a cikin manufofin aiki ko hanyoyin da ke buƙatar aiki daga ma'aikaci ko mai aiki.
Ana ganin kayan kariya na mutum (PPE) ba su da tasiri fiye da na injiniya da na gudanarwa, amma suna iya taimakawa wajen hana wasu abubuwan da ke faruwa.
Dole ne a zabi dukkan nau'ikan PPE bisa ga haɗarin da ke tattare da ma'aikaci, a saka su yadda ya kamata (misali na numfashi), a saka su yadda ya kamata, a duba su akai-akai, a kula da su, kuma a maye gurbin su, idan ya cancanta, kuma a cire su yadda ya kamata, a tsabtace su, a adana su ko a kawar da su don kauce wa gurɓatawa.
A cewar Hukumar Kula da Lafiya da Lafiya a Aikin Amurka (OSHA), ayyukan da ke da ƙananan haɗarin haɗari suna da ƙananan hulɗa na aiki da jama'a da sauran abokan aiki.
Abubuwan da ake bukata don hana kamuwa da cuta a duk wuraren aiki sun hada da wanke hannuwansu akai-akai da kuma a hankali, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, ɗabi'ar numfashi ciki har da rufe tari da tsatsa, samar da kayan aiki da kuma kwandon shara, shirya don yin aiki a nesa ko kuma a cikin canji idan ya cancanta, hana ma'aikata yin amfani da kayan aiki da kayan aiki na wasu, da kuma kula da tsabtace da kuma kashe ƙwayoyin cuta na yau da kullum na yanayin aiki.
Gano da kuma ware mutanen da ke da cutar nan da nan yana da muhimmanci wajen kāre ma'aikata, abokan ciniki, baƙi, da kuma wasu a wurin aiki.
Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka na Amirka (CDC) sun ba da shawarar cewa ma'aikata da suke da alamun cututtukan numfashi na gaggawa su zauna a gida har sai sun sami rashin zazzabi, alamun zazzabi, da kuma wasu alamun cutar aƙalla sa'o'i 24 ba tare da yin amfani da maganin rage zazzabi ko wasu magunguna da ke canja alamun ba, kuma cewa manufofin izinin rashin lafiya suna da sassauƙa, suna ba ma'aikata damar zama a gida don kula da wani danginsu mai ciwo, kuma cewa ma'aikata sun san waɗannan manufofin.
A cewar OSHA, ayyukan haɗarin haɗarin haɗari na matsakaici sun haɗa da waɗanda ke buƙatar sau da yawa ko kusanci tsakanin ƙafa shida (1.8 m) na mutanen da ba a san su ko waɗanda ake zargin marasa lafiya na COVID-19, amma na iya kamuwa da SARS-CoV-2 saboda watsawar al'umma a kusa da wurin kasuwancin, ko kuma saboda mutumin ya yi tafiya ta ƙasa da ƙasa zuwa wani wuri tare da yaduwar watsa COVID-19.
Waɗannan sun haɗa da ma'aikata waɗanda ke da hulɗa da jama'a kamar a makarantu, yanayin aiki mai yawan jama'a, da wasu saitunan kiri masu yawa.Sharar injiniya don wannan da rukunin haɗarin haɗari sun haɗa da shigar da matattarar iska mai inganci, haɓaka yawan iska, shigar da shinge na zahiri kamar masu kare tsananin filastik, da shigar da taga ta hanyar sabis na abokin ciniki.Shararorin gudanarwa don wannan da rukunin haɗarin haɗari sun haɗa da ƙarfafa ma'aikatan marasa lafiya su zauna a gida, maye gurbin tarurruka na fuska da fuska da sadarwar kai tsaye, kafa jiragen ruwa masu tasowa, dakatar da balaguron da ba su da mahimmanci zuwa wuraren da ke daɗaɗɗen COVID-19 ke gudana, haɓaka tsare-tsaren sadarwar gaggawa gami da taron amsa matsalolin ma'aikata, samar da ma'aikata tare da ingantaccen ilimi da horo kan abubuwan haɗarin COVID-19 da halayen kariya na sirri, kula da ma'aikatan da ke buƙatar amfani da kayan aiki da kayan aiki na yau da kullun, haɗa da sanya kayan aiki da ƙarancin hannu da ke rufe fuska, ba da ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin COVID-19, ba da kuma ba da ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin
Ma'aikata a wannan rukunin haɗari ba sa bukatar yin amfani da na'urar numfashi.
Idan mutum ya yi rashin lafiya a jirgin sama, ana yin amfani da matakan da za su kare ma'aikata da sauran fasinjoji don ware mutumin da ke rashin lafiya daga wasu da nisan ƙafa 6, a naɗa wani ɗan jirgin don ya yi wa mutumin da ke rashin lafiya hidima, kuma a ba da abin rufe fuska ga mutumin da ke rashin lafiya ko kuma a gaya wa mutumin da ke rashin lafiya ya rufe bakinsa da hanci da kayan shafawa lokacin da yake tari ko kuma yin sneezing.
Ma'aikatan jirgin ya kamata su sa sa safofin hannu na likita na kwance lokacin da suke kula da wani mai tafiya mai ciwo ko kuma suna taɓa ruwa na jiki ko kuma farfajiyar da za ta iya zama mai ƙazanta, kuma wataƙila su saka ƙarin kayan kariya idan mai tafiya mai ciwo yana da zazzabi, tari mai ciwo, ko kuma wahalar numfashi.
Dole ne a zubar da safofin hannu da sauran kayan da za a iya amfani da su a cikin jakar haɗari na rayuwa, kuma ya kamata a tsabtace da kuma kashe ƙwayoyin cuta a bayan haka. Don jiragen ruwa na kasuwanci, gami da jiragen ruwa da sauran jiragen ruwa, kula da haɗari sun haɗa da jinkirta tafiya lokacin da kake rashin lafiya, da kuma ware kanka da sanar da cibiyar likitanci na jirgin nan da nan idan mutum ya sami zazzabi ko wasu alamomi yayin jirgin.
A mafi kyau, dole ne a lura da likita a cikin ɗakin mutum mai keɓewa.Ga makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan gajeren lokaci don tsaftacewa ko kashe ƙwayoyin cuta idan mutum mai kamuwa da cuta ya kasance a cikin ginin makaranta ba tare da la'akari da yaduwar al'umma ba.
Lokacin da akwai ƙananan zuwa matsakaiciyar watsawa ta al'umma, ana iya aiwatar da dabarun nesa da zamantakewa kamar soke tafiye-tafiye na filin, taro, da sauran manyan tarurruka kamar ilimin jiki ko darussan mawaƙa ko abinci a cikin kantin abinci, ƙara sararin samaniya tsakanin tebur, lokacin isowa da sallama mai ban mamaki, iyakance baƙi marasa mahimmanci, da amfani da wani wuri na ofishin kiwon lafiya daban don yara masu alamun mura.
Lokacin da akwai yaduwar yaduwar cutar a cikin al'ummar gida, ban da dabarun nisantar zamantakewa, ana iya la'akari da tsawaitawar sallamar makaranta.Ga ma'aikatan tilasta bin doka da ke yin ayyukan yau da kullun, CDC ta ɗauki haɗarin lafiyar kai tsaye a matsayin ƙasa.
Jami'an tsaron doka waɗanda dole ne su tuntuɓi mutane da aka tabbatar ko ake zargin suna da COVID-19 an ba da shawarar su bi ka'idoji iri ɗaya da na masu aikin likitanci na gaggawa, gami da kayan kariya na sirri.
Idan akwai kusanci mai zurfi yayin kamawa, ma'aikata ya kamata su tsabtace da kuma kashe kayan aikin su kafin su sake amfani da su ta amfani da spray na gida ko wanke, kuma su bi ka'idodin aiki na yau da kullun don riƙewa da kawar da PPE da aka yi amfani da su da kuma don riƙewa da wanke tufafi.
OSHA ta yi la'akari da wasu ma'aikatan kiwon lafiya da kuma gawawwakin gawawwaki da ke cikin manyan ko kuma manyan nau'ikan haɗarin haɗari.
Ayyukan haɗarin haɗari sun haɗa da bayar da kiwon lafiya, tallafi, dakin gwaje-gwaje, da ma'aikatan sufuri na likita waɗanda aka fallasa su ga sanannun ko waɗanda ake zargin marasa lafiya na COVID-19.
Waɗannan suna zama haɗarin haɗari sosai idan ma'aikata suka yi hanyoyin samar da sinadarai a kan, ko tattara ko sarrafa samfurori daga, sanannun ko waɗanda ake zargin marasa lafiya na COVID-19.
Hanyoyin samar da aerosol sun hada da intubation, hanyoyin shigar da tari, bronchoscopes, wasu hanyoyin hakora da jarrabawa, ko tattara samfurin da ya shafi.
Ayyukan da ke cikin dakin gawa masu haɗarin haɗari sun haɗa da ma'aikata da ke aiki wajen shirya gawarwakin mutanen da suka san ko kuma ake zargin cewa suna da cutar COVID-19 a lokacin mutuwarsu; waɗannan suna zama haɗarin haɗari sosai idan suka yi aikin gawa. Ƙarin aikin injiniya don waɗannan rukunin haɗarin sun haɗa da ɗakunan keɓewa don marasa lafiya da aka sani ko ake zargin COVID-19, gami da lokacin da ake gudanar da hanyoyin samar da sinadarai.
Ƙarfafa iska mai ƙarancin matsa lamba na musamman na iya zama da kyau a wasu wuraren kiwon lafiya da kuma gawawwaki.
Ya kamata a bi da samfurori da matakan tsaro na Biosafety Level 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa a raba marasa lafiya masu shigowa zuwa wuraren jiran daban-daban dangane da ko suna da zargin COVID-19. Baya ga sauran PPE, OSHA ta ba da shawarar masu numfashi ga waɗanda ke aiki a cikin ƙafa 6 na marasa lafiya da aka sani, ko ake zargin suna da cutar SARS-CoV-2, da waɗanda ke yin hanyoyin samar da aerosol.
A Amurka, dole ne a yi amfani da N95 mai tace fuska mai tsabta da aka amince da shi ta NIOSH ko kuma mafi kyau a cikin tsarin cikakken shirin kariya na numfashi da ya ƙunshi gwajin dacewa, horo, da kuma jarrabawar likita.
Sauran nau'ikan kayan numfashi na iya samar da kariya mai yawa da inganta kwanciyar hankali ga ma'aikata. WHO ba ta ba da shawarar rufe tufafi ba, saboda COVID-19 cuta ce ta hanyar numfashi maimakon ta hanyar ruwan jiki.
Hukumar ta WHO ta ba da shawarar yin amfani da abin rufe fuska na tiyata kawai ga ma'aikatan binciken da ke wurin shiga.
Ga waɗanda ke tattara samfurin numfashi daga, kula da, ko jigilar marasa lafiya na COVID-19 ba tare da wani aikin samar da aerosol ba, WHO ta ba da shawarar yin amfani da abin rufe fuska na tiyata, tabarau, ko garkuwa, rigar, da safofin hannu.
Idan an yi aikin samar da aerosol, an maye gurbin abin rufe fuska na tiyata da na numfashi na N95 ko FFP2.
Ganin cewa wadatar PPE a duniya bai isa ba, WHO ta ba da shawarar rage buƙatar PPE ta hanyar telemedicine, shinge na zahiri kamar windows masu tsabta, ba da izinin waɗanda ke cikin kulawa kai tsaye kawai su shiga daki tare da mai haƙuri na COVID-19, ta amfani da PPE kawai da ake buƙata don takamaiman aikin, ci gaba da amfani da na'urar numfashi iri ɗaya ba tare da cire ta ba yayin kula da marasa lafiya da yawa tare da ganewar asali iri ɗaya, saka idanu da daidaita sarkar samar da PPE, da hana amfani da masks ga mutanen da ba su da alamun bayyanar cututtuka.
Daga: Katherine Maher, Shugaba na Gidauniyar Wikimedia
TO: Dukkan ma'aikatan Wikimedia Foundation
TAMBAYA: [Covid-19] Saukakawa da kuma shirya wa nan gaba
RANAR SEND/TIME: 14 ga Maris, 2020, 00:24 UTC
IYAR HASUMI: CC0: Babu haƙƙoƙi da aka tanada
Muna cikin yanayi mai ban mamaki a wannan watan.
Cutar COVID-19 wani abu ne da ya bayyana alaƙarmu ta duniya da kuma nauyin da muke da shi ga juna.
Ba mu da misali ga kalubalen da ke tattare da shi, amma mun san cewa amsarmu mafi kyau ta dogara ne akan irin tausayi na duniya, hadin kai, da kuma gina al'umma da ke cikin zuciyar wannan kungiya.
Abokantaka da kulawar da muka gani tsakanin dukkan abokan aikinmu ta hanyar imel, kira, da tattaunawa tabbaci ne mai ban mamaki na mutane masu ban mamaki da muke da sa'a mu yi aiki tare.
Ba zan iya zama mafi godiya da alfahari da ku duka a matsayin abokan aiki ba.
A makon da ya shige, wani ya gaya mini yadda suke godiya don aikinmu.
Sun tunatar da ni yadda yake da muhimmanci ga duniya ta iya juya zuwa Wikipedia a yanzu, da kuma abin da alama mai karfi ne ga wannan muhimmin albarkatun ya kasance a kan layi kuma yana samuwa ga kowa.
Aikinku ya sa hakan ya yiwu, ko kun ci gaba da ajiye wuraren, ko kuma abokan aikinmu sun biya ko kuma al'ummominmu sun kasance a cikin aminci.
Duniya tana bukatar bayanan da Wikipedia ke bayarwa, yanzu fiye da kowane lokaci.
Wannan lokaci ne da ba kawai abin da muke yi ba, amma yadda muke yi, zai yi tasiri mai ma'ana a duniya.
Saboda muhimmancin wannan aikin da kuma rawar da kuke takawa a ciki, za mu yi wasu canje-canje masu muhimmanci ga yadda muke aiki tare, daga wannan makon mai zuwa.
Gyara ayyukanmu da kuma jadawalinmu
Kamar yadda Robyn ta ambata a baya, ƙungiyar c-ta haɗu a daren jiya don tattauna tsarinmu da jadawalinmu na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun yi la'akari da abin da muka yi tunanin zai zama amsa mai dacewa ga abin da muke fuskanta da kuma hanya mafi kyau don kiyaye ƙungiyar mai dorewa a wannan lokacin.
Mun so mu kawar da damuwa kuma mu tallafa wa aikinmu na dogon lokaci.
Idan kana bukatar ka sake kira, to, ba laifi.
Ga dukkan ma'aikata, masu kwangila, da ma'aikatan kwangila:
tsammaninmu na yau da kullum na aiki zai kasance game da 4 hours a rana, ko 20 hours a mako har zuwa wani sabon sanarwa.
Ba mu sanar da hutu ba - idan za ka iya aiki a lokutan da suka fi dacewa, aikin zai iya amfani da kai.
Amma, ba za a iya sanin yanayin duniya ba a yanzu, kuma ko kana bukatar ka kula da ƙaunatattunka, ka sayi kayan abinci, ko ka je wurin likita, muna saka lafiyarka a kan gaba.
Ba mu bin sa'a ba.
Idan kana rashin lafiya, kada ka yi aiki.
Wannan ya kamata ya tafi ba tare da faɗi ba, amma muna faɗi shi.
Babu kwanakin rashin lafiya ko PTO da ake bukata - kawai gaya wa manajanka kuma ka taimaka wa ƙungiyarka ta sake duba kalandar da jadawalin don tabbatar da cewa an rufe manyan wuraren aiki.
(Idan an gano cewa kana da cutar COVID-19, don Allah ka sanar da Bryan a cikin T&amp;C Ops don T&amp;C ta iya taimakawa tare da tallafi kuma tabbatar da cewa yanayin ka ya sami kulawa ta dace daga gudanarwa).
Za a biya mutanen da suke aiki a kowace awa.
Mun riga mun ce, kuma muna sake yin alkawarin cika alkawuranmu ga masu kwangila da abokan aikinmu na awa daya.
Kowane mutum za a biya shi bisa ga sa'o'in da ya saba yi a yanayi na yau da kullum.
Hakan ya haɗa da idan kana rashin lafiya kuma ba za ka iya yin aiki ba.
Idan kana son ka yi aiki, za mu goyi bayanka.
Mutane da yawa suna amfani da aikin su wajen sa su riƙa damuwa da abubuwan da ke faruwa a duniya.
Abin da muke yi yana da amfani sosai, musamman a irin wannan lokacin.
A sake, wannan game da kula da kai ne.
Muna roƙon ka ka yi magana da manajanka, don mu san abin da za mu yi tsammani kuma mu daidaita bisa ga hakan.
Ana ganin cewa wasu ayyuka suna da muhimmanci.
Akwai wasu abubuwa da dole ne mu ci gaba da yi.
SRE, HR Ops, Trust & Safety, da kuma Tattalin Arzikin Tattalin Arzikin (a tsakanin wasu) suna yin aiki mai mahimmanci wanda zai iya buƙatar ƙarin tallafi.
Za mu fara wani tsari tare da dukkan sassan don kimanta manufofin da muke da su a yanzu kuma mu mayar da hankalinmu ga tallafawa abin da yake da muhimmanci ga aikinmu.
Akwai abubuwa da yawa da za mu yi domin dukanmu, amma za mu mai da hankali ga ayyukan da suka fi muhimmanci.
Saurin jinkiri yanzu ba zai cutar da ni ba.
Ba mu da niyyar yin sau biyu don kamawa da zarar annobar ta wuce.
Ba za a sa ran ka yi aiki na karin sa'o'i ba don ka cika takaddun da ba su dace ba yanzu.
Mun yarda cewa yanayi ya canza, kuma za mu yi aiki don saita sababbin manufofi da kuma lokacin da ya dace.
Mene ne zai faru da APP (Tsarin Shekara-shekara)?
Don daidaitawa da sabon yanayinmu da kuma tsammanin lokutan aiki na yau da kullum, muna da niyyar daidaita jadawalin lokacin don isar da Shirin Shekararmu na 2020-2021.
Manufarmu ita ce mu gabatar da tsawaita shirinmu na 2019-2020 wanda zai ba da ƙarin lokaci don tsara kasafin kuɗi don ba da damar ma'aikata su ba da fifiko ga aiki mai mahimmanci, kula da kansu, da kula da ƙaunatattun su yayin da suke karɓar waɗanda suke buƙatar ko so su yi aiki a rage jadawalin a cikin makonni masu zuwa.
Wannan tsawo na lokaci yana rage yawan aiki da kuma matsa lamba a cikin dukan kungiyar.
Za mu gabatar da shawarwarinmu ga Hukumar a mako mai zuwa kuma za mu sanar da wakilan da ƙungiyoyi game da matakai na gaba da zarar mun samu tabbaci.
Na gode wa tawagar APP don jagorancinku a wannan.
Matsayin ofishin, bayyanar da tsabtace
A makon da ya gabata, mun koyi cewa wataƙila ɗaya daga cikin abokan aikinmu na SF ya kamu da cutar COVID-19.
Amma, saboda muna da hankali sosai, mun yi amfani da ma'aikatan tsabtace-kayan rigakafi don su kashe ƙwayoyin cuta a dukan ofishin da ke birnin San Francisco.
Sun yi amfani da maganin rigakafi na asibiti don kashe ƙwayoyin cuta a kowane wuri, da kuma wuraren da ake shiga da kuma tashar hawa da ke shiga bene.
Ginin yana amfani da tsarin kula da kansa ta amfani da kayayyakin da ke tallafawa lafiyar mazauna su.
Muna jin daɗin cewa za a shirya mana ofishin sosai sa'ad da muka koma.
Ofishinmu na DC yana cikin WeWork, wanda ya raba yarjejeniyar COVID-19 tare da mu da duk ma'aikatan DC.
A makon da ya gabata, ofishinmu na DC ya koma wani wuri mai nisa bisa ga umarnin da San Francisco ta ba mu.
Kamar yadda wasu abokan aikinmu da ke birnin New York suka sani, mun tattauna game da hayar wani wuri a Brooklyn.
Ana ci gaba da tattaunawar amma za a iya jinkirta.
Wasu abokan aikinmu suna aiki daga nesa a karon farko.
Abokan aikinmu na dogon lokaci sun san cewa zai iya zama gyara, kuma sun so su ba ku shawara:
Ka rage tsawon taron zuwa sa'a ɗaya ko biyu.
Idan ana bukatar zaman lokaci mai tsawo, ka yi la'akari da yadda za a iya raba su a cikin kwanaki da yawa.
Ka bayyana taron a fili, ka shirya abin da za a yi, kuma ka aika da littattafan da za a karanta a gaba.
Yi bidiyon ta tsohuwa, tare da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da haɗin kai.
Ka sami jagora don ya taimaka wa kowane taro, wani ya lura da tattaunawar don tambayoyi da kuma bin jerin masu jawabi, kuma wani ya taimaka maka ka rubuta rubutu (ko kuma ka yi rubutu tare da su).
Aika imel zuwa goyon bayan fasaha idan kana bukatar wani m belun kunne.
Ka yi amfani da kuɗin kiwon lafiyarka don cin abinci.
Ka shiga tashar #remoties a Slack don yin magana da abokan aikinka game da aikin rarraba
Ƙungiyar HR Operations tana neman jagorar ergonomics ta yanar gizo don tallafawa karuwar aikin rarraba a duk faɗin Gidauniyar.
A makon da ya gabata mun nemi duk masu karbar tallafin al'umma su soke taron jama'a da Wikimedia ke tallafawa, kamar taron editing, har sai WHO ta bayyana cewa annobar ta ƙare.
Mun sanar da su cewa mun fahimci cewa bukatarmu ta sokewa da kuma wasu ƙuntatawa na iya sa ya zama ba zai yiwu a kammala ayyukan ba da tallafi da aka amince da su ba kuma ba za a hukunta kowa ba don jinkirta ko gyara waɗannan manufofin.
A wannan makon mai zuwa za mu bi ta da ƙarin jagora akan Wikimania da sauran taron yanki da na al'umma.
Halin da ke tattare da al'umma a duniya ya zama kamar baƙin ciki ne game da wannan rikici amma yana da sauƙi game da bayyanar da ikon mayar da hankali ga al'ummomin su, Wikimedia da sauransu.
A gaba, CRT na aiki don kafa shafi a kan Meta-Wiki don samar da sarari ga al'umma don saka idanu kan tasirin da kuma bin hanyoyinmu na sadarwa tare da su.
Kasancewa a cikin hulɗa game da batutuwan da suka shafi COVID-19
Za mu aika gayyata zuwa kalandarku na ranar Alhamis mai zuwa, 14:00 UTC/07:00 PT don taron ma'aikata na musamman.
Za mu yi amfani da wannan lokacin don raba ƙarin sabuntawa, amsa tambayoyinku kuma mu ciyar da lokaci don haɗuwa da juna.
Muna cikin wannan tare kuma muna nan don taimakawa yadda za mu iya.
A halin yanzu, za ka iya ci gaba da samun bayanai daga wannan imel ɗin, da duk sauran mahimman bayanai masu alaƙa da COVID-19, a kan Office Wiki.
Cibiyar CRT za ta ci gaba da sabunta waɗannan shafuka da duk bayanan a wuri ɗaya.
Muna kuma aiki don mu ci gaba da sadarwa da ma'aikatan da ke zama a ƙasashen da ake fama da cutar sosai.
Idan kana da wasu tambayoyi game da tafiya, abubuwan da suka faru, babban aiki, ko kalubale a cikin ɗaukar hoto, ko wani abu da za ka iya bukatar taimako da shi, don Allah kada ka yi shakka a sanar da kuma aiki tare da CRT.
Muna nan don taimakawa wajen samar da tallafi da kuma tuntuɓar idan ya cancanta.
Idan kana da wani abu mai sirri ko mai mahimmanci, don Allah aika imel zuwa Bryan Judan - Daraktan HR International Global Operations.
Bai kamata mu ɗauki waɗannan canje-canjen a matsayin barin aikinmu da kuma ayyukanmu ba.
Maimakon haka, sun nuna cewa a wannan lokacin, aikinmu da kuma hakkinmu za su bukaci su daidaita a hanyar da ba mu taɓa yi ba a dā.
Waɗannan su ne matakan da muke ganin wajibi ne don tallafa wa juna domin mu ci gaba da aiki, mu ba da motsinmu da goyon bayan da suke bukata, da kuma duniya da sabis ɗin da suke dogara da shi.
Aikin da muka shirya zai kasance yana jiranmu a lokacin da lokaci ya yi.
A yanzu, lokaci ya yi da za mu tallafa wa juna kuma mu ba da sarari don aikin da za a yi a makonni da wata-wata.
Muna bukatar ku duka ku sa hakan ya faru, don haka muna bukatar ku kula da kanku da iyalanku domin ku kasance cikin mafi kyau a lokacin da ake bukatar hakan.
Yanzu, don Allah - wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da sauran ƙungiyar jagoranci (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
b' Angiotensin- mai canza enzyme 2 (ACE2) wani enzyme ne da aka haɗa zuwa farfajiyar waje (ƙwayoyin sel) na ƙwayoyin a cikin huhu, jijiyoyi, zuciya, koda, da hanji.
ACE2 yana hana aikin enzymes da ke canza angiotensin (ACE) ta hanyar rage adadin angiotensin-II da haɓaka Ang(1-7) yana mai da shi kyakkyawan magani don magance cututtukan zuciya.ACE2 kuma yana aiki a matsayin hanyar shiga cikin sel don wasu ƙwayoyin coronaviruses.
Ana kiran sigar mutum na enzyme hACE2.
Angiotensin- mai canza enzyme 2 wani zinc ne wanda ya ƙunshi metalloenzyme wanda ke located a farfajiya na endothelial da sauran kwayoyin.
Protein ACE2 ya ƙunshi yankin N-terminal peptidase M2 da kuma yankin C-terminal collectrin renal amino acid transporter.
ACE2 shine furotin membrane mai wucewa guda ɗaya na nau'in I, tare da yankin enzymatically mai aiki a farfajiya na ƙwayoyin a cikin huhu da sauran kayan.
Ƙaramar ƙwayoyin halitta na ACE2 ta rabu da yankin transmembrane ta wani enzyme da aka sani da sheddase, kuma an saki furotin mai narkewa a cikin jini kuma a ƙarshe an fitar da shi cikin fitsari.
ACE2 yana cikin mafi yawan kwayoyin: ACE2 yana haɗe da membrane na ƙwayoyin cuta na ƙwayoyin cuta na huhu na II, ƙwayoyin enterocytes na ƙananan hanji, ƙwayoyin endothelial na jijiyoyin jini da na jini da ƙwayoyin jijiyoyin jini a mafi yawan kwayoyin.
Hakanan ana samun bayyanar ACE2 mRNA a cikin ƙwaƙwalwar ƙwaƙwalwa, striatum, hypothalamus, da ƙwaƙwalwar ƙwaƙwalwa.
Babban aikin ACE2 shine ya zama mai daidaitawa ga ACE.
ACE ta raba hormone na angiotensin I zuwa cikin angiotensin II mai hana jini.
ACE2 kuma ya raba carboxyl- terminal amino acid phenylalanine daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma ya hydrolyses shi zuwa vasodilator angiotensin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 kuma zai iya raba wasu wasu peptides ciki har da [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, da ghrelin.
ACE2 kuma yana daidaita safarar membrane na mai ɗaukar amino acid SLC6A19 kuma an haɗa shi da cutar Hartnup.
A matsayin furotin na transmembrane, ACE2 yana aiki a matsayin babban wurin shiga cikin sel don wasu ƙwayoyin cuta, gami da HCoV-NL63; SARS-CoV (ƙwayoyin cuta da ke haifar da SARS); da SARS-CoV-2 (ƙwayoyin cuta da ke haifar da COVID-19).
Musamman, ɗaurewar furotin S1 na SARS-CoV da SARS-CoV2 zuwa yankin enzymatic na ACE2 a saman sel yana haifar da endocytosis da kuma canzawar duka kwayar cutar da enzyme zuwa endosomes da ke cikin sel.
Wannan tsari na shigarwa kuma yana buƙatar ƙaddamar da furotin S ta hanyar protease serine TMPRSS2, wanda a halin yanzu ana binciken hana shi a matsayin magani mai yuwuwa. Wannan ya haifar da wasu su yi tunanin cewa rage matakan ACE2, a cikin kwayoyin halitta, na iya taimakawa wajen yaki da kamuwa da cuta.
Duk da haka, kungiyoyi da hukumomi masu yawa sun bada shawarar ci gaba da maganin ACE da ARB.
"Binciken tsarin da kuma meta-bincike da aka buga a ranar 11 ga Yuli, 2012, ya gano cewa ""amfani da masu hana ACE an danganta shi da raguwa mai mahimmanci na 34% na haɗarin cutar huhu idan aka kwatanta da masu kula. """
"Bugu da kari, "hadarin kamuwa da cutar huhu ya rage a cikin marasa lafiya da aka yi musu maganin ACE wanda ke da hadarin kamuwa da cutar huhu, musamman wadanda ke fama da bugun jini da rashin karfin zuciya".
" Amfani da masu hana ACE an kuma danganta shi da rage yawan mutuwar da ke tattare da cutar huhu, ko da yake sakamakon bai kasance mai ƙarfi ba fiye da haɗarin kamuwa da cutar huhu gaba ɗaya. "
Ana zaton ACE2 na mutum mai sake haɗuwa (rhACE2) sabon magani ne don raunin huhu mai tsanani, kuma ya bayyana ya inganta haemodynamics na huhu da satar oxygen a cikin aladu da ke da cututtukan cututtukan numfashi mai tsanani da lipopolysaccharide ya haifar.
Rashin rabi na rhACE2 a cikin mutane yana da kimanin sa'o'i 10 kuma fara aikinsa na minti 30 ban da tsawon sa'o'i 24.
Wasu binciken sun nuna cewa rhACE2 na iya zama magani mai ban sha'awa ga waɗanda ke fama da rashin haƙuri ga masu hana tsarin renin-angiotensin na gargajiya (RAS inhibitors) ko kuma a cikin cututtuka inda angiotensin II da ke yawo ya karu. An kimanta rhACE2 da aka yi amfani da shi a cikin gwaji na asibiti don maganin cututtukan shan numfashi na gaggawa.
"B'COVID-19 apps aikace-aikacen software ne na wayar hannu waɗanda aka tsara don taimakawa bin diddigin lamba a cikin martani ga annobar coronavirus ta 2019-20, watau tsarin gano mutane (""taɗi"") waɗanda na iya kasancewa suna hulɗa da mutum mai kamuwa da cutar. "
An yi amfani da aikace-aikace da yawa ko kuma an gabatar da su, tare da goyon bayan gwamnati a wasu yankuna da hukumomi.
An kirkiro wasu tsarin don gina aikace-aikacen bin diddigin lambobin sadarwa.
An yi ta da hankali kan batun tsare sirri, musamman game da tsarin da ke bisa bin diddigin wurin da masu amfani da app suke.
Sauran hanyoyin da ba su da wuya su haɗa da amfani da siginar Bluetooth don yin rikodin kusanci na mai amfani da wasu wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa aikin don tallafawa irin waɗannan ƙa'idodin ƙa'idodin Bluetooth kai tsaye cikin tsarin aiki na Android da iOS.
A kasar Sin, gwamnatin kasar Sin, tare da Alipay, ta tura wani app wanda ke ba 'yan ƙasa damar duba ko sun yi hulɗa da mutanen da ke da COVID-19.
Ana amfani da shi a birane sama da 200 na kasar Sin. A Singapore, ana amfani da app mai suna TraceTogether.
"An kirkiro app ɗin ta hanyar ƙungiyar IT ta gida, an saki shi azaman buɗe tushen kuma za a mika shi ga gwamnati. Arewacin Macedonia ta ƙaddamar da ""StopKorona!"", aikace-aikacen da ke kan Bluetooth don bin diddigin abubuwan da ke faruwa da mutanen da ke da cutar da kuma ba da amsa mai sauri ga hukumomin kiwon lafiya. "
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya ne suka kirkiro wannan app din.
A ranar 14 ga Afrilu, 2020, app ɗin yana jiran amincewa daga Google Play Store da Apple App Store.
"A ranar 12 ga Afrilu, gwamnati ta bayyana cewa aikace-aikacen bin diddigin lambobin sadarwa yana cikin ci gaba na ci gaba, kuma zai kasance a shirye don turawa cikin makonni. An shirya shirin kama da wannan a Ireland, da Faransa (""StopCovid""). "
Australia da New Zealand suna la'akari da aikace-aikacen da suka dogara da aikace-aikacen TraceTogether na Singapore da yarjejeniyar BlueTrace. Rasha na da niyyar gabatar da aikace-aikacen geofencing ga marasa lafiya da aka gano suna da COVID-19 da ke zaune a Moscow, wanda aka tsara don tabbatar da cewa ba sa barin gida.
Ross Anderson, farfesa na aikin injiniya na tsaro a Jami'ar Cambridge, ya lissafa wasu matsaloli masu yuwuwa tare da tsarin da ke bisa aikace-aikace, ciki har da kuskuren ƙarya da rashin tasiri idan an iyakance amfani da aikace-aikacen ga ƙananan ɓangare na yawan jama'a.
"Da yake magance damuwar game da yaduwar aikace-aikacen "coronavirus" masu yaudarar ko cutarwa, Apple ya kafa iyakoki kan irin kungiyoyin da za su iya ƙara aikace-aikacen da suka shafi coronavirus zuwa App Store, yana iyakance su ga kawai "masu hukuma" ko kuma wasu kungiyoyi masu daraja. "
Google da Amazon sun aiwatar da irin wannan takunkumi.
Masu fafutukar tsare sirri sun nuna damuwarsu game da tasirin saka idanu na taro ta amfani da aikace-aikacen coronavirus, musamman game da ko za a soke tsarin saka idanu da aka kirkira don magance cutar coronavirus da zarar an wuce barazanar.
Amnesty International da fiye da kungiyoyi 100 sun fitar da wata sanarwa da ke kira ga a iyakance irin wannan sa ido.
Ƙungiyoyin sun bayyana sharuɗɗa takwas game da ayyukan gwamnati:
"Sauye-sauyen zai zama ""doka, dole da kuma daidaita"";
tsawaita ayyukan sa ido da kuma sa ido zai bukaci a yi amfani da sassan faɗuwar rana;
amfani da bayanai zai zama iyakance ga dalilai na COVID-19;
tsaro da kuma rashin sunayen bayanan ya kamata a kare kuma a tabbatar da cewa an kare su bisa hujja;
Dole ne a guji kara nuna bambanci da kuma warewa a kan tsarin kula da dijital;
duk wani raba bayanai da wasu na uku zai zama dole a ayyana shi a cikin doka;
ya kamata a samar da kariya kan cin zarafi da kuma hakkin 'yan kasa na amsawa ga cin zarafi;
"Ana buƙatar halartar ma'ana ta duk "masu ruwa da tsaki masu dacewa", gami da na masana kiwon lafiya na jama'a da ƙungiyoyin da aka ware. Ƙungiyar Kwamfuta ta Jamus ta Chaos (CCC) da 'Yan Jarida ba tare da iyakoki ba (Reporter ohne Grenzen) (RSF) sun kuma fitar da jerin bincike".
Shirin da aka gabatar na Google / Apple yana nufin magance matsalar ci gaba da saka idanu ta hanyar cire tsarin bin diddigin daga tsarin aiki na na'urorin su lokacin da ba a sake buƙatarsa ba.
Wasu ƙasashe sun yi amfani da bin diddigin wuri na hanyar sadarwa maimakon aikace-aikace, suna kawar da buƙatar sauke aikace-aikace da kuma ikon guje wa bin diddigin.
A Isra'ila, an amince da bin diddigin da ke cikin hanyar sadarwa.
Maganin da ke kan hanyar sadarwa wanda ke da damar samun bayanai na wuri na asali yana da manyan matsalolin sirri.
Duk da haka, ba duk tsarin da ke da sabobin tsakiya ba ne ya kamata su sami damar samun bayanan wurin sirri; an kirkiro wasu tsarin kiyaye sirrin da ke amfani da sabobin tsakiya kawai don sadarwa (duba sashin da ke ƙasa).
A Koriya ta Kudu, an yi amfani da tsarin da ba a yi amfani da shi ba don bin diddigin lambobin sadarwa.
Maimakon amfani da aikace-aikacen da aka keɓe, tsarin ya tattara bayanan bin diddigin daga tushe daban-daban ciki har da bayanan bin diddigin wayar hannu da bayanan ma'amala na katin, kuma ya haɗu da waɗannan don samar da sanarwa ta hanyar saƙonnin rubutu ga mutanen da ke da yiwuwar kamuwa da cutar.
Baya ga yin amfani da wannan bayanin don gargadi ga masu tuntuɓar da za su iya tuntuɓarmu, gwamnati ta kuma ba da bayanin wurin a fili, wani abu da aka ba da izini saboda canje-canje masu yawa a dokokin tsare sirri na bayanai bayan barkewar cutar MERS a wannan ƙasar.
Ana samun wannan bayanin ga jama'a ta hanyar wasu aikace-aikace da shafukan yanar gizo. Kasashe ciki har da Jamus sun yi la'akari da amfani da tsarin da aka tsara da kuma kiyaye sirrin sirri.
A ranar 6 ga Afrilu, 2020, har yanzu ba a bayyana cikakkun bayanai ba.
Kula da bayanan sirri na tuntuɓar sirri ra'ayi ne mai kyau, tare da babban tarin wallafe-wallafen bincike wanda ya fara zuwa aƙalla 2013. Daga ranar 7 ga Afrilu, 2020, ƙungiyoyin masana sama da goma suna aiki akan hanyoyin da ke da alaƙa da sirrin sirri, kamar amfani da Bluetooth Low Energy (BLE) don yin rikodin kusanci mai amfani da wasu wayoyin salula.
Duk da haka, PEPP-PT wani aiki ne na daidaitawa wanda ya ƙunshi hanyoyin da aka daidaita da na rarraba, kuma ba yarjejeniya guda ɗaya ba.Tsarin da aka rarraba ya haɗa da bin diddigin kusanci na tsare sirri na tsare sirri (DP-PPT/DP-3T), Lambar lamba ta wucin gadi (TCN, fka Lambar taron tuntuɓar, CEN), Litattafan sirri masu mahimmanci da kuma hanyoyin bin diddigin tuntuɓar wayar hannu (PACT) da sauransu.
A cikin wadannan yarjejeniyoyi, bayanan sirri da za a iya ganowa ba su taɓa barin na'urar ba, kuma duk daidaitawa yana faruwa a na'urar.
Ƙungiyar Sirri a MIT Media Lab ta kasance tana haɓaka SafePaths, dandamali don amfani da fasahohin kiyaye sirrin lokacin tattarawa da amfani da bayanan wuri ko hanyar haɗuwa don bin diddigin yaduwar COVID-19.
"An kafa shi ne bisa binciken da aka samu a cikin takarda mai suna ""Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic"" da aka fitar a watan Maris na 2020. Wani irin wannan aikin shi ne dandamali na SafeTrace na Enigma MPC, wani kamfani da ke bunkasa fasahar tsare sirri wanda aka kafa a MIT Media Lab. "
SafeTrace yana amfani da fasahar kayan aiki masu aminci don bawa masu amfani damar raba bayanan wuri da lafiyar masu mahimmanci tare da sauran masu amfani da jami'ai, ba tare da yin hadari da sirrin waɗannan bayanan ba.
A ranar 5 ga Afrilu, 2020, ƙungiyoyin da suka haɗu a kusa da abin da ke da mahimmanci iri ɗaya da kuma yarjejeniyoyi da yawa sun haɗu, tare da manufar rage ɓarna, da kuma ba da damar haɗin kai na duniya na bin diddigin da faɗakar da aikace-aikace, babban ɓangare na cimma yaduwar tallafi.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta buɗe tushen yarjejeniyar BlueTrace da aka yi amfani da ita ta hanyar aikace-aikacen gwamnati na hukuma.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa dandamali na wayar hannu na Android da iOS, sun sanar da wani shiri don bin diddigin lamba, wanda suka yi ikirarin zai kiyaye sirrin sirri, bisa haɗuwa da fasahar Bluetooth Low Energy da ɓoye sirrin sirri.
Sun kuma wallafa takaddun da ke nuna fasahar da ake amfani da ita a cikin tsarin.
A cewar Apple da Google, ana nufin a fara aiwatar da tsarin a matakai uku:
ƙaddamar da kayan aiki don ba da damar gwamnatoci su ƙirƙiri ƙa'idodin bin diddigin coronavirus na hukuma waɗanda ke kiyaye sirrin mutum
wannan aiki hade kai tsaye a cikin iOS da kuma AndroidGoogle da Apple shirin magance da take-up da kuma m saka idanu matsaloli ta hanyar farko rarraba da tsarin ta hanyar aiki da tsarin updates, da kuma daga baya cire shi a cikin wannan hanya da zarar barazana ta wuce.
b'Sake sake sanya magunguna (wanda aka fi sani da sake amfani da magunguna, sake tsarawa, sake aiki ko sauya aikin magani) shine sake amfani da magani da aka amince da shi don maganin wata cuta ko yanayin likita daban da wanda aka fara samar dashi.
Wannan wani nau'i ne na bincike na kimiyya wanda a halin yanzu ake bi don haɓaka hanyoyin lafiya da inganci na maganin COVID-19.
Sauran hanyoyin bincike sun hada da bunkasa allurar rigakafin COVID-19 da kuma karɓar jini na jini.SARS-CoV-2 yana da sunadarai 66 masu amfani da magani, kowannensu yana da wuraren ɗaure ligand da yawa.
Binciken waɗannan wuraren ɗaurewa suna ba da kyakkyawan shiri na haɓaka ingantaccen maganin rigakafin cutar kan furotin COVID-19.
Daga cikin mahimman furotin na SARS-CoV-2 sune protease mai kama da papain, RNA mai dogaro da RNA polymerase, helicase, furotin S, da ADP ribophosphatase.
Hussein A, et al sun yi nazarin wasu magungunan masu neman neman shiga wanda daga bisani suka inganta kuma suka bincika kamaninsu na kasusuwa tare da magungunan da aka amince da su mafi girma don hanzarta haɓaka magungunan rigakafin SARS-CoV-2 mai ƙarfi a cikin binciken sa na farko don a ba da shawarar a cikin ƙirar binciken asibiti.
Chloroquine magani ne na yaki da zazzabin cizon sauro da kuma maganin da ake amfani da shi wajen magance wasu cututtuka masu hana kamuwa da cuta.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine da ke da nasaba zai kasance cikin magunguna huɗu da aka yi nazari a matsayin wani ɓangare na gwajin asibiti na Solidarity.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin jihar New York na chloroquine da hydroxychloroquine zai fara a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate a ƙarƙashin Izinin Amfani da Gaggawa (EUA).
Ba a amince da maganin ba ta hanyar gwajin gwaji na FDA kuma an ba da izinin a ƙarƙashin EUA kawai a matsayin magani na gwaji don amfani da gaggawa a cikin marasa lafiya waɗanda ke asibiti amma ba za su iya karɓar magani a cikin gwajin asibiti ba.
"CCDC ta ce ""amfani, sashi, ko tsawon lokacin hydroxychloroquine don rigakafi ko magani na kamuwa da cutar SARS-CoV-2"" ba a riga an kafa ba. "
" Likitoci sun ce suna amfani da miyagun ƙwayoyi lokacin da "babu wani zaɓi".
Wani rukuni na bincike na Turkiyya a Istanbul na gudanar da karamin bincike kan amfani da chloroquine a hade da zinc, bitamin A, bitamin C da bitamin D.
Akwai manyan bincike a Jami'ar Duke da Jami'ar Oxford.
Makarantar Likitancin NYU Langone tana gudanar da gwaji kan aminci da ingancin amfani da hydroxychloroquine a hanyar rigakafi.
"Tunanin asibiti na kasar Sin a Wuhan da Shenzhen sun nuna cewa favipiravir yana da "ainihin tasiri".
35 marasa lafiya a Shenzhen sun samu mummunan sakamako a matsakaici na kwanaki 4, yayin da tsawon rashin lafiya ya kasance kwanaki 11 a cikin marasa lafiya 45 da ba su karɓa ba.
A cikin binciken da aka gudanar a Wuhan a kan marasa lafiya 240 da ke fama da cutar huhu, rabin sun karɓi favipiravir kuma rabin sun karɓi umifenovir.
Hukumar Magunguna ta Italiya ta tunatar da jama'a cewa shaidun da ke akwai don tallafawa miyagun ƙwayoyi ba su da yawa kuma na farko.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don ajiyarta, kuma ta yi amfani da sojoji don isar da maganin zuwa asibitocin jami'a, inda za a yi amfani da maganin don magance marasa lafiya na COVID-19.
A cewar jaridar South China Morning Post, Shinzo Abe ya yi wa gwamnatin Trump shawarwari game da sayen maganin. Maganin na iya zama ba shi da tasiri a cikin matsanancin yanayin rashin lafiya inda cutar ta riga ta ninka.
Wataƙila mata masu ciki ko waɗanda suke ƙoƙarin yin ciki ba za su iya amfani da shi ba.
"Daya binciken lopinavir / ritonavir (Kaletra), haɗuwa da maganin rigakafin lopinavir da ritonavir, ya kammala cewa ""ba a lura da amfani ba". "
An tsara miyagun ƙwayoyi don hana kwayar cutar HIV ta hanyar ɗaurewa da protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado na ƙoƙarin canza magungunan don nemo wani fili wanda zai haɗu da protease na SARS-CoV-2. Akwai zargi a cikin ƙungiyar kimiyya game da tura albarkatu don sake amfani da magungunan da aka haɓaka musamman don HIV / AIDS.
WHO ta hada lopinavir/ritonavir a cikin gwajin Solidarity na kasa da kasa.
Gilead Sciences ta kirkiro Remdesivir kuma ta haɓaka shi azaman magani don cutar Ebola da kamuwa da cutar Marburg . Gilead Sciences daga baya ta gano cewa Remdesivir yana da aikin antiviral in vitro akan kwayoyin cutar filo-, pneumonia-, paramyxo- da corona- viruses da yawa .
Wata matsala da ake fuskanta a maganin rigakafi ita ce ci gaban rashin ƙarfi ta hanyar canji da zai iya haifar da ciwo mai tsanani da kuma yaduwar.
Wasu nazarin da aka yi kafin a fara gwaji sun nuna cewa remdesivir na iya samun babban shinge na kwayoyin halitta ga juriya. Akwai gwaje-gwaje na asibiti da yawa a kan hanya, ciki har da biyu da Asibitocin Jami'ar Cleveland suka gudanar; daya ga mutanen da ke da rashin lafiya mai matsakaici da kuma wani ga waɗanda ke da rashin lafiya mai tsanani.
Akwai gwaje-gwaje uku na asibiti na bitamin C na intravenous don mutanen da ke asibiti da kuma rashin lafiya mai tsanani tare da COVID-19; biyu suna sarrafawa da placebo (China, Kanada) da ɗaya ba tare da iko ba (Italiya).
Jihar New York ta fara gwaji don maganin maganin azithromycin a ranar 24 ga Maris 2020.
Cibiyar Kula da Lafiya da Magunguna ta Duniya ta Japan (NCGM) tana shirin yin gwaji na asibiti don Alvesco na Teijin (ciclesonide), wani corticosteroid da aka numfasa don asma, don kula da marasa lafiya masu alamun bayyanar cututtuka da suka kamu da sabon coronavirus.
Wani nau'i na enzymes mai canza angiotensin 2, wani gwaji na Phase II yana gudana tare da marasa lafiya 200 da za a karɓa daga matsananciyar, asibitoci masu asibiti a Denmark, Jamus, da Austria don sanin tasirin magani.
Masu bincike daga Cibiyar Zuciya ta Montreal a Kanada a halin yanzu suna nazarin rawar colchicine a rage kumburi da rikitarwa na huhu a cikin marasa lafiya da ke fama da alamun bayyanar cututtukan COVID-19.
Binciken, mai suna COLCORONA, yana daukar manya 6000 masu shekaru 40 zuwa sama waɗanda aka gano su da COVID-19 kuma suna fuskantar alamun bayyanar cututtuka marasa nauyi waɗanda ba sa buƙatar asibiti.
Mata masu ciki ko masu shayarwa ko kuma waɗanda ba su da wata hanyar hana haihuwa mai inganci ba sun cancanta.
Ana gwada wasu magungunan rigakafi a Italiya.
Ana amfani da heparin mai ƙarancin nauyin kwayoyin don magance marasa lafiya, wanda ya sa Hukumar Magunguna ta Italiya ta wallafa jagororin amfani da shi.
An sanar da wani bincike mai yawa a kan marasa lafiya 300 da ke nazarin amfani da sodium enoxaparin a maganin rigakafi da kuma maganin maganin rigakafi a Italiya a ranar 14 ga Afrilu.
Tunda SARS-CoV-2 kwayar cuta ce, an mai da hankali sosai ga ilimin kimiyya kan sake amfani da magungunan rigakafin cutar da aka amince da su waɗanda aka haɓaka don barkewar cutar kamar MERS, SARS, da cutar West Nile.
Ribavirin: an ba da shawarar ribavirin don maganin COVID-19 bisa ga ƙa'idodin fitowar 7 na kasar Sin
Umifenovir: an ba da shawarar umifenovir don maganin COVID-19 bisa ga ƙa'idodin fitowar 7 na kasar Sin
Wasu kwayoyin rigakafi da aka gano cewa suna iya sake amfani da su a matsayin maganin COVID-19:
Tocilizumab (mai karɓar anti- IL-6): An amince da shi a China.
Hakanan gwaji a Italiya da China. da kuma duba Tocilizumab#COVID-19.
allurar rigakafin COVID-19 allurar rigakafin cutar coronavirus 2019 (COVID-19) ce.
Ko da yake babu wani maganin da ya kammala gwajin asibiti, ana ƙoƙari da yawa a ci gaba don samar da irin wannan maganin.
A ƙarshen Fabrairu 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin allurar rigakafin SARS-CoV-2, kwayar cutar da ke haifar da cutar, za ta kasance cikin ƙasa da watanni 18.
Masu neman rigakafin guda biyar sun shiga binciken tsaro na Phase I a watan Afrilu.
An gano COVID-19 a watan Disamba na 2019.
Wani babban annobar da ya bazu a duniya a shekarar 2020, wanda ya haifar da saka hannun jari mai yawa da ayyukan bincike don haɓaka allurar rigakafi.
Kungiyoyi da yawa suna amfani da kwayoyin halitta da aka buga don haɓaka alluran rigakafin SARS-CoV-2.
A watan Afrilu, an bayyana cewa, abubuwan da ake bukata na shirin CEPI don bunkasa allurar rigakafi sune saurin, ƙarfin samarwa, turawa a sikelin, da samun damar duniya.
A watan Afrilu, masana kimiyyar CEPI sun ba da rahoton cewa dandamali daban-daban na fasaha 10 suna cikin bincike da ci gaba a farkon 2020 don ƙirƙirar allurar rigakafin COVID-19.
Babban manufofin dandamali da aka ci gaba a cikin nazarin aminci na Phase I sun haɗa da:
nucleic acid (DNA da RNA) (mai haɓaka mataki na I da mai neman allurar rigakafi: Moderna, mRNA-1273)
mai ɗaukar hoto (mai haɓaka mataki na 1 da mai neman allurar rigakafi: CanSino Biologics, mai ɗaukar hoto na adenovirus nau'in 5)
Kamar yadda masana kimiyya na CEPI suka ruwaito a watan Afrilu, jimlar masu neman allurar rigakafi 115 suna cikin matakan farko na ci gaba, tare da 78 da aka tabbatar a matsayin ayyukan aiki (79, a cewar Cibiyar Milken), da kuma 37 da aka sanar, amma tare da karancin bayanan jama'a da ke samuwa (ana zaton suna cikin shiri ko tsarawa).
Gwajin Phase I-II yana gudanar da gwajin farko na aminci da rigakafi, yawanci ana yin saurin, ana sarrafa shi da placebo, kuma a wurare da yawa, yayin da ake tantance ƙarin madaidaicin, ingantattun allurai.
Gwaje-gwaje na III yawanci sun shafi ƙarin mahalarta, ciki har da ƙungiyar kulawa, da kuma gwajin tasirin allurar rigakafi don hana cutar, yayin da ake lura da sakamako masu illa a mafi kyawun sashi.
"Daga cikin 'yan takarar allurar rigakafi 79 da ke ci gaba da aiki (wanda aka tabbatar a farkon Afrilu 2020), 74 ba su kasance cikin kimantawar ɗan adam ba tukuna (har yanzu suna cikin binciken "kwararrun" bincike). "
A ranar 24 ga Janairu, 2020 a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana binciken yiwuwar allurar rigakafin kwayar cuta ta kwayoyin halitta wanda zai canza kwayoyin cutar ta kwayoyin halitta don motsawar rigakafin.
A ranar 24 ga Janairu, 2020 a Kanada, Cibiyar Hoto ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da fara aikin allurar rigakafi, da nufin fara gwajin mutum a 2021.
An sanar da ayyukan ci gaban allurar rigakafi a Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta kasar Sin a ranar 26 ga Janairu, 2020, da Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, Kamfanonin Magunguna na Janssen, karkashin Hanneke Schuitemaker, sun sanar da cewa sun fara aiki kan samar da allurar rigakafi.
Janssen na hada hannu wajen samar da allurar rigakafi ta baki tare da abokin aikinta na biotechnology, Vaxart.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwa na masana'antu tare da Vaxart don haɓaka allurar.
Ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje OncoGen a Romania ya wallafa takarda kan tsara allurar rigakafi da ke da irin wannan fasaha da ake amfani da ita wajen maganin rigakafin cutar kansa da neoantigen.
A ranar 25 ga Maris shugaban cibiyar bincike ya sanar da cewa sun kammala hada-hadar allurar rigakafi kuma suna fara gwajin.
A ranar 27 ga Fabrairu, 2020, wani kamfanin mallakar Generex, NuGenerex Immuno-Oncology, ya sanar da cewa suna fara aikin allurar rigakafi don ƙirƙirar allurar peptide mai mahimmanci na Ii-Key da ke adawa da COVID-19.
"Suna son samar da takarar allurar rigakafi wanda za'a iya gwada shi a kan mutane ""a cikin kwanaki 90".
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da ayyukanta na haɓaka allurar rigakafi.
A ranar 5 ga Maris, 2020, Rundunar Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula
A kusan 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta haɗu da Novavax Inc.
a wajen samar da kuma samar da allurar rigakafi.
A baya, abokan hulɗa sun sanar da shirye-shiryen gwajin gwaji na farko da gwajin gwaji na farko zuwa Yuli 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki tare da masu keɓewa 11, kuma ko da a hanya mai sauri zai ɗauki aƙalla kimanin shekara ɗaya da rabi zuwa shekaru biyu don haɓaka allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, kamfanin kere kere na kere kere a birnin Quebec, Quebec, ya ba da rahoton ci gaban wani abu mai kama da coronavirus a karkashin wani ɓangare na kudaden da Cibiyoyin Nazarin Lafiya na Kanada suka bayar.
Mai neman allurar rigakafi yana cikin binciken dakin gwaje-gwaje, tare da gwajin mutum da aka shirya a watan Yuli ko Agusta 2020.
"A farkon wannan makon, jaridar The Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba da kyautar CureVac ""'babban kuɗi' don samun damar yin amfani da allurar rigakafin COVID-19"", wanda gwamnatin Jamus ta yi zanga-zanga a kai".
A ranar 17 ga Maris, 2020, kamfanin magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɗin gwiwa don haɓaka allurar rigakafin da ke kan mRNA.
BNT162 mai neman allurar rigakafi mai tushen mRNA, a halin yanzu yana cikin gwajin farko na asibiti tare da gwajin asibiti wanda ake sa ran farawa a watan Afrilu 2020.
A Italiya a ranar 17 ga Maris 2020, Takis Biotech, kamfanin kimiyyar halittu na Italiya ya sanar da cewa za su sami sakamakon gwajin gwaji na farko a watan Afrilu na 2020 kuma ɗan takararsu na ƙarshe na allurar zai iya fara gwajin mutum a cikin kaka.
A Faransa a ranar 19 ga Maris, 2020, Coalition for Epidemic Preparedness Innovations (CEPI) ta ba da sanarwar saka hannun jari na dala miliyan 4.9 a cikin ƙungiyar bincike kan allurar rigakafin COVID-19 da ta haɗa da Institut Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, wanda ya kawo jimlar saka hannun jari na CEPI a cikin haɓaka allurar rigakafin COVID-19 zuwa dala miliyan 29.
Sauran abokan haɗin gwiwar CEPI don haɓaka allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi na masu neman allurar rigakafi daban-daban shida.
Masu binciken Kwalejin Imperial ta London sun sanar a ranar 20 ga Maris 2020 cewa suna haɓaka allurar rigakafin RNA mai haɓaka kanta don COVID-19.
An kirkiro takarar allurar a cikin kwanaki 14 bayan karbar jerin daga kasar Sin.
A ƙarshen Maris, gwamnatin Kanada ta ba da sanarwar dala miliyan 275 a cikin tallafin don ayyukan bincike 96 kan matakan likita na rigakafin COVID-19, gami da masu neman allurar rigakafi da yawa a kamfanonin Kanada da jami'o'i, kamar shirin Medicago da Jami'ar Saskatchewan.
"A daidai wannan lokacin, gwamnatin Kanada ta sanar da dala miliyan 192 musamman don haɓaka allurar rigakafin COVID-19, tare da shirye-shiryen kafa "bank din allurar rigakafi" na ƙasa na sabbin alluran rigakafi da yawa waɗanda za a iya amfani da su idan wani barkewar cutar coronavirus ya faru".
"A ranar 2 ga Afrilu, 2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun ba da rahoton gwajin PittCoVacc, yiwuwar allurar rigakafin COVID-19 a cikin beraye, suna mai cewa ""MNA ta ba da allurar SARS-CoV-2 S1 subunit wanda ya haifar da ƙarfin maganin rigakafin antigen-da keɓaɓɓen antibody [a cikin berayen] wanda ya bayyana a bayyane farawa makonni 2 bayan rigakafi. """
A Kanada a ranar 16 ga Afrilu, 2020, Jami'ar Waterloo School of Pharmacy ta sanar da ƙirar takarar allurar rigakafin da ke kan DNA a matsayin yiwuwar fesa hanci.
Ta amfani da kwayoyin cuta, za a tsara DNA don sake fasalin kwayoyin cikin kwayoyin mutum don samar da ƙwayoyin cuta marasa lahani, wanda zai iya motsa tsarin garkuwar jiki don samar da rigakafi akan cutar SARS-CoV-2.
A watan Maris na 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun haɗa albarkatu don samun damar kwamfutocin super na IBM, haɗe tare da albarkatun ƙididdigar girgije daga Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu alluran rigakafi suna da sakamako iri iri, wanda ake kira sakamako marar musamman.
Hakan yana nufin cewa za su iya samun amfanin da ya wuce na cutar da suke hanawa.
Wani gwaji na bazuwar a Ostiraliya yana neman shiga ma'aikatan kiwon lafiya 4,170.
Yana yiwuwa alluran rigakafi da ake ci gaba da samarwa ba za su kasance masu aminci ko tasiri ba.
Bincike na farko don kimanta tasirin allurar rigakafi ta amfani da samfuran dabbobi na musamman na COVID-19, kamar linzamin kwamfuta na ACE2, sauran dabbobi na dakin gwaje-gwaje, da primates ba na mutum ba, sun nuna buƙatar matakan hana kariya na matakin 3 na lafiyar jiki don sarrafa ƙwayoyin cuta masu rai, da daidaitaccen haɗin gwiwar ƙasa da ƙasa don tabbatar da daidaitattun hanyoyin aminci.
An gwada alluran rigakafin SARS da MERS a kan dabbobi ba na mutum ba.
A shekarar 2020, babu magani ko rigakafin kariya ga SARS wanda aka tabbatar da cewa yana da aminci da tasiri a cikin mutane.
A cewar takardun bincike da aka buga a 2005 da 2006, ganowa da kuma bunkasa sabbin alluran rigakafi da magunguna don magance SARS ya kasance fifiko ga gwamnatoci da hukumomin kiwon lafiyar jama'a a duniya.
Lokacin da MERS ta zama sananne, an yi imanin cewa binciken SARS na yanzu na iya samar da samfurin mai amfani don haɓaka alluran rigakafi da magunguna game da kamuwa da cutar MERS-CoV.
Ya zuwa watan Maris na 2020, akwai allurar rigakafin MERS guda ɗaya (wanda ya dogara da DNA) wanda ya kammala gwajin asibiti na lokaci na I a cikin mutane, da wasu uku a cikin tsari, dukansu alluran rigakafin da ke da ƙwayar cuta, biyu adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac), da kuma ɗaya MVA-vectored (MVA-MERS-S).
Sakonnin kafofin sada zumunta sun inganta ka'idar makirci da ke cewa an san cutar da ke bayan COVID-19 kuma riga an sami allurar rigakafi.
Takaddun shaida da kafofin watsa labarun daban-daban suka ambata sun yi nuni ga takaddun shaida na asali da kuma alluran rigakafi don sauran nau'ikan coronavirus kamar SARS coronavirus.
b'Cutar Coronavirus 2019 (COVID-19) cuta ce mai yaduwa da cutar ta coronavirus 2 (SARS-CoV-2) ta haifar.
Abubuwan da ake gani a yau sun ƙunshi zazzabi, tari, da kuma numfashi.
Wasu cututtuka sun haɗa da gajiya, ciwon tsoka, fitsari, ciwon wuya, rashin wari, da kuma ciwon ciki.
Lokaci daga bayyanar cututtuka zuwa bayyanar cututtuka yawanci yana da kwanaki biyar amma zai iya kasancewa daga kwana biyu zuwa goma sha huɗu.
Ko da yake yawancin cututtuka suna haifar da bayyanar cututtuka masu sauƙi, wasu suna ci gaba zuwa ciwon huhu na kwayar cuta da kuma rashin aiki na gabobin jiki.
Ya zuwa ranar 17 ga Afrilu, 2020, an ba da rahoton fiye da miliyan 2.24 na kamuwa da cutar a cikin ƙasashe da yankuna 210, wanda ya haifar da mutuwar sama da 153,000.
Fiye da mutane 568,000 sun warke. Kwayar cutar tana yadawa tsakanin mutane ne a lokacin da suka yi hulɗa da juna, sau da yawa ta hanyar ƙananan saukad da ke fitowa ta hanyar tari, cizon yatsa, ko magana.
Ko da yake ana yin waɗannan saukad da a lokacin da ake numfashi, yawanci suna fāɗuwa ƙasa ko kuma a kan farfajiya maimakon su zama masu kamuwa da cuta a nesa.
Mutane kuma suna iya kamuwa da cutar ta wurin taɓa wani abu da ya gurɓata kuma su taɓa idanunsu da hancinsu da bakinsu.
Kwayar cutar za ta iya tsira a kan farfajiya har zuwa awanni 72.
Yana da matukar yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, ko da yake yaduwar na iya faruwa kafin bayyanar cututtuka da kuma a cikin matakan cutar. Hanyar ganewar asali ta yau da kullum ita ce ta hanyar juyawa na polymerase na rikodi na lokaci na ainihi (rRT-PCR) daga swab na nasopharyngeal.
Ana ba da shawarar yin amfani da abin rufe fuska ga waɗanda suke zargin cewa suna da cutar da kuma masu kula da su.
Shawarwarin da jama'a ke bayarwa game da yin amfani da abin rufe fuska sun bambanta, wasu hukumomi suna ba da shawarar yin amfani da su, wasu suna ba da shawarar yin amfani da su, wasu kuma suna buƙatar yin amfani da su.
A halin yanzu, babu allurar rigakafi ko takamaiman maganin rigakafin cutar COVID-19.
An samu karuwar cutar a cikin gida a mafi yawan ƙasashe a duk yankuna shida na WHO.
Waɗanda suka kamu da cutar za su iya samun cututtuka marasa kyau ko kuma su sami alamun da suke kama da mura kamar zazzabi, tari, gajiya, da kuma rashin numfashi.
Alamomin gaggawa sun haɗa da wahalar numfashi, ciwo ko matsa lamba a kirji, rikicewa, wahalar farkawa, da kuma fuska ko lebe mai launin shuɗi; ana ba da shawara a nemi likita nan da nan idan waɗannan alamun sun kasance.
Ba sau da yawa, ana iya ganin alamun jijiyoyin numfashi kamar sneezing, hanci mai gudana ko ciwon wuya.
An lura da cututtukan ciki kamar nausy, kumburi da fitsari a cikin kashi daban-daban.
Da farko, wasu mutane a ƙasar Sin sun yi fama da ciwon kirji da kuma bugun zuciya.
A wasu, cutar tana iya zama ciwon huhu, rashin aiki a gabobin jiki da kuma mutuwa.
Wannan lokaci ne da ake kira lokacin yin amfani da kwayoyin halitta.
Lokacin incubacin COVID-19 yawanci kwanaki biyar zuwa shida ne amma na iya kasancewa daga kwana biyu zuwa 14.
Kashi 97.5% na mutanen da suka kamu da cututtuka za su yi hakan a cikin kwanaki 11.5 na kamuwa da cutar. Rahotanni sun nuna cewa ba duk waɗanda suka kamu da cutar suke kamuwa da cututtuka ba.
Ba a san cikakken matsayin wadannan masu dauke da cututtuka ba a watsa su; duk da haka, shaidu na farko sun nuna cewa suna iya taimakawa wajen yaduwar cutar.
Kashi na mutanen da suka kamu da cutar da ba su nuna alamun cutar ba a san su ba a halin yanzu kuma ana nazarin su, tare da Cibiyoyin Kula da Cututtuka da Rigakafin Koriya (KCDC) suna ba da rahoton cewa kashi 20% na duk maganganun da aka tabbatar sun kasance marasa alamun cutar yayin da suke asibiti.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara hada da marasa alamun cututtuka a cikin shari'o'in ta yau da kullun a ranar 1 ga Afrilu; daga kamuwa da cuta 166 a wannan ranar, 130 (78%) ba su da alamun cutar a lokacin gwajin.
Ƙura da saliva suna iya ɗauke da manyan ƙwayar cuta.
Yin magana da ƙarfi yana sa a yi ƙarin saukad da fiye da yadda ake yin magana da mutane.
Wani bincike da aka yi a Singapore ya nuna cewa idan mutum ya yi tari ba tare da ya rufe shi ba, zai iya sa ya yi saɓo da ke kai tsawonsa mita 4.5.
Ko da yake cutar ba ta yaduwa ta iska, Cibiyar Kimiyya ta Kasa ta ba da shawarar cewa watsa kwayoyin halitta na iya yiwuwa kuma masu tara iska da aka sanya a cikin hallway a waje da ɗakunan mutane sun ba da samfurori masu kyau don RNA na kwayar cutar.
Wasu hanyoyin likita kamar intubation da kuma karyar zuciya da huhu (CPR) na iya sa a yi aerosol na ɓoyewar numfashi kuma hakan ya haifar da yaduwar iska.
Ko da yake akwai damuwa cewa zai iya yadawa ta hanyar kwayoyin halitta, ana ganin wannan hadarin yana da ƙananan. Kwayar cutar tana da yawa a lokacin da mutane ke da alamun cutar; yayin da yaduwar za ta iya kasancewa kafin bayyanar cututtuka, haɗarin yana da ƙananan.
Cibiyar Tsaro da Sarrafa Cututtuka ta Turai (ECDC) ta ce ko da yake ba a san yadda cutar take yaduwa ba, mutum ɗaya yakan kamu da wasu biyu zuwa uku. Kwayar tana rayuwa na awanni zuwa kwanaki a farfajiya.
Musamman, an gano cewa cutar za a iya gano ta a rana guda a kan kwali, har zuwa kwanaki uku a kan filastik (polypropylene) da bakin karfe (AISI 304), da har zuwa sa'o'i huɗu a kan 99% jan ƙarfe.
Amma, wannan ya bambanta bisa ga yanayin zafi da kuma zafin jiki.
Sabulu da kuma wanke-wanke suna da tasiri idan aka yi amfani da su yadda ya kamata; kayayyakin sabulu suna lalata kitse mai kariya na kwayar cutar, suna kashe ta, da kuma kawar da su daga fata da sauran farfajiyar.
Sauran magunguna, kamar su benzalkonium chloride da chlorhexidine gluconate (mai kashe cututtuka na tiyata), ba su da tasiri sosai.A cikin wani binciken Hong Kong, an dauki samfurori na saliva a matsakaici na kwanaki biyu bayan fara asibiti.
A cikin marasa lafiya biyar daga cikin shida, samfurin farko ya nuna mafi girman nauyin kwayar cutar, kuma mai haƙuri na shida ya nuna mafi girman nauyin kwayar cutar a rana ta biyu da aka gwada.
Cutar coronavirus ta 2 (SARS-CoV-2) sabon cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Dukkanin fasalulluka na sabon kwayar cutar SARS-CoV-2 suna faruwa a cikin ƙwayoyin cuta masu alaƙa a cikin yanayi.
A waje da jikin mutum, sabulu na gida yana kashe kwayar, wanda ke fashe da kumburinta na kariya. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
huhu sune gabobin da COVID-19 ya fi shafa saboda kwayar cutar ta shiga cikin ƙwayoyin mai masaukin baki ta hanyar enzyme angiotensin-converting enzyme 2 (ACE2), wanda ya fi yawa a cikin ƙwayoyin alveolar nau'in II na huhu.
"Cutar ta yi amfani da glycoprotein na musamman da ake kira ""spike"" (peplomer) don haɗi zuwa ACE2 kuma shiga cikin tantanin halitta".
An gano raunin zuciya mai tsanani a cikin kashi 12% na mutanen da suka kamu da cutar da aka kwantar a asibiti a Wuhan, China, kuma ya fi yawa a cikin mummunan cututtuka.
Yawan cututtukan zuciya da jijiyoyin jini suna da yawa, saboda amsawar kumburi na tsarin da kuma rashin lafiyar tsarin rigakafi a lokacin ci gaban cutar, amma raunin myocardial na iya kasancewa da alaƙa da masu karɓar ACE2 a zuciya.
Masu karɓar ACE2 suna da ƙarfi a zuciya kuma suna da hannu a aikin zuciya.
An sami babban adadin cutar thrombosis (31%) da kuma ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta (25%) a cikin marasa lafiya na ICU tare da kamuwa da COVID-19 kuma yana iya kasancewa da alaƙa da mummunan hangen nesa. A cikin binciken da aka yi na mutanen da suka mutu daga COVID-19, an gano lalacewar alveolar (DAD), da kuma ɓarkewar kumburi mai ƙunsar lymphocyte a cikin huhu.
Kodayake SARS-COV-2 yana da yanayin zafi don ƙwayoyin epithelial na hanyar numfashi na ACE2, marasa lafiya da ke da COVID-19 mai tsanani suna da alamun ciwon hanta na tsarin.
Musamman, an nuna cewa kwayoyin T masu haifar da cututtukan GM-CSF suna da alaƙa da karɓar kwayoyin IL-6 masu ɓarna da kuma mummunan cututtukan huhu a cikin marasa lafiya na COVID-19.
An kuma samu rahoton ɓoyewar lymphocytic a lokacin binciken.
Hukumar WHO ta wallafa wasu hanyoyin gwajin cutar.
Hanyar gwaji ta yau da kullum ita ce ainihin lokacin juyawa na poly-transcription chain reaction (rRT-PCR).
Ana yin gwajin ne a kan samfurori na numfashi da aka samu ta hanyar swab na hanci; duk da haka, ana iya amfani da swab na hanci ko samfurin sputum.
A kullum ana samun sakamako a cikin 'yan sa'o'i zuwa kwanaki biyu.
Ana iya yin gwajin jini, amma ana bukatar a ɗauki samfurori biyu na jini da aka yi mako biyu a tsakanin su kuma sakamakon ba shi da muhimmanci sosai.
Masana kimiyya na kasar Sin sun sami damar ware wani nau'in cutar coronavirus da kuma buga jerin kwayoyin halitta don haka dakunan gwaje-gwaje a duk faɗin duniya za su iya haɓaka gwaje-gwajen polymerase chain reaction (PCR) da kansu don gano kamuwa da cutar.
Ya zuwa ranar 4 ga Afrilu, 2020, ana yin gwajin rigakafin jiki (wanda zai iya gano kamuwa da cuta mai aiki da ko mutum ya kamu da cutar a baya) amma har yanzu ba a amfani da shi sosai ba.
Kwarewar kasar Sin ta gwada gwajin ta nuna cewa daidaito ya kai kashi 60 zuwa 70 cikin ɗari ne kawai.
Hukumar kula da abinci ta Amurka ta amince da gwajin farko a ranar 21 ga Maris, 2020 don amfani a ƙarshen wannan watan.Jagororin bincike da Asibitin Zhongnan na Jami'ar Wuhan ya fitar sun ba da shawarar hanyoyin gano kamuwa da cuta bisa ga halaye na asibiti da haɗarin annoba.
Abubuwan da ke cikin gilashin ƙasa na biyu da ke da ƙananan ƙananan, asymmetric da kuma baya suna da yawa a farkon kamuwa da cuta.
Ƙarƙashin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
Akwai bayanai kaɗan game da ƙananan raunuka da kuma ilimin cututtukan cututtukan COVID-19.
Babban binciken cututtuka a lokacin binciken sune:
Macroscopy: pleurisy, pericarditis, kwantar da huhu da kumburi na huhu
Ana iya lura da nau'i hudu na cutar huhu ta kwayar cuta:
cututtukan huhu: cututtukan huhu, hyperplasia na huhu, manyan cututtukan huhu, kumburi na tsakanin jini tare da shigar da lymphocytic da kuma samar da kwayoyin giant mai yawa
mummunan ciwon huhu: lalacewar alveolar (DAD) tare da exudates alveolar diffuse.
DAD shine dalilin ciwon hankula na numfashi mai tsanani (ARDS) da kuma rashin jini mai tsanani.
warkar da cutar huhu: tsarin exudates a cikin rami na alveolar da kuma pulmonary interstitial fibrosis
Jini: yadawa na intravascular coagulation (DIC); maganin leukoerythroblastic
Matakan rigakafi don rage yiwuwar kamuwa da cuta sun haɗa da kasancewa a gida, guje wa wuraren da mutane suke da yawa, wanke hannuwanka da sabulu da ruwa sau da yawa kuma na akalla sakan 20, yin tsabtace numfashi da kuma guje wa taɓa idanu, hanci ko baki da hannayensu marasa wankewa.
Hukumar ta ce a rufe baki da hanci da kayan shafawa idan kana tari ko kuma kana ta yin sneezing kuma a yi amfani da ciki na ƙugu idan babu kayan shafawa.
Ana bukatar tsabtace hannu da kyau bayan ka yi tari ko kuma ka yi cizon yatsa.
CDC ta ba da shawarar yin amfani da suturar rufe fuska a wuraren jama'a, a wani ɓangare don rage watsawa ta mutane marasa alamomi. Dabarun nesa da zamantakewar jama'a suna nufin rage hulɗar masu kamuwa da cuta da manyan ƙungiyoyi ta hanyar rufe makarantu da wuraren aiki, ƙuntata tafiya da soke manyan tarurruka na jama'a.
Ƙa'idodin nesa kuma sun ce mutane su kasance da nesa da juna aƙalla mita 1.8.
"Babu magani da aka sani yana da tasiri wajen hana COVID-19. Kamar yadda ba a tsammanin allurar rigakafi har zuwa 2021 a farkon lokaci, wani muhimmin ɓangare na gudanar da COVID-19 yana ƙoƙarin rage ƙarancin annobar, wanda aka sani da ""flattening the curve"."
Hukumar ta kuma ba da shawarar cewa mutane su wanke hannuwansu da sabulu da ruwa aƙalla na tsawon dakika 20, musamman bayan sun je gidan wanka ko kuma idan hannuwansu sun ƙazantu sosai, kafin su ci abinci da kuma bayan sun busa hanci, sun yi tari ko sun yi ta hakowa.
Ya kuma bada shawarar yin amfani da maganin hana shan giya mai gina jiki wanda ya ƙunshi akalla kashi 60 cikin dari na giya, amma kawai idan sabulu da ruwa ba su da sauƙi. Don yankunan da ba a samun kayan hana hannu na kasuwanci, WHO ta ba da magunguna biyu don samar da gida.
A cikin wadannan magungunan, aikin antimicrobial ya samo asali ne daga ethanol ko isopropanol.
"Ana amfani da hydrogen peroxide don taimakawa kawar da spores na kwayoyin a cikin barasa; ba ""abu ne mai aiki ba don maganin maganin hannayen hannu"."
Ana ƙara glycerol a matsayin mai ƙonawa.
Ana kula da mutane da taimakon da za su iya yi, wanda zai iya haɗa da maganin ruwa, taimakon iskar oxygen, da kuma tallafa wa wasu gabobin da suka shafi rayuwa.
Hukumar ta bada shawarar cewa duk wanda ya yi zargin cewa yana dauke da cutar ya saka abin rufe fuska.
An yi amfani da oxygenation na membrane na waje (ECMO) don magance matsalar rashin numfashi, amma har yanzu ana la'akari da amfaninta.
An ba da shawarar tsabtace mutum da kuma salon rayuwa mai kyau da kuma cin abinci don inganta rigakafi.
Maganin tallafi na iya zama da amfani ga waɗanda ke da alamun bayyanar cututtuka a farkon matakin kamuwa da cuta. WHO da Hukumar Lafiya ta Kasa ta China sun buga shawarwari don kula da mutanen da ke asibiti da COVID-19.
Masu kula da cututtukan jini da kuma likitocin huhu a Amirka sun tattara shawarwarin da hukumomi dabam-dabam suka bayar game da magani a cikin wani littafi mai suna IBCC.
A watan Afrilu na 2020, babu takamaiman magani ga COVID-19.
Don bayyanar cututtuka, wasu likitoci sun bada shawarar paracetamol (acetaminophen) a kan ibuprofen don amfani na farko.
Dole ne a dauki matakan tsaro don rage hadarin kamuwa da cutar, musamman a wuraren kiwon lafiya lokacin da ake gudanar da hanyoyin da za su iya samar da aerosols, kamar intubation ko iska ta hannu.
Ga ƙwararrun likitocin kiwon lafiya da ke kula da mutanen da ke fama da COVID-19, CDC ta ba da shawarar sanya mutumin a cikin dakin keɓewar kamuwa da cutar ta iska (AIIR) ban da amfani da ƙa'idodin tsaro, matakan tsaro na tuntuɓar da matakan tsaro na iska. CDC ta bayyana jagororin amfani da kayan kariya na mutum (PPE) yayin annobar.
Kayan da aka ba da shawarar su ne: rigar PPE, mai numfashi ko abin rufe fuska, kariya ga idanu, da safofin hannu na likita. Lokacin da ake samun su, ana fifita masu numfashi (maimakon abin rufe fuska).
An amince da kayan numfashi na N95 don yanayin masana'antu amma FDA ta ba da izinin amfani da masks a ƙarƙashin Izinin Amfani da Gaggawa (EUA).
An tsara su don kare daga ƙwayoyin iska kamar ƙura amma ba a tabbatar da ingancin su a kan wani takamaiman wakili na halitta don amfani da su ba tare da lakabi ba.
Idan babu abin rufe fuska, CDC ta ba da shawarar yin amfani da rigakafin fuska ko, a matsayin mafita, abin rufe fuska na gida.
Yawancin shari'o'in COVID-19 ba su da tsanani sosai don buƙatar iska ta inji ko madadin, amma kashi ɗaya na shari'o'in suna da.
Ana nazarin nau'in tallafin numfashi ga mutane da ke fama da matsalar numfashi da ke tattare da COVID-19 a cikin asibiti, tare da wasu shaidu cewa ana iya kauce wa intubation tare da babban canula na hanci ko matsin lamba mai kyau na hanyoyi biyu.
Ba a san ko kowanne daga cikin waɗannan abubuwa biyu yana kawo amfanin ɗaya ga waɗanda suke da ciwo mai tsanani ba.
Wasu likitoci sun fi son yin amfani da iska mai iska mai iska idan akwai saboda wannan fasaha ta rage yaduwar ƙwayoyin aerosol idan aka kwatanta da ƙwayoyin hanci masu yawa.
Kasashe da yawa da suka ci gaba ba su da isasshen gadajen asibiti a kan mutum, wanda ke iyakance ikon tsarin kiwon lafiya don magance ƙaruwar kwatsam a cikin adadin masu cutar COVID-19 da ke da tsanani sosai don buƙatar asibiti.
Wani bincike a kasar Sin ya gano cewa kashi 5 cikin 100 ne aka kwantar da su a cikin cibiyoyin kula da marasa lafiya, kashi 2.3 cikin 100 suna bukatar taimakon iska, kuma kashi 1.4 cikin 100 sun mutu.
A China, kimanin kashi 30% na mutanen da ke asibiti da COVID-19 a ƙarshe ana shigar da su cikin ICU.
Hanyoyin iska na inji sun zama masu rikitarwa yayin da cututtukan numfashi na gaggawa (ARDS) suka samo asali a cikin COVID-19 kuma oxygenation ya zama da wahala.
Ana buƙatar masu iska masu iya sarrafa yanayin matsin lamba da kuma babban PEEP don haɓaka isar da iskar oxygen yayin rage haɗarin raunin huhu da pneumothorax da ke tattare da iska.
Mai yiwuwa ba a samu PEEP mai yawa a kan tsofaffin na'urorin numfashi.
An fara bincike kan yiwuwar maganin a watan Janairun 2020, kuma ana gudanar da gwaje-gwaje na asibiti kan magungunan rigakafin cutar da yawa.
Remdesivir ya zama mafi alƙawarin.
Kodayake sababbin magunguna na iya ɗaukar har zuwa 2021 don haɓaka, da yawa daga cikin magungunan da ake gwadawa an riga an amince da su don wasu amfani ko kuma suna cikin gwajin ci gaba.
Ana iya gwada maganin rigakafi a cikin mutanen da ke fama da mummunan cuta.
Hukumar WHO ta bada shawarar cewa masu aikin sa kai su shiga cikin gwaje-gwaje na inganci da aminci na yiwuwar magani. Hukumar ta FDA ta ba da izini na wucin gadi ga maganin warkewa na jini a matsayin magani na gwaji a lokuta inda rayuwar mutum ke cikin haɗari ko kuma nan take.
Ba a yi nazarin asibiti ba da ake bukata don nuna cewa yana da lafiya da tasiri ga cutar.
A watan Fabrairun 2020, kasar Sin ta kaddamar da wani app na wayar hannu don magance barkewar cutar.
Ana buƙatar masu amfani su shigar da sunayensu da lambar ID.
Aikace-aikacen na iya gano "tausayi na kusa" ta amfani da bayanan sa ido kuma saboda haka yiwuwar haɗarin kamuwa da cuta.
Kowane mai amfani kuma iya duba da matsayi na uku sauran masu amfani.
Idan aka gano yiwuwar haɗari, app ɗin ba kawai yana ba da shawarar keɓe kai ba, har ma yana faɗakar da jami'an kiwon lafiya na gida. Ana amfani da nazarin manyan bayanai akan bayanan wayar hannu, fasahar gane fuska, bin diddigin wayar hannu da kuma ilimin kere kere don bin diddigin mutanen da suka kamu da cutar da mutanen da suka tuntube su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta bai wa hukumomin tsaro damar bin diddigin bayanan wayar salula na mutanen da ake zaton suna da cutar coronavirus.
An dauki wannan matakin ne don tilasta killacewa da kare wadanda zasu iya shiga hulɗa da 'yan ƙasa da suka kamu da cutar.
Hakanan a watan Maris na 2020, Deutsche Telekom ta raba bayanan wurin waya tare da hukumar gwamnatin tarayya ta Jamus, Cibiyar Robert Koch, don bincike da hana yaduwar cutar.
Rasha ta tura fasahar gane fuska don gano masu fasa killacewa.
" Kwamishinan lafiya na yankin Italiya Giulio Gallera ya ce an sanar da shi daga masu amfani da wayar hannu cewa ""40% na mutane suna ci gaba da motsawa ko ta yaya"."
Gwamnatin Jamus ta gudanar da wani hackathon na tsawon sa'o'i 48 a karshen mako tare da mahalarta fiye da 42.000.
Har ila yau, shugaban Estonia, Kersti Kaljulaid, ya yi kira ga duniya don samar da hanyoyin magance yaduwar cutar coronavirus.
Mutane na iya fuskantar wahala daga killacewa, ƙuntatawa a tafiya, sakamako masu illa na magani ko tsoron kamuwa da cuta kanta.
"BBC ta nakalto Rory O'Connor a cikin cewa, ""Ƙara keɓewar zamantakewa, kadaici, damuwa game da lafiya, damuwa da koma bayan tattalin arziki sune hadari mai kyau don cutar da lafiyar tunanin mutane da kuma jin dadin mutane. """
Wannan cuta tana iya zama mai sauƙi, ba ta da alamun bayyanar cututtuka ko kuma ba ta da alamun bayyanar cututtuka, kamar sauran cututtuka na sama na numfashi kamar sanyi.
A yawancin lokaci, marasa lafiya masu sauƙi suna warkewa cikin makonni biyu, yayin da waɗanda suke da ciwo mai tsanani ko kuma na tsanani za su ɗauki makonni uku zuwa shida kafin su warke.
Mata masu juna biyu na iya fuskantar haɗarin kamuwa da cutar COVID-19 mai tsanani bisa ga bayanai daga wasu irin ƙwayoyin cuta, kamar SARS da MERS, amma bayanai game da COVID-19 ba su da yawa.A cikin wasu mutane, COVID-19 na iya shafar huhu wanda ke haifar da cutar huhu.
A cikin waɗanda aka fi shafa, COVID-19 na iya ci gaba da sauri zuwa cututtukan rashin numfashi mai tsanani (ARDS) wanda ke haifar da rashin numfashi, bugun jini ko rashin aiki da yawa.
Rikicin da ke tattare da COVID-19 ya haɗa da sepsis, ɓarkewar jini da lalacewar zuciya, koda da hanta.
An bayyana rashin daidaito na clotting, musamman karuwar lokacin prothrombin, a cikin 6% na waɗanda aka kwantar da su asibiti tare da COVID-19, yayin da aikin koda mara kyau ya bayyana a cikin 4% na wannan rukuni.
Kimanin kashi 20-30% na mutanen da ke da COVID-19 suna nuna haɓakar enzymes na hanta (transaminases).
Bisa ga wannan rahoton, matsakaicin lokaci tsakanin bayyanar cututtuka da mutuwa kwanaki goma ne, kuma biyar daga cikinsu suna cikin asibiti.
Duk da haka, marasa lafiya da aka canja wurin zuwa ICU suna da matsakaicin lokaci na kwanaki bakwai tsakanin asibiti da mutuwa.
A wani bincike na farko, matsakaicin lokaci daga bayyanar cututtuka na farko zuwa mutuwa ya kai kwanaki 14, tare da cikakken zangon kwanaki shida zuwa 41.
A wani bincike da Hukumar Lafiya ta Kasa ta kasar Sin (NHC) ta yi, maza suna da yawan mutuwa na 2.8% yayin da mata ke da kashi 1.7%.
Binciken ilimin lissafi na samfurori na huhu na bayan mutuwa ya nuna lalacewar alveolar da ke da lalacewar fibromyxoid a cikin huhu biyu.
An lura da canje-canje na cytopathic na kwayar cuta a cikin ƙwayoyin cuta.
Halin da aka yi a huhu ya yi kama da na rashin lafiyar numfashi mai tsanani (ARDS).
A cikin kashi 11.8% na mutuwar da Hukumar Lafiya ta Kasa ta kasar Sin ta ruwaito, an lura da lalacewar zuciya ta hanyar yawan matakan troponin ko dakatarwar zuciya.
Bisa ga bayanan watan Maris daga Amurka, kashi 89% na waɗanda aka kwantar da su asibiti suna da yanayin da suka riga sun kasance.
Kimanin mutuwar daga yanayin ya bambanta saboda waɗannan bambance-bambance na yanki, amma kuma saboda matsalolin da ake yi.
Ƙananan adadin marasa lafiya na iya sa a yi karin kimantawa a yawan mutuwa.
Duk da haka, gaskiyar cewa mutuwar ta faru ne saboda wasu cututtuka da aka yi a dā na iya nufin cewa an yi kasa da adadin mutuwar da ake yi a yanzu.
Masu shan sigari sun ninka sau 1.4 na fuskantar alamun COVID-19 mai tsanani kuma kusan sau 2.4 na bukatar kulawa mai tsanani ko mutuwa idan aka kwatanta da waɗanda ba sa shan sigari. An yi ta da damuwa game da sakamakon cutar na dogon lokaci.
Hukumar asibitin Hong Kong ta gano raguwar kashi 20 zuwa 30% a cikin ƙarfin huhu a wasu mutane da suka warke daga cutar, kuma binciken huhu ya nuna lalacewar gabobin.
Wannan kuma zai iya haifar da ciwon ciwon bayan kulawa mai tsanani bayan warkewa.
A watan Maris na 2020, ba a san ko kamuwa da cutar da ta gabata ta ba da rigakafi mai inganci da na dogon lokaci ga mutanen da suka warke daga cutar ba.
Ana ganin rigakafi kamar mai yuwuwa, dangane da halayyar sauran ƙwayoyin corona, amma an ba da rahoton lokuta inda aka dawo da cutar daga COVID-19 tare da gwajin tabbatacce don coronavirus a wani lokaci.
Ana ganin cewa waɗannan lokuta suna da tsanani fiye da sake kamuwa da cuta.
Ana ganin cewa kwayar halitta ce kuma ta fito ne daga dabbobi, ta hanyar kamuwa da cutar.
Ba a san ainihin asalin ba, amma a watan Disamba na 2019 yaduwar kamuwa da cuta kusan gaba ɗaya ta hanyar watsawa daga mutum zuwa mutum.
Wani binciken da aka yi na farkon mutane 41 da aka tabbatar da cutar COVID-19, wanda aka buga a watan Janairun 2020 a cikin The Lancet, ya bayyana farkon ranar fara bayyanar cututtuka a ranar 1 ga Disamba, 2019.
Littattafan hukuma na WHO sun ba da rahoton farkon bayyanar cututtuka a ranar 8 ga Disamba, 2019.
Ana amfani da wasu matakan da yawa don ƙididdige mutuwar.
Wadannan lambobi sun bambanta bisa ga yanki da tsawon lokaci kuma suna rinjayar yawan gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokaci tun farkon barkewar cutar da halayen yawan jama'a kamar shekaru, jinsi da lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta sanya lambobin cutar ICD-10 na gaggawa U07.1 don mutuwar daga kamuwa da cutar SARS-CoV-2 da aka tabbatar a cikin dakin gwaje-gwaje da U07.2 don mutuwar daga COVID-19 da aka gano a asibiti ko annobar cututtuka ba tare da kamuwa da cutar SARS-CoV-2 da aka tabbatar a cikin dakin gwaje-gwaje ba.Hadin kan mutuwar ya nuna yawan mutuwar da aka raba ta yawan waɗanda aka gano a cikin wani lokaci.
Dangane da kididdigar Jami'ar Johns Hopkins, yawan mutuwar duniya zuwa kashi 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu 2020.
Yawan ya bambanta dangane da yankin.Sauran matakan sun haɗa da yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano cewa suna mutuwa daga cutar, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan mutanen da suka kamu (masu kamuwa da cutar da ba a gano ba) da suka mutu daga cutar.
Wadannan kididdigar ba su da iyaka a lokaci kuma suna bin wani yanki na al'umma daga kamuwa da cuta zuwa warwarewa.
Ko da yake ba dukan mutanen da suka kamu da cutar suke samun rigakafi ba, kasancewa da rigakafi zai iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A tsakiyar annobar a Italiya, Castiglione d'Adda, ƙaramar ƙauye ce ta mutane 4600, 80 (1.7%) sun riga sun mutu.
A Gangelt, an yada cutar ta hanyar bukukuwan Carnival, kuma ta bazu ga matasa, yana haifar da ƙananan mutuwar, kuma ba duk mutuwar COVID-19 za a iya rarraba su a matsayin irin wannan ba.
Bugu da ƙari, ba a yi wa tsarin kiwon lafiya na Jamus wuya ba.
A Netherlands, kimanin kashi 3 cikin 100 na iya samun rigakafi, kamar yadda aka kimanta daga masu ba da jini.
An tabbatar da cewa 69 (0.004% na yawan jama'a) sun mutu daga COVID-19.
Tasirin annobar da yawan mutuwar ta bambanta ga maza da mata.
A cikin nazarin da aka gudanar a kasar Sin da Italiya, mace-mace sun fi girma a cikin maza.
Mafi girman hadarin ga maza suna cikin shekaru 50, tare da rata tsakanin maza da mata da ke rufewa a 90 kawai.
A ƙasar Sin, yawan mutuwar maza ya kai kashi 2.8 cikin ɗari, mata kuma kashi 1.7 cikin ɗari.
Ba a san ainihin dalilin wannan bambancin jinsi ba, amma abubuwan da ke cikin jini da kuma halayyar mutum na iya zama dalili.
Bambancin rigakafi na jima'i, ƙananan yawan shan taba a cikin mata da maza da ke ci gaba da cututtukan cututtuka kamar hawan jini a cikin ƙarami fiye da mata na iya taimakawa wajen ƙaruwa cikin mutuwar maza.
A Turai, kashi 57% na mutanen da suka kamu da cutar maza ne kuma kashi 72% na waɗanda suka mutu da COVID-19 maza ne.
A watan Afrilu na 2020, gwamnatin Amurka ba ta bin diddigin bayanan da suka shafi jima'i na kamuwa da COVID-19 ba.
Bincike ya nuna cewa cututtukan kwayar cuta kamar Ebola, HIV, mura da SARS suna shafar maza da mata daban.
Kashi mafi girma na ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, mata ne, kuma suna da mafi yawan damar kamuwa da cutar.
"Kungiyar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu 2020 cewa sunan hukuma na cutar zai zama ""COVID-19"."
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO yana nufin corona, VI don kwayar cuta, D don cuta, da 19 don lokacin da aka fara gano barkewar cutar: 31 ga Disamba, 2019.
An zaɓi sunan don kauce wa tunani game da takamaiman wuri na ƙasa (misali China), nau'ikan dabbobi ko ƙungiyar mutane, daidai da shawarwarin ƙasa da ƙasa don sanya suna don hana lalata. An kira kwayar cutar da ke haifar da COVID-19 da cutar ta coronavirus 2 (SARS-CoV-2).
"WHO ta kuma yi amfani da "kwararriyar cutar COVID-19" da "kwararriyar cutar da ke haifar da COVID-19" a cikin sadarwa ta jama'a. "
"Masu cutar da kuma cutar ana kiransu da "coronavirus".
"A lokacin barkewar cutar a Wuhan, China, an kira cutar da cutar da "coronavirus" da "Wuhan coronavirus".
A watan Janairun 2020, WHO ta ba da shawarar 2019-nCov da 2019-nCoV cututtukan numfashi na gaggawa a matsayin sunayen wucin gadi don kwayar cutar da cutar daidai da jagorar 2015 game da amfani da wurare a cikin sunayen cutar da kwayar cutar.
An ba da sunayen hukuma na COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu 2020.
Saboda iyakancewar iyawa a cikin sarkar samar da kayayyaki na yau da kullun, wasu masana'antun dijital suna buga kayan kiwon lafiya kamar swabs na hanci da sassan iska.
Alal misali, a lokacin da asibiti na Italiya ya bukaci kwandon iska da gaggawa, kuma mai ba da kayayyaki bai iya ba da kayayyakin a lokacin da ake bukata ba, wani kamfanin da ke ƙasar ya yi amfani da shi wajen gyara kwandon kuma ya buga kwandon da ake bukata na 100.
Bayan barkewar cutar COVID-19, ka'idodin makirci, rashin fahimta da rashin fahimta sun bayyana game da asalin cutar, girmanta, rigakafi, magani da sauran fannoni kuma sun bazu cikin sauri akan layi.
Da alama mutane suna iya yada kwayar cutar ga wasu dabbobi.
Binciken bai samu tabbacin cewa kwayar cutar tana karuwa a alade, da dabbobi da kaza ba.
Babu magani ko allurar rigakafi da aka amince da su don magance cutar.
Kungiyoyin gwamnati, kungiyoyin ilimi da masu bincike a masana'antu suna gudanar da bincike na kasa da kasa kan alluran rigakafi da magunguna a COVID-19.
"A watan Maris, Hukumar Lafiya ta Duniya ta fara "Tunanin Solidarity" don kimanta tasirin maganin sinadarai huɗu na riga-kafi da ke da tabbacin inganci".
Babu allurar rigakafi da ake samu, amma hukumomi daban-daban suna aiki sosai wajen samar da allurar rigakafi.
Ana amfani da aikin da aka yi a baya kan SARS-CoV saboda SARS-CoV da SARS-CoV-2 duka suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin mutum.
Ana bincike kan dabarun rigakafi guda uku.
Da farko, masu bincike suna son su yi allurar rigakafin cutar.
Yin amfani da irin wannan kwayar cutar, ko ba ta aiki ko ba ta da rai, yana nufin haifar da amsawar rigakafin jikin mutum cikin sauri ga sabon kamuwa da cutar COVID-19.
Dabara ta biyu, allurar rigakafi ta subunit, tana nufin ƙirƙirar allurar rigakafi wanda ke sa tsarin rigakafi ya ji wasu ƙananan raka'a na cutar.
A cikin yanayin SARS-CoV-2, irin wannan binciken ya mai da hankali ne akan furotin S-spike wanda ke taimakawa kwayar cutar ta shiga cikin mai karɓar enzyme ACE2.
Dabara ta uku ita ce rigakafin nucleic acid (DNA ko RNA rigakafi, sabuwar fasaha don ƙirƙirar allurar rigakafi).
Dole ne a gwada alluran rigakafi na gwaji daga kowane ɗayan waɗannan dabarun don aminci da inganci.A ranar 16 ga Maris, 2020, an fara gwajin asibiti na farko na allurar tare da masu sa kai huɗu a Seattle.
Allurar rigakafi tana dauke da lambar halittar halittar halittar halittar halittar halittar halittar halittar cutar. An yi hasashen cewa ingantaccen maganin rigakafi zai iya zama babban kalubale ga ci gaban allurar rigakafi don SARS-COV-2, amma wannan abu ne mai rikitarwa.
Akwai gwajin asibiti sama da 300 da ke gudana a watan Afrilu na 2020.
An yi gwaje-gwaje bakwai da suka yi nazarin hanyoyin da aka riga aka amince da su don magance malaria, ciki har da nazarin hudu da suka yi game da hydroxychloroquine ko chloroquine.
Magungunan rigakafin rigakafi na sake amfani da su sun ƙunshi yawancin binciken kasar Sin, tare da gwaji tara na III akan remdesivir a cikin ƙasashe da yawa da za a bayar da rahoto a ƙarshen Afrilu.
An yi nazarin ci gaban asibiti na allurar COVID-19 da kuma masu neman magani, tun daga watan Afrilu 2020. Ana kimanta wasu magungunan rigakafin cutar da ke akwai don maganin COVID-19, gami da remdesivir, chloroquine da hydroxychloroquine, lopinavir/ritonavir da lopinavir/ritonavir tare da interferon beta.
Akwai hujjoji na wucin gadi game da ingancin remdesivir, kamar yadda ya kasance a watan Maris na 2020.
An lura da ci gaba a asibiti a cikin marasa lafiya da aka yi wa magani da remdesivir mai amfani da tausayi.
Ana gudanar da gwaje-gwaje na asibiti na mataki na III a Amurka, China da Italiya. An yi nazarin Chloroquine, wanda a baya aka yi amfani da shi wajen magance zazzabin cizon sauro a China a watan Fabrairun 2020, tare da sakamakon farko.
Duk da haka, akwai bukatu don nazarin binciken.
Hukumomin kiwon lafiya na Koriya da na kasar Sin sun bada shawarar yin amfani da chloroquine.
Duk da haka, Cibiyar Kwayar cutar Wuhan, yayin da ta ba da shawarar yin amfani da gram ɗaya a kowace rana, ta lura cewa sau biyu wannan kashi yana da haɗari sosai kuma zai iya zama mai kisa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin gaggawa don amfani da hydroxychloroquine da chloroquine a kan tunanin likitoci da ke kula da mutane da COVID-19. Jagororin fitowar 7 na kasar Sin sun haɗa da interferon, ribavirin ko umifenovir don amfani da COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar manyan allurai na ribavirin don hana SARS-CoV-2 in vitro.
An ba da shawarar Nitazoxanide don ƙarin nazarin in vivo bayan ya nuna rage ƙarancin ƙwayar ƙwayar SARS-CoV-2. Nazarin ya nuna cewa farkon ƙarancin furotin ta hanyar transmembrane protease serine 2 (TMPRSS2) yana da mahimmanci don shigar SARS-CoV-2 ta hanyar hulɗa da mai karɓar ACE2.
Nazarin chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba suna da manyan iyakoki waɗanda suka hana ƙungiyar likitanci karɓar waɗannan hanyoyin magance cututtuka ba tare da ƙarin bincike ba. Oseltamivir baya hana SARS-CoV-2 a cikin vitro kuma ba a san rawar da take takawa a cikin maganin COVID-19.
Guguwar cytokine na iya zama rikitarwa a cikin matakan ƙarshe na COVID-19 mai tsanani.
Akwai hujjoji cewa hydroxychloroquine na iya samun kaddarorin rigakafin hadari na cytokine. Tocilizumab an haɗa shi a cikin jagororin magani na Hukumar Lafiya ta Kasa ta China bayan an kammala karamin bincike.
Ana gwada shi a matakin kasa a Italiya bayan ya nuna sakamako mai kyau a cikin mutane da ke fama da mummunan cutar.
Idan aka yi amfani da gwajin jini na serum ferritin don gano hadari na cytokine, ana nufin ya hana irin wannan ci gaban, wanda ake ganin shi ne dalilin mutuwa a wasu mutanen da cutar ta shafa.
FDA ta amince da antagonist na interleukin-6 mai karɓar karɓa bisa nazarin yanayin baya don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Har zuwa yau, babu wani tabbataccen, gwaji na yau da kullum da aka yi wa gwaji cewa tocilizumab magani ne mai tasiri ga CRS.
Ana gudanar da bincike kan canja wurin tsaftace da kuma maganin rigakafi da tsarin rigakafin na waɗanda suka warke daga COVID-19 zuwa ga mutanen da suke bukatar su a matsayin hanyar rigakafin da ba rigakafi ba.
An gwada wannan dabarar a SARS amma ba a samu sakamako mai kyau ba.
Kashewar kwayar cuta shine tsarin aikin da ake tsammani wanda maganin rigakafin jiki na iya daidaita kariya akan SARS-CoV-2.
Duk da haka, wasu hanyoyin, kamar cytotoxicity na sel da ke dogara da maganin rigakafi da / ko phagocytosis, na iya yiwuwa.
Sauran nau'ikan maganin rigakafi na jiki, alal misali, ta amfani da kwayoyin rigakafi na monoclonal, suna ci gaba.
Za a iya kara samar da magani na magani, wanda ya ƙunshi ruwa daga jinin marasa lafiya da suka warke kuma ya ƙunshi rigakafi na musamman ga wannan kwayar cutar, don saurin amfani.
Cututtukan Coronavirus, rukuni na cututtukan da ke da alaƙa
Li Wenliang, likita a Babban Asibitin Wuhan, wanda daga baya ya kamu da cutar COVID-19 kuma ya mutu bayan ya wayar da kan jama'a game da yaduwar cutar.
